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Abstract 
The sheep (Ovis aries) is commonly used as a large animal model in skeletal re-
search. Although the sheep genome has been sequenced there are still only a limited 
number of annotated mRNA sequences in public databases. A complementary DNA 
(cDNA) library was constructed to provide a generic resource for further exploration 
of genes that are actively expressed in bone cells in sheep. It was anticipated that the 
cDNA library would provide molecular tools for further research into the process of 
fracture repair and bone homeostasis, and add to the existing body of knowledge. 
One of the hallmarks of cDNA libraries has been the identification of novel genes 
and in this library the full open reading frame of the gene C12orf29 was cloned and 
characterised. This gene codes for a protein of unknown function with a molecular 
weight of 37 kDa. A literature search showed that no previous studies had been con-
ducted into the biological role of C12orf29, except for some bioinformatics studies 
that suggested a possible link with cancer. Phylogenetic analyses revealed that 
C12orf29 had an ancient pedigree with a homologous gene found in some bacterial 
taxa. This implied that the gene was present in the last common eukaryotic ancestor, 
thought to have existed more than 2 billion years ago. This notion was further sup-
ported by the fact that the gene is found in taxa belonging to the two major eu-
karyotic branches, bikonts and unikonts. In the bikont supergroup a C12orf29-like 
gene was found in the single celled protist Naegleria gruberi, whereas in the unikont 
supergroup, encompassing the metazoa, the gene is universal to all chordate and, 
therefore, vertebrate species. It appears to have been lost to the majority of cnidaria 
and protostomes taxa; however, C12orf29-like genes have been found in the cni-
darian freshwater hydra and the protostome Pacific oyster. The experimental data 
indicate that C12orf29 has a structural role in skeletal development and tissue ho-
meostasis, whereas in silico analysis of the human C12orf29 promoter region sug-
gests that its expression is potentially under the control of the NOTCH, WNT and 
TGF- developmental pathways, as well SOX9 and BAPX1; pathways that are all 
heavily involved in skeletogenesis. Taken together, this investigation provides strong 
evidence that C12orf29 has a very important role in the chordate body plan, in early 
skeletal development, cartilage homeostasis, and also a possible link with spina bi-
fida in humans. 
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Chapter 1: Introduction 
1.1 BACKGROUND 
When this project was originally mooted, our research group was conducting a 
study of critical-sized bone defects using sheep as a large animal model. This par-
ticular study, which was conducted at the Medical Engineering Research Facility 
(MERF), explored the osteogenic and bone inductive properties of the OP1 (BMP-7) 
implant device. The cell and molecular events taking place in the fracture site in re-
sponse to the application of an OP1 device was of particular interest. The clinical ap-
plication of OP1 has been shown to remedy recalcitrant fracture non-unions 
(Kanakaris et al., 2008), and has not been reported to have any deleterious side-
effects, even at high dosages (Friedlaender et al., 2001). This greatly improves pa-
tient outcomes and has cost benefits by reducing hospital admission times (Dahabreh 
et al., 2009).  
It is well established that fracture healing is a unique physiological process. 
Unlike soft tissues, which heal predominantly through the formation of fibrous scar 
tissue, bone fractures heal by a specialized post-natal process that recapitulates as-
pects of embryological skeletal development (Gerstenfeld et al., 2003). The regenera-
tive capacity of adult bone appears to depend on the re-induction of molecular path-
ways that mediate chondrogenesis and osteogenesis during foetal development. 
Some of the critical pathways involved are Indian hedgehog (Ihh) and Runt related 
gene 2 (Runx-2), which regulate early stages of endochondral ossification (Yoshida 
et al., 2004). Other factors found in the fracture site are vascular endothelial growth 
factor (VEGF) and matrix metalloproteinase 13 (MMP13), both of which are highly 
expressed as chondrocytes undergoing hypertrophy and terminal differentiation 
(Ferguson et al., 1999). Other genes that are activated in the fracture site are the ho-
meobox genes muscle segmentation homeobox 1 and 2 (Msx-1, Msx-2) and Hoxa-2 
and Hoxd-9 (Gersch et al., 2005). It therefore seemed a reasonable hypothesis that 
OP1 augmented the fracture healing process by activating these developmental 
pathways and by recruiting stem cells to the injury site, which accelerated the bone 
regeneration process. However, the mechanism for its actions are not well under-
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stood Therefore, one of the original aims of this project was to learn more about the 
molecular events taking place during OP1 mediated fracture healing in a sheep 
model. To this end it was decided to construct a complimentary DNA (cDNA) li-
brary using bone cells derived from sheep to provide a generic resource for further 
exploration/biological research of the genes that are expressed in bone cells; and to 
identify signalling pathways involved with tissue homeostasis. It was anticipated that 
the cDNA library could provide the basis for further research into our understanding 
of the process of fracture repair and bone biology. 
1.2 CONTEXT 
Ever since cDNA library protocols became common experimental procedures, 
more than three decades ago, this technology has been associated with the discovery 
of novel genes (Ying, 2004). A literature search revealed only one previous study in 
which a cDNA library had been constructed using cells from fracture healing sites in 
sheep (Hecht et al., 2006). In the context of the ongoing work in our own research 
group at IHBI in which sheep are used as a model animal, it was decided to construct 
a cDNA library using cells derived from sheep bones as a means of gene discovery 
and also fill some of the gaps that exist in the transcriptome of this species.  
There were several technical issues to consider before commencing this pro-
ject. The first issue was whether RNA should be extracted directly from the bone tis-
sues or from explant tissue culture; secondly, deciding which cDNA library system 
to use; and the third issue was deciding how to analyse the data generated from the 
library.  
In the study cited above (Hecht et al., 2006), RNA was isolated directly from 
bone tissue harvested from fracture sites. A decision was made to source the RNA 
from explant bone and bone marrow stromal cells, because of the large amounts of 
poly(A)+ mRNA that are required for the library construction, and because this is 
more easily accessible from explant bone cultures than either bone or bone fracture 
sites.  
A number of biotechnology vendors supply cDNA library construction kits, all 
of which have their respective strengths and weaknesses.  A major consideration 
when choosing one cDNA library system over another is the experience of the user. 
Even the simplest library construction systems require experience and a thorough 
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understanding of molecular biology techniques, and some of the kits available were 
considered to have protocols that were too complex for a novice user. The kit that 
was chosen for this project was a Stratagene pBluescript II XR cDNA Library Con-
struction Kit, which uses common molecular biology protocols based on the 
pBluescript vector. This kit produced an insertion rate approaching 100%: 32 ran-
domly selected clones all contained inserts and had an average insert size of 1 kb, 
ranging from 260 to 3,200 bases. These figures  were comparable with those reported 
in other cDNA library studies (Han et al., 2008).  
The third technical consideration was deciding how to analyse the data gener-
ated. Hecht et al., (2006) used an expressed sequence tag (ESTs) approach and this 
generated a large number of ESTs and sequence information. Although the EST ap-
proach can indeed generate novel discoveries, there is also a danger of simply gener-
ating too much information. It was decided that individual clones would be randomly 
selected and subsequently sequenced. This approach was chosen because it generated 
more specific data and larger sequence reads than an EST approach  
Together these decisions provided an experimental set up that provided a more 
hands-on approach and data analysis; and led to the cloning and isolation of an un-
characterised gene, C12orf29. Of all the other possible candidate genes, this particu-
lar gene was selected for closer scrutiny as to its physiological role, primarily be-
cause it met the criterion of being uncharacterised with potentially a very important 
role in skeletal biology 
1.3 PURPOSES 
The purpose of this project was to add to the existing body of knowledge re-
garding skeletal development. A cDNA library using bone cells derived from sheep 
was developed as a generic resource with which to conduct further research into our 
understanding of the process of fracture repair and bone biology.  
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Chapter 2: Literature Review 
2.1 A BRIEF INTRODUCTION TO SKELETAL BIOLOGY 
Bone formation and skeletal development 
The skeleton of an adult human consists of 206 distinct bones. 
More than half of these bones are found in the upper and lower 
extremities, 64 and 62 respectively, whereas 28 bones are situ-
ated in the skull and maxillofacial area, of which six are part 
of the auditory system; the remaining 26 bones are part of the 
vertebral column (Gray, 2001). The skeleton is composed of 
cartilage and bone, which are formed by chondrocytes and os-
teoblasts respectively. Bones are formed during embryonic 
development and throughout life the bone is remodelling con-
tinuously so that most of the adult skeleton is completely replaced about every 10 
years [US Surgeon General (2004)]. There are two distinctly different bone forming 
processes: intramembranous and endochondral ossification. Endochondral ossifica-
tion, which accounts for the majority of skeletal bone formation, takes place in a 
tightly regulated manner whereby mesenchymal condensations differentiate into 
chondrocytes, which forms a cartilaginous template for the skeletal elements; the 
template is subsequently replaced by bone laid down by osteoblast cells (Hartmann, 
2006; Liu et al., 2008). The bones in the skull and the lateral halves of the clavicles 
are formed via intramembranous ossification in which bone growth begins with con-
densation of mesenchymal cells that expand and form a membranous structure which 
then differentiate directly into osteoblasts (Holleville et al., 2003; Liu et al., 2008; 
Rabie et al., 1996; Zhang et al., 2003).  
The condensation of mesenchymal cells is formed by three processes: (i) lo-
calized proliferation of cells at the condensation site; (ii) localized migration of cells 
immediately adjacent to the centre forming the nucleus of the condensation; and (iii) 
localized inhibition of apoptosis at the site of condensation. Cell products associated 
with the incipient differentiated cell type tends to be augmented such that in cartilage 
forming cells the mRNA expression of type II collagen as well as Runt genes is 
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greatly increased (Hall, 1987; Zhang et al., 2003). In mammals, the Runt genes are 
indispensible for skeletal development and Runx2−/− mice completely lack bone (Otto 
et al., 1997). Runx2 and Runx3 are essential for cartilage differentiation, the former 
binding directly to the Indian hedgehog (Ihh) promoter region and affecting, not only 
cartilage differentiation, but also endochondral ossification and limb outgrowth 
(Yoshida et al., 2004). During limb formation mesenchymal cells aggregate at the 
centre of the limb bud and then differentiate into proliferating chondrocytes. The pe-
ripheral cells of this nascent cartilage element flatten and stretch in a longitudinal 
direction, forming sheets of connective tissue. Known as the perichondrium, this tis-
sue encircles the chondrocytes separating them from the surrounding tissue. Chon-
drocytes at the distal ends continue to proliferate whereas chondrocytes in the centre 
of the element differentiate into hypertrophic chondrocytes. This process is accom-
panied by the differentiation of mesenchymal cells in the perichondrium into os-
teoblasts. The osteoblasts form a ring of bone around the hypertrophic region of the 
cartilage (Vortkamp et al., 1998). Next, vascular endothelial cells invade the hyper-
trophic zone, causing the collapse of incompletely mineralized transverse partitions, 
which allows the invasion of osteoblast and osteoclast cells, resulting in the replace-
ment of the cartilage by bone and bone marrow (Sasaki et al., 2000).  
Early vertebrate pattern formation 
In vertebrates, gastrulation is one of the earliest developmental events during 
embryogenesis and establishes the three germs layers: ectoderm, mesoderm and en-
doderm (Gadue et al., 2005). This process takes place by invagination of the blastula 
and is controlled by the T-box transcription factor, Brachyury, an early marker of 
gastrulation (Satoh et al., 2012). Brachyury orthologs have been found in cnidaria 
(e.g. Nematostella) and in all bilateria (protostomes and deuterostomes) and its ex-
pression is found in ectoderm, mesoderm or endoderm, depending on the phylum. In 
the ascidian protochordates, its expression is restricted to the notochord, whereas in 
vertebrate embryos the gene is expressed throughout the early mesoderm (Marcellini 
et al., 2003). The post-gastrulation expression pattern in chordates represents a novel 
secondary role of Brachyury, in which cells fated to become notochord have a con-
tinuous expression of the gene that persists until the differentiation of the notochord 
has progressed to some extent (Satoh et al., 2012). Chordoma is a rare form of bone 
cancer that is thought to arise from undifferentiated notochordal remnants residing in 
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the vertebral bodies and axial skeleton. The most compelling evidence for this hy-
pothesis is the discovery of a gene duplication of the Brachyury gene in patients with 
familial chordoma. Although the mechanism linking Brachyury with chordomas is 
not yet known, one possibility is the gene’s ability to promote epithelial to mesen-
chymal transition (EMT) in other human carcinomas (Walcott et al., 2012).  
In the vertebrates the formation of the primitive streak is the first visible sign of 
gastrulation and cells that migrate to the anterior parts of the streak eventually give 
rise to paraxial and axial mesoderm (Gadue et al., 2005). Axis formation in verte-
brate embryos is induced by dorsally located cells known as the gastrula organizer, 
first described by Spemann and Mangold in 1923 (Spemann and Mangold, 1923). 
The organizer recruits neighbouring cells and instructs their positional fate along the 
anteroposterior (AP) and dorsoventral (DV) axes, and induce their differentiation 
into neural tissue, notochord and somites (Garcia-Fernandez et al., 2007). After gas-
trulation, cells that originated from the organizer are found to occupy the midline of 
all three germ layers: floor plate of the neural tube, mesodermal notochord ventral to 
the neural tube, and dorsal endoderm (Latimer et al., 2002). In vertebrates, the axial 
mesoderm goes on to form the notochord, which is positioned ventrally relative to 
Figure 2-1: Schematic cross-section of the trunk of a vertebrate. The figure shows the posi-
tion of the somites relative to the neural tube and notochord. The ventral component of the
somite buds off and forms the sclerotome which differentiates to become the vertebrae,
whereas the dorsal component forms the dermomyotome which becomes skin and skeletal
muscle. 
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the neural tube (Fig 2–1); the paraxial mesoderm forms the somites which subse-
quently differentiate into the vertebral column and skeletal muscle (Tam and Loebel, 
2007). 
Development of the vertebrae 
The origin of vertebrates was defined by the evolution of a skeleton. In proto-
chordates, the notochord is the primary axial support structure in both embryos and 
adults, whereas in the majority of vertebrates, the embryonic notochord is supplanted 
by the vertebral column as the main axial support in the adult (Zhang, 2009). In the 
vertebrate embryo, paraxial mesoderm development starts when the mesenchymal 
presomitic mesoderm (PSM) forms on both sides of the forming neural tube (Rifes 
and Thorsteinsdottir, 2012). The development of this mesoderm takes place in two 
major domains along the AP axis. The anterior domain is called the cephalic meso-
derm and gives rise to bones and muscles in the head. Caudal to this domain is the 
somitic region which extends along the body axis to the end of the tail (Pourquie, 
2003). The newly formed PSM is a loose mesenchyme which undergoes a process of 
segmentation in which a cleft is formed in the rostral PSM and cells rostral to the 
cleft undergo a mesenchyme to epithelium transition, pinching off as an epithelial 
somite (Rifes and Thorsteinsdottir, 2012). After epithelialization, somites differenti-
ate into a ventral component, the sclerotome, which undergoes EMT whereas the 
dorsal component retains its epithelial cell type and become the dermomyotome (Fan 
and Tessier-Lavigne, 1994). The sclerotome generates the vertebral column, ribs, 
tendons and meninges, and the dermomyotome is the source of vertebral and limb 
Figure 2-2: The somite forms two main components: sclerotome and dermomyotome. The
sclerotome envelops the neural tube and notochord, forming the vertebrae, while the der-
momyotome forms the dermis, and trunk and appendicular muscles.
(www.embryology.med.unsw.edu.au)    
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muscles, dermis, endothelial cells, and cartilage of the scapula blade (Kalcheim and 
Ben-Yair, 2005). The somite, irrespective of its prospective sclerotomal or dermo-
myotomal fates, depends on signals from the neural tube and notochord for its sur-
vival. Removal of both notochord and neural tube in early stage chick embryos re-
sults in the absence of both cartilage and vertebral muscle. Ablation of notochord and 
neural tube does not prevent PSM segmentation but induces apoptosis of Pax1 ex-
pressing sclerotome derivatives as well as dorsal (epaxial) muscle expressing the 
early muscle markers Pax3 or MyoD, whereas the ventral (hypaxial) muscles develop 
normally (Monsoro-Burq, 2005) (Fig 2–2).  
 
Gene transcription networks in vertebral development 
Sonic hedgehog (Shh) is expressed by notochord and floor plate cells of the 
neural tube and its secreted protein is required for the specification of PSM into scle-
rotome and dermomyotome (Fan and Tessier-Lavigne, 1994). In the sclerotome, 
SHH signalling induces the paired-box transcription factors Pax1 and Pax9 which 
activates the chondrogenic differentiation program (Murtaugh et al., 2001). PAX1 
and PAX9 have redundant and overlapping roles in the sclerotome and the absence 
of both factors leads to the failure of the ventromedial structures of the vertebral col-
umn to develop properly (Rodrigo et al., 2003). Both factors are required for the ac-
tivation of Bapx1/Nkx3.2, which acts together with the chondrogenic marker SOX9 
to activate the expression of cartilage specific genes in the sclerotome. BAPX1 and 
SOX9 together promote the survival and proliferation of somitic cells in the presence 
of BMP2/4 signalling. Ectopical expression of either Bapx1 or Sox9 can activate 
chondrogenesis in paraxial mesoderm, but only SOX9 is capable of activating this 
differentiation program in non-cartilage forming tissues (Zeng et al., 2002). BAPX1 
is therefore a critical factor in the formation of the vertebral column and cranial 
bones of mesodermal origin, by maintaining the proliferation of sclerotome cells 
which then migrate ventrally and medially to surround the notochord and neural tube 
and differentiates into chondrocytes (Tribioli and Lufkin, 1999).  
The intervertebral disc (IVD) is a specialized connective tissue structure con-
sisting of three distinct tissues: the outer fibrillar annulus fibrosus, the central viscous 
nucleus pulposus (NP) and the cartilage end-plates, which anchor the discs to the ad-
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jacent vertebral body bones. It has been shown that notochord cells are the embry-
onic precursors to all cells found within the NP of the mature IVD (McCann et al., 
2012). SHH signalling persists in the NP of the developing IVD and it has been 
speculated that SHH has an indirect role in proteoglycan formation and maintenance 
of the NP (DiPaola et al., 2005). This notion is supported by a study in dogs that 
showed that disappearance of notochordal cells in the IVD was correlated with 
greater severity of disc degeneration. NP cells cocultured with notochordal cells were 
induced to produce more proteoglycan than controls (Aguiar et al., 1999).  
The Wnt/-catenin pathway plays an important role in the maturation of the 
axial skeleton. This pathway is modulated by the axis inhibition proteins 1 and 2 
(AXIN1 and AXIN2) and Axin2 is expressed in cartilaginous areas of the axial and 
appendicular skeleton during embryonic development, tissues which are derived 
from paraxial and lateral plate mesoderm. Disruption of Axin2 expression in mice 
accelerates chondrocyte maturation, which results in reduced endochondral bone 
growth and a runt-like phenotype (Dao et al., 2010). Cartilage-derived -catenin is a 
key player in regulating chondrocyte maturation, generation of ossification centres, 
and perichondral bone formation during skeletal development, by inducing chondro-
cyte hypertrophy and maturation, as well as osteoblast differentiation and peri-
chondral bone formation via BMP2 signalling. Chondrocyte-derived -catenin poten-
tially mediates the induction of matrix metalloproteinases (MMPs) and Indian 
hedgehog (Ihh) during the formation of ossification centres to initiate cartilage ma-
trix resorption and vascularization in vivo (Dao et al., 2012).  
IHH has an indispensible role in chondrocyte maturation and endochondral 
bone formation by controlling the transition from proliferating to hypertrophic chon-
drocytes, possibly by maintaining the expression of PTHrP, an inhibitor of chondro-
cyte maturation (St-Jacques et al., 1999). Another means by which IHH affects 
chondrocyte maturation is to trigger BAPX1 protein degradation. This is achieved by 
inhibiting both the canonical WNT co-receptor low-density-lipoprotein receptor re-
lated protein (LRP) and the WNT antagonist secreted frizzled-related protein 
(SFRP), thereby favouring the action of the non-canonical WNT5a protein. WNT5a 
activates the protein kinase CK2, which destabilizes BAPX1, most likely by phos-
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phorylation, after which the BAPX1 molecule is ubiquitinated and destroyed by pro-
teosomal degradation (Choi et al., 2012). 
Notch signalling is also required for a proper balance of chondrogenic prolif-
eration and differentiation at initial stages of somite compartmentalization. During 
normal chondrogenic differentiation in endochondral bone development, Notch in-
tracellular domain (NICD) is not expressed in the proliferative zone, but it is acti-
vated in prehypertrophic and hypertrophic cartilage. Increased NICD inhibits prolif-
eration and prehypertrophic and hypertrophic chondrocyte differentiation, which ul-
timately results in decreased bone formation. SOX9 and its target genes are subject 
to regulation by Notch signalling that ultimately affects chondrogenic proliferation 
and differentiation (Mead and Yutzey, 2009).  
Pax1, Bapx1 and spina bifida 
Pax1, together with Pax9, form one group within the vertebrate paired box 
family of genes, named so for the presence of the paired box that encodes a DNA-
binding domain. Pax1 and Pax9 are the only Pax genes expressed in the sclerotomes, 
where the expression of Pax1 precedes that of Pax9 (Peters et al., 1999). Expression 
of in vivo chondrocyte markers aggrecan (ACAN) and type IX collagen in somitic 
tissue occurs after a considerable lag period following sclerotome formation, and in a 
spatially limited domain within the sclerotome (Murtaugh et al., 1999). In contrast, 
Pax1 is first detected in the ventral domain of epithelial somites in Hamburger–
Hamilton (HH) stage 5 chick embryo (Johnson et al., 1994), whereas ACAN expres-
sion is first detectable by in situ hybridization at approximately HH stage 24, in con-
densing perinotochordal mesenchyme (Murtaugh et al., 1999). In the region of the 
future vertebral bodies, expression of Pax1 and Pax9 is downregulated when sclero-
tomal cells begin to undergo chondrogenic differentiation (Peters et al., 1999). Ho-
mozygous Pax9-mutant mice die shortly after birth and display a lack of thymus, 
parathyroid glands, and ultimobranchial bodies, organs which are derived from the 
pharyngeal pouches. In the limbs of these animals, a supernumerary preaxial digit is 
formed, but the flexor of the hind limb toes is missing. Furthermore, craniofacial and 
visceral skeletogenesis is disturbed, and all teeth are absent. There is, however, no 
obvious phenotype in the vertebrae, which suggests that Pax9 function is rescued by 
Pax1 in the developing vertebrae (Peters et al., 1998). Pax1 transcription in mice can 
first be detected around 8.5 days post coitum (dpc) in the ventromedial part of newly 
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formed somites. This corresponds to the time of EMT of the ventral somite half and 
the emergence of the sclerotome (Wallin et al., 1994). There are a number of mutant 
mouse strains that exhibit specific inherited skeletal defects. The strain undulated 
(un), first described in 1947, shows abnormalities of the vertebrae and IVDs; the 
gene responsible for un has been identified as Pax1 (Balling, 1994; Balling et al., 
1988). Embryonic analyses of un mutant mice have revealed that although sclero-
tomes are formed in mutant embryos, abnormalities can be detected from 10.5 dpc 
onwards. The notochord still influences vertebral body formation some days after the 
sclerotomes are formed and notochord diameter is larger in mutant embryos from 12 
dpc, due to increased cell proliferation (Timmons et al., 1994). In the most strongly 
affected genotypes, the notochord persists as a rod-like structure and the nucleus 
pulposus is never properly formed. The notochord in un strains is Pax1-negative, and 
suggests that in wild type strains there is a bidirectional interaction between noto-
chord and paraxial mesoderm and an early role for Pax1 in sclerotome patterning, as 
well as a late role in IVD development. Pax1 function is therefore required for essen-
tial steps in ventral sclerotome differentiation, for the transition from the mesenchy-
mal stage to the onset of chondrogenesis (Wallin et al., 1994). Both Pax1 and mesen-
chyme forkhead-1 (Mfh1) appear to be downstream effectors of SHH in somitic 
mesoderm; however, the sclerotomal expression domain of Mfh1 is much wider than 
the Pax1 domain (Furumoto et al., 1999). Confocal laser microscopy has shown that 
PAX1 protein is coexpressed with MFH1 in sclerotome cells in the ventrolateral re-
gion. There is a marked reduction of sclerotome cells in Mfh1/Pax1 double mutant 
mice, which results in extreme spina bifida associated with myelomeningocoele and 
a complete lack of vertebral bodies and IVDs, due to a synergistic reduction of the 
mitotic activity of sclerotome cells (Furumoto et al., 1999). 
The undulated-extensive (un-ex) genotype is caused by a deletion of the last 
exon of the Pax1 gene. Both the un and un-ex alleles are regarded as hypomorphs, 
which can lead to occasional mild skeletal abnormalities in heterozygote animals of 
either allele. In the undulated mouse strain short tail (un-s), the whole Pax1 locus is 
deleted resulting in the complete absence of Pax1 expression. (Wilm et al., 1998). In 
contrast to un and un-ex, the un-s genotype is a semi dominant mutation that displays 
a significantly stronger phenotype than either of the un and un-ex mutations (Wallin 
et al., 1994).   
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Surprisingly, it was found that a Pax1 null mutant mouse strain, in which the 
first two coding exons containing both the start codon and entire paired box domain 
of the Pax1 gene were deleted, did not display a more severe phenotype than the un-
ex genotype (Fig 2–3 C cf D) (Wilm et al., 1998). This suggested that there is a com-
pounding effect of the un-s genotype that could not be attributed entirely to the loss 
of the Pax1 gene product.  
The phenotypic effect of the un-s genotype was found to be caused by the ec-
topic activation of the gene Nkx2.2, which flanks the Pax1 gene (Kokubu et al., 
2003). The homeobox gene Nkx2.2 is the vertebrate ortholog of the Drosophila gene 
ventral nervous system defective (vnd). In Drosophila, Vnd protein is detected in the 
nuclei of all ventral column neuroectoderm and neuroblasts and is necessary to spec-
Figure 2-3: Ventral view of vertebral columns of Pax1 null and classical undulated homo-
zygous mice at the newborn stage. (A) The wild-type displays no phenotypic abnormali-
ties. (B) The un homozygote show missing ossification centres in the cervical spine (yel-
low arrow), and several of the lumbar vertebrae have dual ossification centres, whereas
L4 has a completely split centrum (large arrow). (C) In the un-ex homozygote the ossifica-
tion centres of C5 is missing (yellow arrow), and vertebrae of the lumbar region (L2 to L4)
are sagitally split (arrow). (D) The Pax1 null homozygote show a very similar phenotype to
the un-ex homozygote, with no ossification centres in vertebrae C5 and C6 (yellow arrow-
head) and vertebrae of the lumbar region (L3 to L5) being sagitally split (arrow). (E) un-s
homozygotes display the most severe phenotype where the intervertebral discs and ver-
tebral bodies are missing or strongly malformed all along the vertebral column. In the
lumbar region all ossification centres are missing (large arrow) and the tail is extremely
shortened (double arrowhead).           (From Wilm, et al., PNAS, 1998) 
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ify ventral column cell fate and repress intermediate and dorsal column fate within 
the Drosophila central nervous system (CNS) (McDonald et al., 1998). In verte-
brates, Nkx2.2 is selectively expressed in oligodendrocytes in the ventral part of the 
neural tube and in the CNS and is therefore considered to be an evolutionary con-
served regulator of DV patterning (McDonald et al., 1998; Qi et al., 2001). In homo-
zygous un-s mouse embryos, Nkx2.2 is expressed very strongly in the normally 
Pax1-positive domain of sclerotome, whereas Bapx1 expression in the sclerotome is 
reduced significantly. The ectopic activation of Nkx2.2 is most likely the result of 
cis-regulatory or enhancer elements that would normally direct Pax1 expression, still 
remaining in the un-s genome and driving Nkx2.2 expression. It appears that the ec-
topic expression of Nkx2.2 enhances the downregulation of Bapx1, since in the Pax1-
hypomorphic un-ex animals, Bapx1 expression is rescued by PAX9 (Kokubu et al., 
2003).  
Myelomeningocoele is the most common type of spina bifida, affecting as 
many as 1 out of every 800 live births. It is a neural tube defect in which the bones of 
the spine do not completely form, resulting in an incomplete spinal canal. This 
causes the spinal cord and meninges to protrude from the infant’s back (A.D.A.M, 
2009). To date, no clear candidate genes for spina bifida have been identified–this is, 
however, also the case for other common, nonsyndromic and multifactorial human 
birth defects, such as cleft lip and palate, atrial septal defects, pyloric stenosis, and 
club foot. There are as many as 100 reported single-gene mutations that may cause 
spina bifida or neural tube defect phenotypes in mice (Harris, 2001). A Pax1 muta-
tion has been reported in a human spina bifida case. This missense mutation led to an 
amino acid substitution in the paired domain of the PAX1 protein, which may have 
played a role in the aetiology of the neural tube defect, although the authors question 
whether the Pax1 mutation alone would be sufficient to cause the development of the 
disorder (Hol et al., 1996). 
The Klippel-Feil syndrome (KFS) is a heterogenic condition associated with 
various skeletal and/or extraskeletal anomalies, such as scoliosis, cleft palate, hearing 
deficiencies, and cardiac abnormalities. The hallmark definition of KFS is, however, 
defined as congenital fusion of two or more cervical vertebrae and is believed to re-
sult from faulty segmentation along the embryo’s developing axis during weeks 3–8 
of gestation (Karasick et al., 1998) (Fig 2–4). The condition was first described 100 
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years ago by the French physicians Maurice Klippel and Andre Feil. The manifesta-
tion of congenitally fused cervical segments in KFS is associated with impairment of 
the Pax1 gene expression in the developing vertebral column (David et al., 1999; 
Samartzis et al., 2008).  
The human Pax1 gene maps to chromosome 20p11.2 (Schnittger et al., 1992), 
a chromosomal region that is associated with a number of congenital skeletal abnor-
malities, such as clinodactyly, brachydactyly, cleft palate, dysmorphic facial features, 
kyphosis and preaxial hexadactyly (Chaabouni et al., 2007; Chen, 2007; Kang et al., 
2012; Moutton et al., 2012; Sahoo et al., 2011; Williams et al., 2011). An Australian 
study, screening a total of 63 KFS patients, found that Pax1 mutations were a poten-
tial cause in some, but not all cases of KFS. The possibility therefore remains that 
Pax1, alone or in conjunction with other genetic or environmental factors, plays a 
role in the aetiology of KFS (McGaughran et al., 2003).  
  
Figure 2-4: Roentgenography of cervical vertebrae of a 25 year old man with KFS. (A) The
C4 to C7 vertebrae are fused at the facet joints (arrows) and the IVDs are hypoplastic (ar-
rowheads). (B) There is also evidence of spina bifida in the lower cervical and upper tho-
racic vertebrae (arrows). (http://www.radpod.org/2007/10/04/klippel-feil-syndrome-with-sprengel-deformity/) 
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Neural crest and the craniofacial skeleton 
The embryological origin of the craniofacial skeleton is neural crest cells 
which arise from the margins of the neuro-epithelium and from which multiple line-
ages arise from pluripotent progenitor cells. It generates the peripheral nervous sys-
tem, skin melanocytes and meso-ectodermal tissues such as smooth muscle cells, 
bone and cartilage. In mammals it also generates dentin, dental pulp, alveolar bone, 
and periodontal ligament that are associated with teeth (Jheon and Schneider, 2009; 
Shah et al., 1996). It has been suggested that neural crest represents a forth germ 
layer and that vertebrates are therefore quadroblastic rather than triploblastic as is the 
conventional view (Hall, 2000). Molecular evidence has shown the presence of neu-
ral crest-like cells in ascidians, which are invertebrate chordates. In all ascidian spe-
cies examined, it was shown that these cells express the vertebrate neural crest cell 
marker HNK-1 and were initially observed adjacent to the developing neural tube 
(Jeffery, 2006). The role of these cells in protochordates appears to be precursors for 
body pigmentation cells in the adult ascidian, a role that has been maintained in ver-
tebrates. It has been proposed that acquisition of mesenchymal properties by the neu-
ral crest happened after the co-option of one or more mesenchymal determinants, 
such as Twist and AP-2, and was the last feature to appear during its evolution 
(Abitua et al., 2012; Donoghue et al., 2008; Minarcik and Golden, 2003).  
Evidence suggests that craniofacial osteogenesis involves molecular pathways 
different to those required post-cranially. For example, overexpression of hypoxia-
inducible-factor- (HIF-) in transgenic mice has a profound effect on the axial and 
appendicular skeleton, but little or no effect on the flat bones of the skull. This may 
be due to the fact that the bones in the skull form directly into osteoblasts from con-
densing mesenchyme without the need for angiogenesis (Jheon and Schneider, 2009; 
Wang et al., 2007). Neural crest cells are marked by expression of a number of 
genes, including members of the Msx, slug/snail, Zic, Pax-3/7, and the Distalless 
gene families. The neural crest, and the subsequent development of the craniofacial 
skeleton, represents an important evolutionary innovation.  Vertebrates are organised 
around a DV axis and have a dorsal nervous system, whereas Drosophila are organ-
ized around a ventral-dorsal body axis and has a ventral nervous system. The gene 
short order gastrulation (Sog) is a key player in initiating the nervous system in Dro-
sophila, the homologous gene in vertebrates is Chordin (Holley et al., 1995). Inter-
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specific mix-and-match experiments have demonstrated that Chordin counteracts the 
dorsalizing action of Decapentaplegia (Dpp), and Sog the ventralizing action of 
BMP4, in Drosophila and Xenopus embryos, respectively (Hogan, 1996). The major 
signalling gene underlying the vertebrate dorsal nervous system therefore had its 
evolutionary origin within the invertebrate taxa, and its origin involved the modifica-
tion of an existing gene regulatory system. The evolutionary and developmental ori-
gins of the neural crest are therefore uniquely tied to the notochord and to the dorsal 
nervous system (Hall, 2005; Shimeld and Holland, 2000). Neither chondrocytes nor 
osteocytes, however, are unique to neural crest cells; both skeletal cell types also 
arise from the mesodermal cells, which form the axial, appendicular and rib skeleton. 
Cartilage is found in invertebrates, however, in vivo mineralization has not been ob-
served in invertebrate cartilage; therefore, in vivo mineralization of cartilage is a ver-
tebrate innovation. Neither bone nor dentine is found in invertebrate, both are verte-
brate innovations; the production of odontoblasts and deposition of dentine is unique 
to neural crest cells (Hall, 2005). The head of the vertebrate embryo is not only char-
acterized by the possession of neural crest-derived ecto-mesenchyme, but also the 
branchial arches (BAs). The jaws of jawed vertebrates (gnathostomes) is derived 
from the mandibular arch and can be viewed as the establishment of a developmental 
program for the neural crest cells of the mandibular arch to form a DV pattern 
(Kuratani, 2004). The most rostral branchial arch (BA1) gives rise to most of the jaw 
apparatus and associated soft tissues; the two principal proximodistal subdivisions 
being the proximal maxillary and distal mandibular arches, which contribute to the 
upper and lower jaws, respectively (Depew et al., 2002). This patterning is conserved 
even in the jawless lamprey, where the mandibular arch differentiates into the velum, 
the pumping apparatus that lets water into the pharynx, as well as the lower lip, 
which resembles the gnathostome lower jaw (Cohn, 2002; Kuratani, 2004). Pattern-
ing of the BAs requires the establishment of temporal and spatial identities. The Hox 
gene family plays an important role in the differentiation of BA7 to BA2, and its 
DNA binding affinity is regulated by the Pbx1 gene. Loss of Pbx1 is accompanied by 
a homeotic-like transformation in BA2 where, for example, the lesser horns of the 
hyoid are transformed into structures reminiscent of BA1-derived Meckel’s carti-
lages (Selleri et al., 2001). Hox is not expressed in BA1, instead the rostral region is 
under the influence of the osterix (Otx) genes which regulates the expression of dick-
koft-1 (Dkk1) and Shisa encoding Wnt and Fgf antagonists (Couly et al., 2002; 
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Matsuo et al., 1995; Suda et al., 2009). The Dlx genes control the proximodistal (PD) 
axis identity. Dlx5/6−/− mutant mice exhibit homeotic transformation of lower jaws to 
upper jaws, resulting in distal BAs acquiring proximal properties. These mutants lack 
expression of the mdBA1 developmental genes, (Alx4, dHAND, Dlx3, Bmp7, and 
Pitx1), whereas mxBA1 developmental genes (Dlx1, Dlx2, Msx1, Msx2, and Prx1) 
are maintained (Fig 2–5) (Depew et al., 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 2-5: Shows a schematic of the branchial arches and the development of the upper
and lower jaws from the rostral branchial arch and the spatial activation of homeobox genes
responsible for cell specification. (Depew et al., Science, 2002) 
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Vertebrate limb development 
The vertebrate limbs develop from simple limb buds consisting of undifferen-
tiated mesenchyme surrounded by an ectodermal jacket. The limb buds originate 
from a dual contribution of lateral plate and somitic mesoderm at specific regions of 
the lateral plates, called presumptive limb forming regions, at defined positions per-
pendicular to the primary body axis (Johnson and Tabin, 1997). At HH stage 14, 
which is before initial limb bud formation in chicks (Hamburger and Hamilton, 
1992), Dlx-5 is expressed strongly and specifically in the ectoderm of the presump-
tive wing and leg forming regions of the lateral plate. Dlx-5 is therefore one of the 
earliest molecular markers of vertebrate limb bud formation. Implantation of an 
FGF2 soaked bead in the non-limb forming flank of the chick embryo induces Dlx-5 
and results in the formation of an ectopic limb (Ferrari et al., 1999).  
Out of the limb bud grows a complex appendage, which includes cartilage, 
bone, and muscle along their AP, DV and PD axes, a process requiring the coordi-
nated activity of multiple signals to achieve proper arrangements of adult tissues 
(Podlasek et al., 2002). Patterning in the limb depends on cell-cell interactions. Two 
regions crucial for organising the limb are the zone of polarizing activity (ZPA), 
which instructs the AP axis, and the apical ectodermal ridge (AER), which instructs 
the PD axis (Fig 2–6). The AER controls mesoderm outgrowth and is itself depend-
Figure 2-6: Cells acquire their positional value in the progress zone that is specified at the 
distal end of the bud by the apical ectodermal ridge. As the limb bud grows outward, cells in
the progress zone proliferate and acquire a positional value. When they leave the zone, car-
tilage can begin to differentiate and the cartilaginous elements are laid down in a proxi-
modistal sequence, starting with the humerus. The position of the cells along the anteropos-
terior axis is specified by a signal from the polarizing region (or ZPA), which is located at the 
posterior side of the bud. (Wolpert, Pediatric Research, 1999) 
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ent on the underlying mesoderm for its own maintenance. In this way the mesoderm 
generated distally under the AER takes part in the subsequent formation of the more 
proximal endoskeleton (Hinchliffe, 2002). Pattern formation in the limb can be con-
sidered a twostep process. First cells are instructed as to their positional value and 
then, secondly, they interpret this value to form the appropriate structures (Towers 
and Tickle, 2009). The maintenance of the progress zone itself is under the influence 
of polarizing signals from the ZPA; the activity of the ZPA in turn depends on the 
AER, since removal of the AER abolishes polarizing activity (Buxton et al., 1997). 
Opposing functions of FGFs and BMPs, in controlling cell proliferation in progress 
zone mesoderm, suggest that BMPs act either directly to modulate Fgf gene expres-
sion or activity, or indirectly to antagonize factors that maintain proliferation and 
maintenance of the AER (Vogt and Duboule, 1999). FGF-2, FGF-4, and FGF-8 ap-
pear to mimic properties of the AER, whereas retinoic acid (all-trans, RA) and SHH 
mimic those of the polarizing region. FGF-4 expression in the ridge can be regulated 
by SHH expressing cells. Moreover, Shh expression in mesenchyme can be activated 
by FGF-4 in combination with RA. Once induced, Shh expression can be maintained 
by FGF-4 alone, thus establishing a positive feedback loop between ZPA and AER 
(Niswander et al., 1994). The transcription factor slug is associated with the progress 
zone and involved in its maintenance. Removal of the AER results in development of 
limbs truncated at the humerus and leads to the loss of slug expression from the un-
derlying mesenchyme, indicating its dependence on signals from the AER. The role 
of slug appears to be to maintain a population of cells in an undifferentiated state that 
can be recruited by the proximal condensations, possibly by activating factors that 
dissociate the tight junctions between cells (Savagner et al., 1997); its expression, 
therefore, correlates with the location and capabilities of these cells. Loss of slug ex-
pression is seemingly irreversible and cannot be induced by either FGF-2 or FGF-4 
in condensed mesenchyme, suggesting that once cells undergo permanent fate 
changes they become slug-negative and unable to dedifferentiate (Buxton et al., 
1997; Ros et al., 1997). 
Establishing the dorsoventral axis of the limb 
Whereas the PD positional cues of the limb comes from AER signalling mole-
cules such as FGF-4 and FGF-8 and the AP axis instructions are mediated by SHH 
from the polarizing region, the DV limb specifications are derived from the non-
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ridge ectoderm. The Wnt-7a gene is expressed in the dorsal ectoderm and it has been 
suggested that the ventral pattern is the ground state and is modified dorsally by the 
dorsal ectoderm, the Wnt-7a gene playing a key role in patterning the dorsal meso-
derm (Wolpert, 1999).  
WNT-7A controls the dorsal mesenchymal expression of the LIM-
homeodomain factor Lmx-1 (Fig 2–7). Combined data from experiments involving 
ectopic expression in chick embryos and targeted gene disruption in mice have dem-
onstrated that WNT-7A/Lmx-1 are involved in the specification of dorsal identities 
in the limb (Capdevila and Izpisua Belmonte, 2001). The homeobox-containing gene, 
engrailed (En-1), is expressed throughout the ventral ectoderm of the developing 
limb bud in mouse and chick. Loss of En-1 function in mice results in a more dorsal 
phenotype of the ventral paw structure (Logan et al., 1997), and in chick limbless 
mutants, a loss of En-1 expression is accompanied by ectopic ventral expression of 
Wnt-7a (Grieshammer et al., 1996). Loss of Wnt-7a leads to the acquisition of ventral 
characteristics in the distal, dorsal limb regions, and it appears that the function of 
En-1 as a ventral regulator is to repress the expression of Wnt-7a in ventral ectoderm. 
Wnt-7a and En-1, in turn, ensure that Lmx-1 expression is confined to the dorsal 
mesenchyme (Johnson and Tabin, 1997). 
The two tunes of bagpipe 
The homeobox transcription repressor Bapx1/Nkx3.2–the vertebrate homolog 
of the Drosophila bagpipe gene–is a pivotal regulator of chondrogenesis in the axial 
skeleton, but also plays a role in the development of vertebrate limbs. In contrast to 
Figure 2-7: Establishing the DV axis of the limbs. Wnt-7a is expressed in the dorsal ecto-
derm of the progress zone of the limb bud and En-1 is expressed in the ventral ectoderm.
Wnt-7a induces the LIM homeobox gene Lmx-1 in the mesenchyme in the progress zone.
(Adapted from Wolpert, Pediatric Research,1999)    
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its expression in the sclerotome, where Bapx1, together with Sox9, is one of the earli-
est markers of the chondrogenic differentiation (Zeng et al., 2002), in the limbs and 
ribs, Bapx1 transcripts are not detected until after the chondrocytes have become 
committed. In the chick appendicular skeletal elements, Bapx1 is not expressed dur-
ing the initial phase of endochondral bone development, but rather, is expressed in 
the developing skeletal elements prior to the formation of the perichondrium, sug-
gesting it may control the recruitment of chondrocytes into the developing skeletal 
anlagen (Church et al., 2005). Bapx1 expression is also found in the developing distal 
tendon. The expression of Bapx1 overlaps that of Pax9, and given that Bapx1 is itself 
regulated by Pax9, it is possible that the two transcription factors have a combined 
function during tendon development (Church et al., 2005). SHH is required for nor-
mal Bapx1 expression during embryonic development. Shh-/- mutant mice have dra-
matically reduced bone and cartilage elements, but form near normal humeri/femurs 
and malformed tibia/fibulae. Overexpression of Shh leads to induction of endogenous 
Bapx1 in the anterior limb and radial polydactyly; that is, the presence of an addi-
tional digit at the radial (thumb side) of the paw (Tribioli and Lufkin, 2006).      
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The French Flag model 
The “French Flag model” was first proposed by Lewis Wolpert in 1969 
(Wolpert, 1969). The basis of this model is a mechanism whereby the cells in a de-
veloping system may have their position specified with respect to one or more points 
in the system–the positional information (Wolpert, 1969). The concept of positional 
information proposes that cells acquire positional values as in a coordinate system, 
which they interpret by developing in particular ways to give rise to spatial patterns. 
Some of the best evidence for positional information comes from regeneration ex-
periments, and the patterning of the vertebrate limb (Wolpert, 2011). The French 
Flag model was proposed to explain the action of the ZPA in specifying the structure 
of the AP axis of the autopod. It was proposed that the ZPA secreted a diffusible 
Figure 2-8: Models of PD limb axis development. (A) Progress zone model. Positional val-
ues are specified depending on the length of time cells remain in the distal progress zone.
Stylopod (humerus) identity is acquired early, whereas zeugopod (radius/ulna) and autopod
(carpal/digit) elements identities are specified at later time points. (B) Early specification
model. All three positional values (stylopod, zeugopod and autopod) are specified in the
early limb bud and specified fields are expanded by growth. (C) Dual signalling gradient.
Mutual antagonism between proximal retinoic acid (RA) and distal FGF signal from the
AER. The Meis1/2, Hoxa11 and Hoxa13 expression zones respectively mark the proximal,
intermediate and distal regions. (D) The differentiation front model. AER-FGF signals
keep the distal mesenchyme in an undifferentiated state. Spry4 and AP2 are molecular
markers of the undifferentiated zone, whereas Sox9 marks differentiated chondrocytes.
(Benazet and Zeller, CSH Perspective in Biol, 2009) 
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molecule that forms a posterior to anterior gradient which gave the mesenchymal 
cells their positional identities in response to specific concentration thresholds of the 
morphogen (Benazet and Zeller, 2009). Retinoic acid was the first defined chemical 
that was capable of inducing digit duplications comparable to ZPA grafts (Tickle et 
al., 1982). It has, however, never been established that the ZPA does, in fact, produce 
endogenous RA, nor does it specify the AP axis; but there is good evidence that RA 
functions in the specification of the PD axis by activating and maintaining Meis 
genes in the limb (Fig 2–8) (Benazet and Zeller, 2009). After limb-bud emergence, 
RA synthesis and signalling is restricted to the proximal limb by FGF activity. A 
model for PD limb development has been proposed, in which FGF activity promotes 
limb distalization through inhibition of the proximalizing RA signal required to 
maintain the Meis activity (Mercader et al., 2000). By the time cells in the chondro-
genic condensations start to differentiate into cartilage, Hoxa11 is a precise marker 
for the entire zeugopod, while Hoxa13 is an equally good marker for the entire auto-
pod (Tabin and Wolpert, 2007). 
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Bone formation by autoinduction 
Autoinduction of bone in a demineralized bone matrix was first reported in the 
1960s by the pioneering bone researcher Marshall Urist (Urist, 1965). In a process he 
called heterogeneous induction Urist described an inductor which was (i) cross tis-
sue, as well as cross species specific; (ii) obtainable from both adult and embryonic 
material; (iii) active in heterotopic sites; and (iv) resistant to even the harshest 
chemicals and fixatives. Long bones from both adult laboratory animals, as well as 
human cortical bone, were decalcified in 0.6 N HCl for 5 days, and then implanted 
ectopically in 300 laboratory animals, and orthotopically into the ulna of 10 rabbits 
and the lumbar vertebrae of 3 dogs. After 3 weeks ectopically in the anterior ab-
dominal wall, the typical implant was enveloped in loose, highly vascular, inflamma-
tory, and fibrous connective tissue. New bone formation appeared at 4–6 weeks from 
osteoprogenitor cells at the interior of the implant, and between 8–16 weeks bone 
had formed from proliferating connective tissue cells associated with vascularisation, 
calcification, and replacement of the cartilage by the typical route of endochondral 
ossification. The evidence for osteogenesis was based entirely on morphology, but 
was never the less substantial: bone formation occurred in extra-skeletal implants of 
demineralized bone matrix, and the new osteoblasts were derived, not from the im-
plant, but from proliferating multipotent cells in the host. Comparable implants of 
undemineralized dead bone rarely produced osteogenesis, and only in scant amounts 
after a latent period of several months (Urist, 1965). Other researchers showed that 
acid insoluble powders from demineralized femur and calvarial parietal bone, when 
transplanted subcutaneously into rats, rapidly and consistently produced plaques with 
alkaline phosphatase activity, a marker of osteogenesis. Interestingly, histological 
examination revealed much cartilage in plaques derived from femoral matrix, typical 
of endochondral ossification, whereas small amounts of cartilage were found in 
plaques induced by acid-insoluble residue of bone from the calvarium, which embry-
onically develops by membranous ossification without the intervening cartilaginous 
stage (Reddi and Huggins, 1972).  
Bone morphogenic protein – a member of the TFG-beta superfamily  
The bone inducible factor described by Urist was later purified and character-
ized from diaphysial bovine bone matrix; this was a mammoth undertaking requiring 
1 metric ton of bovine bone and yielding only a few micrograms of osteogenic 
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protein (Luyten et al., 1989), which became known as osteogenic protein 1 (OP1) or 
bone morphogenic protein 7 (BMP-7) (Celeste et al., 1990; Sampath et al., 1987). 
BMPs, of which 30 are known, are members of the transforming growth factor-beta 
(TGF- superfamily (Laurikkala et al., 2003). All members of the TGF- super-
family are secreted as precursors, which are approximately three to four times larger 
than the mature form and whose pro-region sequences have only limited homology. 
The mature proteins are cleaved off from the in the C-terminal domain and a number 
of TGF--like proteins share a conserved pattern of seven cysteine residues (Fig 2–9 
B). All mature forms of TGF--like proteins occur as disulfide linked dimers and 
Figure 2-9  The BMP protein family. (A) An unrooted phylogenetic tree of 14 known mem-
bers of the human BMP protein family and TFG-β1 and 3 using ClustalX. BMP-7 forms a
separate clade together with BMPs -5, -6 and -8. (B) The TFG-β protein family is character-
ized by a pattern of highly conserved cysteine residues at the C-terminal end.  
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several of the precursors have been found associated as dimers (Ozkaynak et al., 
1990). The active mature form of bovine osteogenic protein is composed of het-
erodimers of the bovine equivalent of human OP1 and BMP2 (Sampath et al., 1990). 
The human OP1 cDNA was cloned by means of degenerate oligonucleotides based 
on the bovine OP1 peptide sequence. The recombinantly expressed human OP1 pro-
tein is secreted as a mature homodimer, composed of two 139 amino acids proteins. 
Comparison of amino acid sequences indicate that OP1 is most closely related to the 
BMP5/6 gene products (88%, 87%), less so to BMP2/4 (60%, 58%) (Fig 2–9 A) 
(Cook and Rueger, 1996). Both Decapentaplegia protein and 60A protein have been 
implicated in pattern formation during Drosophila embryogenesis. Within the C-
terminal domain, Dpp and 60A are similar to human BMP2 (75% identity) and hu-
man OP1 (70% identity), respectively. Recombinant mature disulfide-linked 
homodimers of Dpp and 60A induce the formation and differentiation of endo-
chondral bone in a rat subcutaneous bone induction model, demonstrating that re-
lated proteins from phylogenetically distant species are capable of inducing bone 
formation in mammals when placed in sites where progenitor cells are available 
(Sampath et al., 1993).  
Mechanisms of BMP signalling 
TFG-like proteins such as BMP mediate their activities via tetramers of ser-
ine/threonine kinase receptors, consisting of two type I and two type II receptors. 
BMP ligands bind to the constitutively active type II receptors which then recruit the 
type I receptors into a stable complex. The type I receptor is phosphorylated by 
kinase activity of the type II receptors at the GS domain; a region highly conserved 
in all type I receptors. Signal transduction studies have revealed that Smad-1,-5, and-
8, also known as receptor Smads, are the immediate downstream molecules of BMP 
receptors. After release from the activated receptor, the phosphorylated Smad pro-
teins associate with the related Smad-4, which acts as a shared partner. Activated 
Smad complexes translocate to the nucleus and act as transcription factors to induce 
expression of BMP-responsive genes. Noggin is a BMP antagonist which binds with 
BMP-2, -4, and -7 and blocks BMP signalling. Smad-6 binds to BMP type I recep-
tors and prevents the activation of Smad-1,-5, and-8. Over expression of Smad-6 in 
chondrocytes causes delay in chondrocytes differentiation and maturation. Tob inter-
acts specifically with BMP activated Smad and inhibits BMP signalling. Smad ubiq-
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uitin regulatory factor 1 (Smurf1) is an E3 ubiquitin ligase. It interacts with Smad-1 
and -5 and mediates the degradation of these Smad proteins (Fig 2–10) (Chen et al., 
2004; Lavery et al., 2008; Wrana et al., 1994). 
Osteogenic protein-1 restores large segmental bone defects 
Implantation of recombinant human OP1 in a collagen matrix preparation, into 
surgically induced critical sized segmental defects, leads to regeneration of new bone 
that is fully functional biologically and biomechanically. This has been demonstrated 
in rats (Hak et al., 2006) rabbits (Smajilagic et al., 2007), dogs (Salkeld et al., 2001), 
and primates (Cook et al., 1995). In a primate model, the application of OP1 was ca-
pable of healing defects that did not heal with autogenous bone. Bone formation in 
segmental defects implanted with OP1 first appears as fracture calluses 2–3 weeks 
after surgery. The island of newly formed calcified tissue then remodels to form 
normal bone that bridged and filled the defect. After 8 weeks the new bone was suf-
ficiently remodelled such that new cortices have formed. The mass of bridging new 
bone continued to remodel with new cortices fully integrated and continuous with the 
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Figure 2-10: The BMP signalling cascade. All TFG-β-like proteins signal via tetrameric ser-
ine/threonine kinase receptors. The ligand binds to the constitutively active type II receptor
which then recruits and phosphorylates the GS domain of the type I receptor. The signal is
then carried by receptor regulated Smads which form a heteromeric complex with the com-
mon mediator Smad-4. The activated Smad complex translocates to the nucleus and acts
as a transcription factor for BMP responsive genes, such as Runx2. (Adapted from Chen, D. et
al., Growth Factors, 2004) 
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cortices of the adjacent bone. In all animal models the limb strength is nearly 100% 
of the intact limb, something which is not achieved with defects treated with autoge-
nous bone (Cook and Rueger, 1996). In a human study of 24 patients undergoing 
high tibial osteotomy, bridging was observed radiologically earlier with OP1 than 
with demineralized bone (DMB). The pattern differed between these groups. Patients 
treated with DMB showed a central formation within the medial and lateral borders 
of the defect, while those treated with OP1 had a spherical formation which began at 
the external borders of the defect. Preferential stimulation by BMPs of periosteum-
derived cells over bone-marrow derived cells may contribute to this different pattern 
(Geesink et al., 1999).  
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2.2 COMPLEMENTARY DNA LIBRARIES AND THEIR UTILITY IN 
BIOLOGICAL RESEARCH 
Genomic sequence libraries represent all the genetic information in somatic 
cells–both coding and non-coding, whereas expressed sequence tag (EST) and com-
plementary DNA (cDNA) libraries reflect the gene expression at certain times for 
specific cells or tissues. Genes encode proteins that are essential for the cellular or-
ganization of tissues, the information of which is transcribed as a complementary se-
quence that carries the genetic information from the nucleus to the protein synthesiz-
ing machinery of the cytoplasm (Ying, 2004). EST and cDNA sequence libraries 
provide direct evidence of all the sampled transcripts and are still the most important 
resources for transcriptome exploration (Nagaraj et al., 2007). EST libraries are 
large-scale single-pass sequencing of cDNA clones, randomly picked from libraries, 
and have proven to be a powerful approach to discover novel genes (Bonaldo et al., 
1996). The name EST or Tag sequencing stems from the finding that as many as 
98% of the genes in a human cDNA library can be identified by sequencing a length 
no longer than 30 nucleotides. This is an automated, high throughput process in 
which a large number of cDNA clones are sequenced typically by pyrosequencing–a 
sequencing technique that is based on the detection of released pyrophosphate (PPi) 
during DNA synthesis. In a cascade of enzymatic reactions, visible light is generated 
that is proportional to the number of incorporated nucleotides (Ronaghi, 2001). The 
principal benefit of the EST library approach is its high throughput, but the major 
disadvantage is short read lengths, typically ranging from 100–700 bp and sampling 
of only a limited portion of the transcript (Tanaka et al., 1996). An EST sequence is 
often flanked by fragments from the vector backbone and, since it is only sequenced 
once, the fidelity of the sequence is often low. The effective information length of 
the sequence read is therefore roughly 60% of the length of the insert, and sequenc-
ing artefacts, such as base-calling errors as high as 5%, base stuttering (repeated 
bases, specifically G and T) and low quality sequences are some of the frequently 
observed errors in ESTs (Nagaraj et al., 2007). A more in-depth analysis of genes 
identified as ESTs, requires the recovery of full-length clones or cDNAs. Standard 
methods for the isolation and recovery of cDNA clones have changed little since they 
were first introduced in the 1980s. These methods, plaque/colony hybridization, are 
limited by inherent drawbacks that impede larger-scale screening efforts. Filter hy-
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bridization screening is time consuming and labour intensive, typically requiring 
three or four rounds of plating to purify clones and filter replicas of cDNA libraries 
have finite life-spans and must frequently be regenerated, resulting in the rapid con-
sumption of the valuable library stock (Munroe et al., 1995).  
A full-open reading frame (ORF) cDNA clone provides the best experimental 
evidence of transcription, transcript processing, and gene structure. The availability 
of full-length cDNA sequence data for all genes within a species is a key resource for 
identifying coding regions within the genome, determining the structure of genes, 
including of splice variants, and understanding the proteome (Baross et al., 2004). 
The mRNAs from a typical somatic cell are distributed in three frequency classes 
that are maintained in representative cDNA libraries. On average, the most prevalent 
class consists of about 10 mRNA species, each represented by 5000 copies per cell, 
whereas the class of high complexity comprises 15,000 different species each repre-
sented by 1–15 copies only. Even the rarest mRNA sequences from any tissue is 
likely to be represented in a cDNA library of 107 recombinants but the identification 
of such transcripts is very difficult given their low abundance, which tend to be on 
the order of 2 x 10-6 of the total pool of transcripts (Soares et al., 1994).  
The evolution of the cDNA library 
 Complementary DNA library construction did not become routine until the 
mid to late 1980s when cloning, DNA sequencing, and polymerase chain reactions 
became standard methods and commonly used in laboratories (Brock, 1997). The 
construction of a cDNA library requires careful planning and preparation but can 
easily be performed by smaller labs. Converting the labile mRNA molecule into a 
stable cDNA molecule is done in a series of interrelated enzymatic reactions involv-
ing the first strand synthesis of a cDNA copy from mRNA, which is subsequently 
converted into double stranded cDNA and then inserted into a cloning vector (Das et 
al., 2001) (Fig 2–11). The technology of cDNA library construction was revolution-
ised by the introduction of recombinant RNase H, DNA polymerase. The RNase H 
replaces the mRNA with the second complementary DNA strand by creating nicks 
and gaps in the RNA, which is then filled in by the PolI DNA polymerase (Okayama 
and Berg, 1982). Until this technological advance was made, second strand synthesis 
relied on the ability of single-stranded cDNA to form a hairpin at its 3'-end to prime 
the synthesis of the second DNA strand. However, before the double stranded (ds) 
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cDNA could be cloned into a plasmid vector it was necessary to digest the hairpin 
loop of the ds-cDNA with S1 nuclease, which resulted in the loss of sequences corre-
sponding to the extreme 5'-terminal region of the mRNA (Land et al., 1981). After 
the cDNA has been combined with the cloning vector it can be transformed into 
competent bacterial cells, most commonly Escherichia coli, and colonies isolated by 
selection on antibiotic selective agarose gels. An antibiotic resistance gene engi-
neered into the plasmid backbone imparts antibiotic resistance to the E. coli cells that 
carry a cDNA clone, which allows it to propagate in selective medium. Once the 
plasmids have been purified the inserted cDNA can be sequenced and subcloned for 
functional studies, such as transient or constitutive protein expression in cell lines, 
fluorescent labelling and other genetic engineering techniques (Fig 2–11) (Das et al., 
2001).  
Figure 2-11: cDNA library construction; schematic showing the process of constructing a
cDNA library. Total mRNA is extracted from target cells or tissues. The polyA mRNA is en-
riched and in a series of enzymatic steps the mRNAs are converted to first a single strand
then a double stranded cDNAs. These are then cloned into plasmids, which are transformed
into competent bacterial cells. Individual clones can be isolated from selective agarose
plates and further amplified under antibiotic selective pressure. The purified plasmid prepa-
ration is then sequenced and analysed, and can subsequently be used in downstream mo-
lecular biology applications. (Adapted from Formation of a cDNA Library, Wikimedia Commons) 
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Library screening 
The traditional method for screening cDNA libraries has been to use gene-
specific DNA probes on colonies or plaques transferred to a nylon membrane. This 
method is time consuming and relatively insensitive, particularly so when the clones 
of interest are rare in the library (Campbell and Choy, 2002). PCR based screening 
methods have been described which require the arraying of individual clones into 
microtitre wells and therefore only effective for screening transcripts which are 
abundantly expressed (Alfandari and Darribere, 1994; Munroe et al., 1995). One 
PCR screening method called “Method for Amplification and isolation of Comple-
mentary DNA from plasmid libraries that require no Hybridization”–MACH for 
short (Haerry and O'Connor, 2002), is based on a modification of  a site-directed 
mutagenesis protocol, which was first described in 1990 (Jones and Howard, 1990). 
MACH applies two sets of primers to amplify the same gene. The two PCR products 
are isolated from an agarose gel, mixed in equal amounts and allowed to anneal. The 
fragments form circular, nicked structures which are transformed into E.coli. Another 
PCR based method termed “Self-Ligation of Inverse PCR Products” (SLIP), has fea-
tures similar to that of MACH. This method was developed by the Berkeley Droso-
phila Genome Project and has been used to recover full-length cDNA clones from 
their Drosophila gene libraries (Wan et al., 2006). Both of these methods were ap-
plied as a method for library screening in this project.  
 
2.3 THE SHEEP AS AN ANIMAL MODEL 
The sheep (Ovis aries) is widely used as a large animal model in skeletal re-
search (Reichert et al., 2009), and has been used for research in mandible and maxil-
lofacial bone (Abu-Serriah et al., 2005; Bahr and Lessing, 1992), the spine and in-
tervertebral disc (Aebli et al., 2006; Ahlgren et al., 2000; Goldhahn et al., 2006; 
Gunzburg et al., 2009), articular cartilage (Shea et al., 2002; Siebert et al., 2003; 
Young et al., 2005), postmenopausal diseases (Thorndike and Turner, 1998), dis-
placed intra-articular fractures (Trumble and Verheyden, 2004), fracture healing 
(Ament and Hofer, 2000; Steen and Fjeld, 1989; Stoffel et al., 2000), and tendon and 
ligament repair (Amendola and Fowler, 1992; Bosch et al., 1994; Goradia et al., 
2000; Gwynne-Jones et al., 2008). The sheep is also an important livestock animal 
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farmed for meat and fibre. Despite its economic and scientific value, there is still 
only limited annotated sequence information available for sheep, in particular full 
length cDNA sequences (Hecht et al., 2006). Given their sheer size, sequencing of a 
mammalian genome is a major undertaking, requiring large scale laboratory and 
computer resources. The human genome project, for example, fully sequenced in 
2001, was a world-wide collaboration between 20 research groups (Lander et al., 
2001); and it was only recently that the sheep genome was fully sequenced by an in-
ternational consortium (Dalrymple et al., 2007). In spite of the sheep genome having 
been fully sequenced, there are still large gaps in the annotated sequence information 
available in the sheep transcriptome (i.e. mRNA sequences), particularly when com-
pared with the sequence information available for other model species, such as the 
cow (Bos taurus), mouse (Mus musculus), rat (Rattus norvegicus) and humans.  
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Figure 2-12: WNT/-Catenin, FGF, NOTCH, Hedgehog, and TGF/BMP are the major path-
ways regulating skeletal development. These pathways orchestrate the interaction of the cell 
types involved in skeletogenesis, regulating cell proliferation and differentiation, and induce
the production of the many structural genes that make up the skeleton. (From: Deng,  FIBS, 2008)
2.4 SUMMARY AND IMPLICATIONS 
Vertebrate skeletal development involves a complex interaction of multiple cell 
types and signalling pathways. There are five pivotal signalling pathways, WNT/-
catenin, FGF, NOTCH, Hedgehog, and TGF/BMP that orchestrate the array of 
genes and gene products that are needed to make a functional skeleton (Fig 2–12) 
(Deng et al., 2008).  
The canonical Wnt signalling pathway controls cell fate determination at an 
early developmental stage. Mesenchymal progenitor cells in the condensation are 
bipotential and during intramembranous ossification, higher Wnt signalling in the 
condensation leads to inhibition of chondondrocyte differentiation and promotion of 
osteoblast differentiation. During endochondral ossification, however, Wnt signalling 
is kept low in the condensation such that only chondrocytes can differentiate. Later, 
when Wnt signalling is upregulated in the peripheral of the cartilage, osteoblasts will 
differentiate (Yang, 2012).  
The fibroblast growth factor (FGF) pathway plays an important role in all as-
pects of skeletal development. As was touched on in the section on appendicular de-
velopment, FGF-2, FGF-4 and FGF-8 are all associated with the PD axis specifica-
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tion during formation of the limbs (Mercader et al., 2000). The biology of FGFs and 
FGFRs is very complex because of different receptors with alternative splicing; mul-
tiple ligands, some having different isoforms; and different heparan sulfate pro-
teoglycans. Achondroplasia, hypochondroplasia, and thanatophoric dysplasia are 
caused by mutations in FGFR3. Achondroplasia is the most common and well known 
of the skeletal dysplasias and is characterized by short stature with a disproportionate 
shortening of the proximal limbs (Cohen, 2002).  
The Notch signalling pathway is required for the proper segmentation of 
somites and therefore has an early role in vertebrate development. The formation of 
vertebrate somites is associated with a molecular oscillator, called the segmentation 
clock. Molecular evidence for the existence of such a clock in presomitic mesoderm 
has been demonstrated by the periodic expression of several genes, a large number of 
which are related to the Notch signalling pathway (Pourquie, 2001). Inactivation of 
many components of the Notch pathway in mouse models results in dramatic seg-
mentation defects and a severe impairment of the periodic expression of the cyclic 
genes. It has been suggested that the Hes genes, which behave as transcriptional rep-
ressors downstream of the Notch pathway, act by repressing Notch activity and thus 
directly participate in the generation of the transcriptional periodicity seen in the 
PSM cells (Dubrulle and Pourquie, 2002).  
The Hedgehog pathways, in particularly Sonic hedgehog, are pivotal in overall 
skeletal patterning. SHH signals from the notochord and neural tube floor plate in-
duce the expression of Pax1 and Pax9 in the sclerotome which in turn activate Bapx1 
to switch on chondrogenesis in the sclerotome (Rodrigo et al., 2003; Zeng et al., 
2002). Within the somite, it is the sclerotome that produces the axial skeleton of ver-
tebrates. The somites of the protochordate amphioxus are also subdivided into dis-
tinct zones, but there is no evidence of it having a sclerotome (Shimeld and Holland, 
2000). Furthermore, the amphioxus orthologous genes for Pax1 and Pax9 are not ex-
pressed in the somites of amphioxus (Holland et al., 1995). The evolution of sclero-
tome and therefore vertebrates probably involved changes downstream of these sig-
nals. The co-option of Pax gene expression into the somite is likely to be one of sev-
eral such changes (Shimeld and Holland, 2000). This appears to be the case with 
bagpipe related genes, which in the Drosophila specifies the visceral mesoderm 
which gives rise to gut musculature (Tribioli et al., 1997). In vertebrates the bagpipe 
 Chapter 2: Literature Review  39 
orthologous gene, Bapx1, was modified and its expression modus became specific to 
the sclerotome and necessary for vertebral development (Lettice et al., 2001).  
Bone morphogenetic proteins stimulate osteoblast differentiation through the 
enhancement of runt-related gene 2 (Runx2)-based transcriptional activity. Bone 
morphogenetic protein-regulated Smads (Smad1/5/8) have been reported to progress 
osteogenesis by associating with Runx2, which is a key transcription factor in bone 
formation (Furumatsu et al., 2005). The differentiation of chondrocytes is regulated 
by the effects of TGF-. In the chick, TGF- promotes the differentiation of embry-
onic limb cartilage and primary chondrogenesis derived from mesenchymal stem 
cells (MSCs) needs TGF- signals. Smad3, which is activated downstream from the 
TGF- receptor complex, stimulates primary chondrogenesis through forming the 
transcriptional complex with SOX9 and CBP/p300 and this functional modulation of 
SOX9 is a critical step for the initiation of chondrogenesis (Furumatsu et al., 2005). 
The implications of the literature review is an appreciation of the complex na-
ture of the biology and evolution of skeletal development, and a framework in which 
to formulate a working hypothesis for the principal findings deriving from the ex-
periments performed in course of this project. One of the most significant discoveries 
deriving from the literature is the tentative link between Pax1 and, by extension, 
Bapx1, and spina bifida. It is reasonable to assert that the SHH-PAX1-BAPX1 sig-
nalling cascade is one of a number that uniquely defines the vertebrate subphylum, 
ranging from the zebrafish to human beings.   
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Chapter 3: Methods and Materials 
3.1 METHODOLOGY AND RESEARCH DESIGN 
3.1.1 Introduction 
The rationale for constructing a cDNA library from bones derived from sheep 
was (i) gene discovery–to find novel genes expressed in the cells and culture condi-
tions used; and (ii) to produce a resource from which to isolate full-length cDNA 
clones which could be used for applications such as overexpression experiments by 
sub-cloning into mammalian expression vectors, and production of riboprobes for in 
situ hybridization studies.  
There were a number of issues that had to be considered before commencing 
with this experiment. Chief amongst these was what type of cDNA library construc-
tion kit to use. There are a range of cDNA library kits available on the market and a 
search of the scientific literature failed to come up with any kit or methodology that 
stood out as the best option. The Stratagene pBluescript II XR cDNA Library Con-
struction Kit was chosen primarily for its ease of use, which was a valid considera-
tion for a novice user of cDNA library kits. The writer had also used the pBluescript 
vector in previous molecular biology applications and was therefore familiar with 
this particular plasmid. 
The second consideration was whether to extract total RNA directly from bone 
or use explant cell cultures in order to get the greatest amount of RNA for the cDNA 
template. We opted to use explants cultures since the cDNA kit required relative 
large amounts of enriched polyadenylated [poly(A)+] mRNA for the construction. 
The percentage of the poly(A)+ mRNA fraction is estimated from 2.3% to 11% of the 
total RNA (Milcarek et al., 1974; Werner et al., 1984), so it was assumed that the 
poly(A)+ fraction from the cell lysates would be approximately 5% of the total RNA. 
Each reaction of the cDNA library kit required a total of 5 g of poly(A)+ mRNA; it 
was therefore deemed unfeasible to enrich sufficient amounts of poly(A)+ mRNA 
directly from bone samples.  
The third consideration was the choice of cell types. Given that we were inter-
ested in the gene expression of osteogenesis this choice was self evident; we opted 
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Figure 3-1: Effect of in vitro Dex treatment of human BMSCs. Dex leads to significantly
higher calcium accumulation of the extracellular matrix than BMP-7. (Chaudhary, Bone, 2004) 
for bone marrow stromal cells (BMSCs) isolated from bone marrow drawn from the 
iliac crest of the sheep, and bone derived osteoblasts from long bones (femur and 
tibia) and flat bones from sheep mandibles. 
The forth consideration was what composition of osteogenic induction medium 
was going to be used to stimulate osteogenically expressed genes and also whether a 
set of control cells grown in regular medium should be included. Dexamethasone 
(Dex) is a synthetic glucocorticoid that is widely used as an anti inflammatory medi-
cation, which, when given to patients, can abolish the effect of the inflammatory cy-
tokines TNF-, IL-6 and IL-8 (El Azab et al., 2002). Paradoxically, glucocorticoids 
have a significant impact on bone cells in vivo, and continued exposure of skeletal 
tissue to these steroids results in osteoporosis (Canalis and Delany, 2002).  
Osteogenic induction medium containing Dex has been demonstrated to induce 
BMP2 in preosteoblastic 3T3-E1 cells and results in higher content of osteocalcin in 
conditioned medium and the formation of mineralized nodules (Martinovic et al., 
2006). Dex treatment of human BMSCs leads to significantly greater calcium accu-
mulation in the extracellular matrix than even BMP-7, and is strong evidence of its 
osteogenic effect (Fig 3–1) (Chaudhary et al., 2004). There was therefore sufficient 
proof available to suggest that Dex would have the desired osteogenic effect on the 
cell types used in this experiment. It was decided not to run a non-osteogenic control 
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cells since we had not planned to perform any subtractive hybridization experiments 
(Diatchenko et al., 1996).   
The Methods and Materials chapter will be presented in this order: 
 cDNA library construction 
Cell culture 
cDNA library construction 
Library screening 
Isolation of targeted clones by PCR based methods  
Validation of cDNA library 
 C12orf29 – characterization of a protein of unknown function 
Subcloning C12orf29 cDNA into epitope tagged expression vector 
C12orf29 antibody validation by western blot analysis 
Immunofluorescent microscopy 
Immunohistochemistry 
Real time quantitative PCR  
Western blot analysis 
 Bioinformatics analyses of C12orf29 
Phylogenetic analyses 
Molecular genetics analyses 
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3.2 CONSTRUCTION OF A CDNA LIBRARY TO IDENTIFY GENES 
EXPRESSED IN CELLS DERIVED FROM SHEEP BONE 
3.2.1 Cell culture  
All cell culture work was performed at the Medical Engineering Research Fa-
cility (MERF) at the Princess Alexandra Hospital at Chermside. Sheep explant cell 
cultures were grown from the following tissues: bone from the tibia and femur, bone 
from the mandible, and bone marrow extracted from the iliac crest. The sheep were 
sourced from ongoing in vivo studies with all the necessary animal ethics approvals 
from the QUT and Prince Charles Hospital Ethics Committees. Tibia bone and bone 
marrow samples were typically taken during the course of a surgically inducing tibial 
bone defect on the animals. Mandible bone was taken from the lower jaw after the 
animals had been euthanized at the end of the surgical phase of the experiments.  
Bone marrow explant cultures 
Bone marrow stromal cells (BMSCs) were isolated from the bone marrow by 
density gradient centrifugation over Lymphoprep (Axis-Shield PoC AS, Norway). 
Five millilitres of bone marrow was diluted in an equal volume of phosphate buff-
ered saline (PBS) in a 50 mL Falcon tube and 10 mL of Lymphoprep carefully 
placed underneath the bone marrow with a serological pipette. The erythrocytes were 
separated out by centrifugation at 800 x g for 20 min at room temperature. The upper 
layer of the column (~ 10 mL) was removed and mixed with 30 mL of growth media 
containing Dulbecco’s Modified Eagle Medium (DMEM; Life Technologies, Mt 
Waverley, VIC, Australia), supplemented with 10% (v/v) foetal calf serum (FCS; 
InVitro Technology, Noble Park, VIC, Australia), 50 U/mL penicillin, 50 µg/mL 
streptomycin and 0.5 µg/mL Fungizone (Life Technologies) (complete media). Cells 
were plated out in two 175 cm2 (T175) tissue culture flasks. Unattached hematopoi-
etic cells were removed by media change 24–48 h later. The cells were grown to con-
fluence, typically 5 x 106 cells per flask, and then trypsinized and stored in liquid ni-
trogen for later use. 
Bone explant cultures 
Bone samples from sheep mandible and tibia were processed by first removing 
the soft tissues; particular care taken to remove all periosteal membranes. The bones 
were fragmented into smaller pieces, approximately 15 x 6 x 6 mm, using a double 
acting bone rongeur and the fragments washed three times in sterile PBS, then trans-
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ferred into 50 mL Falcon tubes and washed with 35% ethanol for several minutes by 
vigorous shaking in order to sterilize the fragments. The ethanol was removed and 
the fragments washed three times with PBS, before being incubated in 5 mL of 
0.25% trypsin (Life Technologies) for 10 min at 37ºC, followed by PBS washing to 
remove any residual trypsin. The bone fragments were transferred to a T175 flask 
with 25 mL of complete medium. The flasks were incubated at 37oC in 5% CO2. Os-
teoblast cells would typically be seen growing from the edge of the fragments within 
a week of being explanted. Once reaching 70-80% confluence, the cells were 
trypsinized and sub-cultured into two T175 flasks and, when confluent, trypsinized 
and frozen down in liquid nitrogen for later use. 
Mineralizing induction  
Cells were plated out from liquid nitrogen stock in preparation for subsequent 
osteogenic induction in a defined mineralizing induction media (Hamidouche et al., 
2008); complete media containing 100 nM dexamethasone, 10 mM -
glucerophosphate, and 50 µg/mL L-ascorbic acid (Sigma, Castle Hill, NSW, Austra-
lia). Eight BMSC cell lines, five mandible osteoblast cell lines (mOBs), and eight 
tibia cell lines (tOBs) were plated out in individual T175 flasks. Once reaching con-
fluence, the cells were expanded three times into T175 flasks for a total of 63 flasks. 
When the cells had reached approximately 80% confluence the standard medium was 
switched to mineralizing media for 3, 7 and 12 days, at 21 flasks for each time point 
and the medium was changed every three day thereafter. 
 
3.2.2 RNA extraction 
Cells were washed twice in PBS and then trypsinized with 2 mL of 0.25% 
trypsin and resuspended in 5 mL DMEM. Cells from seven flasks were pooled into 
one of three 50 mL Falcon tubes and pelleted by centrifugation at 700 x g for 7 min. 
The cell pellet was washed with PBS and then the cells were lysed with 3.6 mL of 
lysis buffer containing 3.6 µL β-mercaptoethanol (-ME) and transferred to 15 mL 
Falcon tubes, in which it was stored at -80ºC until all the samples had been collected. 
The lysis buffer was provided by the Macherey-Nagel NucleoSpin RNA L midi kit 
(Scientifix, Cheltenham, VIC, Australia). The total RNA was extracted following the 
manufacturer’s instructions.  
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Poly(A)+ mRNA purification 
The total RNA was first ethanol precipitated by mixing it with 0.1 volume of 
diethyl pyrocarbonate (DEPC) treated 3 M NaAc and 2.5 volumes of 100% ethanol 
and then incubate overnight (ON) at -20ºC. The mixture was centrifuged the follow-
ing day at 14,000 rpm for 30 min at 4ºC and the supernatant (SN) removed. The 
RNA pellet was washed with 1 mL 70% ethanol at room temperature (RT) and cen-
trifuged for 5 min at max rpm at RT. The SN was removed and the tubes briefly spun 
to remove any residual liquid. Poly(A)+ mRNA was isolated from 800 to 1500 g of 
total RNA using MN NucleoTrap poly(A)+ RNA kit (Scientifix) following the manu-
facturer’s instructions. The amount of purified RNA was quantified using a Nano-
drop spectrophotometer. The three samples for each of the three time points were 
pooled into three lots with a total amount of 10 µg of poly(A)+ mRNA per time point. 
This was ethanol precipitated and resuspended in 42 µL of RNase free water for a 
final concentration of 250 ng/µL, which was the RNA concentration recommended 
by the cDNA library construction kit.  
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Figure 3-2: The sequence of the 50-base oligonucleotide primer. At the 5’ end of the linker 
primer is a short GA repeat sequence, there to protect the XhoI restriction site (in bold) fol-
lowed by an 18 base poly (dT) sequence. 
3.2.3 cDNA library construction 
The cDNA library was constructed using a Stratagene pBluescript II XR cDNA 
Library Construction Kit (Integrated Sciences, Willoughby, NSW, Australia) follow-
ing the manufacturer’s instructions. This kit is designed to generate directional 
cDNA libraries in the pBluescript II SK (+) vector.   
First strand synthesis 
A master mix for three sample reactions and a test RNA sample was set up 
with 5 µL of 10X first strand buffer, 3 µL first strand dNTP mix, 2 µL of XhoI-
oligo(dT) linker primer (Fig 3–2), 1 µL if RNase inhibitor for a total volume of 11 
µL per sample. A total of 5 µg of template poly(A)+ mRNA in a 36 µL volume was 
used per reaction. The oligo(dT) primer mix and mRNA was allowed to anneal to the 
polyA tail of the enriched mRNA for 10 min at RT, then 3 µL of Moloney murine 
leukemia virus (MMLV) reverse transcriptase was added to each reaction and incu-
bated at 42ºC for 1 h.  
 
Second strand synthesis 
A master mix for three first strand samples and the test RNA was set up with 
20 µL of 10X second-strand buffer, 8 µL of second-strand, and 114 µL of ddH2O for 
a total volume of 142 µL per reaction. This was added, on ice, to 45 µL of the first 
strand mix. An enzyme master mix of 2 µL of RNase H and 11 µL DNA polymerase 
I was added, on ice, to each reaction tube, and the reaction incubated at 16ºC for 2 h 
and 30 min.  
Blunting the cDNA termini 
A master mix containing 23 µL of blunting dNTP mix and 2 µL of recombi-
nant Pfu DNA polymerase was added to each reaction which was incubated at 72ºC 
for 30 min and then placed on ice.  
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Phenol-chloroform DNA extraction 
The double stranded (ds) cDNA was transferred to 1.5 mL tubes and then ex-
tracted by the addition of 200 µL of phenol-chloroform (Lomb Scientific, Coopers 
Plain, QLD, Australia) equilibrated to pH 7–8 with NaOH. The reaction tubes were 
spun at 14,000 rpm for 2 min at RT, and the upper aqueous phase (~200 µL) trans-
ferred to new tubes to which 200 µL of chloroform was added and centrifuged at 
14,000 rpm for 2 min at RT. The aqueous phase was transferred to new tubes and the 
cDNA precipitated using 20 µL of 3 M NaAc and 400 µL 100% ethanol added with 
ON incubation at -20ºC. The following day the tubes were centrifuged at 14,000 rpm 
at 4ºC for 1 h, then the SN was taken off and the cDNA pellets washed with 500 µL 
of 70% ethanol and centrifuged at 14,000 rpm for 2 min at RT. The ethanol was re-
moved and the tubes briefly dried in a vacuum centrifuge. The resulting pellets were 
resuspended in 9 µL of the supplied EcoRI adapter solution and incubated at 4ºC for 
1 h.  
Ligating the EcoRI adapters 
A master mix containing 1 µL of 10X ligase buffer, 1 µL of 10 mM rATP, and 
1 µL of T4 DNA ligase was added, on ice, to each sample tube. The ligations were 
incubated for two days at 4ºC, then heat inactivated at 70ºC for 30 min and placed on 
ice. The adapters are composed of 10-mer and 14–mer which are complementary in 
such a way that the adapter has an EcoRI cohesive end. The 10-mer is phosphory-
lated at the 5’ end which facilitates the adapter’s ligation to the termini of the cDNA. 
The adapter has the following sequence:               
 
 
Phosphorylation of EcoRI ends 
A master mix containing 1 µL of 10X ligase buffer, 2 µL of 10 mM rATP, 5 
µL of ddH2O and 2 µL of T4 polynucleotide kinase was added to each reaction tube 
and the reaction allowed to proceed at 37ºC for 30 min, before the enzyme was heat 
inactivated at 70ºC for 30 min and the sample placed on ice. 
XhoI endonuclease digestion 
A master mix containing 28 µL of XhoI buffer and 3 µL of XhoI restriction en-
zyme (RE) was added to each reaction and the reaction then incubated at 37ºC for 
5’-OH-AATTCGGCACGAGG 
          |||||||||| 
       3'-GCCGTGCTCC-P-5'
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11/2 h. Following the digestion reaction the cDNA was precipitated with the addition 
of 5 µL of 10X STE buffer (1M NaCl, 200 mM Tris-HCl, 100 mM EDTA) and 125 
µL 100% ethanol and incubated ON at -20ºC. The following day the samples were 
spun at max rpm at 4ºC for 1 h, the SN removed and then completely dried by vac-
uum centrifugation for 3-4 min. The pellets were resuspended in 14 µL of 1X STE 
buffer and 3.5 µL of column loading dye (50% v/v glycerol, 10% v/v 10X STE 
buffer, 40% w/v saturated bromophenol blue) and stored at -20ºC.  
Size fractionation 
The column was assembled according to the instruction in the kit manual. 
The sample was loaded into the column (~17.5 µL) and 3 mL of 1X STE buffer 
loaded on top. Once the sample had settled onto the top of the Sepharose gel, the tip 
of the pipette was unplugged and the buffer allowed to flow through the column. The 
dye front migrated to the 0.4 mL graduation mark before three drops per fraction 
were collected in 15 separate 1.5 mL tubes. The remainder of the pooled sample (35 
µL) was fractionated after the column had been washed twice with 20 mL of 1X STE 
buffer to wash out any residual cDNA fractions.  
Processing the cDNA fractions 
The fractions collected from the Sepharose CL-2B column (~120 µL each) 
were extracted with phenol-chloroform and precipitated with ethanol to recover the 
size fractionated cDNA and remove any proteins from preceding steps, in particular 
kinases. The library construction manual that the fractions containing the longest 
cDNA fractions were those collected from tube 3 to 7 and these were processed by 
DNA precipitation by the method described previously. The STE buffer contained 
sufficient amounts of NaCl for the precipitation so the addition of NaAc was not 
necessary. After the ethanol wash steps the supernatant was carefully removed and 
then the samples were briefly dried by SpeediVac for 4 min. The test RNA sample 
was suspended in 4 µL of ddH2O and the samples proper in 10 µL of water.  
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cDNA quantisation by ethidium bromide plate assay   
Quantisation of the fractionated cDNA was done according to the kit manual 
by UV visualization on ethidium bromide agarose plates. Plates were prepared by 
melting 0.8% (w/v) agarose in 100 mL Tris-acetate buffer. The molten agar was 
cooled to ~50ºC and 10 µL of 10 mg/mL EtBr stock added. The agar was then 
poured into 10 cm dishes at approximately 10 mL per dish. A DNA standard was 
prepared from DNA Marker XIV (Roche Diagnostics, Castle Hill, NSW, Australia), 
ranging from 200 to 10 ng/µL, and 0.5 µL of each was spotted out on the EtBr agar 
plate. Next, the same volume of sample (0.5 µL) was spotted out on the plate and 
then allowed to absorb into the agar before being placed on a UV light box and pho-
tographed. The quantisation was done by comparing signal intensity of the sample 
DNA against that of the standards.  
Ligating cDNAs into plasmid vector 
The pBluescript vector supplied with the kit was pre-digested at the XhoI and 
EcoRI RE sites within the multiple cloning site and phosphatase treated to remove 5’ 
phosphate groups. A pilot ligation was performed with sample fractions 3, 4, 5 and 6 
and a Kan test insert. A master mix containing 1 µL of pBluescript vector (20 ng), 
0.5 µL of 10X ligase buffer and 0.5 µL of rATP was added to 10 ng of insert, fol-
lowed by 0.5 µL of T4 DNA ligase for a final reaction volume of 5 µL. The reactions 
were incubated ON at 12ºC.  
Transformation into competent E.coli cells 
An aliquot of Escherichia coli (XL10-Gold) cells were thawed on ice and β-
mercaptoethanol at 4 µL per 100 µL of cells was added. Seven 10 mL polypropylene 
tubes were labelled, placed on ice and 65 µL of cells aliquoted into each. To each of 
the sample tubes and the Kan insert control tube 3.2 µL of ligation mixture was 
added. The pUC18 transformation control vector was first diluted 1:1 in water and 
500 pg was applied to the cells; 1 µL of water was applied to an empty control. The 
cells were incubated on ice for 30 min and then heat pulsed in a 42ºC water bath for 
30 s and placed on ice. After 2 min on ice 950 µL of preheated NZY+ recovery broth 
was added to each tube which were incubated at 37ºC for 1 h at 225 rpm. The cells 
were collected by centrifugation at 10,000 x g for 30 s then resuspended in 150 µL of 
fresh NZY+ broth. The cells were plated out on non selective, kanamycin (Kan) and 
ampicillin (Amp) selective LB agar plates and incubated ON at 37ºC.  
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PRIMER SEQUENCE LENGTH
GC 
CONTENT   T m
M13 #3 Fwd 5'-CGCCAGGGTTTTCCCAGTCACGAC 24 62.5% 64.1ºC
M13 #5 Rev 5'-AGCGGATAACAATTTCACACAGGA 24 41.7% 56.7ºC
Plasmid extraction and analytical digests 
Colonies were picked from each plate and grown ON in 2 mL of LB media 
with 100 µg/mL ampicillin. The cells were pelleted by centrifugation at 11,000 x g 
for 2 min and the plasmid DNA extracted using a MN NucleoSpin Plasmid miniprep 
kit (Scientifix) following the manufacturer’s instructions. Two microliter per samples 
was analysed on a 1% electrophoresis agarose gel and revealed the presence of plas-
mid DNA in all the samples. Equal amounts of DNA (~100 ng), from each plasmid 
prep was digested with XbaI and XhoI restriction enzymes to release the insert from 
the vector, and the digests were analysed on a 2% electrophoresis gel. 
Archival storage of bacterial cultures grown on agar plates  
The agar plate bacterial colonies of the cDNA library were prepared for archi-
val storage by applying 2 mL of LB broth to the plates and resuspending the colonies 
with a sterile cell scraper and transferring the cells to a 15 mL Falcon tube. An equal 
volume of LB broth containing 30% glycerol was added to the cells and the tubes 
were vortexed to homogenise the cell culture. The homogenate was aliquoted into 
four labelled cryovials for each one of the four samples and then stored in a -80ºC 
freezer (Sambrook and Russell, 2001). 
Sequencing of extracted plasmid DNA 
Universal M13 forward and reverse primers (Geneworks, TheBarton, SA, Aus-
tralia) were used to sequence the plasmid preps–primer sequences are shown in table 
3–1. These primers are complementary to regions immediately flanking the multiple 
cloning site (MCS) of all pUC based vectors, such as pBluescript. One forward and 
one reverse reaction was set up for each plasmid: 400 ng of plasmid in a 12 µL vol-
ume to which was added 1 µL of 10 µM of either forward or reverse M13 primer 
(Table 3–1). The reactions were submitted to the Australian Genome Research Facil-
ity (AGRF, St Lucia, QLD, Australia) for purified DNA sequencing.  
  
Table 3-1: M13 universal primer sequences. 
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Additional ligation reactions and library amplification 
A further two rounds of cDNA insert ligations were performed, which com-
bined, yielded tens of thousands of colonies on selective agarose plates. Archival 
glycerol stocks were made from all of these plates, and stored at -80ºC. The library 
was amplified using a semi-solid amplification method, in which cDNA clones are 
amplified suspended in 2x LB soft agarose; this method allows for three-
dimensional, uniform colony growth, reducing the potential for under-representation 
of slow growing clones (Kriegler, 1990). Four 500 mL bottles were prepared with 
450 mL 2x LB broth to which 1.35 g of Seaprep agarose (Lonza, Mt Waverley, Vic, 
Australia) was added and stirred with a magnetic stir bar. The bottles and stir bars 
were autoclaved for 30 min and then brought to 37ºC in a water bath. Ampicillin at 
100 µg/mL final concentration was added to the broth and then 3.5 mL of pooled 
glycerol stock was added to each bottle and stirred for several minutes to distribute 
the seeding culture evenly throughout the broth. The bottle caps were tightened and 
the bottles incubated in an ice water bath, the ice water being level with the media in 
the bottles. After one hour incubation in the ice water, the bottles were carefully 
moved to an incubator, the caps loosened and the cultures incubated at 30ºC for 45 h. 
An optical density reading was performed of the broths to make an estimate of the 
number of colonies per mL of broth to determine how much buffer to use for the 
maxi prep plasmid extraction. The contents were poured into sterile 250-mL centri-
fuge bottles and centrifuged at 10,000 x g for 20 min at RT. The plasmid DNA was 
extracted using an MN Nucleobond Xtra Maxi kit with a Nucleobond Finalizer (Sci-
entifix) following the manufacturer’s instructions. The final elution volume was 500 
µL and was analysed on a Nanodrop spectrophotometer.  
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3.2.4 PCR based methods for isolating full length cDNA clones 
After it was confirmed that the library construction had succeeded by screening 
randomly chosen colonies from the selective agarose plates, two PCR based meth-
ods, previously described in the literature, were trialled in an effort to develop a 
method for isolating individual clones without the need for traditional hybridization 
methods. Here we describe the isolation of a full length clone of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) using a method for amplification and isolation 
of cDNA from plasmid libraries that require no hybridization, or MACH. The de-
scription of the isolation of a partial TGF-3 clone by MACH and the full length 
clone of -actin (ACTB) using the self ligation of inverse PCR product(SLIP) 
method is described in appendix B.  
3.2.5 Library Screening: Method for amplification and isolation of cDNA from 
plasmid libraries that require no hybridization (MACH) 
The MACH library screening method was adapted from a protocol described 
previously (Haerry and O'Connor, 2002). This method requires two rounds of PCR 
using two sets of abutting primers specific to the gene of interest. The linearized PCR 
products are gel separated and purified, followed by phenol-chloroform extraction. 
The two products are mixed in equal amounts and denatured and annealed by the ac-
tion of base complementarity to form overlapping cohesive ends, some of which will 
assemble into circularized structures, with no need for ligation enzymes. These plas-
mids are stable enough to be transformed into competent bacterial cells, where they 
are repaired and replicated, and thereby imparting antibiotic resistance to the cells 
allowing selection of successfully transformed cells.   
Primer design 
The mRNA sequences of human GAPDH (Genbank accession number: 
NM_002046) was BLAST (Basic Local Alignment Search Tool) searched against 
the sheep virtual genome on the International Sheep Genome Consortium web portal 
(https://isgcdata.agresearch.co.nz/) to identify a  region of the gene sequence most 
suitable for the primers (Fig 3–3A). MACH primers are designed to abut with no 
overlaps such that reverse primer 1 (R1) abuts forward primer 2 (F2) and reverse 
primer 3 (R3) abuts forward primer 4 (F4). The primers pairs (R1/F2 and R3/F4) can 
be adjacent to each other such that primers F2 and R3 are complementary as was the 
case with the GAPDH MACH primers, or can be offset with no overlap between F2 
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and R3 as was the case with the TGF-3 MACH primers. The outside primers (OS5’ 
and OS3’) flank the area of the MACH primers (Fig 3–3A) and were used to identify 
the relative abundance of the gene of interest. The primer sequences are shown in 
Table 3–2. 
 
Table 3-2: MACH primer sequences for sheep GAPDH 
PCR setup 
All primers (Geneworks) were diluted to a working concentration of 10 M 
and for each target gene 300 ng of cDNA library template were used in two separate 
reactions with primers R1/F2 and R3/F4. Each reaction was set up in a final volume 
of 50 L using Phusion Hot Start II (Genesearch, QLD, Australia) following the 
manufacturer’s instructions. The reactions were pre-heated for 3 min at 98oC, after 
which 5U (2.5 L) of DNA polymerase was added per reaction.  
 
Table 3-3: PCR cycling parameters used for the MACH isolation protocol. 
PRIMER SEQUENCE LENGTH
GC 
CONTENT   T m
GAPDH OS5' 5'-GACCACTGTCCACGCCAT 18 61.1% 57.8ºC  
GAPDH OS3' 5'-AACCTGGTCCTCAGTGTAGC 20 55.0% 56.5ºC  
GAPDH R1 5'-ATGGCGTGGACAGTGGTC 18 61.1% 57.8ºC  
GAPDH F2 5'-CACTGCCACCCAGAAGACT 19 57.9% 57.1ºC  
GAPDH R3 5'-AGTCTTCTGGGTGGCAGTG 19 57.9% 57.1ºC  
GAPDH F4 5'-GTGGATGGCCCTTCCGGGA 19 68.4% 62.5ºC  
Phase 1 Step Temp Time
1 Initial denature 98oC 3 min
Stop and add 2.5 uL Phusion polymerase per tube
Phase 2 Step Temp Time
2 Initial denature 98oC 20 s
3 Denature 98oC 10 s
4 TD anneal 70-55oC 30 s
5 Elongation 72oC 3'45"
Steps 3-5 repeated 15 times, temp decreasing 1oC/cycle
Phase 3 Step Temp Time
6 Denature 98oC 10 s
7 Anneal 58oC 30 s
8 Elongation 72oC 3'45"
Steps 6-8 repeated 33 times
Termination Step Temp Time
9 Elongation 72oC 7 min
10 Halt reaction 11oC 10 min
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A touchdown PCR protocol was applied where the initial annealing tempera-
ture (Tm) was set 15ºC above that of the lowest Tm of the primer sets and lowered 
1ºC per cycle over 15 cycles (Korbie and Mattick, 2008). The thermal cycling pa-
rameters are shown in Table 3–3. 
 
Figure 3-3: MACH library screening protocol. (A) Two sets of abutting primers (R1/F2 and 
R3/F4) are used to produce two linear DNA products in separate PCR reactions. (B) After 
the parent library is digested with DpnI restriction enzyme the PCR products are separated 
on an agarose gel and bands of equal sizes (~5 kb) cut out and purified. The purified PCR 
products are then combined in a single tube, denatured and allowed to anneal. Only strands 
with complementary overhangs, i.e. 1+4 or 2+3, will form nicked circles which, when trans-
formed into competent cells, are repaired and replicated as circular plasmids. (Adapted from 
Haerry and O’Connor, Gene, 2002) 
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DpnI digest 
The PCR products were column purified using a Mackerey Nagel NucleoSpin 
Extract II kit (Scientifix, VIC, Australia) and eluted in 25 L final volume. The tem-
plate cDNA, which was methylated, was digested with DpnI restriction enzyme 
(NEB, Genesearch, QLD, Australia); the amplified PCR product, being unmethy-
lated, was not digested.   
Gel separation and purification 
The digested samples were loaded onto a 0.7% agarose gel and separated by 
electrophoresis. Equal sized DNA fragments were excised from the gels (Fig 3–3B, 
step 3) and column purified and a 1 L aliquot from each sample separated by gel 
electrophoresis for quality control.    
Annealing step 
Equal volumes (6 L) of R1/F2 and R3/F4 of purified PCR product was com-
bined with 1.5 L 10X NEB 2 buffer and 1.5 L of water. The fragments were dena-
tured once at 95oC for 5 min then allowed to anneal for four cycles at 65oC for 2 min 
and 25oC for 15 min. The fragments can only circularize by forming complementary 
overhangs between R1+F4 and R3+F2 (Fig 3–3B, step 4). The overhangs for the 
GAPDH MACH primers were 21 bases.  
Transformation, plasmid extraction and screening by analytical digest 
The circularized plasmids were transformed into chemically competent -
Select Competent cells (Bioline, NSW, Australia) and the transformed cells plated 
out on ampicillin selective agarose. Colonies were picked the following day and 
grown in liquid LB medium with 100 g/mL ampicillin. The plasmids were ex-
tracted using Nucleospin Miniprep kit (Mackerey Nagel). The plasmid DNA was 
analysed by restriction enzyme digests and positive samples were submitted to 
AGRF for sequencing.  
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3.2.6 Validation of cDNA library  
The cDNA library was further validated by real time quantitative PCR (RT-
qPCR) assay of a panel of genes that are known to be involved in bone and cartilage 
tissues. In addition, another mineralization medium induction experiment was per-
formed on a subset of cell lines used for the cDNA library. The cells were exposed to 
osteogenic medium for 21 days, since at the 12 day time point there was no minerali-
zation nodules visible on the cells used for the cDNA library. 
 
RT-qPCR setup  
The RT-qPCR reactions were performed using a 96 well plate format on an 
ABI Prism 7000 Real Time PCR machine (Applied Biosystems, Foster City, CA) 
with SYBR Green detection reagent (Life Technologies). The cDNA library plasmid 
stock (80 ng/L) was diluted to a working concentration of 5 ng/L and 5 L applied 
to each well in a total volume of 25 L. All the genes were assayed in triplicate and 
the relative expression of the genes were normalized against the housekeeping gene 
GAPDH by comparative cycle of threshold (Ct) value method (Bookout and 
Mangelsdorf, 2003). The primer sequences are listed in table 3–4 and were all pur-
chased from Geneworks.   
Alizarin red S mineralization experiment 
In order to ascertain that the cell types used for the library had mineralizing po-
tential, two cell lines each from the BMSCs, mOBs and tOBs used for the cDNA li-
brary were plated out on 6 well tissue culture plates and grown to 80% confluence at 
37oC in a CO2 incubator. Osteogenic induction medium was applied to the cells for 
21 days, with changes every three days.  
After 21 days the cell monolayers were washed in PBS and fixed with 10% w/v 
paraformaldehyde (PFA) for 15 min at RT. The cells were washed twice with excess 
ddH2O after which 1 mL of 40 mM of Alizarin red S (ARS) (Sigma-Aldrich). The 
ARS was prepared in ddH2O and the pH adjusted to 4.1 with ammonium hydroxide 
(Sigma-Aldrich). The plates were incubated on a rocking platform for 20 min at RT, 
followed by four 5 min washes in excess ddH2O (Gregory et al., 2004). The plates 
were allowed to dry and images of the stained cells layers captured on an inverted 
microscope. 
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Table 3-4: List of primers used for RT-qPCR validation of cDNA library. 
 
   
PRIMER SEQUENCE LENGTH
GC 
CONTENT   T m
ACAN Fwd 5'-AGTCACACCTGAGCAGCATC 20 55.0% 57.3ºC
ACAN Rev 5'-AGTTCTCAAATTGCATGGGGTGTC 24 45.8% 57.9ºC
ALP Fwd 5'-CAAAGGCTTCTTCCTGCTGGTG 22 54.5% 58.6ºC
ALP Rev 5'-ACCCGCCAAAAGGTAAAGACGTG 23 52.2% 59.9ºC
BMP2 Fwd 5'-TGGACTTGTACCGCCAGCACTC 22 59.1% 61.5ºC
BMP2 Rev 5'-TCCCACTCATTTCCGGCAGTTC 22 54.5% 59.6ºC
BMP4 Fwd 5'-TGAGGAGCTTCCACCACGAAG 21 57.1% 59.1ºC
BMP4 Rev 5'-ATGAAAGCCCTGCTCCCAGTCAG 23 56.5% 61.4ºC
BMP7 Fwd 5'-TGGCAGGACTGGATCATCG 19 57.9% 57.0ºC
BMP7 Rev 5'-ACCGTTTCCGGGTTGATGAAGTG 23 52.2% 59.7ºC
COL1 Fwd 5'-AGAACAGCGTGGCCTACATG 20 55.0% 57.6ºC
COL1 Rev 5'-TCCGGTGTGACTCGTGC 17 64.7% 57.7ºC
CX43 Fwd 5'-TGAGGAGTTCAATCACTTGGCTTGC 25 48.0% 59.5ºC
CX43 Rev 5'-AGTAGCAGGATTCGGAAAATGAAAAGGAC 29 41.4% 58.9ºC
DERMO Fwd 5'-GCTGCGCAAGATCATCCC 18 61.1% 56.9ºC
DERMO Rev 5'-GTAGCTGCAGCTGGTCATC 19 57.9% 55.9ºC
FGF2 Fwd 5'-TGTCTATCAAAGGAGTGTGTGCAAACCG 28 46.4% 60.7ºC
FGF2 Rev 5'-AGTTCGTTTCAGTGCCACATACCAAC 26 46.2% 59.5ºC
FGFr2 Fwd 5'-GAGTGTACACCCATCAGAGTGATGTC 26 50.0% 58.5ºC
FGFr2 Rev 5'-TACAGTTCGTTGGTGCAGTTTGCTG 25 48.0% 59.9ºC
GAPDH Fwd 5'-TCAGCAATGCCTCCTGCAC 19 57.9% 58.3ºC
GAPDH Rev 5'-TCTGGGTGGCAGTGATGGC 19 63.2% 60.4ºC
HSP27 Fwd 5'-TCCCTGGATGTCAACCACTTC 21 52.4% 56.8ºC
HSP27 Rev 5'-ATCACCGGCAAGCACGA 17 58.8% 57.5ºC
IGF1 Fwd 5'-ACACCGACATGCCCAAGGCTC 21 61.9% 62.5ºC
IGF1 Rev 5'-ACTCGTGCAGAGCGAAGGATC 21 57.1% 59.3ºC
IGF2 Fwd 5'-CTTCGCCCGCTGTTCGGTTTG 21 61.9% 61.6ºC
IGF2 Rev 5'-GTAAGCAGCATAGCAGCACGAG 22 54.5% 58.3ºC
OCN Fwd 5'-CACAGCCTTCGTGTCCAAGC 20 60.0% 59.0ºC
OCN Rev 5'-GCTCACACACCTCCCTCCTG 20 65.0% 60.0ºC
OPN Fwd 5'-TGACCATTCCAACGAGTCTCACCATTC 27 48.1% 60.4ºC
OPN Rev 5'-TGGCATCTGGACTCTCAACGTTAGATC 27 48.1% 59.8ºC
TGF-b1 Fwd 5'-ACCAACTACTGCTTCAGCTCCAC 23 52.2% 59.1ºC
TGF-b1 Rev 5'-TGGTTGTACAGGGCCAGGAC 20 60.0% 59.5ºC
TGF-b3 Fwd 5'-ACCGGCTAGACAGCCCAG 18 66.7% 59.7ºC
TGF-b3 Rev 5'-TGTCTGAGCTGCGGAGGTATG 21 57.1% 58.9ºC
TWIST1 Fwd 5'-TCTTACGAGGAGCTGCAGACGCA 23 56.5% 62.2ºC
TWIST1 Rev 5'-ATCTTGGAGTCCAGCTCGTCGCT 23 56.5% 62.2ºC
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3.3 C12ORF29 – CHARACTERIZATION OF A PROTEIN OF UNKNOWN FUCTION 
One of the clones isolated from the random screening was the uncharacterized 
gene C12orf29, which, an initial phylogenetic search revealed, is highly conserved in 
all vertebrates. Given that nothing was known of the biological role of this gene, its 
novelty made it an attractive target for closer scrutiny. This presented a unique op-
portunity to explore a gene of unknown function, and being the first research group 
to describe its biological role to the scientific community. The clone was re-
sequenced and a full open reading frame (ORF) was obtained.  
At the time of isolating C12orf29 there were no commercially available anti-
bodies for C12orf29. The fastest way to begin piecing together a possible biological 
role for C12orf29 was to subclone the cDNA into an epitope tagged mammalian ex-
pression vector. Such an approach would make it possible to determine the cellular 
distribution of the protein by expressing the recombinant protein in transfection per-
missive cell lines. As is often the case with molecular cloning, this work proved 
more challenging than anticipated, but after a number of attempts the C12orf29 
cDNA was cloned into an expression vector with an in-frame hemagglutinin (HA) 
tag at the 5’ end of the ORF. 
Meanwhile, in the time taken to clone an HA tag to the C12orf29 cDNA, as 
many as three different companies had released C12orf29 antibodies onto the market. 
This made it possible to explore the endogenous expression of the protein from a 
number of different angles and, by doing so, get a clearer picture of whether this pro-
tein of unknown function played a role in skeletal biology.  
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3.3.1 Subcloning C12orf29 cDNA into an epitope tagged expression vector 
The epitope tagging of the C12orf29 cDNA was accomplished in a two-step 
process. First the cDNA was successfully cloned into what was thought to be an HA 
tag modified pcDNA3.1(+) plasmid. When it was discovered that the vector did not 
have an HA tag, several attempts were made to clone the cDNA with a forward 
primer containing the HA sequence, all of which failed. In the end, an HA tag was 
retro fitted to the original clone by inserting a short HA sequence created by two 
complementary oligonucleotides. When annealed the oligonucleotides formed two 
sticky ends which facilitated the directional insertion into the multiple cloning site 
(MCS) of the plasmid. 
Cloning strategy #1 
A pcDNA3.1(+) cloning vector with an HA tag epitope engineered into the 5’ 
end of the multiple cloning site (MCS) was obtained from another laboratory. The 
HA tag had been inserted on the HindIII and EcoRI RE sites in the MSC of the plas-
mid (Fig 3–4 A). The HA tag, which is derived from the hemagglutinin molecule of 
the influenza virus and corresponds to amino acids 98-106, has been extensively used 
as a general epitope tag in expression vectors (Brizzard, 2008; Field et al., 1988). 
The cloning strategy chosen was to insert the 5’ end of the cDNA on the EcoRV RE 
site, which is a blunt ended RE site, whereas at the 3’ end the cDNA would be in-
serted on a XhoI site.  
Primer design 
To limit the number of additional residues included into the recombinant pro-
tein, only two possible sites were available on which to insert the C12orf29 cDNA: 
an EcoRI and an EcoRV site. An in silico RE site analysis identified an EcoRI RE 
site within the CDS of C12orf29, 837 bases downstream from the start codon (Fig 3–
4 B). This ruled out EcoRI, leaving the EcoRV site as the optimal 5’ cloning site. 
EcoRV is a blunt cutter and the Phusion Hotstart polymerase produces blunt ended 
products, so the forward primer such that the insert was joined, in-frame, on the third 
base of the methionine start codon (Fig 3–4 C). The 3’ end of C12orf29 had been in-
serted into the pBluescript vector on a XhoI site during the construction of the li-
brary. A reverse primer was designed 50 bases downstream from the XhoI site. The 
XhoI site in the PCR product would be opened up with a restriction enzyme digest to 
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facilitate cloning into the pcDNA3.1-HA vector. The primer sequences are listed in 
table 3–5. 
 
Table 3-5: The cloning primers used for subcloning C12orf29 into a pcDNA3.1(+) plasmid 
PCR setup 
Two PCR reactions were set up using 500 and 250 ng of C12orf29 template from 
clone the clone containing C12orf29 (Table 3–6).  
PCR MM 500 ng 250 ng
5x HF buffer 4 4
dNTP (10 mM) 0.4 0.4
Plasmid DNA (250 ng/uL) 2 1
Fwd primer 1 1
Rev primer 1 1
Phusion DNA pol 0.2 0.2
Water to 20 uL 11.4 12.4
Volume 20 L 20 L
Template
 
Table 3-6: Two reactions were setup to amplify the C12orf29 ORF with the cloning primer. 
A touchdown PCR protocol was used; the temperature cycling parameters are 
shown in table 3–7. 
Phase 1 Step Temp Time
1 Initial denature 98oC 30 s
2 Denature 98oC 7 s
3 TD anneal 72-59oC 20 s
4 Elongation 72oC 25 s
Steps 2-4 repeated 13 times, temp decreasing 1oC/cycle
Phase 2 Step Temp Time
5 Denature 98oC 7 s
6 Anneal 62oC 20 s
7 Elongation 72oC 25 s
Steps 5-7 repeated 30 times
Termination Step Temp Time
8 Elongation 72oC 5 min
9 Halt reaction 11oC 5 min  
Table 3-7: Touchdown temperature cycling conditions for C12orf29 PCR amplification. 
PRIMER SEQUENCE LENGTH
GC 
CONTENT T m
pc3.1-HA Fwd 5'-GAGGCGCTTGGGGTCGGTG 19 73.7% 64.0ºC  
pc3.1-HA Rev 5'-TTGTAAAACGACGGCCAGTGAGCG 24 54.2% 61.8ºC  
 62  Chapter 3: Methods and Materials 
 
A
C
B
5’ end of C12orf29 CDS: 
121 ctactagcac cgcttgagga cccaccatga ggcgcttggg gtcggtgcag cggaaaatgc 
    |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| 
    gatgatcgtg gcgaactcct gggtggtact ccgcgaaccc cagccacgtc gccttttacg 
 
 
3’ end of C12orf29 CDS: 
1081 atcagaaatt tggtaggctc aaagatataa tacttaatgt ataaactgga agtgcaatta 
     |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| 
     tagtctttaa accatccgag tttctatatt atgaattaca tatttgacct tcacgttaat 
                   XhoI 
1141 aaaaccagct tcattgttaa aaaaaaaaaa aaaaaactcg agggggggcc cggtacccaa 
     |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| 
     ttttggtcga agtaacaatt tttttttttt ttttttgagc tcccccccgg gccatgggtt 
           
1201 ttcgccctat agtgagtcgt attacgcgcg ctcactggcc gtcgttttac aacgtcgtga 
     |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| |||||||||| 
     aagcgggata tcactcagca taatgcgcgc gagtgaccgg cagcaaaatg ttgcagcact 
pcDNA3.1(+)HA MSC   
                    Start        HA tag 
     HindIII   codon  Y  P  Y  D  V  P  D  Y  A   
gtttaaacttaagcttccgccatggcctatccctatgacgtgcccgactacgccagcctg 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
caaatttgaattcgaaggcggtaccggatagggatactgcacgggctgatgcggtcggac 
 EcoRI     EcoRV      NotI   XhoI  XbaI 
ggaattctgcagat atccagcacagtggcggccgctcgagtctagagggc 
|||||||||||||| |||||||||||||||||||||||||||||||||||| 
ccttaagacgtcta taggtcgtgtcaccgccggcgagctcagatctcccg 
Figure 3-4: The pcDNA3.1(+) expression vector. (A) The vector had been fitted 
with an HA tag that had been inserted between the HindIII and EcoRI sites in the 
MCS. (B) An EcoRI restriction enzyme site in the CDS of C12orf29 ruled out this 
site in the MCS. (C) The forward cloning primer was designed to start on the third
base of the Met start codon (base 149; bold underlined italics). Both the EcoRV 
restriction enzyme and the Phusion DNA polymerase produce blunt-ends; the 
5’end would be a blunt-end ligation. The reverse primer was placed 50 down-
stream from the XhoI site (base 1,229, underlined italics). The ligation reaction 
would be directional by digesting both vector and PCR product with a XhoI restric-
tion enzyme. The stop codon is highlighted in yellow and the polyadenylation sig-
nal in blue. 
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The full volumes of the reactions were run out on an agarose gel to separate out 
the PCR products (Fig 3–5, lanes 4 and 5). The bands were cut out from the gel and 
the DNA extracted using the Nucleospin Extract II kit and eluted in 50 L of elution 
buffer.  
 
Figure 3-5: The pcDNA3.1-HA vector was double digested with EcoRV/XhoI. One reaction 
was digested overnight (lane 1), the other for 2h at 37oC (lane 2). Lane 3 is undigested con-
trol. These bands were excised and gel purified. The PCR products were separated on the 
same gel. Lane 4 is the reaction using 250 ng of template, whereas lane 5 is the 500 ng 
template reaction. From this it appears that 250 ng of template produced a greater amount of 
product than the 500 ng template reaction. The bands, which were at the anticipated size of 
1 kb, were excised and gel purified. 
 
Phosphorylation and XhoI digest of PCR product 
The DNA concentration of the PCR product was increased by ethanol precipi-
tation and resuspended in 10 L of water. The product was phosphorylated with 
polynucleotide kinase (Life technologies) to add a phosphate to the blunt ends, which 
is necessary for blunt-end ligations. The reaction was carried out with the following 
reagent volumes: 
M      1      2      3      M      4      5
1 kb
6 kb
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T4 PNK 1x
PCR product 10
10x PNK buffer 1.5
T4 PNK 2
Water 1.5
Volume 15 L  
The sample was incubated for 30 min at 37oC followed by 70oC for 30 min to 
denature the kinase. After this incubation the phosphorylated product was digested 
with XhoI to release the XhoI site which was required for the directional ligation. 
This reaction was carried out with the following reagent volumes: 
Xho I digest 1x
Phospho PCR product 15
10x BSA 5
NEB buffer 4 5
Xho I 5
Water 20
Volume 50 mL  
The reaction was incubated for 2 h at 37oC, after which the PCR product was 
purified by NaAc precipitation and resuspended in 10 L of water. A small sample 
(1 L) of the PCR product and the double digested pcDNA3.1-HA vector were run 
out on a 1% gel for quality control and to determine the relative amounts of DNA in 
preparation for the ligation reaction (Fig 3–6). The gel showed very clear bands of 
both the insert and vector, and ample material for a ligation reaction.  
 
Figure 3-6: Pre-ligation quality control. Before the insert and vector are ready for ligation the 
products were run out on a gel to assess quality and amounts. Lane 1 shows the C12orf29 
PCR product following gel extraction, phosphorylation, digestion and ethanol precipitation. 
The band is at the correct size at 1 kb. Lane 2 shows the double digested pcDNA3.1-HA 
vector at a molecular weight of 5.4 kb. 
1 kb
6 kb
1    2 
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Ligation reaction 
The following reagent volumes were used for the ligation reaction: 
Ligation reaction 1x
pcDNA3.1 E5/X1 1
C12orf29 insert 1.5
10x ligase buffer 2
T4 DNA ligase 1
Water 14.5
Volume 20 L  
The reaction was incubated at 4oC for 48 h and terminated by incubation at 
70oC for 10 min. The T4 DNA ligase was from Life Technologies. 
Transformation into competent cells 
 Four transformation reactions were set up with 40 L of -Select Competent 
cells:  
1 Water
2 pcDNA3.1-HA  (1 ng/uL)
3 pcDNA3.1-HA (Eco RV/Xho I)
4 Ligation reaction  
One microliter of DNA (or water) was added to the cells and the cells were 
transformed by heat shock protocol. The cells were plated out on LB-ampicillin aga-
rose plates and incubated at 37oC overnight. 
Results of transformations 
The water only and undigested plasmid controls produced no colonies and a 
lawn of colonies respectively. There were an unexpected large number of colonies 
(1,000+) on the EcoRV/XhoI double digested pcDNA-HA vector transformants, 
which indicated that there were still intact plasmids after the double digest reaction. 
The Ligation transformed plate contained several thousand colonies, but given that 
the double digested plasmid control had such a large number of colonies it was likely 
that many of the colonies on the Ligation plate were false positives. 
Not I digest 
 A NotI RE site between the EcoRV and XhoI sites in the MCS of the 
pcDNA3.1(+) vector (Fig 3–4 A) could be used to eliminate the number of false 
positive colonies by digesting the Ligation plasmid prep with a NotI restriction en-
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zyme. There remained 18 L of the ligation reaction; 13 L was used in a NotI RE 
digest reaction: 
Not I digest 1x
Ligation product 13
10x BSA 2
NEB buffer 3 2
Not I 1.5
Water 1.5
Volume 20 mL  
The reaction was incubated for 2 h at 37oC and inactivated at 65oC for 20 min.  
Transformation 
The volume of remaining non NotI digested ligation prep was adjusted to have 
the same concentration as the NotI digested sample. Two tubes with 20 L of -
Select Competent cells were prepared, one was transformed with 1 L of NotI di-
gested DNA, the other with non-digested DNA. The transformed cells were incu-
bated on LB-amp overnight at 37oC. 
Result of NotI digest on colony numbers 
 The NotI digest had culled half of the plasmids compared to the non-digested 
sample, yielding 247 colonies versus 511 colonies respectively. Ten colonies on the 
NotI digest plate were picked and grown overnight in 5 mL of LB broth containing 
100 g/mL ampicillin. The DNA plasmids were extracted the following day.  
Analytical digest 
The C12orf29 cDNA contained an XbaI and an EcoRI RE site within its coding 
sequence (Fig 3–4 B) and the pcDNA3.1-HA contain an EcoRI site upstream from 
the EcoRV insertion point and an XbaI site downstream from the XhoI insertion point 
(Fig 3–4 C). An EcoRI digest would produce an 850 bp fragment, whereas an XbaI 
digest would produce a 470 bp fragment. Two master mixes were made and 5 L of 
plasmid prep digested for 2 h at 37oC  
Eco RI digest 1x 10.5x XbaI digest 1x 10.5x
Plasmid prep 5  / Plasmid prep 5  /
10x BSA 1 10.5 10x BSA 1 10.5
EcoRI buffer 1 10.5 NEB buffer 2 1 10.5
Eco RI 1 10.5 Xba I 1 10.5
Water 2 21 Water 2 21
Volume (L) 10 52.5 Volume (L) 10 52.5
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pcHA-10 (Query) vs conceptual pcDNA-HA-C12orf29 (Sbjct)
 
                                                      HindIII 
Query  61    ACTCACTATAGGGAGACCCAAGCTGGCTAGCGTTTAAACTTAAGCTT--G--GT-ACCGA  115
             |||||||||||||||||||||||||||||||||||||||||||||||  |   |  || | 
Sbjct  870   ACTCACTATAGGGAGACCCAAGCTGGCTAGCGTTTAAACTTAAGCTTCCGCCATGGCCTA  929
 
                   BamHI 
Query  116   --GCTCGGA--T--CC-ACTA-GTCCAGTGTGGTGGAATTCTGCAGATGAGGCGCTTGGG  167
                ||  ||  |  || |||| | ||||  | | |||||||||||||||||||||||||| 
Sbjct  930   TCCCTATGACGTGCCCGACTACG-CCAGCCT-G-GGAATTCTGCAGATGAGGCGCTTGGG  986
             HA tag                             EcoRI     EcoRV  
The digests were run out on a 1% agarose and showed that 8 out the 10 plasmid 
preps produced bands suggesting they carried the C12orf29 insert (Fig 3–7). Samples 
from plasmids 1, 2, 3, 4, 6, 7, 9, and 10 were all sent to AGRF for sequence analysis.  
 
Figure 3-7: An analytical digest of the plasmid preps: ten colonies picked from the NotI di-
gested ligations show that 8 out of the 10 contained inserts that produced DNA fragments at 
the correct sizes. 
Sequencing results 
The sequencing results revealed that the cloning had been successful and that 
all eight samples contained the C12orf29 insert in-frame on the EcoRV but also that 
the vector, thought to contain an HA sequence, was in fact a plain pcDNA3.1(+) vec-
tor (Fig 3–8). The cloning had technically succeeded but failed to produce the de-
sired result, a HA-C12orf29 recombinant plasmid.  
  
1   2  3   4   5  6  7   8   9  10 1   2  3   4   5  6  7   8   9  10
EcoRI XbaI
1 kb
0.5 kb
Figure 3-8: Sequencing results of C12orf29 inserts – aligned against conceptual sequence
shows that the cloning had succeeded in cloning the C12orf29 cDNA. However, the vector
did not contain the HA sequence. The Query line shows the sequence of the actual plas-
mid, the Sbjct line shows the anticipated recombinant plasmid sequence. 
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PRIMER SEQUENCE LENGTH
GC 
CONTENT Tm
Sense Hind3 5'- AGC TAT GTA TCC CTA TGA CGT- 37 59.50% 69.6ºC
    GCC CGA CTA CGC CGG G
Antisense BamH1 5'- GAT CCC CGG CGT AGT CGG GCA- 37 59.50% 69.5ºC
    CGT CAT AGG GAT ACA T
Cloning strategy #2 – retrofitting an HA tag to pcDNA3.1-C12orf29  
A number of attempts were made to clone a PCR amplified C12orf29 cDNA 
with a 57mer forward primer containing an HA sequence. When this approach failed, 
it was decided to retrofit the existing pcDNA-C12orf29 vector with a short HA se-
quence motif using the HindIII and BamHI sites in the plasmid’s MCS. Using two 
RE sites for a retrofit would result in a directional insert. This method consisted of 
using two complementary primers that, when annealed, would have two sticky ends 
corresponding to the HindIII and BamHI RE sites.  
 
Primer design 
 The restriction enzymes HindIII and BamHI create 5’ overhangs on the an-
tisense strand and sense strand, respectively. The primers were complementary to 
each other with 3’ overhangs that matched the sense strand primer to the HindIII 
overhang of the vector antisense strand and the antisense primer with the BamHI 
overhang on the sense strand (Fig 3–9 C). The primers were designed such that the 
HindIII site was altered at the first base adenine in the start codon, replacing the out-
side thymidine of the RE site; the BamHI site remained intact. This feature would 
allow the plasmids to be screened by a single HindIII digest; negative clones would 
be linearized by the digest, positive clones would not be cut and remain circular. The 
primers sequences are shown in table 3–8.  
 
   
Table 3-8: Primer sequence of retrofit HA tag. The sequences were complementary but con-
tained sticky ends that were complementary with the HindIII and BamHI sites of the
pcDNA3.1 MCS. 
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A
B
C
D
 
                 H3                B1                   EcoRI 
5’-GCGTTTAAACTTAAGCTTGGTACCGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATG 
3’-CGCAAATTTGAATTCGAACCATGGCTCGAGCCTAGGTGATCAGGTCACACCACCTTAAGACGTCTAC 
                                 
 
 
 
5’-GCGTTTAAACTTA-3’            5’-GATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATG 
3’-CGCAAATTTGAATTCGA-5’            3’-GTGATCAGGTCACACCACCTTAAGACGTCTAC 
 
 
 
           agctATGTATCCCTATGACGTGCCCGACTACGCCggg 
               TACATAGGGATACTGCACGGGCTGATGCGGcccctag 
              
 
5’-GCGTTTAAACTTA-3’            5’-GATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATG 
3’-CGCAAATTTGAATTCGA-5’            3’-GTGATCAGGTCACACCACCTTAAGACGTCTAC 
 
 
 
5’-GCGTTTAAACTTAagctATGTATCCCTATGACGTGCCCGACTACGCCgggGATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATG
3’-CGCAAATTTGAATTCGATACATAGGGATACTGCACGGGCTGATGCGGcccctagGTGATCAGGTCACACCACCTTAAGACGTCTAC
*
  
 
 
 
 
 
Plasmid digests 
Three microgram of pcDNA3.1-C12orf29 plasmid was digested with HindIII 
and BamHI in separate tubes: 
BamHI digest 1x Hind III digest 1x
Plasmid (791 g/L) 3.8 Plasmid (791 g/L 3.8
BamHI buffer 5 Hind III buffer 5
BamHI 5 Hind III 5
Water 36.2 Water 36.2
Volume (L) 50 Volume (L) 50  
The digests were incubated for 3 h then column purified and eluted in 20 L of 
elution buffer. This was followed a second round of RE digests with the other en-
zyme: 
BamHI digest 1x Hind III digest 1x
Hind III cut plasmid 20 BamHI cut plasmid 20
BamHI buffer 5 Hind III buffer 5
BamHI 5 Hind III 5
Water 20 Water 20
Volume (L) 50 Volume (L) 50  
Figure 3-9: Strategy to retrofit an HA sequence into pcDNA-C12orf29. The C12orf29
CDS contained no HindIII or BamHI restriction sites, leaving these sites available
in the plasmid MCS to be used to retrofit an HA sequence into the pcDNA3.1-
C12orf29 plasmids. The HA sequence was made by annealing two 37mer oli-
gonucleotides creating two 3’ overhangs. The HindIII restriction site was destroyed
by the first base adenine of the start codon (*). The BamHI site was unaltered.
This would allow positive clones to be identified by their resistance to the HindIII
restriction enzyme, whereas negative clones would be cut. 
 70  Chapter 3: Methods and Materials 
The double digests were column purified and eluted in 25 L of elution buffer. 
The DNA was quantitated on a Nanodrop spectrophotometer (Thermo Fisher):  
BamHI / HindIII = 72 ng/L x 25 L = 1,800 ng (60% recovery) 
HindIII / BamHI = 84 ng/L x 25 L = 2,100 ng (70% recovery) 
The two samples were pooled and ethanol precipitated and resuspended in 20 L 
volume. The DNA concentration was measured and showed a near tripling in con-
centration to 221 ng/L (Fig 3–10).   
Figure 3-10: Double digestion of the 
pcDNA3.1-C12orf29 plasmid. The 
plasmid DNA was digested with 
BamHI and HindIII in two separate 
steps with DNA column purification 
after each step. The samples were 
pooled and ethanol precipitated. 
Nanodrop analysis showed the 
overall plasmid recovery was 60%.  
HA tag preparation 
 Each of the short HA tag sequences were resuspended to a working concen-
tration of 450 ng/L (400 M) and annealed before being phosphorylated. A specific 
annealing buffer was used; 10x annealing buffer: 100 mM Tris HCl; 1 M NaCl; 10 
mM EDTA (From http://www.oligos.com/annOligonucleotides.htm). The annealing 
temperature ramp down was: 80oC for 10 min, followed by 110 decrements of 0.5oC 
for 30 s to 25oC. The annealed product was ethanol precipitated and resuspended in 
50 L of water. The concentration was measured by Nanodrop and was 1.44 g/L.  
 The phosphorylation reaction was performed with buffer spiked with freshly 
made ATP and DTT:  
T4 PNK 1x
HA tag (1.4g/L) 1
10x PNK buffer 5
10 mM ATP 1
50 mM DTT 5
T4 PNK 5
Water 33
Volume (L) 50  
 Chapter 3: Methods and Materials  71 
The reaction was incubated at 37oC for 30 min and inactivated at 65oC for 20 
min. The DNA was column purified followed by ethanol precipitation and resus-
pended in 10 L of water. The DNA concentration and quality was assessed by 
Nanodrop: 
 
Figure 3-11: Nanodrop quantification of annealed HA oliogonucleotides. Following annealing 
and phosphorylation of the HA tag, the DNA concentration and quality was assessed. The 
concentration was low but the 260/280 and 260/230 ratios were satisfactory. 
The recovery was only 17.4% but the A260/A280 and A260/A230 ratios were 
1.78 and 2.52, respectively, indicating high purity DNA (Fig 3–11).  
Ligation  
 The double digested vector was diluted to 100 ng/L. One ligation reaction 
and two controls were prepared: 
Ligation rxn 1x  +lig, - ins  -lig, - ins
B1/H3 plasmid (100 ng/L) 1 1 1
HA tag (17.4 ng/L) 5 0 0
10 mM ATP 1 1 1
10x ligase buffer 1 1 1
T4 DNA ligase 1 1 0
Water 1 6 7
Volume (L) 10 10 10  
The reactions were incubated at 4oC overnight, then for 10 min at 37oC and in-
activation at 65oC for 20 min. 
The ligation reaction and controls were digested with HindIII to eliminate false 
positives: 
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Hind III digest 1x 3x
Ligation rxn 10  /
Hind III buffer 2 6
Hind III 0.5 1.5
Water 7.5 22.5
Volume (L) 20 35  
The samples were incubated for 2 h at 37oC and inactivated at 65oC for 20 min.  
Transformations 
 Forty microliters of -Select Competent cells were transformed with 2 L of 
digested ligation mix and a water only control. The cells were plated out on LB-amp 
agar plates and incubated at 37oC overnight. The number of colonies is listed in table 
3–9. 
Table 3-9: Colony numbers from transformation with HA retrofitted plasmids. 
These results indicated that a large number of plasmids were left uncut by the 
HindIII digest. Another HindIII digest was performed on what was left of the ligation 
reaction (~18 L): 
 
Hind III digest 1x 3x
Ligation rxn 18  /
Hind III buffer 2 6
Hind III 1 3
Water 10 30
Volume (L) 30 39  
The digests were incubated for 3 h at 37oC and inactivated at 65oC for 20 min. 
Forty microliters of -Select Competent cells were transformed with 2 L of DNA 
and incubated overnight. The results from these transformations showed a clear re-
duction of the number of false positives, although the number of colonies from the 
controls was still high (Table 3–10). 
 
 
Plate Transformations # of colonies
1 pcDNA(+ins)(+lig) ~1000
2 pcDNA(+ins)(-lig) ~1000
3 pcDNA(-ins)(-lig) ~1000
4 water 0
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Plate Transformations # of colonies
1 pcDNA(+ins)(+lig) 2xH3 ~150
2 pcDNA(+ins)(-lig) 2xH3 ~50
3 pcDNA(-ins)(-lig) 2xH3 ~100
4 water 0  
Table 3-10: Colony numbers following HindIII digest of HA retrofitted plasmids 
PCR screening of clones 
 Fortyeight colonies were picked from plate 1 for PCR screening. The colo-
nies were dissolved in 10 L of water and 5 L used as template. The sense Hind3 
primer was used together with the C12orf29 reverse primer to identify potential posi-
tive clones using the following volumes of reagents: 
PCR screen MM 1x 52x
Template 5  /
5x HF buffer 2 104
dNTP (10 mM) 0.2 10.4
Fwd Sense Hind3 0.7 36.4
Rev primer (C12orf29) 0.7 36.4
Phusion DNA pol 0.1 5.2
Water 1.3 67.6
Volume  (L) 10 260  
The PCR reactions were separated on an agarose gel and the results were encourag-
ing (Fig 3–12). Colonies 6, 15, 18, 22, and 31 were picked and grown in 5 mL of LB-
amp overnight for plasmid extraction.  
 
Figure 3-12: PCR analysis of colonies selected from plate #1 (Table 3–10). Colonies corre-
sponding to the numbered lanes were amplified in liquid LB-amp for plasmid extraction and 
further analysis. 
   
6 15         18             22
31
0.5 kb
0.5 kb
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HindIII analytical digest 
The plasmid DNA yield from the overnight incubation is shown in table 3–11. 
Sample ID ng/ul A260 A280 260/280 260/230 
Retro HA tag #6 934.1 18.682 9.743 1.92 2.31
Retro HA tag #15 887.1 17.743 9.245 1.92 2.34
Retro HA tag #18 762.4 15.248 7.914 1.93 2.31
Retro HA tag #22 976.1 19.522 10.193 1.92 2.34
Retro HA tag #31 949.1 18.982 9.898 1.92 2.33  
Table 3-11: DNA plasmid yields from colonies identified from analytical PCR reaction. 
An analytical HindIII digest, which would linearize false positives but not posi-
tive clones containing the HA insert was performed. Six HindIII digest reactions 
were prepared with these reagent volumes: 
Hind III digest 1x 6.5x
Plasmid DNA (100 ng/L) 1  /
Hind III buffer 1 6.5
Hind III 0.5 3.25
Water 7.5 48.75
Volume (L) 10 58.5  
The reactions were incubated for 2 h at 37oC and inactivated at 65oC for 20 
min. The reaction were analysed by gel electrophoresis shown in figure 3–13.  
 
 
Figure 3-13: Analytical digest of colonies identified as potential carriers of the HA tag. Five 
colonies were picked and propagated overnight in Amp selective broth. The plasmid preps 
were digested with HindIII; two sample, r6 and r31, were not linearized by the HindIII restric-
tion enzyme, indicating they were positive for the HA tagged insert.   
Samples r6 and r31 were identified as HA tag positive and were submitted for 
sequencing.   
r6   r15   r18  r22   r31   c2      r31   c2
HindIII digest           Uncut
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3.3.2 Validation of C12orf29 antibody specificity by western blot (WB) analysis 
Three companies released anti-C12orf29 antibodies onto the market during 
2011, and a further anti-C12orf29 antibody was produced by Everest Biotech on our 
specifications in 2012. This represented a tremendous opportunity to explore the bio-
logical function of this protein. Having C12orf29 specific antibodies made it possible 
to determine the cell and tissue distribution of this protein in bone and cartilage, 
which were the tissues of greatest interest for this project. Since there was no infor-
mation in the scientific literature as to the specificity of these antibodies, except for 
that given by the manufacturers, it was therefore necessary to determine their speci-
ficity for C12orf29. The HA-tagged C12orf29 recombinant plasmid was ideal as a 
positive control. The C12orf29 antibodies used for this work were purchased from 
Abcam (ab107423l, rabbit polyclonal); Santa Cruz (sc-241230, goat polyclonal); 
Sigma-Aldrich (HPA039663; rabbit polyclonal) and Everest Biotech (EB11549, goat 
polyclonal). 
It will be demonstrated here is that all four antibodies can detect proteins at 
molecular weight (MW) bands that overlap each other, and which therefore provides 
evidence that they are specific to the target protein C12orf29. For the sake of sim-
plicity the emphasis in this section is to compare the blots of one antibody against 
that of another, in which the sample is the same.  
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Antibody specifications from the manufacturers 
 
Abcam anit-C12orf29 antibody, rabbit polyclonal (ab107423l).  
According to the manufacturer’s specifications the ab107423l antibody reacts 
with mouse and human. The immunogen is a synthetic peptide conjugated to KLH, 
between amino acids 68–96 from the N-terminal region of human C12orf29, high-
lighted in yellow below. 
>NP_001009894 Human C12orf29 
1   MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
61  TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
121 AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
181 ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
241 FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
301 KCLFNHFLKIDNQKFVRLKDIIFDV 
 
Figure 3–14 shows WB analyses from the Abcam C12orf29 antibody specifica-
tion sheet. Lane A is a cell lysate from a human lung cancer cell line showing a band 
with a MW between 36 and 55 kDa (arrowhead) and another band at ~70 kDa (ar-
row). Lane B is a mouse bladder tissue lysates and shows a band at ~37 kDa (arrow-
head) and one at ~70 kDa (arrow). 
 
Figure 3-14: WB analysis of C12orf29 expression with Abcam C12orf29 antibody. (A) Anti-
C12orf29 antibody 1/100 dilution + NCI-H460 cell line lysate at 35 µg. (B) Anti-C12orf29 an-
tibody at 1/100 dilution + Mouse bladder tissue lysate at 35 µg. (From http://www.abcam.com/ 
C12orf29-antibody-ab107423.html#description_images_1) 
 
   
A B
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Santa Cruz anti-C12orf29 antibody, goat polyclonal (sc-241230).  
According to the manufacturer specifications the SC-C12orf29 antibody is an 
affinity purified goat polyclonal antibody raised against a peptide mapping within an 
internal region of C12orf29 of human origin, with no sequence specifics. Figure 3–
15 shows a WB image from the Santa Cruz antibody specification sheet, which indi-
cates an antibody with high specificity for a protein at approximately 37 kDa. 
 
Figure 3-15: WB analysis of C12orf29 expression with Santa Cruz C12orf29 antibody. (A) 
non-transfected 293T: sc-117752, (B) human C12orf29 transfected 293T: sc-111519, (C) 
NCI-H460, (D) T-47D, (E) HL-60 whole cell lysates. (From http://datasheets.scbt.com/sc-241230.pdf) 
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Sigma-Aldrich anti-C12orf29 antibody, rabbit polyclonal (HPA039663) 
According to the manufacturer’s specifications, HPA039663 is an affinity puri-
fied rabbit polyclonal antibody raised against a synthetic peptide between amino ac-
ids 225–297 from the C-terminal region of human C12orf29, highlighted in yellow 
below. 
>NP_001009894 Human C12orf29 
1   MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
61  TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
121 AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
181 ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
241 FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
301 KCLFNHFLKIDNQKFVRLKDIIFDV 
 
Figure 3–16 shows a WB image from the Sigma-Aldrich C12orf29 antibody 
specification web page (http://www.proteinatlas.org/ENSG00000133641). The band 
in lane C is lysate from human plasma with an apparent MW of 95 kDa. 
 
Figure 3-16: WB analysis of C12orf29 expression with Sigma C12orf29 antibody Lane (A) 
RT-4; (B) U-251 MG; (C) Human Plasma; (D) Liver; (E) Tonsil. (From http://www.proteinatlas.org/ 
ENSG00000133641/antibody) 
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Everest Biotech anti-C12orf29 antibody, goat polyclonal (EB11549) 
This antibody was made to our specifications in early 2012 by the UK based 
company Everest Biotech. The immunogen is a synthetic peptide between amino ac-
ids 30–43 from the N terminal region of the human C12orf29 protein, highlighted in 
yellow below.  
>NP_001009894 Human C12orf29 
1   MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
61  TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
121 AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
181 ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
241 FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
301 KCLFNHFLKIDNQKFVRLKDIIFDV 
 
Figure 3–17 shows a WB image from the EB11549 data sheet. There is a band at ap-
proximately 37 kDa from lysate from HeLa cells.  
Figure 3-17: WB analysis of C12orf29 expression with Everest Biotech C12orf29 antibody. 
EB11549 (1μg/ml) staining of HeLa lysate (35μg protein in RIPA buffer). Primary incubation 
was 1 hour. (From Everest Biotechnology EB11549 - Goat Anti-CLO29 (aa30-43) Antibody Data Sheet) 
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Cell culture and transient transfections 
Transfection experiments were performed using both HA-tagged (HA-
C12orf29) and non-tagged (pcC12orf29) recombinant C12orf29 vectors as positive 
controls to determine the specificity of the antibodies by WB analysis.  
Cell culture 
Chinese hamster ovary (CHO) cells were seeded at 150,000 cells per well in 
F12/HAMS medium with 5% FBS (Life Technologies) without antibiotics and left to 
recover overnight in an incubator.  
Transfection protocol 
Roche X-tremegene 9 DNA transfection (Tfx) reagent (Roche Australia) was 
used for this experiment following the manufacturer’s instructions. Three separate 
DNA/Tfx ratios were used to find the optimum combination. A verified HA-tagged 
IMPDH plasmid was used as a transfection controls (Table 3–11). 
HA‐C12o29 HA‐IMPDH pcC12o29
Plasmid conc 2.1 ug/ul 260 ng/ul 620 ng/ul
2 ug/5 uL Tfx (20 
uL Tfx in 380 uL 
Optimem)
100 uL HA‐
PUF + 100 uL 
of 5 uL Tfx 
mix
100 uL HA‐
IMP + 100 uL 
of 5 uL Tfx 
mix
100 uL 
pcPUF + 100 
uL of 5 uL 
Tfx mix
2 ug/10 uL Tfx (40 
uL Tfx in 360 uL 
Optimem)
100 uL HA‐
PUF + 100 uL 
of 10 uL Tfx 
mix
100 uL HA‐
IMP + 100 uL 
of 10 uL Tfx 
mix
100 uL 
pcPUF + 100 
uL of 10 uL 
Tfx mix
2 ug/20 uL Tfx (80 
uL Tfx in 320 uL 
Optimem)
100 uL HA‐
PUF + 100 uL 
of 20 uL Tfx 
mix
100 uL HA‐
IMP + 100 uL 
of 20 uL Tfx 
mix
100 uL 
pcPUF + 100 
uL of 20 uL 
Tfx mix
3 uL in 300 
uL Optimem
23 uL in 280 
uL Optimem
9.6 uL in 290 
uL Optimem  
Table 3-12: Reagent volumes for transfection for antibody specificity experiments. 
Dilute tfx reagent in Optimem.  
Dilute 2 g of plasmids in Optimem  
Mix tfx and plasmid mixes in 12 separately labelled tubes. 
Incubate for 20 min at RT.  
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Add DNA:tfx mix to cells in 6 well plates. 
The plates were incubated overnight and the medium changed to complete 
F12/HAMS the following day. After 72 h the cells were harvested in 175 L lysis 
buffer containing 20 mM Tris-HCl (ph 7.5), 100 mM NaCl, 0.01% Trition X, and a 
protease inhibitor cocktail (Roche), and then homogenised using a syringe with a 
23G needle. The protein concentrations were measured using a BCA protein assay 
kit (Pierce, Thermo Scientific Australia) following the manufacturer’s instructions. 
 
SDS PAGE and Western blot 
Total protein lysates were separated by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE). Separating gels were prepared with the following 
reagents: 
10% Resolving gel 1x 4x
40% Acrylamide 1.5 6
0.75 M Tris+0.4% SDS 3 12
Water 1.5 6
APS (L) 30 120
TEMED (L) 5 20
Volume (mL) 6 24
4% Stacking gel 1x 4x
40% Acrylamide 0.2 0.8
0.25 M Tris+0.4% SDS 0.95 3.8
Water 0.8 3.2
APS (L) 10 40
TEMED (L) 3 12
Volume (mL) 1.96 7.85  
A total of 18 g of protein from each sample was separated by electrophoresis 
in SDS running buffer (0.025M Tris base, 0.192M glycine, 0.1% SDS and the pH 
adjusted to 8.3) at 100 V until the dye front reached the bottom of the separating gel. 
The separated proteins were transferred to a nitrocellulose membrane using semi-dry 
transfer protocol using 10% methanol in running buffer for 60 minutes at 150 mA. 
Following the transfer the membranes were blocked for 1h in Tris-buffered saline 
containing 0.1% Tween20 and 2% bovine serum albumin (BSA), followed by incu-
bation with primary antibodies in 2%BSA/Tris buffered saline with 0.05% Tween 
(TBST) using the dilutions in table 3–12.  
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1o Antibody  Dilution
Anti HA (SantaC) 1:1000
Anti C12orf29 (Abcam) 1:500
Anti C12orf29 (SantaC) 1:1000
Anti C12orf29 (Sigma)  1:500
Anti C12orf29 (EB49)  1:500  
Table 3-13: Primary antibody solutions for WB analysis. 
The membranes were incubated overnight at 4oC and washed 6 x 5 min in 
TBST then incubated in 2%BSA/TBST with secondary antibodies in the following 
dilutions: 
1o Antibody  2o Antibody  Dilution
Anti HA (SantaC) Rabbit anti mouse (Life Tech) 1:10,000
Anti C12o29 (Abcam/Sigma) Goat anti rabbit (Life Tech) 1:10,000
Anti C12o29 (SantaC/EB49) Rabbit anti goat (Life Tech) 1:10,000  
The membranes were incubated for 1h at RT then washed 4 x 5 min in TBST 
and 2 x 5 min in PBS. The antibody conjugates were detected using SuperSignal 
West Femto Chemiluminescent Substrate (Thermo Scientific) and exposed on X-ray 
film (Fuji Film, Australia) for visualization.   
Licor double labelling system 
Membranes used for Licor double labelling were blocked in Licor blocking 
buffer (Millenium Science, Australia) for one hour then incubated overnight at 4oC in 
blocking buffer with the same antibody dilutions as in table 3–12. The membranes 
were washed 6 x 5 min in TBST and incubated in goat anti-mouse IgG DyLight 680 
and goat anti-rabbit DyLight 800 secondary antibodies (Thermo Scientific, Austra-
lia), or Alexa Fluor 680 donkey anti-goat (Life Technology), diluted 1:10,000 in 
Licor buffer for 1 h at RT. Alternatively an IRDye 800CW donkey anti-goat (Mille-
nium Science) was used. The membranes were washed and scanned on an Odyssey 
Infrared Fluorescence Scanner (Millenium Science).  
   
 Chapter 3: Methods and Materials  83 
3.3.3 Immunofluorescent (IF) microscopy 
Laser confocal and immunofluorescent microscopy was performed to visualize 
the cellular distribution of C12orf29 in various cell types. The cell types used for 
these experiments were 3T3-E1 pre-osteoblast cells, sheep periodontal ligament 
(PDL) cells, sheep mOBs and cells from the human prostate cancer cell line, PC3.  
 
Transfection of cells for immunofluoresence microscopy 
Cell culture 
NIH3T3-E1 cells were used for this experiment. The cells were seeded at 
20,000 cells per glass cover-slip placed in 24 well plates. The cells were left to re-
cover overnight in an incubator before being transfected.  
Transfection protocol  
The transfection protocol was essentially the same as that used above. The 
transfection reagent used was Roche X-tremegene HP DNA transfection (Tfx) 
(Roche Australia) reagent with the HA-C12orf29 plasmid using the following vol-
umes: 
Per well: Area cm2 Tot vol
Tfx 
complex 
(uL)
3:1 
DNA 
(ug)
Tfx 
reagent 
(uL)
24 well format 1.9 0.5 mL 50 0.5 1.5
Per plasmid (x12)  / 6 mL 600 L 6 g 18 L  
After two days the cells were fixed with 4% paraformaldehyde for 1 h on ice.  
IF labelling protocol 
The cells were prepared for immunofluoresence by the following method: (i) 
removed the medium and washed three times with PBS; (ii) fixed with 4% PFA for 1 
hour on ice; (iii) permeabilized with 0.1% Triton X for 5 min; (iv) quenched with 
0.15M glycine for 15 min; (v) blocked in 1% BSA/PBS for 1 h; (vi) incubated with 
1º antibody (1:50 dilution) in 1% BSA/PBS for 1 h on parafilm; (vii) washed 3 x 5 
min in 0.1%BSA/PBS approximately 100 L per wash on parafilm (viii) incubated 
with 2º antibody (1:400) in 1% BSA/PBS for 30 min–DAPI (1:2000; Life Technol-
ogy) and Rhodamine Phalloidin (1:1000; Life Technology) was applied to this incu-
bation. Following the secondary incubation the cover-slips were washed 3 x 5 min in 
0.1%BSA/PBS, with a final wash in MilliQ water to clear away salts. The coverslips 
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were mounted on a microscope slide in 7 L of Prolong Gold mounting medium 
(Life Technology.) and secured with three spots of clear nail varnish. An anti-mouse 
IgG Alexa Fluor 488 Conjugate secondary antibody (Cell Signaling, Genesearch 
Australia) was used against the anti-HA, and a goat anti-rabbit IgG Alexa Fluor 488 
(Life Technology) used against the Abcam C12orf29 antibody, both at 1:1000 dilu-
tion. 
Image acquisition 
Fluorescent images were captured with a Zeiss Axio Imager microscope using 
the ZEN software package (Carl Zeiss Pty. Ltd., Australia).  
Confocal images were captured with a Leica TCS SP5 confocal laser scanning 
microscope (Leica Microsystems, Gladesville, Australia) fitted with 40x and 63x oil 
immersion objectives. Image analysis was performed with Leica TCS SP5 Leica 
LAS AF software package, and ImageJ (rsbweb.nih.gov/ij/) was used to pseudo col-
our the images.  
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3.3.4 Immunohistochemistry (IHC) 
The fundamental principle behind IHC is the demonstration of antigens within 
tissue sections by means of specific antibodies raised against the antigen. Once anti-
gen–antibody binding occurs, it is visualized with a coloured histochemical reaction 
visible by light microscopy (Ramos-Vara, 2005). 
Samples 
All bone and tissue samples used in this work had been gathered and prepared 
for immunohistochemistry by colleagues at IBHI for use in their respective research 
projects. Human bone and cartilage samples were collected from patients undergoing 
knee replacement surgery at the Prince Charles Hospital, having given informed con-
sent. The rat samples were from juvenile animals (approximately 2 months old) and 
had been prepared from a previous osteoarthritis animal model studies. All the sam-
ples used here were from normal controls. Mouse embryo samples were harvested at 
13.5 dpc and were provided by Ms Elanore Wainwright of the Koopman Lab at the 
University of Queensland, St Lucia. The human embryo sample was from a termina-
tion of a 7–8 week old pregnancy and was provided by Prof. Katja Schenke-Layland, 
of the Dept. of Thoracic and Cardiovascular Surgery, of the University of Tübingen, 
Germany.     
IHC labelling protocol  
Standard IHC protocols were used for these experiments. The majority of the 
samples used had been previously prepared by other researchers in our group in the 
course of their own work. All samples had been fixed in 4% PFA for 24 to 48 h at 
RT and bone samples, in addition, had been decalcified in 10% EDTA over a period 
of 4–5 weeks. All samples were embedded in paraffin wax. Tissue slices, 5 m thick, 
were sectioned by microtome, placed on 3-aminopropyltriethoxy-silane coated glass 
slides and air-dried. Tissue slices were dewaxed in xylene and rehydrated in descend-
ing concentrations of ethanol (EtOH) (100% to 70%). Endogenous peroxidases and 
non-specific binding was blocked by incubation in 0.3% H2O2 in PBS for 15 min fol-
lowed by repeated washing in PBS. The samples were incubated with Proteinase K 
for 20 min for antigen retrieval and washed twice in PBS for 3 min. Alternatively, 
some samples were subjected to heat-based antigen-retrieval (HBAR) in which the 
samples were heated in a pressure cooker to 106 oC in a solution of 1 mM EDTA for 
4 min and then the temperature allowed to fall to 70 oC, after which the samples were 
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rinsed in running tap water for 5 min (Pileri et al., 1997). All sections were blocked 
in 0.1% swine serum in PBS for 1 h at RT. A series of trials were performed in order 
to find the optimal antibody dilution and antigen retrieval method. The following 
primary antibody dilutions were used: 
1o Antibody  Dilution
Anti C12orf29 (Abcam)  1:100
Anti C12orf29 (EB49)  1:100
Anti COL2 (Abcam)  1:200
Anti BAPX1 (Abcam)  1:150
Anti SOX9 (Abcam)  1:150  
Following primary antibody incubation, the sections were washed once in PBS 
buffer containing 0.1% Triton (X-100) for 3 min and then 2x 3 min in PBS. The sec-
tions were incubated with a biotinylated swine-anti-mouse, rabbit, goat secondary 
antibody (DAKO Multilink, CA, USA) for 15 min, and then incubated with horse-
radish perioxidase-conjugated avidin-biotin complex for 15 min. Antibody com-
plexes were visualized by the addition of a buffered diaminobenzidine (DAB) sub-
strate for 1–2 min and the reaction stopped by immersion and rinsing the sections in 
PBS. Sections were lightly counterstained with Mayer’s haematoxylin for 5 min and 
rinsed with running tap water for 10 min. Following this, they were dehydrated with 
ascending concentrations of EtOH solutions (70%, 90%, 2 x 100%), cleared twice 
with xylene and mounted with a cover-slip using DePeX mounting medium (BDH 
Chemicals, Australia). Controls for the immunostaining procedures included condi-
tions where the primary antibody was omitted.  
Safranin O staining for cartilage 
Safranin O is a cationic dye that binds to polyanions. It was commonly used for 
plant histology and general cytology in combinations with fast green or light green as 
a counterstain and with iron-haematoxylin as a nuclear stain until it was discovered 
to be useful for staining cartilage. The dye does not bind to collagen but rather to car-
tilage mucopolysaccharides, such as chondroitin 6-sulphate, glucosamines and galac-
tosamines in a stoichiometric ratio, proportional to their distribution concentration 
and which therefore gives an accurate measure of these integral cartilaginous mole-
cules (Mathews and Glagov, 1966; Rosenberg, 1971). 
Samples were dewaxed in xylene and rehydrated in descending concentrations 
of ethanol and one wash of distilled water, then stained with Weighert’s iron haema-
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toxylin (Sigma-Aldrich) working solution for 2 min and rinsed in running tap water 
for 10 min. This was followed by a brief 15 s immersion in 1% acid alcohol (1% v/v 
hydrochloric acid [38%] in 70% EtOH), and 5 min rinsing in running tap water. The 
samples were stained with 0.01% fast green solution for 5 min and rinsed with 1% 
v/v acetic acid for 10–15 s, followed by 0.01% safranin O solution for 10 min. After 
this incubation the samples were dehydrated with ascending concentrations of EtOH 
solutions (70%, 90%, 2 x 100%), cleared twice with xylene and mounted with a 
cover-slip using DePeX mounting medium. This protocol resulted in the cell nuclei 
appearing as black, the cytoplasms as gray/green and cartilage staining orange to 
bright red.  
Image acquisition 
Images were acquired with a Zeiss Axio Imager microscope with a motorised 
stage (Carl Zeiss). Images of larger samples were acquired using the tiling and stitch-
ing function of the ZEN imaging software package (Carl Zeiss).  
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3.3.5 RT-qPCR analysis of C12orf29 expression in sheep primary cells 
Real time quantitative PCR (RT-qPCR) analysis was performed to determine 
the gene expression of C12orf29 in osteoblasts and BMSCs in standard growth me-
dium and mineralization induction medium.  
Cell culture 
Osteoblast cells from sheep mandible (mOB) and tibia (tOB) bone mesenchy-
mal stromal cells (BMCSs) were plated out on 6 well plates at 60,000 cells per well 
and allowed to recover overnight in a CO2 incubator. One lot of cells were treated 
with mineralization induction medium for 6 h, 72 h, 7 days and 21 days. The control 
cells were grown in standard growth medium and harvested at the same time points 
as the treatment cells.  
Methods 
Total RNA was isolated with TRIZOL reagent and DNase treated (Life Tech-
nologies). cDNA was synthesized from 200ng total RNA using a DyNAmo cDNA 
Synthesis Kit (Finnzymes, Genesearch, Australia) following the manufacturer’s in-
structions. PCR primers specific for sheep C12orf29 were designed by first determin-
ing the exon boundaries of the mRNA by a BLAST search with the sheep mRNA 
sequence against the sheep genome database on the Agresearch database 
(https://isgcdata.agresearch.co.nz/). The reverse primer was placed across the bound-
ary of exon 6 and 7. The annealing temperature of both primers was 58oC and did not 
have any hairpin or self annealing motifs. RT-qPCR was performed on an Applied 
Biosystems 7900HT Fast Real-Time PCR System in a 384 well plate (Applied Bio-
systems, Foster City, CA) with SYBR Green Master Mix (Life Technologies). In 
brief, 2 L of cDNA (1:10 dilution of stock), 1 L each of forward and reverse prim-
ers and 5 μL of 2X SYBR Master Mix were used in a 10 μL reaction volume; all 
samples were set up in triplicates. The thermo cycling parameters were as follows: 1 
cycle at 95°C for 10 min to activate the polymerase, 40 cycles of 15 s at 95°C and 1 
min at 60°C for amplification. Dissociation curve analysis was carried out to verify 
the absence of primer dimers and/or non-specific PCR products. The primer se-
quences are listed in table 3–13. The relative expression of the genes of interest was 
normalized against a geometric mean of the -actin (ACTB) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) housekeeping genes by comparative cycle of 
threshold (Ct) value method (Vandesompele et al., 2002). The difference between the 
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mean Ct values of the gene of interest and the geomean of the housekeeping genes is 
labelled ΔCt, the log2 (ΔCt) gives the relative value of gene expression (Bookout and 
Mangelsdorf, 2003).  
Table 3-14: List of primers used for RT-qPCR of C12orf29 mRNA expression in sheep cells. 
The treatment versus control groups was tested for significance using the Wil-
coxon signed rank test in which the null hypothesis was that there was no effect on 
C12orf29 gene expression in response to the treatment with osteogenic induction 
medium; the alternative hypothesis was that there was an increased gene expression 
in response to the treatment. Statistical significance was set to 0.025 (Wilcoxon, 
1946; Yuan et al., 2006). 
 
 
   
PRIMER SEQUENCE LENGTH
GC 
CONTENT   Tm
ACTB Fwd 5'-TTCGAGCAAGAGATGGCCAC 20 55.0% 57.6 ºC
ACTB Rev 5'-ACAGGACTCCATGCCCAG 18 61.1% 57.1 ºC
C12orf29 Fwd 5'-CAGTGCCGCTCTCAGATCTTC 21 57.1% 57.7 ºC
C12orf29 Rev 5'-GATGGTGGCGATGGACCTTG 20 60.0% 58.5 ºC
GAPDH Fwd 5'-TCAGCAATGCCTCCTGCAC 19 57.9% 58.3 ºC
GAPDH Rev 5'-TCTGGGTGGCAGTGATGGC 19 63.2% 60.4 ºC
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3.3.6 WB analysis of C12orf29 protein expression in sheep primary cells 
In this experiment primary cells derived from periodontal ligament (PDL), 
mandible bone (mOB) and femur bone (fOB) from sheep were treated with osteo-
genic induction medium for 3 and 12 days. The purpose of this experiment was to 
explore whether there was a discernible change in C12orf29 protein expression in 
response to this treatment.  
Cell culture   
 PDL, mOB and fOB cells were seeded at 120,000 cells per well in 6 well 
plates for three time points: 0, 3 and 12 days. The cells were allowed to recover 
overnight and day 0 samples were harvested in a lysis buffer (10 mM Tris.HCl pH8, 
150 mM NaCl, 0.05% Tween) containing a protease inhibitor cocktail (Roche), and 
day 3 and 12 samples subjected to the osteogenic induction medium (complete me-
dium containing 100nM dexamethasone, 10 mM glucerophosphate, and 50 µg/mL 
L-ascorbic acid). The lysates were homogenised with a 23 g syringe and cell debris 
pelleted by centrifugation for 20 min at 14,000 rpm and 4 oC.  
WB analysis 
The protein lysates were separated on a 10% SDS-PAGE gel and transferred to 
a nitrocellulose membrane as described on pages 81 and 82 above. Two separate 
membranes were probed with the Abcam and Santa Cruz C12orf29 antibodies and 
visualized with SuperSignal Chemiluminescence. A third membrane was labelled 
with a mouse monoclonal -Tubulin antibody (1:2000; Abcam) using the Licor Od-
yssey WB system (Millenium Science, Australia). The membrane was incubated in 
goat anti-mouse IgG DyLight 680 diluted 1:15,000 in Licor buffer for 1 h at RT and 
scanned on an Odyssey Infrared Fluorescence Scanner.   
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3.4 BIOINFORMATICS ANALYSES OF C12ORF29 
Comparative sequence analysis is an important tool for biological research. 
BLAST searches of a new DNA or protein sequence can give researchers hints about 
the function and other properties of a gene. Comparative analyses rely on a phyloge-
netic tree that describes the evolutionary relationships between the sequences 
(Holder and Lewis, 2003). These comparisons benefit greatly from the ever increas-
ing number of genomes that have been sequenced in recent years. The first metazoan 
genome to be sequenced was that of the Drosophila melanogaster, in 2000 (Adams 
et al., 2000), whereas the initial draft human genome was released to great fanfare 
the following year (Lander et al., 2001; Venter et al., 2001). Since then, the draft ge-
nomes of a number of metazoan species of have been released, including the ascidian 
Ciona intestinalis (Dehal et al., 2002); the mouse Mus musculus (Waterston et al., 
2002); the chicken Gallus gallus (Hillier et al., 2004); the domestic dog Canis famil-
iaris (Lindblad-Toh et al., 2005); the lancelet Branchiostoma floridae (Putnam et al., 
2008); the cow Bos taurus (Elsik et al., 2009); the freshwater Hydra Hydra magni-
papillata (Chapman et al., 2010); the Atlantic cod Gadus morhua (Star et al., 2011); 
the gorilla Gorilla gorilla (Scally et al., 2012); and most recently the Pacific oyster 
Crassostrea gigas (Zhang et al., 2012); to name but a few.  
 
3.4.1 Phylogenetic analyses 
In the phylogenetic analysis two sets of analyses are performed. In the first 
analysis the sequences of C12orf29-like proteins from the most basal organisms were 
compared to the human protein. In the second analysis C12orf29-like proteins from 
as many as 60 species are subjected to a Bayesian Markov chain Monte Carlo 
(MCMC) method statistical phylogenetics.  
Methods 
Data assembly and analysis of C12orf29-like proteins in basal organisms 
Sequences from basal organisms with high homology with human C12orf29 
protein were identified by BLASTP search on the National Center for Biotechnology 
Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/). A basal organism in this 
context was defined as any non-vertebrate species. The main criteria for a candidate 
protein to be considered as a potential ortholog was having the approximate same 
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length as the human protein (~325 amino acids) and at least 30% amino acid identity 
across the sequence. The Hahella chejuensis hypothetical protein HCH_06039 
clearly fell outside the sequence length criterion by being only 205 amino acids. It 
was included after a pairwise alignment against human C12orf29 revealed 30% 
amino acid identity and 39% positives along the length of the human sequence. Pro-
tein sequences from the following species were retrieved from Genbank/Ensembl 
and assembled in FASTA format: Homo sapiens (NP_001009894); Saccoglossus 
kowalevskii (XP_002740769); Branchiostoma floridae (XP_002594108); Hydra 
magnipapillata (XP_002156396); Ciona intestinalis (XP_002130306); Ciona savi-
gnyi (ENSCSAVP00000016212); Naegleria gruberi (XP_002672595); and Hahella 
chejuensis (YP_437114).  
The sequences were analysed with COBALT, a multiple protein alignment tool 
on the NCBI website (http://www.ncbi.nlm.nih.gov/tools/cobalt/), using the defaults 
parameters. COBALT uses an all-against-all collection of pairwise constraints to rep-
resent each group of conserved columns. These constraints are derived from database 
searches, sequence similarity and user input, and the program combines the con-
straints and then incorporates them into a progressive multiple alignment. Conserved 
columns may contain gaps, but sequences that contain gaps in a conserved column 
do not participate in pairwise constraints for that column. This exception allows con-
served columns to be used for most profile–profile alignments, while generating 
pressure on slightly misaligned sequences to shift position (Papadopoulos and 
Agarwala, 2007). The alignment file generated by COBALT was imported into the 
ClustalX software program, which colours the bases making the visual assessment of 
the alignment easier. This alignment was printed to a file as a postscript using Ghost-
script, which was converted into a portable document format and printed in colour. 
The sequences of the non-vertebrate species Saccoglossus kowalevskii (acorn worm); 
Branchiostoma floridae (Florida lancelet); Hydra magnipapillata (freshwater Hy-
dra); Ciona intestinalis and Ciona savignyi (sea squirts); Naegleria gruberi (amoebo-
flagellate); and Hahella chejuensis were compared against the human C12orf29 pro-
tein by BLASTP to assess amino acid identity and overall protein similarity.  
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Constructing a phylogenetic tree of C12orf29 from all known taxa 
C12orf29 has been identified in species in every major class of vertebrates: car-
tilaginous fish; bony fish; amphibians; reptiles; birds; and mammals. To date, it has 
been possible to assemble full or partial C12orf29 sequences from 61 different spe-
cies; the majority (41) of these sequences are full reading frames and those of the 
remaining species are partial sequences. The latter tended to be the case when nu-
cleotide sequences were retrieved from the Genbank expressed sequence tag (EST) 
database. In some cases sequence data had yet to be assembled and uploaded to the 
Ensembl database (www.ensembl.org). Instead, some sequences were held in the 
principal sequencing institution’s own database as was the case with the bottlenose 
dolphin (Tursiops truncatus), whose genome has been sequenced by the Baylor Col-
lege of Medicine in the US, but is not yet fully assembled. This database was BLAST 
searchable and it was therefore possible to assemble the entire ORF for the bottle-
nose dolphin C12orf29 protein from sequencing contigs.  
The amino acid sequences were assembled in Fasta format and aligned with 
ClustalX 2.0 using the Neighbor-Joining (NJ) method (Larkin et al., 2007). Bayesian 
posterior probabilities were calculated using MrBayes v3.2.1 (Ronquist et al., 2012), 
with 4 chains, 4 runs and 5 million generations. Sample frequency was set to 500, 
burnin to 10,000, the rate matrix for amino acids was set to “fixed (jones)”, and the 
likelihood model was set to “invgamma”. The MrBayes analyses were run on the 
QUT High Performance Computing facility on a SUSE Linux Operating System. 
The consensus tree was visualized using the FigTree tree viewer 
(http://tree.bio.ed.ac.uk/software/figtree/). 
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3.4.2 Molecular genetics analyses 
In humans, the gene C12orf29 is located on the long arm of chromosome 12, at 
position 12q21.32 (Fig 3–18). The gene has been given a provisional name in accor-
dance with the guidelines of the Human Gene Nomenclature Committee; these are 
for putative genes predicted from EST clusters or from genomic sequences with EST 
evidence but showing no known structural or functional homology. Such genes are 
designated by the chromosome of origin, the letters orf stands for open reading 
frame, followed by a number in a series–in the case of C12orf29: chromosome 12 
open reading frame 29 (Wain et al., 2002). The gene sequence for C12orf29 was first 
predicted in 2002 by a large Japanese cDNA sequencing consortium (Ota et al., 
2004) and since then several other groups have submitted human versions of the 
cDNA sourced from a number of tissues. C12orf29 appears to be a unique gene se-
quence and the inferred protein returns no similarities to any known conserved do-
mains in any bioinformatics database searches. This uniqueness is not limited to 
C12orf29 however, a neighbouring gene on the opposite strand, C12orf50–which is 
also uncharacterised–returns no similarities with other genes in the human genome. 
When the first draft of the human genome was published in 2001, the number of an-
notated genes was estimated at 26,383, with as many as 42% having no known func-
tions; when genes of so-called hypothetical proteins were included, the percentage 
rose to 59% (Venter et al., 2001). Orthologs of the human C12orf29 gene are found 
in all vertebrate species that have been sequenced and in every one of those species 
the gene is described as a hypothetical protein. 
 
 
 
   
Figure 3-18: In humans, the gene C12orf29 is located on the long arm of chromosome 12 
(from Ensembl.org). 
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Methods 
Defining the cis-regulatory region of human C12orf29 
In this section the cis-regulatory (promoter) region of human C12orf29 is de-
fined and subjected to an in-depth analysis of putative transcription factor (TF) bind-
ing motifs. In order to define the cis-regulatory region, sequence similarity is primar-
ily identified in a process known as phylogenetic footprinting. This assumes that mu-
tations within functional regions of genes will accumulate more slowly than muta-
tions in regions without sequence-specific function, the comparison of sequences 
from orthologous genes can indicate segments that might direct transcription. Pair 
wise comparisons of promoters from closely related species, such as human–
chimpanzee, generally provide little benefit, as the sequences closely resemble each 
other, whereas promoters from widely divergent species (primate–fish) would show 
little detectable similarity (Wasserman and Sandelin, 2004).  
To define the promoter region for this analysis, 5’ flanking regions were as-
sembled from the four great ape species in order to arrive at a consensus region ap-
plicable to the human C12orf29 gene. The size of the region analysed was set to 
2,779 bases upstream from the cryptic translation start codon in exon 1a (see below); 
this length was chosen primarily because of a gap existing in the gorilla sequence 
upstream from this region. When the four sequences were aligned with ClustalX, a 
region of high sequence homology was immediately apparent, starting approximately 
2.5 kb upstream from the start codon, which is highlighted with a red box in Fig. 3–
19. The promoter region extends a further 1.9 kilo bases downstream from the se-
quences shown here. 
Identifying CpG island in the human C12orf29 gene 
The entire human length of the human C12orf29 gene, including a 3,000 nu-
cleotide bases upstream from the translation start site, was analysed for the presence 
of a CpG island using the European Molecular Biology Laboratory’s EMBOSS 
CpGPlot analysis platform. (http://www.ebi.ac.uk/Tools/emboss/cpgplot/).  
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Figure 3-19: Defining the cis-regulatory region for the human C12orf29 gene by phylogenetic
footprinting. See text for details. 
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In silico promoter analysis using online search portals 
An in silico promoter analysis has clear limitations as to the true nature of gene 
regulation, but can flag potential transcription factors that affects a particular gene 
and is therefore widely used tool for predicting what signalling pathways may influ-
ence gene regulation (Chang et al., 2006; Tharakaraman et al., 2008; Xie et al., 
2005). The C12orf29 5’-flanking region was analysed using three separate platforms. 
An initial analysis was performed on the Softberry NSITEM/Recognition of Regu-
latory motifs platform, which mines the TRANSFAC database, applying a proprie-
tary search algorithm (Solovyev et al., 2010). This platform allows an inter-species 
comparison in which the promoter regions of human, chimpanzee, gorilla and 
orangutan were analysed in parallel. Only promoter sites that appeared in two or 
more species was returned as a positive hit. A major drawback with this platform was 
that it returned a number of TF binding motifs from non-vertebrate species such as 
Drosophila and Saccharomyces. This led to a number of hits for the Drosophila spe-
cific zinc finger protein hunchback (HB). There is no conclusive evidence yet that 
this transcription factor exists in vertebrates, although a 2006 report claims to have 
identified a functional hunchback-binding site consensus sequence in the 5’-flanking 
region of murine transforming growth factor-beta 3 (TGF-β3) (Yamazaki et al., 
2006). There have been no other reports of HB-like homologs in vertebrates, and 
given this paucity of follow-up studies it was decided to apply other search portals to 
analyse the C12orf29 promoter region. 
The second analysis was performed on the Gene-Regulation platform, which 
is a TRANSFAC search portal for academic and non-profit organizations, adminis-
tered by the commercial entity BioBase (Matys et al., 2006). This is a free version 
that is 5–6 years out of date with respect to the latest biological research. It does pro-
vide a functional user-interface and, importantly, hyperlinks to the scientific papers 
in which the sites were originally published. BioBase has a commercial platform that 
provides biological data from the most up-to-date research and links to the most re-
cent journal articles. The cost to access this platform was, however, not justified for 
the analysis of the promoter region of a single gene. The third platform used to ana-
lyse the promoter region was MIRAGE (Molecular Informatics Resource for the 
Analysis of Gene Expression), using the Tfsitescan option (http://www.ifti.org/). 
This web portal is dedicated to methodologies, tools, and technologies relating to 
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gene expression information and is administered by the Institute for Transcriptional 
Informatics hosted by the Pittsburgh Supercomputing Centre of Carnegie Mellon 
University and University of Pittsburgh in the US. The majority of TF sites identified 
in the present study stemmed from the information provided from the Tfsitescan 
analysis. Every TF binding site identified by this analysis was verified against pri-
mary references in order to put the transcription factor into its relevant biological 
context. 
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Chapter 4: Results 
4.1 RESULTS – INTRODUCTION 
The results presented here are organised into three sections. Section 1 presents 
the results from the cDNA library construction. This will include the identity of the 
cDNA clones isolated by random selection; the MACH isolation of GAPDH; the 
validation of the library and mineralization induction of a subset of the cells used for 
the library.  
Section 2 will include the molecular cloning and fitting of an HA epitope tag to 
the C12orf29 cDNA. This is followed by the characterization of the commercial 
C12orf29 antibodies with respect to their specificity. The results of the IF and IHC 
are presented as is RT-qPCR and WB experiments of C12orf29 mRNA and protein 
expression in osteoblastic cell lines. 
The third section deals with bioinformatics analyses and covers the phyloge-
netic relationships of species with a C12orf29 orthologous gene and also looks at the 
promoter region of the human C12orf29 gene in order to make predictions as to what 
signalling pathways may be involved in the regulation of this gene. The results of 
these analyses are important since they add to the foundation of future studies into 
the role of C12orf29 in skeletal biology. 
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4.2 CDNA LIBRARY CONSTRUCTION 
Cell culture 
The estimation of the total number of cells needed to produce the necessary 
amount of poly(A)+ tailed mRNA for the cDNA library construction was based on 
the assumption that the poly(A)+ mRNA fraction constitutes between 2–5% of the 
total RNA pool. The tOB/fOB cells, mOB cells and BMSCs were expanded to 21 x 
T175 flasks for each cell type, for a total of 63 flasks.  
Induction of osteogenic differentiation of osteoblast and BMSCs 
The cells showed a clear response to the mineralization medium by a pro-
nounced morphological change within days of being exposed to this medium. The 
cell morphology changed from an elongated shape to a compact cobblestone-like ap-
pearance, the effect of the cells laying down a crisscross pattern of extracellular ma-
trix (Fig 4–1). The cells were harvested at three times points, 3, 7, and 12 days, 
which was insufficient length of time for any mineralization nodules to become ap-
parent.   
Figure 4-1: Shows the effect osteogenic induction medium on cell morphology.
(A) Both BMSCs and osteoblast cells have a characteristic elongated shape in regular me-
dia. (B) The cell morphology changes to a cobblestone-like appearance as the result of the
cells laying down a crisscross pattern of extracellular matrix within 3–5 days of being sub-
jected to the osteogenic media.  Scale bar = 300 µm. 
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RNA extraction 
Total RNA 
The total RNA extraction from all the flasks yielded an estimated 3.45 g of to-
tal RNA. The A260/A280 and A260/A230 ratios indicated high quality RNA. The 
samples were diluted 1:10 and measured twice on a Nanodrop spectrophotometer. 
The concentration figures were multiplied by the dilution factor then by the volume 
to arrive at an estimate of the total yield. The results are shown in table 4–1 below.  
 
Table 4-1: The total RNA yields and absorbance ratios produced with the RNA extraction kit.  
Poly(A)+ mRNA purification 
The fraction of poly(A)+ mRNA is estimated to be approximately 5% of the total 
RNA content (Milcarek et al., 1974; Werner et al., 1984). The largest fraction of non 
poly(A)+ tailed RNA is 18S and 28S ribosomal RNA and the poly(A)+ fraction has to 
be purified by removing the non poly(A)+ tailed RNAs. The Nucleotrap Kit yielded 
an average poly(A)+ mRNA yield of 4.4% (Table 4–2) and was close to the figure of 
5% reported in HeLa cells. This amounted to 2–3 times more poly(A)+ mRNA than 
was the minimum requirement for the cDNA library construction. The samples were 
pooled into three lots with a total amount of 10 µg of poly(A)+ mRNA, which was 
then ethanol precipitated and resuspended in 42 L of RNase free water for a final 
target concentration of 250 ng/µL. Nanodrop analysis revealed optimal A260/280 
and A260/230 ratios and poly(A)+ mRNA concentrations ranging from 240 to 270 
ng/µL. 
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Table 4-2: Yield of poly(A)+ mRNA from the Nucleotrap Poly(A)+ enrichment kit.  
 
The cDNA Library  
Quantisation of cDNA fractions 
Following first and second strand cDNA synthesis the samples were size frac-
tionated through a Sepharose gel filtration column to remove fractions less than 400 
bp and unincorporated nucleotides. Three drops (~120 µL) was collected from each 
fraction and the RNA purified by phenol-chloroform extraction and eluted in 4–10 
µL of water. A 0.5 L drop from each of sample was spotted out on an ethidium 
bromide agarose gel and compared to a DNA standard (Fig 4–2). The estimated con-
centration ranged between 5–40 ng/L, which was sufficient for the ligation step.  
Sample ID A260 A280 260/280 260/230 Cursor abs. ng/ul Elution vol
Total 
polyA 
RNA 
(ug)
Combined 
10ug RNA 
from three 
samples
Vol to 
3.33ug
Poly(A)+ 
mRNA % 
yield from 
total RNA
poly A 3A 3.558 1.675 2.12 2.43 1.464 142.31 150 21.35 3.33 23.42 4.1
poly A 3B 2.347 1.125 2.09 2.34 1.001 93.87 150 14.08 3.33 35.51 2.9
poly A 3C 5.532 2.627 2.11 2.31 2.395 221.27 166 36.73 3.33 15.06 6.6
poly A 7A 3.159 1.469 2.15 2.31 1.368 126.36 112 14.15 3.33 26.38 3.8
poly A 7B 3.337 1.56 2.14 2.33 1.431 133.48 90 12.01 3.33 24.97 4.0
poly A 7C 4.133 1.969 2.1 2.3 1.796 165.33 120 19.84 3.33 20.16 4.9
poly A 12A 1.127 0.522 2.16 2.47 0.456 45.09 102 4.60 3.33 73.93 1.3
poly A 12B 6.064 2.841 2.13 2.17 2.792 242.57 72 17.47 3.33 13.74 7.3
poly A 12C 3.601 1.683 2.14 2.28 1.581 144.05 66 9.51 3.33 23.14 4.3
Avg poly(A)+ yield 4.4%
Figure 4-2: Quantification of cDNA fractions on an ethidium bromide gel. (A) The cDNA
concentration for fraction 3 was estimated to be 5 ng/L, fractions 4 and 5 were estimated
to be 20 ng/L and fraction 6 to be 25 ng/L.  (B) Fraction 7 was processed at a later date
and had an estimated cDNA concentration of 40 ng/L. 
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Transformation of competent E.coli cells 
Following ligation of the cDNA fractions into the pBluescript II SK (+) vector 
the plasmids were transformed into chemically competent E.coli cells and plated 
onto selective Amp agarose plates and incubated overnight at 37ºC. The Kan-
resistance insert control cells were plated out on the Kan selective agar and the num-
ber of colonies was estimated at several thousand, which indicated high ligation effi-
ciency. The pUC18 cells failed to grow on Kan selective agar, whereas on Amp se-
lective agar the pUC18 cells formed a complete lawn on the surface. There were in 
excess of 500 distinct colonies on each of the cDNA-insert plates. 
Plasmid extraction and analytical digests 
Three colonies were picked at random from each plate and grown overnight in 
antibiotic selective media. The plasmid DNA extracted and 2 µL per samples was 
analysed on a 1% electrophoresis agarose gel and revealed the presence of plasmid 
DNA in all the samples (Fig. 4–3). 
Equal amounts of each sample were digested with XhoI and XbaI restriction 
enzymes and analysed on an agarose gel. This revealed the presence of cDNA inserts 
in all the samples, ranging in size from <500 bp to >3 kbp (Fig 4–4). The double di-
gest analysis suggested that some of the samples did not contain cDNA inserts, (e.g. 
lanes 6.1 and 6.3), but the subsequent sequencing revealed that all the selected colo-
nies had cDNA inserts; the inserts in plasmids 6.1 and 6.3 were 632 and 663 bp re-
spectively. 
Figure 4-3: Pilot ligation and transformation. Plasmid DNA was extracted from three colo-
nies from each plate and equal volumes were separated by electrophoresis through an
agarose gel, revealing the presence of plasmid DNA of various sizes. The “Fraction” labels
refer to the cDNA fraction from which the cDNA insert ligated with the pBluescript vector in
the subsequent ligation step was derived. 
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Sequencing results 
All plasmids isolated from the pilot ligation and the two subsequent ligations 
were submitted to AGRF for sequencing of the cDNA inserts. A detailed analysis of 
the sequencing results was undertaken by comparing the sequencing data with human 
and bovine mRNA transcripts in the Genbank database and is found in Appendix A. 
Table 3-3 shows the identity of the clones identified from the randomly picked colo-
nies. The average insert size was 1.1 kbp, ranging from 260 bp (clone p6.7) to 3.2 
kbp (clone p3.2). The sequences were assembled and edited on Windows Word 
2007, then formatted on the sequence submission tool Sequin (http://www.ncbi.nlm. 
nih.gov/projects/Sequin/) before being submitted to Genbank. All clones are listed in 
table 4–3; the complete Genbank sequence transcripts are found in Appendix C. 
  
Figure 4-4: The analytical digests revealed the presence of inserts in all of the plasmids, 
ranging in sizes from 500 bp to >3 kbp. Although there are no inserts visible in lanes 6.1 and
6.3 (bottom panel), sequencing confirmed that all of the isolated plasmids contained cDNA 
inserts. 
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Table 4-3: A list of all clones identified in the cDNA library, including ACTB, GAPDH and
TGF-3, which were isolated by PCR protocols. The complete Genbank sequence tran-
scripts are found in Appendix C. 
 
   
Clone ID Gene Description
Gene 
name
Ovine 
mRNA in 
GB
Insert 
size 
CDS 
coverage
GB acc- 
ession #
p3.1 Stearoyl-CoA desaturase variant A SCD1 no 1,402 no JX889613
p3.2 NIPA-like domain containing 3 NIPAL3 no 3,607 no JX889615
p3.3 Cbp/p300-interacting transactivator 2 CITED2 partial 1,518 complete JX534540
p3.4 Serpin peptidase inhibitor clade H member 1 SERPINH1 no 1,813 complete JX534537
p3.5 Proteasome (prosome, macropain) subunit, alpha type, 2 PSMA2 no 888 complete JX534539
p3.6 Annexin A5 ANXA5 no 1,729 partial JX534527
p3.7 MAX dimerization protein 4 MXD4 no 1,021 complete JX534542
p4.1 Peptidylprolyl isomerase A PPIA partial 717 complete JX534530
p4.2 Syntaxin 12 STX12 no 524 no JX889612
p4.3 Peroxiredoxin 5 PRDX5 no 791 complete JX889614
p4.4 Cystatin c CST3 no 724 complete JX534543
p4.5 Coiled-coil domain containing 80 CCDC80 no 1,434 partial JX534534
p4.6 Chromosome 12 open reading frame 29 C12orf29 no 1,176 complete HQ438587
p4.7 Cytochrome c oxidase subunit 3 COIII complete 754 partial JX534526
p5.1 Ribosomal protein L17 RPL17 no 632 complete JX534521
p5.2 Catenin (cadherin-associated protein), beta 1 CTNNB1 partial 817 partial JX534532
p5.4 Maspardin isoform b SPG21 no 933 partial JX534523
p5.5 Binding protein S1, serine-rich domain RNPS1 no 1,855 complete JX534545
p5.7 Vimentin VIM partial 1,509 partial JX534524
p6.1 CD9 molecule CD9 complete 626 partial JX534520
p6.2 Aminolevulinate, delta-, synthase 1 ALAS1 no 1,700 partial JX534541
p6.3 Kallikrein-related peptidase 7, pseudogene KLK7 Ψ no 670 N/A JX534538
p6.4 Phosphatidylinositol glycan anchor biosynthesis, class F PIGF no 944 complete JX534535
p6.5 Ribosomal protein S17 RPS17 no 484 complete JX534531
p6.6 Homocysteine-inducible, endoplasmic reticulum stress-
inducible, ubiquitin-like domain member 1
HERPUD1 no 762 partial JX534522
p6.7 Heat shock 70kDa HSP70 partial 268 no JX534525
p7.1 Mitochondrial DNA D-loop D-loop complete 764 no JX534533
p7.18 Ribosomal protein S8 RPS8 no 761 complete JX534536
p7.39 Tumor protein, translationally-controlled 1 TCTP partial 834 complete JX534529
p7.46 Ferritin, heavy polypeptide 1 FTH1 partial 929 complete JX534528
ACTB_SLIP Actin, beta ACTB complete 1,905 complete HM067830
GAPDH_MACH Glyceraldehyde-3-phosphate dehydrogenase GAPDH partial 1,285 complete HM043737
TGF-3_MACH Transforming growth factor, beta 3 TGF-3 partial 1,862 partial JX534544
No. of clones: 33                Average insert size (bp): 1,141  Range:  (0.27 - 3.6 kb)
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4.2.1 Isolation of GAPDH cDNA clone using the MACH protocol 
Results 
Three individual clones were isolated using the MACH isolation method 
adapted from Haerry and O’Connor (2002). All three clones contained a 1,285 nt 
cDNA which represented the full-length mRNA of Ovis aries GAPDH (Fig 4–5).  
These sequences contained the full ORF which translated into a 333 amino acid 
which was 99.4% identical (331/333) with Bos taurus GAPDH (NP_001029206). A 
BLASTP search revealed that Ovis aries GAPDH has a unique amino acid substitu-
tion variation at amino acid 23 (Fig 4–6). In the vast majority of mammalian species 
this residue is a serine (S), whereas in the sheep this residue is a threonine (T); the 
nomenclature for this variation is p.S23T (den Dunnen and Antonarakis, 2001). This 
amino acid variation is caused by nonsynonymous single nucleotide polymorphism 
(snSNP) on the first base of codon 23, which in most animals is TCT; in the sheep 
this codon is ACT (c.67T>A). Serine and threonine are both small hydrophilic amino 
acids which differ only in that threonine has a methyl group in place of a hydrogen 
group found in serine. This is therefore a conservative substitution since both amino 
Figure 4-5: Three cDNA clones were isolated using the MACH protocol. All three clones had
identical sequence which represented the full length mRNA sequence of Ovis aries GAPDH.
Asterisk (*) indicates perfect alignments.  
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acids can reside both within the interior and on the surface of a protein (Barnes and 
Gray, 2003).  
 
Figure 4-6: The Ovis aries GAPDH protein sequence. The sequence was derived from the 
GAPDH cDNA isolated from the cDNA library and is aligned with Bos taurus GAPDH. A 
BLASTP search revealed that the sheep has a unique amino acid substitution variation at 
amino acid 23 (p.S23T). Another amino acid substitution at position 55 (p.N55H) is not 
unique to the sheep.  
The mRNA sequence was compared with partial Ovis aries mRNA sequences 
in Genbank (AF035421 and AF272837), as well as an EST (Oa1229.1) from the Ovis 
aries EST library published by Hecht et al., (2006). A threonine codon was found at 
the same position in all three of these sequences, which suggests that the presence of 
this snSNP is not a sequencing artefact. The only other vertebrate species that ap-
pears to share the serine to threonine substitution at this position is the African bush 
elephant (Loxodonta africana), although this particular sequence was predicted by 
automated computational analysis from a genomic sequence (XM_003410789) and 
has therefore not been verified. There is an asparagines (N) to histidine (H) substitu-
tion at position 55 (p.N55H), which is caused by a first base adenine to cysteine sub-
stitution (c.163A>C); this is the only other amino acid substitution in Ovis aries 
GAPDH protein compared to Bos taurus GAPDH. This amino acid substitution is, 
unlike the p.S23T substitution, not unique to sheep; other animals such as pig 
>lcl|28619 Ovis aries GAPDH MACH (Query) vs Bos taurus GAPDH (Sbjct) 
Length=333 
 
 Score =  685 bits (1767),  Expect = 0.0, Method: Compositional matrix adjust. 
 Identities = 331/333 (99%), Positives = 333/333 (100%), Gaps = 0/333 (0%) 
 
Query  1    MVKVGVNGFGRIGRLVTRAAFNTGKVDIVAINDPFIDLHYMVYMFQYDSTHGKFHGTVKA  60 
            MVKVGVNGFGRIGRLVTRAAFN+GKVDIVAINDPFIDLHYMVYMFQYDSTHGKF+GTVKA 
Sbjct  1    MVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLHYMVYMFQYDSTHGKFNGTVKA  60 
 
Query  61   ENGKLVINGKAITIFQERDPANIKWGDAGAEYVVESTGVFTTMEKAGAHLKGGAKRVIIS  120 
            ENGKLVINGKAITIFQERDPANIKWGDAGAEYVVESTGVFTTMEKAGAHLKGGAKRVIIS 
Sbjct  61   ENGKLVINGKAITIFQERDPANIKWGDAGAEYVVESTGVFTTMEKAGAHLKGGAKRVIIS  120 
 
Query  121  APSADAPMFVMGVNHEKYNNTLKIVSNASCTTNCLAPLAKVIHDHFGIVEGLMTTVHAIT  180 
            APSADAPMFVMGVNHEKYNNTLKIVSNASCTTNCLAPLAKVIHDHFGIVEGLMTTVHAIT 
Sbjct  121  APSADAPMFVMGVNHEKYNNTLKIVSNASCTTNCLAPLAKVIHDHFGIVEGLMTTVHAIT  180 
 
Query  181  ATQKTVDGPSGKLWRDGRGAAQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTPNVSV  240 
            ATQKTVDGPSGKLWRDGRGAAQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTPNVSV 
Sbjct  181  ATQKTVDGPSGKLWRDGRGAAQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTPNVSV  240 
 
Query  241  VDLTCRLEKPAKYDEIKKVVKQASEGPLKGILGYTEDQVVSCDFNSDTHSSTFDAGAGIA  300 
            VDLTCRLEKPAKYDEIKKVVKQASEGPLKGILGYTEDQVVSCDFNSDTHSSTFDAGAGIA 
Sbjct  241  VDLTCRLEKPAKYDEIKKVVKQASEGPLKGILGYTEDQVVSCDFNSDTHSSTFDAGAGIA  300 
 
Query  301  LNDHFVKLISWYDNEFGYSNRVVDLMVHMASKE  333 
            LNDHFVKLISWYDNEFGYSNRVVDLMVHMASKE 
Sbjct  301  LNDHFVKLISWYDNEFGYSNRVVDLMVHMASKE  333
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(NP_001193288), rabbit (XP_002708267) and horse (NP_001157328) also have his-
tidine residues at position 55. The Ovis aries GAPDH mRNA sequence has been 
submitted to Genbank (HM043737). 
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4.2.2 Validation of the cDNA library 
The cDNA library was further validated by assaying the expression of a panel 
of genes that have been reported to be active in bone and cartilage. Another experi-
ment was also conducted assessing the osteogenic potential of a subset cell lines used 
for the cDNA library. Two cell lines each of mOBs, tOBs and BMSCs were exposed 
to osteogenic induction medium for 21 days, fixed with PFA then stained with ARS 
to determine the presence of mineralized nodules on the extra cellular matrix (ECM).  
 
Results – RT-qPCR 
The primers for the genes assayed are listed in table 3–4 on page 58 and were 
chosen among a number of primers that are routinely used in our laboratory to assess 
osteogenic and chondrogenic gene expression. The expression of the genes fell into 
four distinct levels, whose relative expression ranged across six orders of magnitude. 
The most highly expressed group of genes were type I collagen (COL1), connexin43 
(CX43) and transforming growth factor-beta 3 (TFG-3), whose relative expression 
is shown in Figure 4–7. 
 
Figure 4-7: Very highly expressed genes in the cDNA library. COL1, CX43 and TGF-3 were 
the most highly expressed of the genes assayed. The relative expression of each gene was 
normalised against GAPDH. 
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The expression of the second group of genes was three orders of magnitude 
less than the previous group. These genes included Heat shock protein 27 (HSP27), 
Twist, BMP2, Insulin-like growth factor 2 (IFG2), TGF-1, and ACAN. The relative 
expression of these genes is shown in Figure 4–8.  
Figure 4-8: Highly expressed genes in the cDNA library. The relative expression of HSP27, 
twist, BMP2, IGF2, TGF-1 and ACAN were three orders of magnitude less compared to the 
very highly expressed genes. 
The next category of genes based on relative expression levels were Dermo, Alkaline 
phosphatase (ALP), and BMP4, whose relative expression was five orders of magni-
tude less than the most highly expressed genes and is shown in Figure 4–9. 
 
Figure 4-9: Lowly expressed genes in the cDNA library. The relative expression of Dermo, 
ALP and BMP4 was five orders of magnitude less than the most highly expressed genes. 
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The genes with the lowest relative expression included BMP7, IGF1, Fibro-
blast growth factor receptor 2 (FGFR2), Osteocalcin (OCN), basic fibroblast growth 
factor (FGF2) and Osteopontin (OPN). The expression of these genes was six orders 
of magnitude less than the most highly expressed genes (Fig 4–10).  
Figure 4-10: Genes with the lowest expression in the cDNA library. These included BMP7, 
IGF1, FGFR2, OCN, FGF2 and OPN.  
Only on a logarithmic scale is it possible to view the relative expression of all 
the genes together on one graph (Fig 4–11).  
 
Figure 4‐11: The relative expression of all the genes tested  is shown here on a  logarithmic 
scale. 
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Assessing the mineralization potential of a subset of the cell lines used for 
the cDNA library 
This experiment was performed to assess the mineralization potential of the 
cell lines used for the cDNA library. Twelve days, the longest osteo-induction time 
point used for the cDNA library experiment, was insufficient amount of time for any 
direct evidence of mineralization of the ECM, which typically takes place between 
two to three weeks of exposure to the osteogenic induction medium (Zhou et al., 
2006). The mineralization was visualised by Alizarin Red S staining of the cells after 
being fixed in PFA and was a purely qualitative assessment as to whether the cell 
lines had mineralization potential.  
Results  
All six cell lines (2x BMSCs; 2x mOB; 2x tOB) responded in essentially simi-
lar fashion. The cell morphology of all the cell lines at day 0 is an elongated shape 
typical of fibroblastic cells (Wu et al., 2011) (Fig 4–12; Day 0). By day 12 all the cell 
lines had laid down an ECM seen as a criss-cross pattern (Al-Jallad et al., 2006; 
Hoemann et al., 2009). Inset image show day 12 control cells, which do not exhibit 
the ECM patterning seen in the osteogenic induction medium treated cells (Fig 4–12, 
Day 12). At day 21 all three cell types showed robust calcium deposits as seen by the 
Alizarin red stain, which is evidence that all three cells types had a similar response 
to the effect of the osteogenic medium.  
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Figure 4‐12: Effect of osteogenic  induction medium on BMSCs, mOBs, and tOBs. Bar = 300 
m.  
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4.3 C12ORF29 – EXPERIMENTAL RESULTS 
4.3.1 Subcloning and epitope tagging the C12orf29 cDNA clone 
Results 
The subcloning experiment produced two C12orf29 recombinant plasmids, one 
with an N-terminal HA tag, the other without an HA tag, both in pcDNA3.1+ vector 
backbones. In the initial cloning experiment the C12orf29 cDNA isolated in clone 
p4.6 was amplified by PCR. The 5’ end was engineered such that it would be ligated 
to the blunt end created by the EcoRV restriction enzyme. The reverse cloning 
primer was placed 47 bases downstream from the XhoI RE site, which would be cut 
with a XhoI enzyme. This was a directional cloning strategy, which produced 8 out 
of 10 positive clones on the first attempt. This early success was tempered by the 
discovery that the pcDNA3.1+ cloning vector did not contain an HA tag, as had been 
assumed. After a number of attempts failed to clone the C12orf29 cDNA with a 
57mer cloning primer, the retrofitting of an HA sequence on the original pcDNA-
C12orf29 plasmid succeeded on the second attempt.   
The sequencing data showed that 2 out of the 48 screened colonies, clones r6 
and r31, contained in-frame HA tags and the assembled sequencing reads confirmed 
that the inserted cDNAs had full length ORFs with in-frame stop codons. The com-
plete length of the recombinant protein was 347 amino acids (Fig 4–13), which is 23 
residues longer than the native protein. The theoretical molecular weight of this pro-
tein is 40 kDa, approximately 3 kDa larger than native C12orf29. 
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Figure 4-13: DNA and protein sequence of the recombinant HA-C12orf29 plasmids. The HA 
tag is shown highlighted in blue, the HindIII and BamHI insert sites are highlighted in yellow 
and grey respectively. The C12orf29 protein proper starts at the methionine at position 23.  
   
       1                                     M  Y  P  Y  D  V  P  D   
       1 gggagacccaagctggctagcgtttaaacttaagctatgtatccctatgacgtgcccgac 
 
       9 Y  A  G  D  P  L  V  Q  C  G  G  I  L  Q  M  R  R  L  G  S   
      61 tacgccggggatccactagtccagtgtggtggaattctgcagatgaggcgcttggggtcg 
 
      29 V  Q  R  K  M  P  C  V  F  V  T  E  V  K  E  E  P  S  T  K   
     121 gtgcagcggaaaatgccgtgtgtgtttgtgacggaggtgaaagaggagccttccaccaaa 
 
      49 R  E  H  Q  P  F  K  V  L  A  T  E  T  V  S  H  K  A  L  D   
     181 agggagcatcagccatttaaagttttggcaactgaaactgtaagtcacaaggcattagat 
 
      69 A  D  I  Y  N  A  I  P  T  E  K  V  D  G  T  C  C  Y  V  T   
     241 gcagatatatacaatgcaattccaacagaaaaagtggatggaacatgttgttatgttact 
 
      89 N  Y  K  G  Q  P  Y  L  W  A  R  L  D  R  K  P  N  K  L  A   
     301 aactacaaaggtcagccatacctctgggctcggctagataggaaacctaacaaattagct 
 
     109 E  K  R  F  K  N  F  L  H  S  K  Q  N  S  K  E  F  F  W  N   
     361 gagaaaagatttaaaaattttctacattcaaaacaaaactcgaaagaatttttttggaat 
 
     129 V  E  E  D  F  K  P  V  P  E  C  W  I  P  A  K  D  I  E  Q   
     421 gttgaggaggacttcaaacctgttccagagtgctggataccagcgaaggatatagaacag 
 
     149 L  N  G  N  P  M  P  D  E  N  G  H  I  P  G  W  V  P  V  E   
     481 ttaaatgggaatccgatgcctgatgaaaatggacacattcctggttgggtaccagtggag 
 
     169 K  N  N  K  Q  Y  C  W  H  S  S  V  V  N  Y  E  F  E  I  A   
     541 aaaaacaacaaacagtactgctggcattcgtctgtagtcaattacgagtttgagatcgcc 
 
     189 L  V  L  R  H  H  P  D  D  P  G  L  L  E  I  S  A  V  P  L   
     601 ctggtcctgaggcatcatcctgatgatcctggccttttggaaattagtgcagtgccgctc 
 
     209 S  D  L  L  E  Q  T  L  E  L  I  G  T  N  I  N  G  N  P  Y   
     661 tcagatcttctagaacaaacactggagctcataggaaccaatattaatggaaatccttat 
 
     229 G  L  G  S  K  K  H  P  L  H  L  L  I  P  H  G  A  F  Q  I   
     721 gggttaggaagcaaaaagcatccattacatcttcttataccacatggagcatttcaaata 
 
     249 R  N  L  P  T  L  K  H  S  D  L  L  S  W  F  D  G  C  R  E   
     781 agaaatctacctaccttgaagcacagtgatctgttgtcctggtttgatggttgcagagag 
 
     269 G  K  I  E  G  I  V  W  H  C  N  D  G  C  L  I  K  V  H  R   
     841 ggtaaaattgaaggaatagtatggcattgtaatgatggttgtttaatcaaggtccatcgc 
 
     289 H  H  L  G  L  C  W  P  I  P  D  T  Y  M  N  S  K  P  V  I   
     901 caccatcttggtttatgttggccgatcccagatacttatatgaattcaaaaccagttatt 
 
     309 I  N  M  N  L  N  K  Y  E  Y  A  F  D  A  K  C  L  F  N  H   
     961 atcaacatgaatctgaacaaatatgagtatgcctttgatgctaagtgtttgtttaatcat 
 
     329 F  S  K  I  D  N  Q  K  F  G  R  L  K  D  I  I  L  N  V  *   
    1021 ttttcaaaaatagacaatcagaaatttggtaggctcaaagatataatacttaatgtataa 
 
    1081 actggaagtgcaattaaaaaccagcttcattgttaaaaaaaaaaaaaaaaaactcgagt 
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4.3.2 Validating the specificity of the anti-C12orf29 antibodies  
Anti-human C12orf29 antibodies were released onto the market by three sepa-
rate vendors in 2011 and we collaborated with the company Everest Biotech in 2012 
to produce an anti-C12orf29 goat polyclonal antibody, hereafter referred to as EB49 
anti-C12orf29 antibody.  
Results 
The antibodies were tested for their specificity against the HA-tagged 
C12orf29 recombinant protein. The HA-C12orf29 protein, an HA-IMPDH and 
pcDNA3.1+ controls were overexpressed in CHO cells and the protein lysates sepa-
rated by SDS-PAGE and transferred to a nitrocellulose membrane, which was probed 
with the anti-C12orf29 antibodies.  
Comparing the Sigma, Abcam and Santa Cruz anti-C12orf29 antibodies  
Licor double antibody labelling experiment 
Three membranes were double-labelled respectively with the Sigma, Abcam 
and Santa Cruz antibodies and an anti-HA antibody. The anti-HA antibody was 
probed with an 800 nm fluorophore conjugated secondary antibody. The HA-
C12orf29 (arrow) and HA-IMPDH (arrowhead) proteins appears as green bands in 
panels A, B and C in figure 4–14. The anti-C12orf29 antibodies were probed with a 
Figure 4-14: Western blot experiment using the Licor double antibody labelling system. The
HA tagged recombinant proteins are seen here as green bands. The anti-C12orf29 antibod-
ies were probed with secondary antibodies with red fluorophores. In this experiment only the 
Santa Cruz antibody was capable of detecting the HA-C12orf29 recombinant protein (ar-
row).  
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680 nm fluorophore conjugated secondary antibody. Where the two secondary anti-
bodies co-localised they combine to produce a yellow signal and this is seen in panel 
C in the HA-C12 lane (arrow), which indicated that the Santa Cruz anti-C12orf29 
could detect the recombinant HA-C12orf29 protein. There was no evidence to sug-
gest that either of the Sigma or Abcam anti-C12orf29 antibodies could detect the 
HA-C12orf29 recombinant protein in the Licor double labelling system, and they 
failed to do so in repeat experiments (data not shown).  
WB experiment using ECL 
The samples used in the Licor double-labelling experiment above were sepa-
rated by SDS-PAGE, transferred to a membrane and blocked in 2% BSA and incu-
bated with the primary antibodies diluted in BSA/TBST. The antibodies were probed 
with horseradish peroxidise (HRP) conjugated secondary antibodies and the protein 
bands visualised with enhanced chemiluminescence (ECL).  
This experiment demonstrated that the Abcam anti-C12orf29 antibody could 
detect the HA-C12orf29 recombinant protein (Fig 4–15), albeit with a weak affinity.  
Figure 4-15: The Abcam anti-C12orf29 antibody detects the HA-C12orf29 recombinant pro-
tein but with a weak affinity (double headed arrow). The anti-HA antibody detects the recom-
binant protein at approximately 40 kDa (arrowhead). Images of the two membranes were
lined up side-by-side with the MW markers (dashed yellow lines). The anti-C12orf29 antibody
detects a protein at approximately 37 kDa (arrow). 
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The blots on the anti-C12orf29 antibody and anti-HA antibody membranes 
were compared by lining up their MW markers (dashed yellow lines; Fig 4–15). The 
recombinant protein (MW = 40 kDa) is seen above the dashed yellow line at 37 kDa 
(arrowhead), whereas that band that appears to be endogenous C12orf29 is just be-
low the dashed line (arrow). The recombinant protein in the Abcam blot is indicated 
by the double headed arrow. These results suggest that the Abcam anti-C12orf29 an-
tibody works better in conventional western blotting using a BSA blocking buffer 
than it does in the Licor blocking buffer and most likely detects the endogenous 
C12orf29 protein in the CHO cell lysates. 
3T3-E1 pre-osteoblast cell lysates 
Cell lysates from murine 3T3-E1 pre-osteoblasts were separated by SDS-
PAGE and transferred to membranes. The membranes were blocked in 2% BSA and 
incubated with Sigma, Abcam and Santa Cruz anti-C12orf29 antibodies and HRP 
conjugated secondary antibodies and visualized with ECL. This experiment showed 
that all three antibodies detected protein bands at the same MW and also that each 
antibody had quite varying signal intensity and therefore affinity for protein bands of 
different MWs (Fig 4–16). All three antibodies detected a protein just below the 37 
Figure 4-16: Anti-C12orf29 antibodies detect protein bands of the same molecular weight in
3T3-E1 cell lysates. (A) Sigma anti-C12orf29. (B) Abcam anti-C12orf29. (C) Santa Cruz
anti-C12orf29. All three antibodies detect the same size bands at just below the 37 kDa
marker (yellow arrows) and at approximately 60 kDa (yellow arrowheads).  
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kDa
kDa marker (yellow arrows) and also a ~60 kDa band (arrowheads).  
The Sigma anti-C12orf29 antibody is shown in panel A and required a 24 h ex-
posure time to produce a visible signal. Panel B shows the Abcam anti-C12orf29 an-
tibody and the exposure time here was also 24 h, which was needed to bring out the 
signal at 60 kDa (arrowheads). The 37 kDa band, on the other hand, was visible after 
just 1 min exposure and is therefore quite overexposed in this image (yellow arrow). 
The Santa Cruz anti-C12orf29 antibody blot, shown in panel C, only required a 5 s 
exposure; this was necessary to reduce the high background that otherwise com-
pletely obscured the bands seen here (Fig 4–16 C).  
C-28/12 human chondrocyte cell lysates 
The same panel of antibodies used for the 3T3 E1 cell lysates were used to 
probe cell lysates from the immortalized human chondrocyte cell line C-28/12 
(Loeser et al., 2000). All three antibodies detected a just below 37 kDa (Fig 4–17; 
yellow arrows). The ~37 kDa band in the Sigma blot (panel A) was quite faint com-
pared to the similar sized bands in the Abcam (panel B) and Santa Cruz blots (panel 
C). All three antibodies also detected a prominent band at ~50 kDa (Fig 4–17; yellow 
Figure 4-17: Anti-C12orf29 antibodies detect protein bands of the same molecular weight in
C-28/12 cell lysates. (A) Sigma anti-C12orf29. (B) Abcam anti-C12orf29. (C) Santa Cruz
anti-C12orf29. All three antibodies detect bands at approximately 37 kDa (yellow arrows) as
well as at 50 kDa (yellow arrowheads).  
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arrowheads). There was also a band at ~75 kDa that all three antibodies detected, al-
though this band was difficult to resolve in the Santa Cruz blot due to high level of 
background signal. The 75 kDa bands were also seen in the 3T3-E1 Sigma and Ab-
cam blots but the Santa Cruz blot did not have a distinct band at 75 kDa (Fig 4–16). 
Comparing the Abcam, Santa Cruz and Everest anti-C12orf29 antibodies  
In early 2012 we contracted with the UK based firm Everest Biotech to de-
velop an anti-human-C12orf29 antibody and delivery was taken of this antibody me-
dio 2012. The Everest anti-C12orf29 antibody, hereafter referred to as EB49, was 
tested on overexpressed C12orf29 lysates from CHO cells.  
Licor antibody labelling experiment 
The CHO cells were transfected with the HA-C12orf29 and pcDNA-C12orf29 
plasmids and cell lysates harvested after two days. The lysates were separated by 
SDS-PAGE and transferred to nitrocellulose membranes, which were blocked in 
Licor blocking buffer, and the membranes were incubated with EB49, Santa Cruz or 
Abcam anti-C12orf29 antibodies. As was the case in previous Licor based WB ex-
periments (e.g. Fig 4–14), the Abcam antibody failed to work in the Licor buffer 
(data not shown). The EB49 and the Santa Cruz antibodies, on the other hand, both 
detected the pcDNA-C12orf29 and HA-C12orf29 recombinant proteins (Fig 4–18 
A&B). The non-epitope tagged C12orf29 plasmid appears to have a much higher 
pcDNA‐
C12orf29
CHO 
control
HA‐
C12orf29
pcDNA‐
C12orf29
CHO 
control
HA‐
C12orf29
EB49 C12orf29 Santa Cruz C12orf29
37
50
75
A B
* *
kDa
#
+
Figure 4-18:  EB49 and Santa Cruz anti-C12orf29 antibodies were tested on CHO cell lys-
ates overexpressing recombinant C12orf29. Both antibodies detect recombinant C12orf29
proteins (arrows and arrowheads) as well as endogenously expressed C12orf29 (*). The
bands at ~60 kDa (#), 50 (star), and ~20 kDa (+) do not reciprocally co-localise on the two
membranes. (Data courtesy of Ms Sahar Keshvari, MMRI) 
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protein expression (arrow) than does the HA-tagged C12orf29 plasmid (arrowhead), 
which suggests that the presence of the HA tag impedes protein expression. Both an-
tibodies detect a ~37 kDa protein in the CHO control lanes (*), most likely endoge-
nously expressed C12orf29. Whereas the EB49 antibody detects a relatively uni-
formly expressed band at approximately 50 kDa across the three samples (star), the 
Santa Cruz antibody detects bands across all three samples at ~60 kDa (#) and at ~ 
20–25 kDa (+). Since these bands do not reciprocally co-localise one cannot immedi-
ately assume these protein bands are C12orf29.  
Comparing Abcam and EB49 anti-C12orf29 antibodies by ECL  
Cell lysates from murine 3T3-E1 pre-osteoblasts were separated by SDS-
PAGE and transferred to membranes. The membranes were blocked in 2% BSA and 
incubated with Abcam and EB49 anti-C12orf29 antibodies and HRP conjugated sec-
ondary antibodies and visualized with ECL. Both antibodies detected a strong band 
at 50 kDa (dashed double headed arrow) (Fig 4–19). The Abcam antibody detected a 
strong band at 37 kDa (arrowhead), whereas the EB49 antibody produced a relatively 
faint yet distinct signal at the same MW (arrowhead); both antibodies detected a faint 
band at ~30 kDa (arrow).   
   
Figure 4-19: The Abcam and EB49 anti-C12orf29 antibodies were tested on 3T3-E1 cell
lysates. Both antibodies detected a robust band at 50 kDa (dashed double headed arrow)
and a faint band at ~30 kDa (arrow). The Abcam antibody detected a strong band at ~37
kDa (arrowhead), whereas the EB49 antibody detected a distinct but fainter band at this
MW (arrowhead). 
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4.3.3 Immunofluorescent microscopy 
Laser confocal and immunofluorescent microscopy was performed to visualize 
the cellular distribution of C12orf29 in various cell types. The cell types shown here 
are 3T3-E1 pre-osteoblast cells, sheep periodontal ligament (PDL) and mOB cells, 
and human PC3 cells.  
Results – IF microscopy  
HA-C12orf29 Transfected Cells 
The HA-C12orf29 transfected cells were probed with a mouse monoclonal 
anti-HA antibody (Santa Cruz) and Alexa Fluor 488 conjugated secondary antibody. 
The nucleus was visualized with DAPI stain (blue) and the cytoskeleton with Phal-
loidin (red). The images were captures with a Leica SP5 confocal microscope. The 
Figure 4-20: Murine 3T3-E1 cells transfected with HA-C12orf29 plasmid and probed with an
anti-HA antibody. The recombinant protein can be seen as a green punctuate stain in the
cytosol of the cells. Inset, a non-transfected 3T3 E1 cell probed with anti-HA antibody shows
no evidence of non-specific staining. 
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HA-C12orf29 recombinant protein can be seen as a punctuate stain in the cytosol 
(Fig 4–20). Non-transfected controls showed no staining in the green channel, sug-
gesting an absence of non-specific staining with this antibody. The recombinant ex-
pression seen in these cells suggested a cytosolic localization of the protein and was 
therefore an indication of where to expect to see the endogenous C12orf29 expres-
sion.  
 
Sheep mandible osteoblast cells  
Sheep mOBs were labelled with the Abcam anti-C12orf29 antibody, Phalloidin 
and DAPI and images captured by laser confocal microscopy (Fig 4–21). The 
C12orf29 proteins are seen in main image as large intracellular aggregates and also 
as a fine punctuate stain similar to that seen in the figure 4–20 above. 
Figure 4-21: Sheep mandible osteoblast cells labelled with Abcam anti-C12orf29 antibody 
and Phalloidin/DAPI. The C12orf29 is seen as green intracellular aggregations. There is also 
a finer punctuate stain throughout the cytosol. Images were captured on a Leica SP5 laser 
confocal microscope. Bar = 20 m. 
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Sheep periodontal ligament cells 
In sheep PDL cells the C12orf29 expression is similar to that is seen in the os-
teoblast cells with a punctuate distribution throughout the cytosol (Fig 4–22). A 
prominent ridge of aggregated proteins can be seen in the cell in the centre of the im-
age (arrows), and a Z stack analysis of this area showed a high accumulation of pro-
tein within a defined area near the cell surface (data not shown). This pattern of ac-
cumulation suggests the protein is being secreted out of the cell via the cell’s secre-
tory pathways.  
 
Figure 4-22: Sheep PDL cells labelled with Abcam anti-C12orf29 antibody and Phal-
loidin/DAPI. There is a prominent ridge of aggregated protein (arrows) that appears to accu-
mulate near the cell surface, which suggests it is being secreted out of the cell. Image cap-
tured by a Leica SP5 laser confocal microscope. Bar = 20 m. 
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Figure 4-23: Sheep PDL cells. The C12orf29 protein appears to accumulate at the edges of 
many of the cells (arrowheads). It is noteworthy that the expression is not uniform across all 
the cells, with some cells having little or no C12orf29 expression at all (arrows). Images were 
captured on a Carl Zeiss AxioScope fluorescent microscope. Bar = 20 m. 
Figure 4–23 show a number of cells with areas of high protein accumulation 
(arrowheads) and also reveals that expression is not uniform in every cells, with a 
number of cells expressing little or no C12orf29 protein at all (arrows). 
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Figure 4-24: PC3 cells labelled with Abcam anti-C12orf29 and Phalloidin/DAPI. The 
C12orf29 signal is faint and more or less uniform in every cell. The images were captured by 
confocal microscopy with gain and exposure settings the same as those used in figures 4–21 
and 22.  Bar = 20 m. 
PC3s are human prostatic carcinoma cells of epithelial origin (Kaighn et al., 
1979). They were useful controls to the primary mOB and PDL cells, which are mes-
enchymal of origin. The images shown in figure 4–24 were captured using the same 
gain and exposure as those used for figures 4–21 and 4–22. The C12orf29 expression 
in the PC3 cells is shown to be uniform and faint when compared to mOB and PDL 
cells. This pattern of expression suggests that endogenous protein expression of 
C12orf29 is significantly greater in mesenchymal cell types than epithelially derived 
cells. 
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4.3.4 Immunohistochemistry 
Results – IHC  
Normal human full thickness articular cartilage 
The full thickness cartilage samples were from the lateral compartment of the 
tibial head of a knee collected from a patient undergoing full knee replacement sur-
gery. The safranin O stain (Fig 4–25 A) shows an intense red staining indicative of 
high concentration of mucopolysaccharides. There is a slight fraying of the upper 
surface of the cartilage; however, the overall appearance is of normal and functional 
cartilage. The arrows indicate the tidemark, which is the border between the non-
calcified (NCC) and calcified cartilage (CC), whereas immediately underneath can 
be seen the boundary (arrowheads) between the CC and subchondral bone (SCB).  
The C12orf29 antibody staining is distinct but shows a slightly different distri-
bution between the Abcam and EB49 antibodies.  
The Abcam antibody (Fig 4–25 B) show faint staining of the superficial layer 
of the cartilage, but strong staining in the middle and deep layers. The staining is 
seen throughout the extracellular structure of the cartilage, extending right down to 
the SCB, where it stops. In the middle layers there appears to be a halo of fainter 
staining surrounding the embedded chondrocytes, whereas in the deep layer the op-
posite effect is seen, with a ring of stronger staining surrounding the chondrocytes 
and also intracellular staining, seen as darker points within the centers of these rings.  
Compared to the Abcam antibody, the EB49 antibody (Fig 4–25 D) stain ap-
pears to extend into the superficial layer of the cartilage. There is little evidence of 
intracellular staining in the superficial and middle layers, but there is relatively 
strong staining surrounding the cells in the deep layer of the cartilage. The staining 
stops at the border of the SCB, which is easily distinguishable in this sample. 
The COL2 antibody staining is seen throughout the sample (Fig 4–25 C). In the 
upper and middle layers of the cartilage there is strong staining surrounding the cells. 
The extracellular staining is most intense in the lower middle and upper deep layers 
and becomes faint in the lower deep layer towards the SCB border. In contrast to the 
C12orf29 stains, COL2 staining can be seen in the SCB below the borderline (arrow-
heads).  
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Figure 4-25: Normal human full thickness articular cartilage. (A) Safranin O staining shows 
the normal distribution of mucopolysaccharides in articular cartilage. The border between 
NCC and CC is seen at the arrows, whereas arrowheads delineate the SCB. (B) Distribution 
of C12orf29 as revealed by the Abcam C12orf29 antibody. The expression is seen in the 
middle (m) and deep (d) layers of the cartilage. (C) COL2 expression is seen throughout the 
cartilage with the strongest expression in the lower middle and upper deep cartilage. The 
expression extends into the SCB. (D) Distribution of C12orf29 as revealed by the EB49 
C12orf29 antibody. Unlike that Abcam antibody, with the EB49 antibody the expression of 
C12orf29 can be seen in the superficial layer (s) of the cartilage. Bar = 1 mm. 
 
Osteoarthritic human articular cartilage 
The osteoarthritic cartilage samples were from the medial compartment of the 
tibial head from the same patient. The safranin O staining (Fig 4–26 A) reveals that 
the superficial and much of the middle layer of the cartilage has eroded compared to 
that shown in the normal cartilage. The distribution pattern of C12orf29 as revealed 
by the Abcam (Fig 4–26 B) and EB49 (Fig 4–26 D) C12orf29 antibodies are near 
indistinguishable, with staining strong in the upper layers and tapering off towards 
the SCB. There is little or no expression in the CC (arrows) or the SCB in the region 
below the boundary delineated by arrowheads, but osteocytes in the SCB show 
C12orf29 positive staining. COL2 expression (Fig 4–26 C) in seen throughout the 
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SafraninO
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d
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sample, and is similar to the C12orf29 expression in the cartilaginous areas. COL2 
staining can also be seen in the extracellular SCB below the cartilage/SCB border.  
 
Figure 4-26: Osteoarthritic human articular cartilage. (A) Safranin O staining shows that the 
superficial and much of the middle layer cartilage has been eroded away. The CC and SCB 
areas are not affected, having similar appearance to the normal cartilage in the figure above. 
(B) Distribution of C12orf29 as revealed by the Abcam C12orf29 antibody. There is strong 
expression in the NCC, which becomes sparser in the CC and not extending beyond the 
SCB border; however, osteocytes in the SCB stain weakly positive for C12orf29. (C) COL2 
expression in the cartilage shows a distribution similar to that of C12orf29; however, in con-
trast to C12orf29, there is COL2 expression in the SCB and embedded osteocytes. (D) Dis-
tribution of C12orf29 as revealed by the EB49 antibody. The pattern of staining is indistin-
guishable to that seen in panel B, with no C12orf29 expression in the SCB. Bar = 1 mm. 
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Rat tibial head  
Rat tibial heads were harvested from 2 months old animals that were normal 
controls in other experiments. The Safranin O staining show the position and extent 
of the growth plate, in what was still a growing animal at the time of harvesting (Fig 
4–27 A; arrows). The expression of C12orf29 and COL2 can be seen along the 
length of the growth plate (Fig 4–27 B, C, D; arrows).  
 
Figure 4-27: Rat tibial head showing the growth plate and trabecular bone. (A) Safranin O 
staining showing the extent of the growth plate (arrows) and the articular cartilage at the top 
of the tibial head. (B) Distribution of C12orf29 as revealed by the Abcam antibody is seen in 
the growth plate (arrows). (C) Strong COL2 expression is seen along the growth plate (ar-
rows) and also as a weaker staining throughout the articular cartilage and SCB. (D) Distribu-
tion of C12orf29 as revealed by the EB49 antibody is seen as a distinct and clearly defined 
band along the growth plate. Bar = 1 mm. 
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Rat femoral head growth plate 
Rat femoral head samples were harvested from 2 month old animals. The Sa-
franin O staining show a close-up section of the growth plate with the underlying 
trabecular bone (Fig 4–28 A). In simple terms, the growth plate can be divided into 
two zones: the zone of proliferating chondrocytes (P), and the zone of hypertrophic 
chondrocytes (H). In the proliferative zone immature chondrocytes undergo cell divi-
sion and organize in a column-like orientation where they produce large amounts of 
Figure 4-28: Rat femoral head growth plate. (A) Safranin O staining show the presence of 
large amounts of ECM proteins in the proliferative (P) and hypertrophic (H) zones of the
growth plate, which persists in the trabecular bone (arrows). (B) The Abcam C12orf29 anti-
body shows strong C12orf29 expression in the hypertrophic zone (arrowheads) and in the
trabecular bone (arrow). (C) COL2 expression is seen in proliferative zone, particularly in the
vicinity of the cell columns (arrowheads). Expression in the trabecular bone is less pro-
nounced (arrows). (D) The EB49 antibody reveals C12orf29 expression predominantly in the
proliferative zone (arrowheads) rather than the hypertrophic zone as seen in panel B. There
is distinct expression of C12orf29 in the trabecular bone (arrows) but not as strong as in 
panel B. Bar = 500 m. 
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ECM proteins, which is evident by the Safranin O staining. At some point during the 
proliferating stage the cells enter into the prehypertrophic stage, after which they stop 
dividing and become hypertrophic, which is characterized by a large rounded ap-
pearance and secretion of copious amounts of ECM protein (van der Eerden et al., 
2003), which persists in the newly formed trabecular (arrows).  
The Abcam anti-C12orf29 antibody (Fig 4–28 B) detects strong C12orf29 ex-
pression in the hypertrophic zone of the growth plate (arrowheads) and also in the 
trabecular bone (arrows), in areas that would appear to co-localize with the safranin 
O staining of the trabecular bone in panel A.  
The EB49 antibody (Fig 4–28 D) reveals strong C12orf29 expression in the 
proliferative zone (arrowheads) and significantly less expression in the hypertrophic 
zone. There is evidence of C12orf29 expression in the trabecular bone, but this ex-
pression is less pronounced than that seen with the Abcam antibody in panel B. 
The COL2 antibody (Fig 4–28 C) shows strong COL2 expression in the prolif-
erative zone, particularly within the cell columns (arrowheads). COL2 expression in 
the trabecular is relatively weak (arrows), compared to that of C12orf29, particularly 
with the Abcam antibody in panel B 
Mouse embryos (13.5 dpc) 
Safranin O staining of the 13.5 dpc mouse embryo suggest there are limited 
amounts of mucopolysaccharides at this stage of murine development, judging by the 
low intensity of the red colour (Fig 4–29 A) There are two areas staining orthochro-
matically for ECM proteins: the shoulder region (yellow arrowhead) and the hip re-
gion (yellow arrow). The black arrowheads show the parietal cartilage anlagen of the 
forebrain (fb) and hindbrain (hb) cranial vaults. The Abcam C12orf29 antibody 
stains strongly in the cartilage anlagen in general, particularly on the external edge of 
the cranial vaults (Fig 4–29 B; arrowheads). There is also strong staining of the hind 
limb (arrow). A similar pattern of staining is seen with the EB49 C12orf29 antibody 
(Fig 4–29 D). The parietal anlagen show staining of the external edge and a slightly 
lighter staining across the anlagen (arrowheads). There is strong C12orf29 staining of 
the hind limb (arrow) but little discernible staining of the fore limb. COL2 staining is 
also visible along the forebrain cranial vaults (Fig 4–29 C; arrowheads). There is 
strong staining of the skeletal elements of the front limb (yellow arrows) and hind 
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limb (red arrows) as well as the shoulder area (star) Inset in panel A shows there is 
little or no non-specific staining of the no primary antibody control. 
 
Figure 4-29: Mouse embryo at 13.5 dpc. (A) Safranin O staining suggests there are low 
amounts of ECM proteins in the skeletal elements at this stage of development, with the ex-
ception of the shoulder region (yellow arrowhead) and hip region (yellow arrow). The parietal 
bones of the skull are formed by membranous ossification on a non-mineralizing cartilage 
anlagen seen at the forebrain (fb) and hindbrain (hb) vaults (arrowheads). Inset: no primary 
antibody control. (B) The Abcam C12orf29 antibody detects C12orf29 protein expression 
permeating throughout the parietal cartilage anlagen and the expression is highest along the 
external edge of the cranial vaults (arrowheads). There is a granular expression in the cra-
nial mesenchymal cells at the base of the chondrocranium (*). Strong C12orf29 expression is 
seen in the hind limb (arrow). (C) COL2 expression is seen throughout the parietal anlagen 
(arrowheads) and also in the fore limb (yellow arrows), hind limb (red arrows) and shoulder 
(star). (D) The EB49 antibody detects C12orf29 expression on the outer edge of the cranial 
vaults (arrowheads), but unlike the Abcam C12orf29 antibody, has a more limited expression 
pattern that does not extend to the floor of the forebrain cranial vault. Some limited C12orf29 
staining can be seen in the hind limb (arrow).   Bar = 1 mm.  
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Human embryo sample (7–8 weeks of gestation) 
The safranin O staining shows the ventral view of the axial skeletal elements of 
the lower half of the developing human spine (Fig 4–30). Ribs VIII, IX and X, has 
the most intense safranin O staining, suggesting they, at this particular stage of de-
velopment, have a higher concentration of ECM proteins than in the floating ribs (XI 
and XII) and the vertebrae. The sacral and tail bone elements have only just fused 
and S4, S5 and the coccyx have yet to produce any detectible ECM. The right femur 
has some trace of ECM, whereas no ECM is seen in the ilium, which forms the up-
permost part of the pelvis.   
 
Figure 4-30: Human embryo sample at 7–8 weeks of gestation, showing the lower half of the 
developing spine and five of the ribs. The thoracic vertebrae T8 to T12 and the partial T7 all 
show some degree of ECM protein, whereas the lumbar and sacral vertebrae show little 
ECM protein expression at this early stage of development. In this section the sacrum and 
coccyx vertebrae have only just fused in the middle. Bar = 1 mm.  
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Type II collagen expression in the developing axial skeleton 
COL2 expression was seen in all of the skeletal elements, particularly the ribs 
(arrowheads), femur (arrow) and ilium (star), with relatively lower expression seen in 
the vertebrae (Fig 4–31). The samples required heat based antigen retrieval (HBAR) 
for the COL2 antibody to produce a signal.  
COL2 is expressed in the human embryo in precartilaginous mesenchymal 
cells from 5 weeks of gestation and its expression persists in the axial skeleton until 
the onset of osteogenic differentiation in weeks 11 and 12 (Krengel et al., 1996).  
   
Figure 4-31: COL2 expression in the developing human axial skeleton. The COL2 protein
expression is seen in all the skeletal elements, with the highest expression seen in the ribs
(arrowheads), femur (arrow) and ilium (star). HBAR was necessary for the COL2 antibody
to produce a signal. Bar = 1 mm. 
COL2
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C12orf29 expression in the developing axial skeleton – Abcam C12orf29 
With the Abcam C12orf29 antibody the expression of C12orf29 in the develop-
ing spine shows a very specific distribution, being limited only to the skeletal ele-
ments (Fig 4–32). The no primary antibody control shows there is no non-specific 
staining resulting from the secondary antibodies (inset panel A). Panel B is a high 
magnification of a section of T8 and is representative of both the ribs and vertebrae. 
Figure 4-32: C12orf29 expression in the developing axial skeleton of a human embryo at 7–8
weeks gestation using the Abcam C12orf29 antibody. The expression of C12orf29 is strictly
limited to the skeletal elements, which at this stage have not yet ossified. (A) No primary an-
tibody control. There is a complete absence of non-specific signal from the secondary anti-
body. (B) High magnification of an area of T8 shows a representative image of the densely
packed chondrocytes of the vertebrae and ribs. The C12orf29 expression is seen in the ECM
(arrows). (C) C12orf29 expression in the sacral vertebrae shows extremely high expression
at the edges of the still unfused segments (arrowheads). Vertebras S1 (panel C) and S2
(main image) still have very high levels of C12orf29 expression in the region where the ver-
tebrae have just fused (*). Main image bar = 1 mm. Panel B bar = 50 m. 
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It shows strong C12orf29 expression in the ECM, between the densely packed chon-
drocytes (arrows) but is not expressed intracellularly. Panel C shows the sacrum and 
coccyx. In this particular section, which is from the same series of sections as the 
main image, only S1 has completely fused; in the main image both S1 and S2 are 
fused. There is extremely high C12orf29 expression at the edges of the unfused ver-
tebrae (arrowheads) and also very high expression in the newly fused S1 and S2 ver-
tebrae (*).  
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C12orf29 expression in the developing axial skeleton – EB49 C12orf29 
The EB49 C12orf29 antibody failed to produce a signal in the human embryo 
sample when using proteinase K antigen retrieval (data not shown). The samples 
were therefore subjected to heat based antigen retrieval (HBAR) and probed with an 
EB49 antibody dilution of 1:50. This produced a positive staining pattern that dif-
Figure 4-33: C12orf29 expression in the developing axial skeleton of a human embryo at
7–8 weeks gestation using the EB49 C12orf29 antibody. The staining is not strictly limited
to the skeletal elements as was seen with the Abcam C12orf29 antibody. (A) No primary
antibody control shows an absence of non-specific staining from the secondary antibodies.
(B) There is a strong pattern of staining of the perichondrium surrounding the ribs (arrow-
heads) as well as the vertebrae (arrows). There is a granular staining pattern within the ribs
and vertebrae, which contrasts with the ECM staining seen with the Abcam antibody. (C) In
the sacrum there is strong staining at the edges of S4 (arrowheads) and also in the join
between the two halves of S3 (arrow.). There is strong staining of the IVDs (#), which is not
seen with the Abcam antibody. However, the relatively stronger staining seen in S1 and S2
mirrors that seen in the Abcam antibody image, albeit far less intense. Bar = 1 mm. 
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fered considerably from the Abcam antibody in that it was not limited to the skeletal 
elements (Fig 4–33). There is stronger staining around the skeletal elements, in par-
ticular the perichondrium surrounding the ribs (Inset B, arrowheads) and IVDs (Inset 
B, arrows). In the sacrum, there is very intense staining seen in the join between the 
two halves of the S3 vertebrae (Inset C, arrow), at the edges of the unfused S4 verte-
brae (Inset C, arrowheads) and also in the IVDs (Inset C, #). There is also higher 
ECM staining in the S1 and S2 (Inset C, *), which mirrors the Abcam antibody stain-
ing (Fig 4–32 C); although the overall level of the EB49 staining is nowhere near as 
intense. An HBAR treated control, in which the primary antibody was omitted, show 
no evidence of non-specific staining from the secondary antibody (Fig 4–33 A).  
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SOX9 and BAPX1 expression in the developing axial skeleton 
SOX9 and BAPX1 are both important transcription factors involved early in 
axial development (Kawato et al., 2012; Yamashita et al., 2009). For this reason an-
tibodies for these transcription factors were applied to the human embryo samples to 
investigate their expression in the developing vertebrae. The interpretation of the 
SOX9 results are challenging since the staining appears to be quite non-specific (Fig 
4–34 A). There appears to be strong staining the perichondrial layer surrounding the 
ribs (red arrows). Other areas of strong staining are just rostral to the intervertebral 
discs (IVDs), and which could potentially be remnant caudal sclerotome (yellow ar-
rows). This interpretation is favoured over the notion that these are neuronal tissues, 
primarily because the BAPX1 antibody also stains positive for this area (Fig 4–34 B, 
SOX9 BAPX1
A B
Figure 4-34: SOX9 and BAPX1 expression in the developing human axial skeleton. (A) The
interpretation of the SOX9 data was made difficult by seemingly high non-specific staining. 
There appears to be strong staining in the perichondrium of the ribs (red arrow), as well as 
areas just rostral to the IVDs (yellow arrows). The IVDs also display some SOX9 expression
(red arrowheads) (B) The BAPX1 expression appears to be highly specific to the same area 
as SOX9 (yellow arrows). Bar = 1 mm. 
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yellow arrows) and neither transcription factors are reported to be expressed in neu-
ronal tissues. It appears that SOX9 stains specifically in the IVDs (red arrowheads). 
It has recently been reported that SOX9 play an important role in the maintenance of 
postnatal IVD (Henry et al., 2012) and it is therefore likely it is expressed embryoni-
cally in these tissues.  
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4.3.5 Real time quantitative PCR analysis 
Real time quantitative PCR (RT-qPCR) analysis was performed to determine 
the gene expression of C12orf29 in osteoblasts and BMSCs in standard growth me-
dium and osteogenic induction medium.  
Results 
Primer specificity 
The melt curve analysis of the sheep specific C12orf29 primers showed a 
sharp, single peak at 77oC, indicating that the primers did not produce any non-
specific products (Fig 4–35).  
C12orf29 gene expression 
The gene expression of C12orf29 was compared between control cells growing 
in standard growth medium and cells grown in osteogenic induction medium. The 
tOB sample showed C12orf29 gene expression peaking at 1 week, with the relative 
expression nearly doubling compared to the 1 week control (Fig 4–36 A). The mOB 
samples showed a biphasic C12orf29 gene expression in response to the treatment 
medium at the 72 h and 3 week time points. At both of these time points the gene ex-
pression doubled compared to the corresponding control time point (Fig 4–36 B). 
The BMSC samples showed a linear increase of gene expression in response to the 
osteogenic medium. The gene expression nearly doubled in the treatment sample at 
week 3 compared to the control, whereas compared to the 6 h time point there was a 
300% increase in gene expression (Fig 4–36 C). The Wilcoxon signed rank test 
Figure 4-35: The melt curve analysis for the sheep C12orf29 primers produced a single, 
sharp dissociation curve, indicating an absence of non-specific amplification. 
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analysis supported the hypothesis that the gene expression of C12orf29 was greater 
in response to the osteogenic induction medium compared to the control. (For calcu-
lations see Appendix E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 4-36: RT-qPCR analysis showed there is clear effect of osteogenic induction me-
dium on the gene expression of C12orf29 in all three cell lines assayed. (A) In tOBs the
gene expression peaked at 1 week and was nearly twice as high as the 1 week control.
(B) The gene expression on mOBs showed a biphasic expression in response the osteo-
genic induction medium with two distinct peaks at 72 h and 3 weeks. (C) The BMSCs had
a linear increase of C12orf29 gene expression in response to the osteogenic induction
medium; there was a three-fold increase in gene expression from 6 h to 3 weeks in the
treatment group. 
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4.3.6 WB analysis of C12orf29 protein expression in sheep primary cells 
In this experiment primary cells derived from periodontal ligament (PDL), 
mandible bone (mOB) and femur bone (fOB) from sheep were treated with osteo-
genic induction medium for 3 and 12 days. The purpose with this experiment was to 
explore whether there was a discernible change in C12orf29 protein expression in 
response to this treatment.  
Results 
 The Abcam C12orf29 antibody detected a band of proteins with a molecular 
weight of approximately 37 kDa, whereas the Santa Cruz C12orf29 antibody failed 
to detect any proteins of this size (Fig 4–37 A). Whereas the Abcam C12orf29 anti-
body did not work in the Licor buffer system, the -Tubulin antibody produced a 
good signal and it was therefore possible to perform densitometric analysis of the 
C12orf29 expression relative to the tubulin housekeeping gene. The densitometry 
analysis was performed using ImageJ. This analysis showed a steady-state protein 
expression in both the PDL and fOB samples whereas the mOBs suggested a robust 
upregulation at day 12 (Fig 4–37 B).  
 
   
Figure 4-37: WB analysis of cell lysates from sheep primary cells treated with osteogenic
induction medium. The relative expression of C12orf29 was normalised to -Tubulin ex-
pression. 
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4.4 C12ORF29 – BIOINFORMATICS ANALYSES 
Bioinformatics has become increasingly central to research in the molecular 
life sciences and analyses of a gene using bioinformatics tools can reveal information 
that allows a researcher to begin to piece together possible biological roles of a gene 
of unknown function. The number of fully sequenced genomes is increasing rapidly 
and the ease with which this information can be accessed has made the data mining 
and analyses of these databases a powerful option for biological research (Gustafson 
et al., 2006; Schneider et al., 2010; Yang and Bielawski, 2000). This section deals 
with the results of analyses, in which the phylogenetic relationship and potential 
regulatory pathways of C12orf29 – in terms of the gene’s place in biological time 
and space, and features and characteristics of its cis-regulatory region – provide an 
intellectual foundation on which to formulate hypotheses to inform targeted future 
experiments.  
4.4.1 Phylogenetic analyses 
Phylogenetic analyses of C12orf29 protein suggest a prokaryote origin  
When the initial BLAST search was performed with the Ovis aries C12orf29 
sequence, the focus was on analysing its phylogeny in relation to other mammals and 
higher vertebrate species such as birds, reptiles and teleost fish. The BLASTP search 
returned orthologs in all vertebrates, and also flagged hypothetical proteins in bacte-
ria, but these similarities did not at first glance seem close enough to warrant further 
attention. It was only after a thorough study of the vertebrate C12orf29 orthologs that 
the prokaryotic sequences were looked at in greater detail. An inferred protein se-
quence from the -proteobacteria species Hahella chejuensis (Jeong et al., 2005) was 
aligned against the human C12orf29 sequence and C12orf29-like sequences from the 
most basal species carrying this gene: the acorn worm Saccoglossus kowalevskii, the 
Florida lancelet Branchiostoma floridae, the sea squirt species Ciona intestinalis and 
Ciona savignyi, and the amoeboflagellate Naegleria gruberi. The assembled se-
quences were analysed using the COBALT platform on the NCBI website. The 
alignment file generated from this program was imported into the ClustalX program 
which colours the bases, making visual assessment of the alignment easier. ClustalX 
also indicates amino acid positions that are completely conserved with an asterisk 
(*); positions with strongly conserved amino acid groups with a colon (:); and 
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weaker conserved amino acid groups with a full stop (.) above the alignments. This 
analysis revealed a high degree of sequence homology between the -
proteobacterium Hahella and the eukaryotic species (Fig 4–37).  
Results 
The inferred sequence of the Hahella chejuensis HCH_06039 protein shows a 
clear sequence homology with all the species with which it was compared. The pro-
karyote Hahella protein aligns across the entire length of the eukaryotic proteins to 
eleven distinct regions, all with various degrees of homology. Those alignments that 
include the Hahella sequence are highlighted with boxes in figure 4–38. All of these 
regions, with the exception of box 5, contain one or more perfect alignments (Table 
4–4). All the eukaryote C12orf29 homologs contain a tryptophan (W) residue in box 
5, whereas the Hahella sequence has a phenylalanine (F) residue at this position. 
Both W and F are hydrophobic amino acids with aromatic 6-carbon ring side chains, 
which in the case of W is part of the bicyclic indole moiety (Berg JM et al., 2002); 
this is therefore a conservative substitution. 
Perfect alignments Amino acid
Box  1 K F
Box  2 A
Box  3 K DG
Box  4 L R D K 
Box  5 (W/F)*
Box  6 H GW P WH
Box  7 T EL G N Y 
Box  8 H HG
Box  9 W
Box 10 EG V
Box 11 K R W  
Table 4-4: The H. chejuensis HCH_06039 protein, at 205 amino acids, is 2/3 the length of 
the eukaryotic C12orf29 homologs. The protein has a number of matching amino acids 
across the length of the eukaryote proteins, with can be seen as discrete boxes of similarity 
(Fig 4–36). In box 5, the Hahella sequence has a phenylalanine (F) residue, where all the 
eukaryotic sequences instead have a tryptophan (W) residue. W and F are both hydrophobic 
amino acids with aromatic side chains; this is therefore a conservative substitution.  
The BLASTP search of H. chejuensis HCH_06039 protein shows that it contains a 
conserved domain, spanning from amino acid 113 to 177 that is similar to RNA li- 
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gase (pfam09414). RNA ligase is a member of the adenylation DNA ligase-like su-
perfamily and suggests HCH_06039 could be related to a prokaryotic informational 
gene. 
The BLAST comparison of C12orf29-like proteins with human C12orf29 gives 
a numerical figure on the degree of conservation over the vast phylogenetic distances 
represented by these species. Of the non-vertebrate species in this comparison, the 
acorn worm protein had the greatest amino acid identity (50%) and overall sequence 
similarity (67%) with human C12orf29 and the amoeboflagellate Naegleria gruberi 
the least with 34% amino acid identity and 47% sequence similarity. The proteobac-
terium Hahella chejuensis had the lowest amino acid identity (30%) and sequence 
similarity (39%) and an E value of 6e-19 (Table 4–5); an E value of less than 1e-10 is 
considered significant (Fritz-Laylin et al., 2010b). 
 
Table 4-5: A numerical evaluation of sequence similarities. The C12orf29-like protein se-
quences of acorn worm, Florida lancelet, C. intestinalis, C. savignyi, freshwater Hydra, Nae-
gleria, and Hahella were compared to human C12orf29 to assess percentage of amino acid 
identity and sequence similarity. The false positive expectations (E) values describe the 
number of hits one can expect to see when searching a database of a particular size. The 
value decreases exponentially when the number of matches increases. An E value of less 
than 1e-10 is considered significant.   
Identity Similarity Gaps Expect
Acorn worm vs human 50% 67% 4% 2E-118
Florida lancelet vs human 45% 64% 3% 2E-104
Ciona intestinalis vs human 43% 59% 9% 1E-90
Ciona savignyi vs human 44% 61% 7% 1E-92
Freshwater hydra vs human 35% 54% 4% 9E-64
Naegleria gruberi vs human 34% 47% 17% 4E-40
Hahella chejuensis vs human 30% 39% 24% 6E-19
Figure 4-38: Sequence alignment of human C12orf29 against orthologous proteins from 
the basal species identified by BLASTP search. The inferred proteins from human, the 
acorn worm, the Florida lancelet, the freshwater Hydra, the sea quirt species Ciona intes-
tinalis and Ciona savignyi, the amoeboflagellate Naegleria gruberi, and the marine bacte-
rium Hahella chejuensis were assembled and analysed on COBALT on the NCBI web-
site. Regions with high homology are boxed in red and tend to overlap with the Hahella 
sequence. This analysis strongly suggests that C12orf29 has its origin in the prokaryote 
kingdom, therefore placing its ancestry before the emergence of eukaryotic life forms. 
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Constructing a phylogenetic tree from 57 taxa using Bayesian analysis 
Phylogenetic analysis was performed by assembling the inferred protein se-
quences from every taxa in which a C12orf29-like protein has been identified. Se-
quences from some species were omitted from the analysis: the African clawed-frog 
(Xenopus laevis), the American bullfrog (Rana catesbeiana), and a C12orf29-like 
protein from the recently sequenced Pacific oyster (Crassostrea gigas).  
The sequences were aligned with ClustalX 2.0 using the NJ method and the align-
ment files saved in Nexus format so they could be further analysed by Bayesian in-
ference analysis using MrBayes v3.2.1. Since Bayesian analysis is very computer 
resource intensive, test runs of 200,000 to 450,000 generations were first performed 
on a desktop computer before being run for a minimum 5 million generations on a 
high performance computer for maximum stringency. Figure 4–39 shows a consen-
sus phylogenetic tree after 20 million generations. This analysis resolved the phylog-
eny of species specific C12orf29 proteins into branches that is in accordance with 
those reported for chordate evolution (Creevey et al., 2011; Dehal and Boore, 2005; 
Vienne and Pontarotti, 2006; Wakeham et al., 2005). The tree is rooted to the Ha-
hella chejuensis and the most basal organisms, such that the single-celled amoebo-
flagellate N. gruberi, branches off the Hahella, followed by the diploblastic freshwa-
ter Hydra, which is then followed by the most basal of the chordate organisms, the 
urochordates Ciona intestinalis and Ciona savignyi. The Acorn worm, Saccoglossus 
kowalevskii, a hemichordate, is generally thought to be a more basal organism than 
urochordates (Henry et al., 2001; Peterson et al., 1999). However, given that the 
Acorn worm ranks highest amongst the most basal organisms carrying a C12orf29, 
with protein 50% identical and 67% similar to human C12orf29 (Table 4–5), it 
branches off the urochordate branch, forming a clade with the Florida lancelet (Bran-
chiostoma floridae). The most basal vertebrate species, the jawless lamprey, is not 
represented in this phylogenetic analysis, although a short segment of a C12orf29-
like protein sequence has been identified from the preliminary genome assembly of 
Petromyzon marinus; however the sequence was too short to be included here. In 
general, all of the higher vertebrate species cluster together in their cognate orders, 
such that teleost fish form a cluster which branches off from cartilaginous fish; the 
Tiger salamander, representing the amphibians, is on a branch below all amniotes: 
i.e. reptiles, birds and mammals. The mammalian branch clusters into classes, such 
 154  Chapter 4: Results 
Figure 4-39: Phylogenetic reconstruction of C12orf29. The tree was constructed from 
C12orf29 protein sequences from 57 species aligned by ClustalX using the NJ method, 
which was then analysed using MCMC on MrBayes to approximate the posterior distribu-
tions of the phylogenies. The tree is rooted on the -proteobacteria H. chejuensis, and the 
phylogenies show that C12orf29 resolve into branches that accord with widely accepted 
metazoan phylogenetic trees. The scale bar represents 0.3 amino acid replacements per 
site. 
  155 
Chapter 4: Results  155 
as marsupials, carnivores, Cetartiodactyla (even-toed ungulates and cetacea), and 
primates. Rodents form two clades in this scheme, one clade with mouse, rat, ham-
ster, Prairie deer mouse, and blind mole; the other clade consisting of ground squirrel 
and guinea pig and being seemingly more closely related to the primate clade (Fig 4–
39). The formation of two rodent clades was repeated in other analyses and was not 
simply an artefact of this particular analysis (data not shown).  
 
   
 156  Chapter 4: Results 
4.4.2 Molecular genetics analyses 
Gene structure 
The human C12orf29 gene spans across seven exons and 14.7 kilo base pairs 
(kbp); the average gene size in the human genome is estimated at 27 kbp (Venter et 
al., 2001). Its messenger RNA (mRNA) is 2,895 bp long, with a coding sequence of 
978 bp, giving rise to an inferred protein of 325 amino acids.  
There are several features about the gene structure that suggest that, although 
the protein sequence itself is under a high degree of conservation, its regulation is 
potentially species specific. An interspecies comparison of the gene structure of 
C12orf29 between human, cow, mouse, chicken and zebrafish shows that exon 
boundaries between these divergent species are identical. There is, however, a high 
degree of difference between intron lengths from one species to another suggesting 
the gene is regulated differently from one species to another. For example, the size of 
the first intron between exons 1 and 2 varies from 4,409 bp in humans, to 2,718 bp in 
the mouse, 1,732 bp in chicken, 1,049 bp in the cow and 341 bp in zebrafish (Table 
4–6). It is likely that intron 1 contains cis-regulatory elements that control the ex-
pression pattern of the gene. This has been demonstrated for a number of genes, such 
as the human HPRT gene (Reid et al., 1990), type 1 collagen (COL1) (Rippe et al., 
1989), human protein C (PROC) gene (Shamsher et al., 2000), and tissue-specific 
expression of the acetylcholinesterase (AChE) gene in skeletal muscle fibers (Chan et 
al., 1999).  
Alternative splicing and multiple polyadenylation signals 
In primates, there is a cryptic exon (Ishibashi et al., 2006) found within the first 
intron of C12orf29, giving rise to a predicted 34.7 kilo Dalton (kDa) protein isoform 
of the gene. The codons for the first six residues of the inferred protein (MSLPFQ) 
start 373 nucleotides downstream from the start codon of isoform 1 
(http://www.uniprot.org/uniprot/Q8N999) and the splice donor sites of both exons 
are identical (Fig 4–40). At this stage it is unclear how this cryptic exon affects the 
expression of the protein, but it is likely that the two isoforms are expressed in a tis-
sue-specific manner. Alternative splicing is now appreciated to regulate both the na-
ture and complexity of mammalian proteomes and, as such, reflects a key aspect of 
the regulation of gene expression (Wang et al., 2008).  
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TCCGCGACTGGACCGGGCGCCGCTCGAAAGCACGCCCTCCATTCGCACTGCTTGTTGGGC 
TCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGG 
TGAAAGAGGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGGGCAGGCTT 
GGCGGCCCGCGTGGGCTCCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGC 
TGGGCGCTTTAGAACTGCCCTGCAGGCCAGGAACCTCTGTAGGTTTCCCTGGGGAGGTCT 
GGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCTTGTACTTTTCTTAGTTGTGAGGG 
AGGGAATTTGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTCCTCGCAAGGAAAT 
GGATAACTCACATCCACAGCATGTCCCTTCCTTTTCAGGTCAGCACCTTTTGGGGAAACC 
CCCTAATCAGGTAATTGCCACAGTCCAAGCTTTACTACTTTTCAAGAGTGCAGTAAGAAA 
Exon 1
Intron 1
Exon 1a
Another facet of the post-transcriptional regulation of C12orf29 is the fact that 
there are at least six polyadenylation sites (PAS) in the 3’ untranslated region (UTR) 
of the human gene. This is a likely source of differential expression of genes; the 
mechanism by which this takes place is, however, not fully understood. The occur-
rence of alternative PAS selection for mRNA was initially considered to reflect a 
relatively random process. The failure of one PAS to fully end the mRNA resulted in 
further downstream cryptic PAS acting to end the rest of the transcripts. Thus, the 
insertion of multiple, identical PAS at the 3’ end of artificial gene constructs results 
in all of the PAS working to some degree, yielding mRNA with different-length 3’ 
UTRs (Proudfoot, 2011).  
Precursor RNA produced in the cell nucleus by RNA polymerase II undergoes 
a number of post-transcriptional modifications before the mature mRNA is exported 
out of the nucleus, where it is translated on ribosomes in the cytoplasm. Two such 
modifications are the removal of introns and splicing of the exons, as well as 3’ 
polyadenylation, with the addition of up to 200 adenosines to the end of the message. 
It is thought that the bulk of DNA transcripts never reaches the cytoplasm but is in-
stead rapidly degraded in the nucleus. Small changes to the effective strength of a 
particular splicing or polyadenylation in a particular cell can act as an important con-
trol point for gene expression in a tissue or developmental stage-specific manner; 
transport of the mRNA into the cytoplasm is therefore dependent on splicing and 
polyadenylation (Edwalds-Gilbert et al., 1997).  
Figure 4-40: In primates there is a cryptic exon (exon 1a) within the first intron. This gives
rise to second isoform of C12orf29, a hypothetical 34.7 kDa protein, approximately 3.2 kDa
smaller than isoform 1. The 3’ splice donor sites of both exons 1 and 1a are the same; the 5’
UTR of exon 1a is not known at present. The start codons (ATG) of both isoforms are high-
lighted here in purple. 
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Conserved exon boundaries 
A comparison of the human C12orf29 gene with those of gorilla, orangutan, 
and chimpanzee, also reveals that exon size and boundaries are identical between all 
four species, with the exception of the first and last exon, which contain the untrans-
lated regions (UTRs). The lengths of the introns are nearly identical as well, which 
suggests the C12orf29 gene is regulated in a similar way in all of these closely re-
lated species. There is a high degree of exon boundary conservation across species, 
ranging from human, cow, mouse, chicken and fish (Table 4–6). Human and mouse 
are thought to have diverged from a common ancestor approximately 65 million 
years ago (Mya) (Antequera, 2003), the last common ancestor of birds and mammals 
is thought to have lived approximately 310 Mya (Hillier et al., 2004), whereas the 
last common ancestor of teleost fish and mammals is more uncertain and estimated to 
have existed 420 Mya (Chen et al., 2012).   
 
Table 4-6: Species comparison of intron/exon boundaries of the gene structure of C12orf29. 
This revealed the presence of identical exon lengths between the divergent species and hu-
man, cow, mouse and chicken. This high degree of the exon boundary conservation sug-
gests the gene has been under strong selective pressure throughout vertebrate evolution. In 
the primates, intron lengths are also conserved. The large differences in intron size between 
human, cow, mouse and chicken suggest the gene is regulated differently between species. 
In chicken there is one less codon within exon 5, which does not affect the exon splice sites. 
The last common ancestor of birds and mammals is thought to have lived ~310 Mya and of 
fish and mammals more than 420 Mya.  
   
Comparison of C12orf29 intron and exon lengths in human and great apes
Species Ensembl Gene ID Exon 1 Intron 1 Exon 2 Intron 2 Exon 3 Intron 3 Exon 4 Intron 4 Exon 5 Intron 5 Exon 6 Intron 6 Exon 7 
Human ENSG00000133641 248 4409 118 2559 96 676 117 1863 198 1025 170 1257 1927
Chimpanzee ENSPTRG00000005277 248 4466 118 2562 96 672 117 1871 198 1032 170 1275 1924
Gorilla ENSGGOG00000005986 293 4397 118 2564 96 677 117 1872 198 1037 170 1271 1224>
Orangutan ENSPPYG00000004813 202 4422 118 2567 96 678 117 1834 198 1039 170 1257 1919
Interspecies comparison of C12orf29 intron and exon lengths
Species Ensembl Gene ID Exon 1 Intron 1 Exon 2 Intron 2 Exon 3 Intron 3 Exon 4 Intron 4 Exon 5 Intron 5 Exon 6 Intron 6 Exon 7 
Cow ENSBTAG00000018743 247 1049 118 2989 96 875 117 1515 198 992 170 1309 393
Mouse ENSMUSG00000046567 233 2718 118 2181 96 5482 117 956 198 1274 170 1956 1528
Chicken ENSGALG00000011168 221 1732 118 526 96 359 117 374 195* 1440 170 568 948>
Zebrafish ENSDARG00000045785 223 341 118 5118 96 859 117 82 198 1174 170 82 674
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The C12orf29 Promoter Region 
The RNA polymerase II (Pol II) promoter is a key region involved in differen-
tial transcription regulation of eukaryotic protein-coding genes and some RNA 
genes. The gene-specific architecture of promoter sequences makes it very difficult 
to devise the general strategy for predicting promoters. Promoter 5’-flanking regions 
may contain dozens of short (5–10 bases long) motifs that serve as recognition sites 
for proteins providing initiation of transcription as well as specific regulation of gene 
expression. About 30–50% of all known promoters contain a TATA-box at a position 
about 25 to 30 bp upstream from the transcription start site. The TATA-box is the 
most general functional signal in eukaryotic promoters. In some cases, it can direct 
accurate transcription initiation by Pol II even in the absence of other control ele-
ments and many highly expressed genes contain a strong TATA box in their core 
promoter (Solovyev et al., 2010).  
C12orf29 has many features that are common in vertebrate promoter regions. 
The core promoter region features a TATA box (TATTAAA) (Dynan et al., 1985), 
which is a sequence that is recognised by the multi-protein transcription factor IID 
(TFIID). The information provided by these proteins is communicated to Pol II, and 
in most mammalian genes a TATA box positions the transcription start site to a point 
25–30 nucleotides downstream, suggesting that this element plays an important role 
in relaying information to RNA polymerase from factors bound to distal control ele-
ments (Smale et al., 1990). One of the most obvious features of the C12orf29 pro-
moter region is the presence of a clearly defined CpG island (CGI).  
CpG island 
The entire human C12orf29 gene, including a 3,000 bp stretch upstream from 
the translation start site, was analysed using the European Molecular Biology Labo-
ratory’s EMBOSS CpGPlot analysis platform.  
The ratio of observed/expected (Obs/Exp or O/E) CpG is calculated as follows: 
 
where N is the total number of nucleotides being analysed. A moving average value 
for percentage (%) G+ C and for Obs/Exp CpG is calculated for each sequence, using 
a 100 bp window (N = 100) moving across the sequence at 1 bp intervals. CpG-rich 
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regions are defined as stretches of DNA > 200 bp, where both the moving average of 
% G + C is greater than 50, and the moving average of Obs/Exp CpG is greater than 
0.6 (Gardiner-Garden and Frommer, 1987). This analysis revealed a 500 bp CpG is-
land extending 300 bp upstream and 200 bp downstream from the translation start 
codon in exon 1 (Fig 4–41). It is noteworthy that the CGI extends beyond the transla-
tion start codon of exon 1–its position in front of the cryptic start codon of exon 1a, 
as well as the presence of a number of conserved promoter sites in front of this start 
codon suggests this shorter transcript variant could be as physiologically relevant as 
the longer transcript variant. 
 
Figure 4-41: CpG islands are regions in vertebrate genomes with greater than average per-
centage of G and C nucleotides and a moving average of CpG dinucleotides greater than 
0.6. The human C12orf29 gene has a distinct 500 bp CpG island extending both upstream 
and downstream past exon 1. The two translation start codons (ATG) are highlighted in pur-
ple. The putative TATA box (TATTAAA) is highlighted in grey.  
 
 
 
 
 
 
 
 
 
   
TCTTTTTTTTTTTTTTTTCACGGTTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGT 
GGGAACCCACCAGGCGCCTCAGCTTCTGCACTACAACTCCCAGAAGGCGCCGCGGCCAGG 
AAGCCGCTTCTGGACGGGCGTTCCCGCCCCTCGCTGGGCTTGGTAGTTGGGGCGCAGCCG 
CGGTGGCTGGGCGCGGAGTGTGCGTGGCCTGAGCCGTGCGGGTGACTGCTTCAGGGCTTC 
TCCGCGACTGGACCGGGCGCCGCTCGAAAGCACGCCCTCCATTCGCACTGCTTGTTGGGC 
TCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGG 
TGAAAGAGGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGGGCAGGCTT 
GGCGGCCCGCGTGGGCTCCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGC 
TGGGCGCTTTAGAACTGCCCTGCAGGCCAGGAACCTCTGTAGGTTTCCCTGGGGAGGTCT 
GGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCTTGTACTTTTCTTAGTTGTGAGGG 
AGGGAATTTGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTCCTCGCAAGGAAAT 
GGATAACTCACATCCACAGCATGTCCCTTCCTTTTCAGGTCAGCACCTTTTGGGGAAACC 
CpG island 
Translation 
start codon 
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Identifying putative TF binding sites 
The core promoter recruits the general transcriptional apparatus and supports 
basal transcription, while the proximal promoter (the region immediately upstream of 
the core promoter) engages various transcriptional factors (TFs), which are necessary 
for appropriate transcription activation or repression. Further upstream is located the 
distal part of the promoter that may also contain TF binding sites and enhancer ele-
ments. A typical organization of a Pol II promoter region is shown in figure 4–42. 
The distal promoter part is usually the most variable region of promoters and gener-
ally poorly described; therefore, most of computational promoter recognition tools 
use the characteristics of only the core and/or proximal regions (Solovyev et al., 
2010).  
 
Figure 4-42: A schematic showing the structural organisation of an RNA polymerase II pro-
moter. C12orf29 contains both a CpG island and a TATA box in its core promoter region. 
(Adapted from Levine and Tjian, 2003; and Solovyev, et al., 2010)  
The identification of putative TF binding sites in the human C12orf29 promoter re-
gion was performed by mining the TRANSFAC database using the Tfsitescan pro-
gram on the MIRAGE platform. This search returned a large number of putative TF 
binding sites that were assessed for their biological relevance by careful reading of 
the relevant scientific literature that were hyperlink to Pubmed. This approach re-
sulted in a compilation list of candidate transcription factors that may play a role in 
the regulation of C12orf29 and are listed in table 4–7. 
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Table 4-7: Compilation of putative transcription factor binding sites in the 5’ region of hu-
man C12orf29. The sites were identified using the TFSitescan analysis platform which
searches the TRANSFAC database. The analysis indicates that C12orf29 is regulated by
a number of important developmental pathways.  
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The putative TF binding sites were identified and their positions highlighted on 
the consensus proximal promoter region for human C12orf29 (Fig 4–43). This region 
was determined by aligning 5’ upstream sequences of human, chimpanzee, gorilla 
and orangutan C12orf29 genes (see Fig 3–19; page 96). 
 
Figure 4-43: C12orf29 promoter sites identified by the TFSitescan search. Consensus bind-
ing sites are coloured in green. Where sites are back-to-back, one of the sites are high-
lighted in grey. The CGI is highlighted in light blue, and the two putative translation start 
codons are highlighted in purple. 
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Detailed Promoter Analysis 
Specificity protein 1 
The Specificity Protein-1 (Sp1) was the first mammalian transcription factor to 
be isolated and cloned (Dynan and Tjian, 1983). It binds to GC-rich sequences, in-
cluding GC and CACCC and GT boxes, basic transcription elements known as Sp1 
sites (Imataka et al., 1992; Yu et al., 1991). The fact that Sp1-sites are found in the 
promoters of many housekeeping genes led to the widely held notion that Sp1 acts as 
a basal transcription factor and that Sp1 sites represent constitutive promoter ele-
ments that support basal transcription at these promoters. There are an estimated 
12,000 Sp1-like binding sites in the human genome (Cawley et al., 2004) and Sp1 is 
implicated in the activation of a large number of genes, such as housekeeping, tissue-
specific and cell cycle-regulated genes, and is also required to prevent methylation of 
CpG islands (Suske, 1999). There are several putative Sp1 sites within the CGI of 
human C12orf29 (Fig 4–43), of which one is located between the TATA box and the 
putative transcription start site (TSS), where it may be responsible for recruiting 
TATA-binding protein (TBP) and fixing the TSS, and therefore having a role in the 
constitutive expression of C12orf29 (Pugh and Tjian, 1991).  
 
Activating Protein 2  
As many as six putative Activating Protein 2 (AP-2) sites were identified in the 
promoter region of C12orf29, five of which are within the CGI and one immediately 
outside the CGI (Fig 4–43). All of the binding sites adhered to the following consen-
sus pattern: (C/G)CCNN(C/G/A)(A/G)G(C/G/T) (McPherson and Weigel, 1999). 
The enhancer-binding protein AP-2 is an inducible transcription factor that is in-
volved in the process of signal transduction and cell-specific expression. The protein 
binds to a GC-rich recognition sequence present in the cis-regulatory regions of sev-
eral viral and cellular genes, including the enhancers of SV40, HIV-1, human metal-
lothionein IIa, and mouse major histocompatibility complex H-2K b (Williams et al., 
1988). The expression of AP-2 mRNA and protein is stimulated by retinoic acid-
induced cell differentiation and also appears to be expressed in a cell-type-specific 
manner: AP-2 is absent in the human hepatoma cell line HepG2 but present in human 
HeLa fibroblast cells (Williams and Tjian, 1991a; Williams and Tjian, 1991b). AP-2 
has been shown to modulate the Wnt/-catenin developmental signalling pathway by 
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associating with the adenomatous polyposis coli (APC) tumor suppressor protein in 
the nucleus. AP-2/APC/-catenin complex formation appears to suppress -catenin 
transactivation by shifting the pool of nuclear -catenin toward an inactive form, 
which has reduced binding to TCF/LEF transcription factors (Li and Dashwood, 
2004). Target genes with AP-2-binding sites in their promoter sequences are in-
volved in biological processes such as cell growth and differentiation and include, 
p21WAF/CIP, transforming growth factor-, keratinocyte-specific genes, tyrosine 
kinase receptor gene c-KIT, insulin-like growth factor binding protein 5 (IGFBP5), 
prothymosin-, the estrogen receptor. AP-2 also negatively regulates a number of 
genes, including MCAM/MUC18; C/EBP-, during adipogenesis; and c-MYC 
(Hilger-Eversheim et al., 2000). AP-2 is expressed in the growth plate and in articu-
lar cartilage, and is a negative regulator of chondrocyte differentiation. The expres-
sion of cartilage-derived retinoic acid-sensitive protein (CD-RAP) and type II colla-
gen is negatively correlated with AP-2 expression, and AP-2 thus acts as a sup-
pressor of these two cartilage matrix genes during cartilage differentiation. High ex-
pression levels of AP-2 in chondroprogenitor cells maintain these cells in an early 
differentiation phenotype and inhibit the transition to differentiated chondrocytes 
(Wenke and Bosserhoff, 2010).  
 
Is C12orf29a direct target of canonical Notch-1 signals?  
C12orf29 may be a direct target of the core Notch signalling pathway. Once 
NICD is cleaved from the membrane bound receptor it translocates to the nucleus 
and binds the transcription factor CSL (C-promoter binding factor 1 (CBF-1), sup-
pressor of hairless (Su(H)), lin-12 and glp-1 (Lag-1)). This results in recruitment of 
the transcriptional coactivator Mastermind, which then converts CSL from a repres-
sor to an activator of transcription of Notch responsive genes. CSL is a sequence 
specific DNA binding protein that binds the consensus sequence (C/T)GTGGGAA 
(Jarriault et al., 1995). DNA sequences similar to this consensus have been identified 
within the promoter regions of Notch target genes in organisms ranging from flies 
and worms to humans (Friedmann and Kovall, 2010). The C12orf29 promoter has a 
CSL consensus sequence that overlaps the c-MYC binding site (E-box), shown in 
figure 4–44. The implication of this is that C12orf29 is potentially a gene directly 
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regulated by Notch. This would add C12orf29 to a small but growing list of genes; 
other confirmed Notch-1 target genes include HES-1, nuclear factor-kappa B (NF-
κB), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), matrix 
metalloproteinase-9 (MMP-9), extracellular-regulated kinase (ERK), Akt, cyclin D1, 
c-MYC, p21 cip1, p27 kip1, p53 (Wang et al., 2010), and possibly also EGF contain-
ing fibulin-like extracellular matrix protein 1 (EFEMP1), inhibitor of DNA binding 1 
(ID1), SHQ1 homolog (SHQ1), GTPase, IMAP family member 5 (GIMAP5),  and T-
cell-specific surface glycoprotein CD28 (CD28) (Chadwick et al., 2009).  
 
 
HES-1 and the Notch-1 regulatory pathway 
HES-1 is a mammalian homolog of the Drosophila pair-rule genes, hairy and 
enhancer of split, which is known to act as a negative regulator in neurogenesis 
(Matsue et al., 1997). HES-1 is a Notch effector molecule and its mRNA expression 
is directly upregulated by Notch ligand binding. Notch-1 plays a pivotal role in the 
differentiation of many tissues; its function is a critical moderator of the fate of all 
stem cells (Kopan and Ilagan, 2009). The basic-helix-loop-helix (bHLH) family of 
transcriptional regulators proteins, which includes HES-1, bind DNA as dimers on 
specific DNA sequences that are classified into three classes. HES proteins are class 
C transcriptional repressors, binding preferentially to class C sites (CACGNG) and 
N-box sequences (CACNAG) (Grogan et al., 2008); the HES-1 binding site in the 
core promoter region is an N-box sequence (Fig 4–44).  
 
c-MYC 
The C12orf29 core promoter region contains an E box motif (CACGTG; Fig 
4–44), that has been found to be the DNA target site of c-MYC (Halazonetis and 
Figure 4-44: Immediately downstream from the C12orf29 TATA box, are located TF con-
sensus sites for Sp1, c-MYC, and HES-1. The CSL/RBP-Jk binding motif CGTGGGAA ex-
tends from the third base of the c-MYC enhancer box, and suggests C12orf29 is a direct
regulatory target of the Notch signalling pathway. 
 
TTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGTGGGAACGCACCAGGCGCCTCAGCTTCTG 
 c‐MYCSP1 
HES‐1
TATA 
CSL/RBP‐Jk
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Kandil, 1991). MYC was one of the first oncogenes to be described in the late 1970. 
The avian acute leukemia virus was shown to promote malignancies such as myelo-
cytomas, sarcomas, and importantly, carcinomas, and the transforming sequence was 
named viral myelocytomatosis (v-Myc) after the resultant leukemia (Gaubatz et al., 
1995). The cellular homolog was subsequently identified in normal cells from many 
species, which reinforced the realization that oncogenic transformation could be 
caused by the activation of a cellular gene (Wasylishen and Penn, 2010). Full-length 
c-MYC, on its own, is unable to bind DNA and later a binding partner, MAX (Myc-
associated factor X), was identified (Ayer and Eisenman, 1993). In contrast to MYC, 
MAX does not contain a transactivation domain and was shown to be a constant and 
obligate partner for MYC, with consistent and abundant expression in proliferating 
and quiescent cells, which was not altered in response to extracellular stimuli. Both 
the MYC–MAX heterodimer and MAX–MAX homodimer bind DNA effectively 
(Dang et al., 1999), but since MAX lacks a transactivation domain, its over-
expression repress the transcription of genes bearing c-MYC binding sites (Zhang et 
al., 1997). 
 
The SOX connection: is C12orf29 a chondrogenesis marker gene?  
There are as many as four binding sites in the C12orf29 promoter that fit the 
SOX consensus motif (Wegner, 1999): (TTCAAAG; AACAAAG; TTCAATG; and 
TAGTTAC), and two SOX9 specific binding motifs (CATTGTYY, where Y = C or 
T) (Fig 4–45). This SOX9 DNA binding motif was identified as being one, of a 
group of 174, most highly conserved mammalian TF binding sites in a major study 
published by the Broad Institute in 2005 (Xie et al., 2005). Besides playing a pivotal 
role in chondrogenic differentiation, SOX9 is highly expressed in the Sertoli cells of 
the testis and involved in male gonad differentiation. The phenotypes of these tissues 
are so different that SOX9 is likely to act on completely different genes (Lefebvre et 
al., 1998). These different functions of SOX9 are the result of its cooperation with 
other enhancer proteins, and in COL21 expressing cells these were designated 
CSEPs, for chondrocyte-specific enhancer-binding proteins, and were found to be a 
long form of SOX5 (L-SOX5), and SOX6, both of which are members of a SOX 
subclass different from that of SOX9. L-SOX5 and SOX6 harbour a coiled-coil do-
main that mediates protein dimerization and efficient binding to adjacent high mobil-
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AGCTTGGGTGATAGAGCGAGACTCCATCTAAAAAAAAAAAAAAAAAGCTACTACTGCCCTATAAGGATGA
TTACTCCTGTAATAAAGAATGATGGGAAATTTGTCTCCAGGGCTGGAAGTAGGCCTGAAAATTCTGTTAG
TACTTTGTGTTGGCCAAAGCAGGCTCACATTGCGTGTCTTTCATCTTTGATGCTTACTAGAGCACTAACA
TATTAGAGAAGAAAGACTTTCTTCTATTTTGTAATCCTGTGACACCACTTTAAGTACAGTGGCTGGTAGC
AACTCCTTGGTGACCCTTCAGAATTATGAGAATTGGGCAAAGTTGATGGCTGCTACCCGTGAGAGCAGGA
GTCCAGTTTATAACCGTGAATTGATCCTGTGCCTCTTCCCTGATGAGGATTTGTGTTTCTGCCAGAAGCT
TTGCTCCAGGTACTGATGAAACCAAAGTTTTGGAAATAGAAAGTGCTTCCTGAGAGATGACTAGCTTTGC
AACTACTATTCAAAGAATAAGTAGAGTGTGTTTTAGAAGATGAGTATTTCCCACAAATGACAGAATGTTG
GACTTAAAAGGTTCTGTGGCAGTTTGGGAGGTGACAGTTGATAGTTGTGAAAGTTGTTGTCTCTGAGATT
CGTGAAACACGCCGCTTTTTAGAATGCCTCTGAAAGAACAAAGAAGTCACTGGCACTCGACTATAATATG
CTAAAAAGTTTCTGGTTCCAACAGCACACGGCCAGAATCAGGTGTTTTCTTTTTTGATAAATGCAGGCAG
GGTGTGATGTGGGAGAACATTTTGTGTTTTCCTGTGAGAAAAAGATAGTAGAAAAGAAAGTAAACACTTT
GAAATGGCAAATCTCTTTCTTCCTCCCTCCCCTCTGAATCCAGTAATCAAAAAACTGTGAACTTTTTTTA
AATTTTATTTTTTTTCACTGTCAGTATTCAATATAACTGTGAACTTTTTGAAGGAAGATGTTTTATTCTT
TGAGAACCCCCTTACTAGTTAGATACCTCTAAGTGAGATATAGTTGTTTAATTTTTCCAAGGGCTAAGTC
AGTAACATGCTGGACAGTTGAGTACATGCAGATAAGACAAAGAAATGAGACCTGGGCCTAGTCCAAGCCC
ATAAAGGATGGCAGTGAAGTCAAAATTCCCCTACAACTTCAGGCTAGGAACTACTACATTCAATGAGATG
GAAAGGCTACTATTCCTAAATATTTAGTATTTATTTTATTTAGTCATTGTCCATCTTATCACTTACCCTG
AAAATATTCTTTTGAGCAGTAAGTTAAGGCTGTTTTTAGCTCGCAGTTGATTGACTACCATTCTCAAGCC
ATTTGGGCTGTTGGAGCTCACCTTTAATTAAACAAGATTCTTATGAAAAACTTGAGAATGAAATCTGGTT
GTAGGTATTCCTGTACTTTTGGATTAGTCTAAGGCTGAAATTTCGCACTCACTCCGAAAAGAACATCAGA
ATCATTTCGACCATGCTATCCTGCACAATAAGGCGTAGTTCAAACGACAACTTTTTTTGATCCCAGGTGT
TTTATTATAGGGTTTTCTGATAGTCTTACCGGAAAGGAAGTTTTCATTCTGCTTGGGAATCTGGGGATGT
CTCTAGCCATTTCTAAACTTCTACAGTGCTTTCCCCACGAACTAAAGATAACAGGCAAGCAGTTTCCATT
GGAACTGTGTTAAATCGACATCTGAAATGTTCATTGCTTATAATTTGATCTTATTTAATTTCCAAAAAAA
TCATTAGTTACTAGGTATTGCTAAGTACCCACGTTCGGGAAACGCATCTGTTTTTTTTTTTTTTTTTTTT
TCACGGTTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGTGGGAACGCACCAGGCGCCTCAGCTTCT
GCACTACAACTCCCAGAAGGCGCCGCGGCCAGGAAGCCGCTTCTGGACGGGCGTTCCCGCCCCTCGCTGG
GCTTGGTAGTTGGGGCGCAGCCGCGGTGGCTGGGCGCGGAGTGTGAGTGGCCTGAGCCGTGCGGGTGACT
GCTTCAGGGCTTCTCTGCGACTGGACCGGGCGTCGCTCGAAAGCGCGCCCTCCATTCGCACTGCTTGTTG
GGCTCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGGTGAAAGA
GGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGCGCAGGCTTGGCGGCCCGCGTGGGCT
CCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGCTGGGCGCTTTAGAACTGCCCTGCAGGC
CAGGAGCCTCTGTAGGTTTCGCTGGGGAGGTCTGGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCT
TGTACTTTTCTTAGTTGTGAGGGAGGGAATATGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTC
CTCGCAGGGAAATGGATAACTCACATCCACAGCATG 
SOX
SOX
SOX
SOX9
SOX9
SOX
ity group (HMG) DNA sites (de Crombrugghe et al., 2000). The clustering of HMG 
DNA binding sites in the promoter region of C12orf29 strongly suggests it is a target 
of SOX9 signalling and therefore a protein closely associated with chondrocytes and 
cartilaginous tissues. 
 
 
   
Figure 4-45: There are at least six SOX consensus binding sites in the promoter region of the
human C12orf29 gene. Two of these sites are potential SOX9 specific motifs, highlighted in
green. The other SOX sites confer with the consensus sequence (A/T)(A/T)CAA(A/T)G.  
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NKX3.2 – A mesodermal homeobox protein 
The NKX family of proteins belong to the ANTP homeobox class, which also 
includes the HOX gene family. NKX3.2, also known as BAPX1 after the Drosophila 
bagpipe gene, is structurally related to NKX2.5, the vertebrate homolog of the Tin-
man gene which is vital for the specification of visceral mesoderm in Drosophila 
(Evans, 1999). The NKX genes are related to the muscle segmentation homeobox 
(MSX) and distalless homeobox (DLX) genes (Holland et al., 2007). Sequence-
specific binding of NKX3.2 to the TAAGTG motif has been confirmed by electro-
phoretic mobility shift assays, and mutagenesis of this sequence revealed that 
HRAGTG (where H represents A, C, or T, and R represents A or G) is the consensus 
DNA binding site for NKX3.2 (Kim et al., 2003). There are as many as ten putative 
NKX3.2 binding sites in the promoter region of C12orf29 (Fig 4–46), suggesting that 
it is regulated by NKX3.2 and therefore likely to be part of the chondrogenesis dif-
ferentiation program from the very earliest stages of embryonic development. 
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AGCTTGGGTGATAGAGCGAGACTCCATCTAAAAAAAAAAAAAAAAAGCTACTACTGCCCTATAAGGATGA
TTACTCCTGTAATAAAGAATGATGGGAAATTTGTCTCCAGGGCTGGAAGTAGGCCTGAAAATTCTGTTAG
TACTTTGTGTTGGCCAAAGCAGGCTCACATTGCGTGTCTTTCATCTTTGATGCTTACTAGAGCACTAACA
TATTAGAGAAGAAAGACTTTCTTCTATTTTGTAATCCTGTGACACCACTTTAAGTACAGTGGCTGGTAGC
AACTCCTTGGTGACCCTTCAGAATTATGAGAATTGGGCAAAGTTGATGGCTGCTACCCGTGAGAGCAGGA
GTCCAGTTTATAACCGTGAATTGATCCTGTGCCTCTTCCCTGATGAGGATTTGTGTTTCTGCCAGAAGCT
TTGCTCCAGGTACTGATGAAACCAAAGTTTTGGAAATAGAAAGTGCTTCCTGAGAGATGACTAGCTTTGC
AACTACTATTCAAAGAATAAGTAGAGTGTGTTTTAGAAGATGAGTATTTCCCACAAATGACAGAATGTTG
GACTTAAAAGGTTCTGTGGCAGTTTGGGAGGTGACAGTTGATAGTTGTGAAAGTTGTTGTCTCTGAGATT
CGTGAAACACGCCGCTTTTTAGAATGCCTCTGAAAGAACAAAGAAGTCACTGGCACTCGACTATAATATG
CTAAAAAGTTTCTGGTTCCAACAGCACACGGCCAGAATCAGGTGTTTTCTTTTTTGATAAATGCAGGCAG
GGTGTGATGTGGGAGAACATTTTGTGTTTTCCTGTGAGAAAAAGATAGTAGAAAAGAAAGTAAACACTTT
GAAATGGCAAATCTCTTTCTTCCTCCCTCCCCTCTGAATCCAGTAATCAAAAAACTGTGAACTTTTTTTA
AATTTTATTTTTTTTCACTGTCAGTATTCAATATAACTGTGAACTTTTTGAAGGAAGATGTTTTATTCTT
TGAGAACCCCCTTACTAGTTAGATACCTCTAAGTGAGATATAGTTGTTTAATTTTTCCAAGGGCTAAGTC
AGTAACATGCTGGACAGTTGAGTACATGCAGATAAGACAAAGAAATGAGACCTGGGCCTAGTCCAAGCCC
ATAAAGGATGGCAGTGAAGTCAAAATTCCCCTACAACTTCAGGCTAGGAACTACTACATTCAATGAGATG
GAAAGGCTACTATTCCTAAATATTTAGTATTTATTTTATTTAGTCATTGTCCATCTTATCACTTACCCTG
AAAATATTCTTTTGAGCAGTAAGTTAAGGCTGTTTTTAGCTCGCAGTTGATTGACTACCATTCTCAAGCC
ATTTGGGCTGTTGGAGCTCACCTTTAATTAAACAAGATTCTTATGAAAAACTTGAGAATGAAATCTGGTT
GTAGGTATTCCTGTACTTTTGGATTAGTCTAAGGCTGAAATTTCGCACTCACTCCGAAAAGAACATCAGA
ATCATTTCGACCATGCTATCCTGCACAATAAGGCGTAGTTCAAACGACAACTTTTTTTGATCCCAGGTGT
TTTATTATAGGGTTTTCTGATAGTCTTACCGGAAAGGAAGTTTTCATTCTGCTTGGGAATCTGGGGATGT
CTCTAGCCATTTCTAAACTTCTACAGTGCTTTCCCCACGAACTAAAGATAACAGGCAAGCAGTTTCCATT
GGAACTGTGTTAAATCGACATCTGAAATGTTCATTGCTTATAATTTGATCTTATTTAATTTCCAAAAAAA
TCATTAGTTACTAGGTATTGCTAAGTACCCACGTTCGGGAAACGCATCTGTTTTTTTTTTTTTTTTTTTT
TCACGGTTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGTGGGAACGCACCAGGCGCCTCAGCTTCT
GCACTACAACTCCCAGAAGGCGCCGCGGCCAGGAAGCCGCTTCTGGACGGGCGTTCCCGCCCCTCGCTGG
GCTTGGTAGTTGGGGCGCAGCCGCGGTGGCTGGGCGCGGAGTGTGAGTGGCCTGAGCCGTGCGGGTGACT
GCTTCAGGGCTTCTCTGCGACTGGACCGGGCGTCGCTCGAAAGCGCGCCCTCCATTCGCACTGCTTGTTG
GGCTCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGGTGAAAGA
GGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGCGCAGGCTTGGCGGCCCGCGTGGGCT
CCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGCTGGGCGCTTTAGAACTGCCCTGCAGGC
CAGGAGCCTCTGTAGGTTTCGCTGGGGAGGTCTGGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCT
TGTACTTTTCTTAGTTGTGAGGGAGGGAATATGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTC
CTCGCAGGGAAATGGATAACTCACATCCACAGCATG 
Figure 4-46: The NKX3.2 transcription factor binds to the consensus motif HRAGTG, where
H = A, T or C; and R = A or G. There are at least ten sites with this pattern in the promoter
region of C12orf29, suggesting that this gene is directly regulated by NKX3.2 in tissues with
chondrogenic potential. 
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Wnt and beta-catenin 
The signalling mechanism of Wnt proteins is mediated by three intracellular 
pathways: the canonical -catenin-TCF/LEF pathway; a Ca2+-dependent pathway; 
and a Rho A activation pathway. The -catenin-TCF/LEF pathway is the one best 
characterized and involves the translocation of -catenin from the cytoplasm to the 
nucleus (Rao and Kuhl, 2010). In the absence of activation of the cell surface recep-
tor Frizzled by extracellular Wnt ligand, -catenin remains confined in the cytoplasm 
where its degradation is promoted by molecules such as GSK-3b, Axin2 and APC. 
When Wnt ligands bind to the receptors, this degradation system is inactivated and a 
free form of catenin accumulates in cytoplasm. The -catenin then translocates to the 
nucleus and interacts with transcription factors such as T-cell factor/lymphoid en-
hancer factor (TCF/LEF) proteins and activates specific target genes (Kitagaki et al., 
2003). The mammalian testis determining factor SOX9 together with TCF/LEF rep-
resent a transcription factor subclass of these proteins, having a single HMG box that 
 
AGCTTGGGTGATAGAGCGAGACTCCATCTAAAAAAAAAAAAAAAAAGCTACTACTGCCCTATAAGGATGA
TTACTCCTGTAATAAAGAATGATGGGAAATTTGTCTCCAGGGCTGGAAGTAGGCCTGAAAATTCTGTTAG
TACTTTGTGTTGGCCAAAGCAGGCTCACATTGCGTGTCTTTCATCTTTGATGCTTACTAGAGCACTAACA
TATTAGAGAAGAAAGACTTTCTTCTATTTTGTAATCCTGTGACACCACTTTAAGTACAGTGGCTGGTAGC
AACTCCTTGGTGACCCTTCAGAATTATGAGAATTGGGCAAAGTTGATGGCTGCTACCCGTGAGAGCAGGA
GTCCAGTTTATAACCGTGAATTGATCCTGTGCCTCTTCCCTGATGAGGATTTGTGTTTCTGCCAGAAGCT
TTGCTCCAGGTACTGATGAAACCAAAGTTTTGGAAATAGAAAGTGCTTCCTGAGAGATGACTAGCTTTGC
AACTACTATTCAAAGAATAAGTAGAGTGTGTTTTAGAAGATGAGTATTTCCCACAAATGACAGAATGTTG
GACTTAAAAGGTTCTGTGGCAGTTTGGGAGGTGACAGTTGATAGTTGTGAAAGTTGTTGTCTCTGAGATT
CGTGAAACACGCCGCTTTTTAGAATGCCTCTGAAAGAACAAAGAAGTCACTGGCACTCGACTATAATATG
CTAAAAAGTTTCTGGTTCCAACAGCACACGGCCAGAATCAGGTGTTTTCTTTTTTGATAAATGCAGGCAG
GGTGTGATGTGGGAGAACATTTTGTGTTTTCCTGTGAGAAAAAGATAGTAGAAAAGAAAGTAAACACTTT
GAAATGGCAAATCTCTTTCTTCCTCCCTCCCCTCTGAATCCAGTAATCAAAAAACTGTGAACTTTTTTTA
AATTTTATTTTTTTTCACTGTCAGTATTCAATATAACTGTGAACTTTTTGAAGGAAGATGTTTTATTCTT
TGAGAACCCCCTTACTAGTTAGATACCTCTAAGTGAGATATAGTTGTTTAATTTTTCCAAGGGCTAAGTC
AGTAACATGCTGGACAGTTGAGTACATGCAGATAAGACAAAGAAATGAGACCTGGGCCTAGTCCAAGCCC
ATAAAGGATGGCAGTGAAGTCAAAATTCCCCTACAACTTCAGGCTAGGAACTACTACATTCAATGAGATG
GAAAGGCTACTATTCCTAAATATTTAGTATTTATTTTATTTAGTCATTGTCCATCTTATCACTTACCCTG
AAAATATTCTTTTGAGCAGTAAGTTAAGGCTGTTTTTAGCTCGCAGTTGATTGACTACCATTCTCAAGCC
ATTTGGGCTGTTGGAGCTCACCTTTAATTAAACAAGATTCTTATGAAAAACTTGAGAATGAAATCTGGTT
GTAGGTATTCCTGTACTTTTGGATTAGTCTAAGGCTGAAATTTCGCACTCACTCCGAAAAGAACATCAGA
ATCATTTCGACCATGCTATCCTGCACAATAAGGCGTAGTTCAAACGACAACTTTTTTTGATCCCAGGTGT
TTTATTATAGGGTTTTCTGATAGTCTTACCGGAAAGGAAGTTTTCATTCTGCTTGGGAATCTGGGGATGT
CTCTAGCCATTTCTAAACTTCTACAGTGCTTTCCCCACGAACTAAAGATAACAGGCAAGCAGTTTCCATT
GGAACTGTGTTAAATCGACATCTGAAATGTTCATTGCTTATAATTTGATCTTATTTAATTTCCAAAAAAA
TCATTAGTTACTAGGTATTGCTAAGTACCCACGTTCGGGAAACGCATCTGTTTTTTTTTTTTTTTTTTTT
TCACGGTTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGTGGGAACGCACCAGGCGCCTCAGCTTCT
GCACTACAACTCCCAGAAGGCGCCGCGGCCAGGAAGCCGCTTCTGGACGGGCGTTCCCGCCCCTCGCTGG
GCTTGGTAGTTGGGGCGCAGCCGCGGTGGCTGGGCGCGGAGTGTGAGTGGCCTGAGCCGTGCGGGTGACT
GCTTCAGGGCTTCTCTGCGACTGGACCGGGCGTCGCTCGAAAGCGCGCCCTCCATTCGCACTGCTTGTTG
GGCTCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGGTGAAAGA
GGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGCGCAGGCTTGGCGGCCCGCGTGGGCT
CCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGCTGGGCGCTTTAGAACTGCCCTGCAGGC
CAGGAGCCTCTGTAGGTTTCGCTGGGGAGGTCTGGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCT
TGTACTTTTCTTAGTTGTGAGGGAGGGAATATGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTC
CTCGCAGGGAAATGGATAACTCACATCCACAGCATG 
-2483 
-2413 
-2343 
-2273 
-2203 
-2133 
-2063 
-1993 
-1923 
-1853 
-1783 
-1713 
-1643 
-1573 
-1503 
-1433 
-1363 
-1293 
-1223 
-1153 
-1083 
-1013 
-943 
-873 
-803 
-733 
-663 
-593 
-523 
-453 
-383 
-313 
-243 
-173 
-103 
-33 
Figure 4-47: TCF/LEF consensus DNA binding motifs in the C12orf29 promoter region.
TCF/LEFs are transcription factors that interact with -catenin in the cell nucleus and regu-
late the expression of Wnt responsive genes.  
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recognise specific DNA sequences whose consensus is (A/T)(A/T)CAAAG (Harley 
et al., 1994). In spite of recognising similar DNA binding sites, in vitro data suggests 
SOX9 does not bind TCF/LEF binding site, nor does TCF/LEF bind a chondrocyte 
specific enhancer (Akiyama et al., 2004). There are eleven putative TCF/LEF DNA 
binding motifs in the C12orf29 promoter, making this gene a candidate for canonical 
Wnt signalling (Fig 4–47).  
 
SMAD3 and the TGF- signalling pathway 
SMAD3, which confer TGF- and activin, but not bone morphogenetic protein 
(BMP) stimulation of target genes, binds directly to the “CAGA” sequence. CAGA 
elements are essential and sufficient for the induction by TGF-; bacterially ex-
pressed Smad3 and Smad4 proteins, but not Smad1 or Smad2 proteins, bind directly 
AGCTTGGGTGATAGAGCGAGACTCCATCTAAAAAAAAAAAAAAAAAGCTACTACTGCCCTATAAGGATGA
TTACTCCTGTAATAAAGAATGATGGGAAATTTGTCTCCAGGGCTGGAAGTAGGCCTGAAAATTCTGTTAG
TACTTTGTGTTGGCCAAAGCAGGCTCACATTGCGTGTCTTTCATCTTTGATGCTTACTAGAGCACTAACA
TATTAGAGAAGAAAGACTTTCTTCTATTTTGTAATCCTGTGACACCACTTTAAGTACAGTGGCTGGTAGC
AACTCCTTGGTGACCCTTCAGAATTATGAGAATTGGGCAAAGTTGATGGCTGCTACCCGTGAGAGCAGGA
GTCCAGTTTATAACCGTGAATTGATCCTGTGCCTCTTCCCTGATGAGGATTTGTGTTTCTGCCAGAAGCT
TTGCTCCAGGTACTGATGAAACCAAAGTTTTGGAAATAGAAAGTGCTTCCTGAGAGATGACTAGCTTTGC
AACTACTATTCAAAGAATAAGTAGAGTGTGTTTTAGAAGATGAGTATTTCCCACAAATGACAGAATGTTG
GACTTAAAAGGTTCTGTGGCAGTTTGGGAGGTGACAGTTGATAGTTGTGAAAGTTGTTGTCTCTGAGATT
CGTGAAACACGCCGCTTTTTAGAATGCCTCTGAAAGAACAAAGAAGTCACTGGCACTCGACTATAATATG
CTAAAAAGTTTCTGGTTCCAACAGCACACGGCCAGAATCAGGTGTTTTCTTTTTTGATAAATGCAGGCAG
GGTGTGATGTGGGAGAACATTTTGTGTTTTCCTGTGAGAAAAAGATAGTAGAAAAGAAAGTAAACACTTT
GAAATGGCAAATCTCTTTCTTCCTCCCTCCCCTCTGAATCCAGTAATCAAAAAACTGTGAACTTTTTTTA
AATTTTATTTTTTTTCACTGTCAGTATTCAATATAACTGTGAACTTTTTGAAGGAAGATGTTTTATTCTT
TGAGAACCCCCTTACTAGTTAGATACCTCTAAGTGAGATATAGTTGTTTAATTTTTCCAAGGGCTAAGTC
AGTAACATGCTGGACAGTTGAGTACATGCAGATAAGACAAAGAAATGAGACCTGGGCCTAGTCCAAGCCC
ATAAAGGATGGCAGTGAAGTCAAAATTCCCCTACAACTTCAGGCTAGGAACTACTACATTCAATGAGATG
GAAAGGCTACTATTCCTAAATATTTAGTATTTATTTTATTTAGTCATTGTCCATCTTATCACTTACCCTG
AAAATATTCTTTTGAGCAGTAAGTTAAGGCTGTTTTTAGCTCGCAGTTGATTGACTACCATTCTCAAGCC
ATTTGGGCTGTTGGAGCTCACCTTTAATTAAACAAGATTCTTATGAAAAACTTGAGAATGAAATCTGGTT
GTAGGTATTCCTGTACTTTTGGATTAGTCTAAGGCTGAAATTTCGCACTCACTCCGAAAAGAACATCAGA
ATCATTTCGACCATGCTATCCTGCACAATAAGGCGTAGTTCAAACGACAACTTTTTTTGATCCCAGGTGT
TTTATTATAGGGTTTTCTGATAGTCTTACCGGAAAGGAAGTTTTCATTCTGCTTGGGAATCTGGGGATGT
CTCTAGCCATTTCTAAACTTCTACAGTGCTTTCCCCACGAACTAAAGATAACAGGCAAGCAGTTTCCATT
GGAACTGTGTTAAATCGACATCTGAAATGTTCATTGCTTATAATTTGATCTTATTTAATTTCCAAAAAAA
TCATTAGTTACTAGGTATTGCTAAGTACCCACGTTCGGGAAACGCATCTGTTTTTTTTTTTTTTTTTTTT
TCACGGTTATTAAAACCGAGGGTGGGGGGCGGAGGACGCACGTGGGAACGCACCAGGCGCCTCAGCTTCT
GCACTACAACTCCCAGAAGGCGCCGCGGCCAGGAAGCCGCTTCTGGACGGGCGTTCCCGCCCCTCGCTGG
GCTTGGTAGTTGGGGCGCAGCCGCGGTGGCTGGGCGCGGAGTGTGAGTGGCCTGAGCCGTGCGGGTGACT
GCTTCAGGGCTTCTCTGCGACTGGACCGGGCGTCGCTCGAAAGCGCGCCCTCCATTCGCACTGCTTGTTG
GGCTCATCATGAAGCGCTTGGGCTCCGTGCAGCGGAAAATGCCGTGTGTGTTTGTGACGGAGGTGAAAGA
GGAGCCTTCCTCCAAAAGGGAGCATCAGGTACGGAGGAGCGCCGCGCAGGCTTGGCGGCCCGCGTGGGCT
CCTCCCCGCGGCGCTGGCTCAGTGCGAACCCGGCGAGGGCGGCTGGGCGCTTTAGAACTGCCCTGCAGGC
CAGGAGCCTCTGTAGGTTTCGCTGGGGAGGTCTGGGGTGGGAGTTCCGTACGCCCTGAGCTCCAGGTTCT
TGTACTTTTCTTAGTTGTGAGGGAGGGAATATGCGAAAGAATTTTCCTTATCAGGAGATTCAAACTTGTC
CTCGCAGGGAAATGGATAACTCACATCCACAGCATG 
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Figure 4-48: The DNA sequence motif CAGA is essential and sufficient for the induction of
TGF- responsive genes. This motif specifically binds SMAD3, but not SMADS 1, 5 and 8,
which are BMP receptor SMADS. There are at least 13 putative CAGA boxes in the
C12orf29 promoter region, suggesting it is a downstream target of TGF-.  
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to this sequence in vitro. The presence of CAGA boxes in TGF- responsive regions 
of several genes suggests that this may be a widely used motif in TGF--regulated 
transcription (Dennler et al., 1998). The presence of 13 putative CAGA boxes in the 
promoter region suggests C12orf29 is regulated by TGF- signalling (Fig 4–48).  
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Chapter 5: Analysis and Discussion 
5.1 INTRODUCTION  
In this chapter the results will be interpreted and analysed with reference to the 
existing literature, and a hypothesis will be put forward which argues a potential bio-
logical role for C12orf29 based in the preliminary results presented in the previous 
chapter. 
The first part of this chapter will deal with the outcomes of the cDNA library 
where the role a number of the genes isolated will be explored in some detail. The 
construction of a cDNA library will be discussed in terms of its utility in today’s 
laboratory environment.  
The second part of this chapter draws on the results of the experiments related 
to C12orf29. Have these results provided any clues as to the role of this gene in gen-
eral, and more specifically, does it have a role in skeletal biology? 
In the third section the results of the bioinformatics analyses are scrutinised to 
determine whether this work has contributed to a clearer picture of the role of 
C12orf29. It will be argued that these analyses are an integral part of biological re-
search since molecular bioinformatics puts the evolutionary and developmental his-
tory of a gene into a wider perspective, without which the exploration of a gene of 
unknown function is, metaphorically, a hit-and-miss affair.  
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5.2 THE CDNA LIBARY – ANALYSIS AND DISCUSSION 
The first reports of cDNA cloning appeared in 1975–76 (Efstratiadis et al., 
1976; Rougeon et al., 1975; Rougeon and Mach, 1976) and the application of this 
procedure became commonplace during the 1980s, when reagents such as RNase H 
and DNA polymerase I simplified the process of second strand cDNA synthesis 
(Gubler and Hoffman, 1983). By the mid 1990s as many as many as 1,850 papers 
describing the cloning of cDNA were published per year (Fig 5–1).  
 
Figure 5-1: The first reports of cDNA cloning and libraries appeared in 1975, and over the 
following two decades a large number of papers were published in which cDNA libraries 
were part of the experimental procedures.  (Source: PubMed). 
Kits are available from a number of vendors for the construction of a cDNA li-
brary, making the process a whole lot easier than in the pioneering early days. How-
ever, the application of a cDNA library construction kit involves a number of mo-
lecular biology techniques that require careful planning and execution for a success-
ful outcome. The main purpose for undertaking this particular project was to isolate 
and sequence osteogenic genes in the sheep transcriptome to create a library that 
could be used as a primary tool for screening genetic pathways active during osteo-
genesis. Although the sheep genome has for the most part been sequenced, there is 
still much work to be done before its transcriptome, i.e. mRNAs, reach the same de-
gree of annotation as that of other species, such as the fruit fly, rat, mouse, cattle or 
human.  
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 A good example with which to illustrate why genomic sequence data does not 
automatically lead to accurate transcriptome data is the Bos taurus BMP7 gene. The 
cDNA of this gene was fully sequenced by 1990 (Luyten et al., 1989). The full Bos 
BMP7 gene sequence (GI:194672592), which includes 3’ and 5’ UTRs, seven exons 
and six introns, is 85,138 base pairs in length. The mRNA itself is 1,900 base pairs 
long (XM_612246), whereas the coding sequence is only 1,296 bp, or mere 1.5% of 
the genomic BMP7 sequence. This gene structure is typical of the mammalian ge-
nome (Mattick, 2007) and reflects the problem inherent with strictly computational 
approaches to mRNA predictions; such programs would, on average, predict exon 
boundaries correctly approximately 80% of the time. The Bos BMP7 gene, which 
consists of seven exons, would therefore only have a 0.87 = 21% chance of being cor-
rectly predicted by computational algorithms; this fact still makes it necessary to iso-
late full length cDNAs to determine the correct gene structure (Haas et al., 2002).  
There are many other reasons why having the full-length physical cDNA–in 
the form of a recombinant cDNA in a vector–is of great value. Functional studies 
such as site specific mutagenesis and the identification of functional domains within 
a protein requires the physical cDNA of the gene of interest in an appropriate vector 
system (Berger et al., 2002; Futer et al., 2002; Litvak et al., 2002), and riboprobes 
used for in situ hybridization studies are synthesized by in vitro transcription of a 
cDNA template in, for example, a pBluescript vector (Braissant and Wahli, 1998). 
The annals of life science are replete with tales of serendipitous discoveries 
(Clarkson, 2003; Lawrence, 2003; Lee, 2011; Mayer and Tichy, 1995; Steinberg, 
2011; Steinman, 2001), and cDNA libraries have been powerful tools for uncovering 
novel genes (Bonaldo et al., 1996; Fahrenkrug et al., 2002; Nagaraj et al., 2007; 
Natarajan et al., 2010; Preuss, 2012; Wolfsberg and Landsman, 2002; Womack, 
2005; Zhou et al., 2012).  
What follows is a review of some of the genes isolated from the cDNA library 
(See table 4–3; page 105). Not all of the genes are exclusively involved in bone and 
skeletal biology, but they all have important functions that warrant their inclusion in 
this review. 
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5.2.1 A brief review of some of the genes isolated from the cDNA library 
 
CITED2, short for cAMP-responsive element-binding-protein-binding-protein 
CBP/p300 interacting-transactivators with glutamic acid and aspartic acid rich tail, 
is expressed in chondrocytes in a load-dependent manner in a pattern inversely re-
lated to MMPs (Sun, 2010). Chondrocytes in cartilage experience a variety of 
stresses, strains, and pressure that result from normal daily activities. Shear stress 
alters chondrocyte metabolism affecting both matrix destruction and stimulation of 
cartilage repair and regeneration. CITED2 is inducible by varying stimuli including 
lipopolysaccharide, hypoxia, and cytokines such as IL-9 and IF-. In inflammatory 
joint diseases such as rheumatoid arthritis and osteoarthritis, MMPs are considered 
pivotal proteinases of cartilage degradation (Yokota et al., 2003). Because IL-1 and 
TNF- are known to stimulate the expression and activities of MMPs, cytokine an-
tagonists and receptor-blocking antibodies have been studied as potential agents for 
blocking cartilage destruction in joint diseases. The association of CITED2 with 
p300 is affected by TGF- but not by the inflammatory cytokine IL-1, and suggests 
that CITED2-mediated mechanical responses leads to down-regulation of MMP-1 
and that MMP-13 expression is regulated by the TGF- signalling pathway (Yokota 
et al., 2003). 
CITED2 negatively regulates hypoxia-inducible factor-1 alpha by competing 
for a binding motif on the p300 CH1 domain (Freedman et al., 2003). HIF-1 is a 
key component in the regulation of chondrogenesis. It achieves this by its regulation 
of SOX9 expression in hypoxic prechondrogenic cells (Amarilio et al., 2007).  
HIF-1α plays a central role in cellular adaptation to hypoxia, and is closely 
related to the pathogeneses of life-threatening disorders. HIF-1α induces the 
expression of numerous hypoxia-induced genes through two transactivation domains; 
N-terminal TAD (NAD) and C-terminal TAD (CAD). Furthermore, p300 is known to 
boost CAD-dependent transactivation, and CITED2 inhibits HIF-1α-driven gene 
expression by interfering with the interaction between CAD and p300 (Yoon et al., 
2011).  
The HIF-1 and CITED2 domains utilize partly overlapping surfaces of 
TAZ1 to achieve high affinity binding and to compete effectively with each other for 
interaction with CBP/p300; CITED2 and HIF-1 use these binding sites differently 
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to maintain similar binding affinities in order to displace each other in a feedback 
loop during the hypoxic response (De Guzman et al., 2004).  
HIF-1 steady state protein levels are similar under conditions of both hypoxia 
and normoxia, suggesting that it is constitutively expressed. HIF-1 and HIF-2 
modulate their own transcriptional activity through CITED2, which therefore 
effectively modulates hypoxia-inducible factor-dependent expression of vascular 
endothelial growth factor (VEGF) in nucleus pulposus cells of the IVDs in the rat 
(Agrawal et al., 2008). CITED2 regulates VEGF promoter activity and expression 
and when CITED2 is blocked, irrespective of the oxemic state of the tissue, VEGF 
promoter activity is elevated. This would suggest that HIF-2 may control VEGF 
expression indirectly through CITED2. Hypoxia would serve to elevate VEGF levels 
in the disc in a HIF-1 and HIF-2–dependent manner, an activity that would enhance 
angiogenesis and/or vascular invasion. It has been suggested that the two arms of the 
regulatory circuit serve to maintain survival activities and inhibit angiogenesis in the 
healthy disc. As far as CITED2 function is concerned, based on studies of HIF-1, it 
is likely that by binding to and sequestering p300 in the intervertebral disc, this 
protein inhibits transactivation of HIF-1 and HIF-2 (Agrawal et al., 2008). 
 
 
 
Annexin A5 
Annexin A5 is a major component of matrix vesicles (MVs), which are cell 
membrane-derived microstructures that have a critical role in initiating mineraliza-
tion of skeletal tissues. In most of the hard tissues, mineralization is initiated within 
and at the surfaces of extracellular MVs derived from adjacent osteoblasts, chondro-
cytes, and odontoblasts. During the process of cartilage mineralization, the first crys-
tal phase forms and grows inside the vesicle lumen as an initial step of calcification. 
The MVs are enclosed by a membrane, so proteins are required to mediate influx of 
mineral ions into the vesicles. After these intralumenal crystals have reached a cer-
tain size and structure, they rupture the membrane and grow out into the matrix. 
There is evidence that annexin A5, a major component of matrix vesicles, mediates 
Ca2+ influx into these particles (Kirsch et al., 1997).  
Types II and X collagen interact with annexin A5, which regulates 
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mineralization of growth plate chondrocytes. Binding of type II collagen and/or type 
X collagen to annexin A5 stimulates its Ca2+ channel activities, leading to an influx 
of extracellular Ca2+ ions into growth plate chondrocytes. This influx results in 
constitutively elevated [Ca2+]i levels, which then initiate a terminal differentiation 
process that leads to increased alkaline phosphatase activity and eventual 
mineralization of the extracellular matrix (Kim and Kirsch, 2008). 
 
 
 
MAX dimerization protein 4  
The basic helix-loop-helix-leucine zipper (bHLHZip) protein Max associates 
with members of the Myc family, as well as with the related proteins Mad (Madl) 
and Mxil. Whereas both Myc:Max and Mad:Max heterodimers bind related E-box 
sequences (CACGTG), Myc:Max activates transcription and promotes proliferation 
while Mad:Max represses transcription and suppresses Myc dependent 
transformation (Hurlin et al., 1995). These DNA-bound heterodimers recruit 
coactivator or corepressor complexes that generate alterations in chromatin structure, 
which in turn modulate transcription. Initial identification of target genes suggests 
that the Myc/Max/Mad network regulates genes involved in the cell cycle, growth, 
life span, and morphology (Grandori et al., 2000).  
In both primary osteoblast cultures and nontransformed osteoblast cell lines, 
expression of differentiation markers follows a clear temporal sequence. Genes 
associated with cell proliferation–such as H4 histone, c-Fos, and c-Myc–are 
expressed early along with those encoding the pro alphal(l) and pro alpha2(1) 
propeptides of type I collagen (Franceschi, 1999). Through regulation of Mxd4 
expression, PTHrP can influence the activity of c-Myc, which prevents the 
differentiation of cultured chondrocytes into hypertrophic chondrocytes (Hoogendam 
et al., 2007). 
 
 
 
Serpin peptidase inhibitor clade H member 1 (SERPINH1)  
The function of SERPINH1 (also known as HSP47) is that of a collagen-
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specific molecular chaperone and provides a quality control mechanism specific for 
procollagen maturation. Triple helix formation of procollagen is a prerequisite for 
refined structures such as fibers and meshworks. SERPINH1 is an ER-resident stress 
inducible glycoprotein that specifically and transiently binds to newly synthesized 
procollagens. It is assumed that SERPINH1 binds to and stabilizes the triple helix 
forms of procollagens to avoid their wasteful unfolding in the ER and that, during 
heat shock, expression of SERPINH1 is induced to prevent thermal denaturation 
(Nagai et al., 2000). Localization of SERPINH1 correlates with that of types I and II 
collagen in a number of cells and tissues, such as chondrocytes, smooth muscle cells, 
endothelial cells in blood vessels, and renal epithelial cells, during the embryonic 
development of mice (Masuda et al., 1998).  
Disruption of SERPINH1 in SERPINH1−/− embryos causes severe 
abnormality in the accumulation of properly processed mature molecules of type I 
collagen and results in embryonic lethality. The severe phenotypes of SERPINH1 
disruptants reflect pleiotropic roles for SERPINH1 during the maturation of 
procollagens. SERPINH1 null fibroblast cell lines transfected with SERPINH1 
gene resulted in the restoration of triple helix formation of the procollagen and is 
further demonstration of the important role of SERPINH1 in the correct triple helix 
formation of procollagens in the ER (Nagai et al., 2000).  
All known ER-localized stress proteins in mammalian cells are induced by 
various ER stresses through the unfolded protein response pathway. SERPINH1 is 
the only heat shock protein that resides in the ER of mammalian cells that is induced 
by cytosolic stresses, including heat shock, but it is not induced by ER stress. This 
induction depends on the presence of the heat shock element in the SERPINH1 
promoter. The constitutive expression of SERPINH1, on the other hand, appears to 
be coregulated with that of several types of collagens (Yasuda et al., 2002). 
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CD9 molecules (CD9)  
By interacting with each others, the tetraspanins CD9, CD81, and CD82 are 
thought to assemble a network of molecular interactions, the tetraspanin web. These 
tetraspanin/tetraspanin interactions include, in part, the palmitoylation of the 
proteins. Tetraspanins have been shown to interact with cholesterol as indicated by 
the precipitation of tetraspanin/tetraspanin complexes by digitonin, a cholesterol-
precipitating reagent, and the in vivo labeling of the tetraspanins CD9, CD81 and 
CD82 with a photo-activatable cholesterol (Charrin et al., 2003).  
The chondrosarcoma cell line, HCS-2/8, as well as the chondrogenic cell line 
ATDC5, have been shown to co-express CD9 with SERPINH1 on their cell 
surfaces. A study showed that the amount of total CD9 protein or mRNA in HCS-2/8 
cells is not affected by anti-sense SERPINH1 oligonucleotide treatment. However, 
in spite of high intracellular levels, CD9 and SERPINH1 do not 
coimmunoprecipitate in untreated HCS-2/8 cells; only after release of SERPINH1 
from the endoplasmic reticulum to the cell surface, does CD9 form stable complexes 
with SERPINH1 (Hattori et al., 2005). It is still unclear whether CD9 has a role in 
stabilizing SERPINH1 on the cell surface, or in presenting SERPINH1 on the 
surface of chondrocytes as an autoantigen. By its colocalization with SERPINH1 on 
the cell surface, it is possible that CD9 may control integrin-mediated signals from 
the extracelluar matrix. Furthermore, annexin-5 binding to the cell surface and the 
level of a number of apoptosis-related genes including caspase-9 is increased after 
SERPINH1 sense oligonucleotide treatment, which suggests that enhanced surface 
expression of SERPINH1 and CD9 may be initiating apoptosis (Hattori et al., 2005). 
CD9 appears to be essential for sperm-egg fusion, a process involving the 
CD9-associated integrin 61. Homozygous adult CD9−/− mice show no obvious 
abnormalities and appear healthy. However, when CD9−/− mice are intercrossed, 
fertility is severely reduced. Normal fertility rates are observed when CD9−/− males 
are mated with wildtype or heterozygous females. By contrast, only half of CD9−/− 
females produce litters after being maintained for up to 2 months in the presence of 
fertile wild-type, heterozygous, or CD9−/− males. The delay before the beginning of a 
successful pregnancy was 19 to 30 days on average for CD9−/− females, as compared 
with 4.5 days for wildtype animals (Le Naour et al., 2000).  
CD9, CD81, and CD82, as well as interacting with each other, also interact 
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with 1 integrins to form tetraspanin webs. These multicomponent webs are thought 
to orchestrate cell surface functions such as cell signaling, perhaps in cholesterol-rich 
rafts or raft-like plasma membrane microdomains. It seems likely that an egg surface 
tetraspan web involving 1 integrins and 1 integrin-associated proteins may define 
or help maintain a site for sperm fusion on the surface of oocytes. Even though it is 
not essential for fertilization, it is considered plausible that 61 is involved in, or at 
least is present in a tetraspan web that is intimately associated with, the process of 
fertilization in a normal egg (Takahashi et al., 2001). 
 
 
 
Peptidylprolyl isomerase A (PPIA)  
Cyclophilin A (PPIA) is a ubiquitously distributed protein belonging to the 
immunophilin family and recognized as the intracellular receptor for the powerful 
immunosuppressive drug cyclosporine A (CyA). PPIA possesses peptidyl-prolyl 
isomerase activity and plays an important role in protein folding and trafficking, such 
as nuclear translocation of ERK1/2 and apoptosis-inducing factor (AIF). It has been 
shown that PPIA is a part of a cytosolic trafficking complex consisting of caveolin, 
heat-shock protein 56, cyclophilin 40, and cholesterol. Although PPIA was initially 
believed to function primarily as an intracellular protein, recent studies have revealed 
that it can be secreted by cells in response to inflammatory stimuli, especially 
reactive oxygen species. Extracellular PPIA is a potent leukocyte chemoattractant 
for human monocytes, neutrophils, eosinophils, and T cells, and it stimulates 
inflammatory responses when injected in vivo. Most importantly, plasma PPIA is 
significantly increased in patients with inflammatory diseases such as rheumatoid 
arthritis and sepsis (Nigro et al., 2011).  
CyA is a cyclic undecapeptide of fungal origin, whose lack of myelotoxicity 
makes it unique among nonsteroidal drugs currently given for immunosuppression. It 
is recognized as one of the most useful therapeutic agents for the prevention of graft 
rejection. It is widely employed in kidney, heart, liver and bone marrow 
transplantations (Laupacis et al., 1982). It appears to act primarily on the T-cell 
compartment, but inhibition of B cells, hepatocellular toxicity, nephrotoxicity and 
disturbances in the central nervous system have also been documented. Its 
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immunosuppressive action is thought to result at least in part from a specific and 
complete inhibition of lymphokine mRNA production in helper T cells. PPIA is a 
protein with binding activity for CyA and was first isolated from bovine thymus and 
later from human spleen. Two isoforms were identified in both cases. The complete 
amino acid sequence of the bovine protein shows no significant homology to any 
other protein sequenced. The 72 amino-terminal amino acids of human spleen PPIA 
are identical to the corresponding part in the bovine protein. This high evolutionary 
conservation together with a broad tissue and species distribution suggests that 
cyclophilin has an important functional role in the cell (Haendler et al., 1987).  
A differential proteomics analysis of osteoarthritis (OA) and normal cells 
cultured under hypoxia showed that PPIA is increased in OA chondrocytes under 
hypoxia. This finding was confirmed by WB analysis of chondrocytes lysates from 
age-matched OA and control donors. PPIA was significantly increased in OA cells. 
This increased PPIA amount points to a role of this protein in OA pathogenesis 
(Ruiz-Romero et al. 2009). CyA has been shown to decrease cartilage damage in an 
animal model of experimental OA suggesting a novel therapeutic strategy (Yoo et al., 
2007). Given that PPIA is the major receptor of CyA, the high abundance PPIA in 
OA cartilage could explain the positive effects of CyA on this disease (Ruiz-Romero 
et al., 2010). 
 
 
 
Peroxiredoxin 5 (PRDX5)  
Articular chondrocytes, embedded in an avascular matrix, are exposed to a 
low partial oxygen pressure and exhibit a predominantly anaerobic metabolism. The 
defence mechanisms in articular chondrocytes against reactive oxygen species (ROS) 
are generally weak and chondrocytes are susceptible to attacks by ROS. However, 
chondrocytes have the potential to increase their antioxidant status. To prevent 
toxicity by ROS, mammalian cells possess a well-coordinated antioxidant enzyme 
system. The peroxiredoxins (PRDX), has been identified in many living organisms. 
Six isoforms of PRDX have been found in mammals, all of which participate directly 
in eliminating H2O2 and neutralizing other oxidizing chemicals. PRDX5 protein is 
constitutively expressed in cartilage and has been shown to be up-regulated in 
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osteoarthritic cartilage. This up-regulation is caused by inflammatory cytokines, such 
TNF-alpha and IL-1beta, and the effect of these cytokines is immediate, with 
increased PRDX5 levels detected within 3 h of cytokine treatment in vitro. The 
significantly increased expression of PRDX5 in OA, in response to inflammatory 
cytokines, may act as a protection to cartilage against ROS-induced oxidative 
damage (Wang et al., 2002).  
 
 
 
 Cystatin C (CST3) 
CST3 is an extracellular inhibitor of the cysteine proteanase cathepsin K. The 
temporospatial distribution of cathepsin K in osteoarthritic cartilage suggests a role 
for this enzyme in the pathogenesis of osteoarthritis. Because cathepsin K can digest 
cartilage matrix components it may contribute to the development of osteoarthritic 
lesions. CST3 has a wide expression pattern, and has been linked to arthritis, and its 
activity has been studied mainly in synovial tissue. In osteoarthritic cartilage with 
severe lesions, decreased inhibitory activity has been detected, which suggests that 
down regulation of CST3 contributes to articular cartilage damage (Morko et al., 
2004). 
CST3 is a potent inhibitor of bone resorption, primarily by inhibiting organic 
matrix breakdown by osteoclasts in the Howship lacunae. It has been suggested that 
the mechanism of action is caused by inhibition of cysteine proteinase activity 
extracellularly in the Howship lacunae by CST3, without any effect on the proton 
pump. The reason that the breakdown of bone will be inhibited by CST3 is that the 
protons released cannot continue to dissolve mineral crystals unless the bone matrix 
is concomitantly degraded (Brage et al., 2005). The molecular mechanism sensitive 
to CST3 inhibition during osteoclastogenesis is not known, but has been shown to be 
associated with decreased mRNA expression of calcitonin receptor (CTR) and the 
transcription factor NFAT2, but unchanged mRNA expression of receptor activator of 
NF-kB ligand (RANKL) and alkaline phosphatase. These observations indicate that 
CST3 inhibits osteoclast formation without affecting the osteoblastic phenotype of 
stromal cells (Brage et al., 2005). 
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Coiled-coil domain containing 80 (CCDC80)  
CCDC80 shares some sequence homology with the consensus repeat domains 
in the chicken equarin, mouse URB and human SRPX proteins, which suggests it 
belongs to the same gene family, the recently defined as the sushi-repeat containing 
protein superfamily (Mu et al., 2003). Expression of the CCDC80 gene was found to 
be increased in brown adipose tissue (BAT) of obese BRS-3-deficient mice com-
pared to wild-type controls, whereas in white adipose tissue (WAT) no difference in 
expression was observed. In the mouse, CCDC80 mRNA is expressed in all tissues 
examined, including brain, digestive system (stomach, colon, rectum), liver, lung, 
kidney, and testis. In the CNS, CCDC80 is expressed in the choroid plexus, a tissue 
containing cells that filter liquid from the blood that becomes cerebrospinal fluid 
(Davson, 1976).  
The long form of the leptin receptor mRNA is also expressed in WAT, BAT, 
choroid plexus, and hypothalamus. Although mRNA levels of the leptin receptor in 
adipose tissues do not correlate with body weight, patterns of gene expression are 
similar to those of CCDC80 and suggest that the CCDC80 gene may play a unique 
role in energy metabolism in the brain and BAT (Aoki et al., 2002).  
CCDC80 has been shown to be necessary for adipocyte differentiation and it 
appears to be regulated in a biphasic manner during adipocyte differentiation. This 
expression pattern is distinct from classical secreted adipokines, such as adiponectin 
or leptin, but reminiscent of that of Wnt10b, a known adipocyte-secreted protein with 
an important role in adipogenesis. Reducing the expression of CCDC80 in 3T3-L1 
cells by RNAi significantly reduced the ability of these cells to differentiate into 
adipocytes and accumulate lipids. It is likely that CCDC80 regulates TCF-mediated 
transcription using a signaling pathway that is distinct from the upstream elements of 
the Wnt/catenin pathway, and CCDC80 could be defined as an element involved 
in the switch between catenin signaling and PPAR, a transition required for 
adipocyte differentiation. CCDC80 therefore plays a critical role in mediating the 
transition between preadipocyte and adipocyte, in part by controlling the switch 
between Wnt/-catenin signaling and the induction of master regulators of 
adipogenesis C/EBP and PPAR(Tremblay et al., 2009).  
Transformation of normal epithelial cells by oncogenes results in 
fundamental changes in the transcriptional program of a cell. The Wnt/APC/-
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catenin/TCF pathway is frequently deregulated in human cancers, with more than 
80% of colorectal cancers showing constitutive activation of this pathway. CCDC80 
expression has been shown to be substantially reduced in the majority of colon and 
pancreatic cancer cells as well as in primary colorectal cancers compared with 
adjacent normal epithelium. Downregulation of CCDC80 is not uniquely the effect 
of catenin, as RK3E cells transformed by other oncogenes including RAS 
proteins, GLI, and c-MYC also revealed reduced expression levels of CCDC80. This 
suggests that inhibition of CCDC80 expression may be an important event in the 
development of colorectal and pancreatic cancers (Bommer et al., 2005). 
CCDC80 is expressed in post-natal human BMSCs and its expression 
disappears during in vitro osteogenesis. In mouse, this gene is preferentially 
expressed by developing chondrocytes and exhibit temporal and spatial expression 
patterns during mouse embryonic development, strongly suggesting an involvement 
in skeletal formation. With a time-course experiment it was shown that CCDC80 
expression decreases drastically during osteoblastic differentiation and becomes 
undetectable at the completion of the in vitro osteogenesis. These findings support 
the possibility of using gene CCDC80 as a stemness marker for BMSCs (Liu et al., 
2004). 
 
 
 
Phosphatidylinositol glycan anchor biosynthesis, class F (PIGF)   
Many cell surface proteins of various eukaryotes such as protozoa, yeast, and 
mammals are bound to the plasmamembrane through a glycosylphosphatidyl inositol 
(GPI) anchor. GPI lipid anchoring is an important post-translational modification of 
eukaryote proteins in the endoplasmic reticulum. The backbone of the GPI anchor is 
conserved among different organisms, being composed of phosphatidylinositol (PI), 
non-N-acetylated glucosamine, three mannoses (Man), and ethanolamine phosphate 
(EtNP) (Ohishi et al., 1996). The GPI anchor precursor is synthesized in the endo-
plasmic reticulum (ER) by the stepwise addition of glycan components from donors 
to intermediates. Nascent peptides of GPI-anchored proteins have at their carboxy 
termini a GPI signal sequence that directs cleavage of the signal and replacement 
with the GPI anchor precursor. Many genes are involved in this biosynthesis pathway 
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(Kinoshita and Inoue, 2000). As many as 19 genes have been directly implicated in 
the anchor synthesis and the substrate protein modification pathway. PIGA and 
PIGH are involved in the first step of the synthesis pathway, at which N-acetylglucos 
amine is transferred to PI. PIGF is involved late in the pathway and executes some, 
as yet unknown, auxiliary but essential role for the transfer of phosphoethanolamine 
to the second and/or third mannose. It is thought that PIGF is an integral membrane 
protein and has a role in fixing the conformation of the GPI lipid anchor for the 
phosphoethanolamine modification (Matsuo et al., 1995).  
 
 
 
Maspardin isoform b (SPG21) 
Maspardin isoform b, is encoded by the gene spastic paraplegia 21 (SPG21), 
also known as ACP33 (acidic cluster protein 33), which was first identified as a 
novel 33-kDa protein intracellular binding partner of CD4. The cell surface glyco-
protein CD4 is expressed on subsets of thymocytes and mature T lymphocytes and, 
in humans, on monocytes and macrophages. Early clues to CD4 function came from 
a strong correlation between CD4 expression and MHC1 class II restricted T helper 
cell activity that corresponds to the MHC class I-mediated cytotoxic response of 
CD8-positive T cells. Analysis by immunofluorescent microscopy of the partially 
activated T cell line, HUT 78, showed that the majority of CD4 molecules co-
localize with endogenous SPG21 to intracellular vesicles, supporting the notion that 
binding of SPG21 is required for subtle changes in subcellular trafficking of CD4. 
Since SPG21 contains a cluster of four aspartic acid residues, it might function by 
connecting CD4 to related cellular sorting factors, thus regulating the fate of internal-
ized CD4. Endosomal CD4 is targeted to lysosomes, to glycolipid enriched mem-
brane compartments, or back to the plasma membrane, depending on the cellular ac-
tivation status (Zeitlmann et al., 2001).  
 Mast syndrome is an autosomal-recessive complicated form of hereditary 
spastic paraplegia that is characterized by dementia, thin corpus callosum, white 
matter abnormalities, and cerebellar and extrapyramidal signs in addition to spastic 
paraparesis (Hanna and Blackstone, 2009). Using an extensive Amish pedigree, the 
Mast syndrome locus was mapped to a small interval of chromosome 15q22.31. 
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Sequence analysis of gene transcripts revealed that all mast syndrome affected cases 
were homozygous for a single base-pair insertion mutation (601insA) of the SPG21 
gene. This frameshift results in the premature termination of the encoded product that 
localizes to intracellular endosomal/trans-Golgi transportation vesicles. It has been 
shown that aberrant subcellular transportation and protein sorting is potentially a 
common mechanism for a number of forms of motor neuron degeneration (Simpson 
et al., 2003).  
 The hereditary spastic paraplegias (HSPs) are a group of neurological 
disorders characterized by progressive spasticity and weakness of the lower limbs. 
They are classified as “pure” if lower extremity spasticity and weakness occur in 
isolation and “complicated” if patients exhibit other neurological abnormalities such 
as cognitive impairment, ataxia, distal amyotrophy, or thinning of the corpus 
callosum. The relatively early onset of SPG21 has led to suggestions that it may be 
in part a neurodevelopmental disorder, although it is clearly progressive during 
adulthood. SPG21 is ubiquitously expressed, which implies that it interacts with 
other proteins in CD4–negative cell types and is therefore likely to have other 
functions. HeLa cells have been found to have high endogenous SPG21 expression 
and co-immunoprecipitation of HeLa cell extracts followed by MALDI-TOF mass 
spectroscopy revealed that SPG21 protein interacts with the aldehyde dehydrogenase 
ALDH16A1. There are as many as 19 separate human ALDH proteins with distinct 
chromosomal locations. ALDHs catalyze the NAD(P)+-dependent irreversible 
oxidation of a wide spectrum of aliphatic and aromatic aldehydes during the 
metabolism of both endogenous and exogenous compounds. Nothing is known about 
the function of ALDH16A1, and it therefore remains unclear whether the interaction 
with ALDH16A1 influences the presumed functions of SPG21/ACP33 in the trans-
Golgi network/endosomal pathway and what, if any, role ALDH16A1 plays in the 
pathogenesis of Mast syndrome (Hanna and Blackstone, 2009).  
 SPG21−/− mice have a clear but slowly progressive defect in motorneuron 
function, with the hind limbs most affected. Some of the characteristic pathological 
features of human mast syndrome, such as white matter disease, are not evident in 
these animals. However, a clear phenotypic effect was seen on neurons cultured from 
the cerebral cortex of neonatal SPG21−/− animals, with significantly more branching, 
but no differences in primary axon length. Gene chip analysis identified a significant 
up-regulation of mRNA levels of another aldehyde dehydrogenase, ALDH18A1, but 
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given that very little is known about either of these two aldehyde dehydrogenase 
subtypes, any pathogenic significance remains speculative. Thus, a key factor 
limiting the interpretation of the reported increase in axonal branching in SPG21−/− 
mice is that the function of SPG21 itself is not well understood, but given that this is 
a protein highly conserved throughout evolution, it likely to have a fundamental role 
within cells (Soderblom et al., 2010).  
 
 
 
Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-
like domain member 1 (HERPUD1) 
Hyperhomocysteinemia, which has both genetic and environmental compo-
nents, is a common risk factor for thrombotic vascular events such as stroke, myo-
cardial infarction, and venous thrombosis. In eukaryotic cells, the normal function of 
the ER is to optimize the synthesis, folding and assembly of membrane proteins and 
soluble proteins destined for secretion or trafficking to lysosomes. Changes leading 
to the accumulation of unfolded proteins in the ER, trigger a stress response referred 
to as unfolded protein response (UPR) (Kokame et al., 2000). Many genes that are 
induced by the UPR either encode proteins that assist folding or promote ER-
associated protein degradation (ERAD). ERAD requires the ubiquitylation of ER-
derived substrate proteins at the cytosolic surface of the ER membrane, which is a 
precondition for their extraction to the cytosol and their degradation by the 26 S pro-
teasome (Kny et al., 2011).  
 HERPUD1 was first identified as one of seven genes in a differential 
display analysis of HUVEC cells exposed to a 4 hour homocysteine challenge. Its 
sequence was found to be identical to that of HUMORF12, one of a random sample 
of human cDNA clones reported in 1994 (Kokame et al., 1996; Nomura et al., 1994).  
 HERPUD1 appears to be constitutively expressed in many human organs, 
such as heart, brain, placenta, lung, liver, and skeletal muscle; its mRNA expression 
is very high in pancreas, suggesting a role for HERPUD1 in that organ. UPR 
proteins, such as GRP78, GRP94, GRP170, calreticulin, FKBP13, PDI, and Erp72 
are all present in the ER lumen; HERPUD1, by contrast, is an integral ER membrane 
protein. The majority of the UPR-inducible proteins in the ER are for the most part 
  189 
Chapter 5: Analysis and Discussion  189 
molecular chaperones or folding enzymes assisting protein folding. It is doubtful that 
HERPUD1 conforms to this category of ER stress since membrane topology 
experiments of the induced protein suggest that both the N and C termini face the 
cytoplasm (Kokame et al., 2000).  
 HERPUD1, which is strongly induced by the UPR, is involved in the 
turnover of ERAD substrates and appears to have an anti-apoptotic effect in the 
cellular response to ER stress. It has been shown that HERPUD1 associates with 
high molecular mass protein complexes, binding directly to the ubiquitin-protein 
ligase (E3) Hrd1, which mediate the ubiquitylation of substrate proteins and their 
retro-translocation to the cytosol. In addition, it has been demonstrated that 
HERPUD1 is able to bind ubiquilin proteins, which have been suggested to mediate 
shuttling of ubiquitylated substrate proteins to the 26 S proteasome (Kny et al., 2011; 
Schulze et al., 2005).  
 One hallmark of Alzheimer’s disease (AD) is the accumulation of  
amyloid (A) plaques. Mutations in the presenilin genes, PS1 and PS2, cause early 
onset familial AD and lead to an increase in the ratio of A42/A40 generation from 
amyloid precursor protein (APP). PS is required for intramembranous cleavage of 
APP (termed -cleavage). Although the -cleavage of APP is a critical step toward the 
production of A, the major intramembranous cleavage site of APP was found to be 
distinct from the -cleavage site. It has been shown that HERPUD1 enhances levels 
of A40 (Sai et al., 2002). Since a significant increase in the level of A42 was not 
observed, the high expression level of HERPUD1 appears to mainly enhance 40--
secretase cleavage. It appears that the regulation of the generation of A42 is distinct 
from that of A40, even though the generation of both A forms requires PS. In the 
normal brain, HERPUD1 is expressed in neurons and highly expressed in vascular 
cells, suggesting that these cells are the major source of A in the normal brain. 
HERPUD1 expression is upregulated in activated microglia in senile plaques in the 
AD brain, which is of interest since activated microglias are thought to play a role in 
the clearance of A. It is possible, however, that some activated microglia, which 
strongly expresses HERPUD1, may generate a high level of A and function in the 
formation of A deposits (Sai et al., 2002).  
 In a subtractive hybridization screen, the murine Herpud1 gene was found 
to be overexpressed in Wnt-1-transformed murine mammary epithelial cells 
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compared to controls. Surprisingly, the transcription levels of the homologous human 
HERPUD1 were not activated in cells with activated -catenin/TCF-mediated 
transcription or its expression induced by -catenin transfection. These results 
indicate different regulation mechanisms of HERPUD1 in murine and human cells 
(Chtarbova et al., 2002).  
 
 
 
Binding protein S1, serine rich domain (RNPS1) 
The mRNA and protein isoforms produced by alternative processing of pri-
mary RNA transcripts may differ in structure, function, localization or other proper-
ties. Alternative splicing in particular is known to affect more than half of all human 
genes, and has been proposed as a primary driver of the evolution of phenotypic 
complexity in mammals (Wang et al., 2008).  
 The typical mammalian gene contains on average 8 exons, which are 
defined by short and degenerate splice-site sequences at the intron/exon borders. 
Components of the basal splicing machinery bind to the splice-site sequences and 
promote assembly of the multi-component splicing complex known as the 
spliceosome. The two primary roles of spliceosome are to first recognize the 
intron/exon boundaries and then perform the cut-and-paste reactions that remove 
introns and join exons. The spliceosome is made up of the small nuclear 
ribonucleoprotein particles (snRNPs) U1, U2, U4/U6, and U5, together with a large 
number of non-snRNP protein factors. Disruption of normal splicing patterns, caused 
by point mutations that lie in the 5' or 3' splice site elements, or the creation of new 
ones at inappropriate locations, result in defects that underlie many human genetic 
diseases (Faustino and Cooper, 2003; Sakashita et al., 2004). On the other hand, the 
flexibility in the splicing process for many pre-mRNAs, allows alternative splice 
sites to be used, often in a regulated way in response to tissue-specific, 
physiologically or developmentally controlled states. This process effectively 
expands the coding potential of individual genes and adds another layer of gene 
regulation in higher eukaryotes (Mayeda et al., 1999).  
 A human RNPS1 clone was first isolated from an osteosarcoma 
expression library. This clone contained a coding sequence of 305 amino acids and its 
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nucleotide sequence shared high homology with a previously published S-phase 
prevalent murine cDNA sequence (mRnps1). A comparison of the derived amino 
acid sequence identified several regions similar to those found in a number of RNA-
binding proteins. The predicted protein contained a 90-amino acid RNA recognition 
motif (RRM), a consensus core sequence which is present in proteins that are able to 
bind RNA. Within this region were located an RNP-1 octamer and an RNP-2 
heptamer, which are signature sub-motifs of the RRM sequence. It also contained an 
RNP-1 octapeptide sub-motif related in amino acid composition and location to those 
reported in the serine/argenine-rich (SR) splicing protein family (Badolato et al., 
1995).  
 In vitro splicing assays (IVSAs) are commonly performed either with 
HeLa cell nuclear extract or with cytosolic S100 extract complemented with SR 
proteins. As is the case of SR proteins, RNPS1 is much less abundant in S100 than in 
nuclear extract. Therefore, to maximize the effects of exogenous RNPS1, IVSAs 
were performed with S100 extract in the presence of limiting amounts of the SR 
protein SF2/ASF, which is essential for splicing. RNPS1 alone did not complement 
the S100 extract efficiently for splicing activity; however, when SF2/ASF was 
titrated into the reaction in limiting amounts to complement the S100 extract, RNPS1 
behaved as a potent activator of the splicing reaction. This effect was not simply 
additive, but rather showed a strong synergy between SF2/ASF and RNPS1. 
Immunoprecipitation demonstrated that RNPS1 and SF2/ASF stably associated with 
complexes containing mRNA, as are other SR proteins. The observation that RNPS1 
stimulates overall splicing activity with a wide variety of pre-mRNA substrates 
suggests that it plays a general role in the splicing reaction; its ubiquitous expression 
is also consistent with such a role (Mayeda et al., 1999).  
 Export of mRNA out of the nucleus requires successful pre-mRNA 
splicing. A final quality-control step in this process is mRNA surveillance, in which 
mRNAs with truncated open reading frames are detected and subjected to nonsense-
mediated mRNA decay (NMD). The potential hazards of failing to degrade mRNAs 
that encode truncated proteins are exemplified by the numerous recessively inherited 
diseases that acquire a dominant-negative phenotype when NMD fails to target 
transcripts that prematurely terminate translation. The process of NMD is highly 
conserved; Saccharomyces have three eukaryotic up-frameshift (UPF) proteins, the 
Caenorhabditis elegans have nine, and in mammals thirteen UPFs have been 
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identified (Isken and Maquat, 2008).  
 When RNPS1 was tethered to the 3' UTR of -globin mRNA it produced a 
striking 30% down-regulation of -globin mRNA. The identification of the nuclear 
splicing activator RNPS1 as a downstream signal for NMD suggests that it should 
exist transiently in the cytoplasm, and experiments showed that it is a 
nucleocytoplasmic shuttling protein and also that it acts directly with the hUPF 
protein complex. These findings explain how a dynamic post-splicing complex can 
function in mRNA quality control by mediating both mRNA export and mRNA 
surveillance. As a result of pre-mRNA splicing, a multiprotein complex is deposited 
upstream of every exon-exon junction on nascent mRNAs. UPF3 joins the 
postsplicing complex, via direct or indirect interaction with RNPS1. If termination 
occurs upstream of the last exon-exon junction, interactions between the translation 
release factors, eRF1 and eRF3, and the downstream RNPS1/UPF complex trigger 
mRNA decapping followed by rapid decay (Lykke-Andersen et al., 2001).  
 
 
 
Catenin beta 1 (β-catenin) 
The Wnt family of secreted glycolipoproteins is one of the fundamental 
mechanisms that direct cell proliferation, cell polarity and cell fate determination 
during embryonic development and tissue homeostasis. The most studied Wnt path-
way is canonical Wnt signaling, which functions by regulating the amount of the 
transcriptional co-activator β-catenin that controls key developmental gene expres-
sion programs (MacDonald et al., 2009). The first insights into understanding the 
mechanism of Wnt signal transduction came from the existence of several fly genes 
with mutant phenotypes consistent with defects in the Wingless (Wg) signalling 
pathway (Cadigan and Nusse, 1997).  
 Axin2 is a key regulator of the Wnt/β-catenin signaling pathway. The Wnt 
signal is received by two membrane receptors, Frizzled and LRP5/6. In the absence 
of a Wnt signal, Axin2 bind GSK-3β and β-catenin, facilitating GSK-3β-mediated 
phosphorylation of β-catenin, which marks the protein for ubiquitination and 
proteasomal degradation. Axin2 is stabilized when phosphorylated by GSK-3β. In the 
presence of Wnt signal, Axin2 is recruited to the Wnt co-receptor LRP5 or 6, and is 
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dephosphorylated. The protein complex formed by Axin2 becomes destabilized, 
which allows β-catenin to accumulate and translocate to the nucleus where it 
regulates gene transcription through TCF and LEF transcription factors (Cong et al., 
2004; Dao et al., 2010).  
 -Catenin, is a promiscuous member and the main effector of the Wnt 
pathway, and found in at least three cellular pools: 1) the adherens junctions in 
association with the transmembrane receptor, E-cadherin, and the cytoskeletal linker, 
-catenin; 2) the cytoplasm; and 3) in the nucleus in association with other 
transcription factors. In these pools, -catenin associate with partners such as E-
cadherin or TCF. When cellular levels of -catenin increase and accumulate in the 
nucleus, it binds to the amino terminus of the high-mobility group (HMG) binding 
protein, TCF, and promotes its interaction with target DNA sequences (A/T A/T 
CAAAG), thereby promoting displacement of the TCF repressors, Groucho and 
CtBP. This, in turn, leads to a concomitant recruitment of coactivators such as CREB 
binding protein (CBP)/p300, Brgl, and CARM1 and an overall de-repression of TCF 
transcription. Activation of the Wnt/-catenin/TCF signaling pathway, either by 
disengagement of the APC/axin/GSK3 complexing, or by Wnt activation, promotes 
induction of downstream gene targets such as cyclin D1, c-MYC, PPAR, TCF-1, 
matrilysin and CD44 (Mulholland et al., 2005).  
 Skeletal elements of vertebrates are derived from mesenchymal cells 
which condense to form initial prechondrogenic cell clusters that adhere through the 
expression of adhesion molecules. Cells within the core of these clusters differentiate 
into chondrocytes, synthesizing and secreting an extensive extracellular matrix; 
whereas cells at the border at the clusters go on to form the perichondrium. 
(Kronenberg, 2003).  
 During skeletal development, Wnt/-catenin signaling controls 
mesenchymal progenitor cells selectively to differentiate into osteoblasts. In the 
absence of -catenin, the progenitor cells differentiate into chondrocytes instead of 
osteoblasts, indicating that -catenin is required to suppress early mesenchymal cell 
differentiation into chondrocytes. The TGF- signaling is involved in multiple 
cellular processes including cell proliferation, differentiation, and apoptosis. TGF- 
ligand transduces its signal through binding with type II and type I receptors leading 
to Smad2/3 phosphorylation, which interact with Smad4 and then translocate into the 
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nucleus. Smad3 and Smad4 have been shown to interact with -catenin and form a 
protein complex. This complex not only stabilizes -catenin to prevent it from 
proteasome degradation, but also assists -catenin in nuclear translocation and 
eventually facilitates -catenin transcription of target genes. Silencing of Smad4 in 
chondrocytes reverses the effect of Smad3 on -catenin, suggesting that the 
interaction of Smad4 with -catenin protects -catenin from degradation (Zhang et 
al., 2010b).  
 -catenin has been shown to function differently at different stages of 
fracture repair. In early stages, precise regulation of -catenin is required for 
pluripotent mesenchymal cells to differentiate to either osteoblasts or chondrocytes. 
In particular, during endochondral ossification, -catenin signaling is activated 
during the early stages of chondrogenesis, but not at later hypertrophic stages of 
chondrogenesis. Once these undifferentiated cells have become committed to the 
osteoblast lineage, -catenin is activated in cells with an osteoblast phenotype, but is 
down-regulated when osteoblasts undergo maturation into osteocytes (Chen et al., 
2007).  
 This is a different function for -catenin than has been reported during 
development. Lithium enhances -catenin signaling by inhibiting GSK3 mediated 
degradation of -catenin. Mice that had received lithium treatment late during the 
fracture repair period displayed an enhanced fracture healing with relatively high 
bone density compared to animals that were treated with lithium prior to the induced 
fracture, which had a lower bone density in the fracture site. Lithium treatment 
increased the level of -catenin in the fracture tissue in both groups. Lithium 
treatment therefore has the potential to improve fracture healing by increasing the 
level of -catenin in the fracture callous, but only if used in later phases of repair, 
after mesenchymal cells have become committed to the osteoblast lineage (Chen et 
al., 2007). 
 
 
 
   
  195 
Chapter 5: Analysis and Discussion  195 
Tumor protein, translationally controlled 1 (TPT1) 
The human histamine releasing factor (HRF), also known as tumor protein, 
translationally controlled 1 (TPT1), causes histamine release from basophils in some 
allergic donors. It has been identified to the translationally controlled tumor protein 
(TCTP), which was previously designated as p23. TPT1 is highly conserved in all 
eukaryotes ranging from plants to animals; the proteins of Arabidopsis thaliana and 
human are of near equal length (168 vs. 172 residues respectively) and share 38% 
identity and 56% sequence similarity (MacDonald et al., 1999). Experimental evi-
dence of TPT1 function in A. thaliana, shows that TPT1 acts as an important regula-
tor of growth, and has a function in target of rapamycin (TOR) activity, which re-
sembles the situation in animals. The role of TPT1 in plants differ from that is ani-
mals in that plants do not have a Ras homolog enriched in brain (Rheb) G-protein, 
suggesting that Arabidopsis TPT1 regulates another GTPase (either a Rhop- or Rab-
like G-protein), which might function in an equivalent way to Rheb (van Dam et al., 
2011).  
Tuberous sclerosis (TSC) is a benign tumour syndrome caused by mutations in 
either TSC1 or TSC2 tumour suppressor genes. TSC1 and TSC2 form heterodimers 
that inhibit TOR (Matthew et al., 2009). Studies in Drosophila and other organisms 
have identified TSC signaling as a conserved pathway for growth control. Human 
TPT1 (hTPT1) and Drosophila TPT1 (dTPT1) are roughly 50% identical in their 
protein sequence, and mutant dTPT1 null Drosophila phenotypes can be rescued by 
expression of hTPT1. hTPT1 interacted most strongly with nucleotide-free hRheb 
and stimulate the GDP/GTP exchange of hRheb in vitro, which suggest that the func-
tion of TPT1 in the TSC pathway is likely to be conserved throughout evolution. 
TPT1 controls cell growth and proliferation by positively regulating Rheb activity 
and the activation of the TSC pathway is mediated by Rheb (Hsu et al., 2007).  
The exact role of TPT1 is still a matter of controversy. TPT1 mRNAs are tran-
scribed in all tissues tested, and this correlates with a model for TPT1 function as a 
component of the microtubular network, as has been suggested (Gachet et al., 1999), 
rather than with the more specialized function as a histamine-releasing factor, as was 
first proposed (MacDonald et al., 1995). There appears to be a strong dependence of 
TPT1 binding to tubulin in the cell cycle, with the highest activity during mitosis. 
This concept is supported by there being low TPT1 mRNA levels in brain tissues, 
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which are characterized by a low mitotic activity (Thiele et al., 2000). Most cancer 
research has primarily focused on the molecular genetic factors that cause normal 
cells to become malignant. Tumor reversion is the process by which some cancer 
cells lose their malignant phenotype. The study of tumor reversion can enable re-
searches to understand how a tumor cell acquires the molecular knowledge of how to 
quit malignancy. Populations of flat revertant cells were isolated from cancer cell 
lines by using the H-1 parvovirus, which preferentially kills tumor cells while spar-
ing their normal counterparts. TPT1 was found to be the most strongly downregu-
lated gene in the revertant cell populations (Tuynder et al., 2002).  
When TPT1 expression in v-src-transformed NIH3T3 cells was inhibited by 
transfection with antisense TPT1, the number of revertant cells rose to 30%. This is 
against the reported rate for spontaneous flat revertants of 10-6. The antisense TPT1 
gave rise to flat revertants and was able to restore contact inhibition and anchorage-
dependent growth. The term "flat" refers to the flatter morphology associated with 
nontransformed cells. The cell density at confluence is another parameter that defines 
the flat revertants and this density was strongly decreased when the expression of 
TPT1 was inhibited. These results suggest that targeting TPT1 and decreasing its 
level of expression in v-src-transformed NIH3T3 leads to strong reversion of the ma-
lignant phenotype (Tuynder et al., 2004).  
A recent finding suggests there is a feedback loop providing a molecular link 
between TPT1, a regulator of tumor reversion, and p53, a key regulator of apoptosis 
and tumor suppression. p53 binds to a p53 responsive element in the promoter of 
TPT1, which leads to the transcriptional repression of TPT1; this finding makes 
TPT1 one of only a handful of genes that have been shown to be directly repressed 
by p53 (Amson et al., 2012).  TPT1, on the other hand, controls p53 by promoting its 
degradation. It does this by directly associating with MDM2 thereby suppressing 
MDM2 auto-ubiquitination. In addition to increasing the amount of MDM2, TPT1 
also increases rate of MDM2-mediated ubiquitination of p53. The ubiquitin ligase 
activity of MDM2 is inhibited by NUMB, which can bind to MDM2, thereby stabi-
lizing p53. There is direct antagonism between NUMB and TPT1 and they probably 
compete for their binding to the MDM2-p53 complex (or to MDM2 alone). The bio-
chemical effects they have are opposite to each other: NUMB is an inhibitor of the 
ubiquitination reaction and TPT1 is a facilitator. High TPT1 status in breast cancer 
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correlated directly with a poor degree of differentiation, high proliferative activity 
and low or negative estrogen receptor expression, all of which are indicative of ag-
gressive neoplastic disease and poor prognoses (Amson et al., 2012).  
 
 
 
Chromosome 12, open reading frame 29 (C12orf29) 
C12orf29 encodes a protein of unknown function with a predicted size of 37 
kDa. Initial phylogenetic analysis revealed that it was conserved in all sequenced 
vertebrate species. RT-qPCR data indicated relatively high expression in both os-
teoblasts and BMSCs. The clone was sequenced with inside and outside primers and 
a full coding sequence (CDS) for sheep was obtained and the sequence has been up-
loaded to Genbank (Accession: HQ438587.1 and NM_001199794.1). C12orf29 has 
not been investigated in detail previously; the gene has been mentioned in only a 
handful of scientific papers, for the most part in supplementary tables, and none these 
studies offer many clues as to its biological function.  
TSC1 and TSC2 are tumor suppressor genes that regulate the activity of mam-
malian target of rapamycin (mTOR) under conditions of hypoxia. mTOR is a path-
way that is often activated in neoplasias, and which is a central promoter of cell 
growth. Another tumor suppressor gene, p53, is also induced by hypoxic conditions 
but is unable to upregulate its established transcriptional targets, due to a failure to 
recruit transcriptional coactivators CBP/p300 (Dao et al., 2010). C12orf29 was found 
to be significantly downregulated (four fold) in cortical tubers from brain tissue sam-
ples in patients with tuberous sclerosis complex. Tuberous sclerosis complex (TSC) 
results from mutations in either the TSC1 or TSC2 gene. This condition leads to neu-
rological symptoms, such as autism, cognitive disabilities, and intractable epilepsy, 
and is histologically characterized by disordered cortical lamination, astrogliosis, 
dysplastic neurons and the presence of so-called “giant cells”. Interestingly, in the 
same study, CCDC80–another gene identified in the cDNA library–was upregulated 
eleven fold in TSC patient samples (Boer et al., 2010).  
The WIPF1 gene is important for cancer development, its encoded WIP protein 
interacts with the Wiskott–Aldrich syndrome protein WASP through a surface that is 
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affected by a WASP mutation, and Wiskott–Aldrich syndrome predisposes to leuke-
mia and lymphoma. It has also been shown that the expression levels of the WIP pro-
tein influence the migratory and differentiation properties of fibroblasts. A module of 
WIPF1-coexpressed genes was identified by bioinformatics mining of microarray 
data from patient samples from colorectal, breast and gliomal cancers. This co-
expression module was assessed for its use as a prognostic signature for colorectal 
cancer, glioma, and breast cancer patients. C12orf29 was identified to belong to a set 
of 38 core genes in a module of 112 WIPF1-coexpressed genes with a strong WIPF1 
correlation and survival/relapse association in colorectal cancers. The majority of 
genes in this module show a down-regulation in several cancer patients with longer 
survival time or time to relapse.  
A large number of genes of the WIPF1 coexpression module, including 
C12orf29, have poorly characterized functions and do not overlap with the "prolif-
eration" gene signature that is regulated during cancer cell mitosis. However, the 
WIPF1 coexpressed genes seem to be linked to proliferation and apoptosis, possibly 
by regulation through c-Myc, ESR1, and p53 (Staub et al., 2009).  
KLF9 is a member of the Sp/KLF family, which contains at least twenty identi-
fied proteins, including Sp1-4 and numerous Krüppel-like factors. KLFs function as 
transcriptional activators or repressors, depending upon cellular context and presence 
of partner co-regulators. Members of this protein family have wide-ranging regula-
tory roles in development, such as stem cell renewal, maintenance of pluripotency, 
lineage determination, organogenesis, and oncogenesis. KLF9 facilitates progester-
one-inductive effects on uterine gene expression by its co-recruitment with the pro-
gesterone receptor and inhibits estrogen receptor α trans-activity by promoting this 
receptor's estrogen induced down-regulation. Mice null for KLF9 exhibits a sub-
fertile phenotype that is possibly due to an out-of phase uterus relative to blastocyst 
development. C12orf29 was downregulated in HEC-1-A endometrial carcinoma cell 
lines stably transfected with a plasmid encoding an antisense RNA to KLF9. Loss of 
KLF9, which regulates secreted and membrane-associated proteins, might constitute 
an early event in the epithelial-mesenchymal transition, leading to invasion and sub-
sequent metastasis. Consistent with this, endometrial tumors of higher grades (and 
with greater invasion and metastasis) have decreased KLF9 gene expression com-
pared to normal endometrium and stage I tumors (Simmen et al., 2008).  
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Inorganic arsenic (iAs) is a carcinogenic environmental contaminant, which 
exerts immunosuppressive effects on human T lymphocytes. It has been shown that 
interleukin-2 (IL2) secretion and T cell proliferation are reduced when peripheral 
blood mononuclear cells (PBMC) that have been chronically exposed to arsenic, are 
stimulated with lectins such as phytohemaglutinin (PHA). In an in vitro study 
C12orf29 was amongst a group of genes upregulated in response to PHA in primary 
T lymphocytes pre-treated with sodium arsenite. Inorganic arsenic can directly inter-
fere with the physiology of human T cells. The immunotoxic effects of iAs may con-
tribute to its systemic toxicity and one of the main effects of iAs are increases in the 
incidence of basal and squamous cell carcinomas (Martin-Chouly et al., 2011). 
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5.2.2 cDNA library construction – Conclusions 
The cDNA library was constructed to provide a generic resource for further 
exploration/biological research of the genes that are expressed in bone cells in sheep; 
and also to identify signalling pathways involved with skeletal tissue homeostasis. It 
was anticipated that the library would provide the basis for further research into our 
understanding of the process of fracture repair and bone biology. 
The cDNA library kit 
The pBluescript II XR cDNA library Construction Kit from Stratagene was 
chosen primarily on the basis that, for a novice user, the relatively simple protocol of 
this kit greatly increased the chance of a successful outcome of the library construc-
tion. The chemistries used with the pBluescript kit are generally the same as those 
described by Gubler and Hoffman in 1983 (Gubler and Hoffman, 1983), which was 
itself a modification of a system described by Okayama and Berg the year before 
(Okayama and Berg, 1982). From a technical perspective the library construction 
was successful. This was evident by a 90% recombination rate of the randomly 
picked clones and an average insert size of 1,000 bp, with some inserts being over 
3,000 bp.  
Validation of the library 
The expression of a number of genes was assessed to determine the “osteo-
genic nature” of the library. A panel of 18 genes (Table 3–4; page 58) were normal-
ised against GAPDH and three genes stood out as having very high expression. Type 
I collagen (COL1) is the most abundant protein of the body and is preferentially syn-
thesized in bone by osteoblasts and in the dermis by fibroblasts (Karsenty and Park, 
1995). COL1 is the most highly expressed gene in osteoblast and BMSC cell cultures 
and its expression is typically greater than that of the housekeeping genes GAPDH 
and -actin (data not shown). In the cDNA library, it was by far the most highly ex-
pressed gene, and this was not unexpected given the majority of the cells used were 
committed osteoblast cells (Fig 4–7; page 111).  
The relative mRNA expression of COL1 was more than 150% greater than the 
second most abundantly expressed gene, connexion 43 (Cx43). Gap junctions pro-
teins, such as Cx43, are expressed in both osteoblasts and chondrocytes, and form 
gap junctional channels that allows intracellular communication between osteoblasts, 
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osteocytes and osteoclasts, which is vital for skeletal development and bone remodel-
ling (Stains and Civitelli, 2005b). Gap junctions modulate both OCN and COL1a1 
gene transcription. Both genes are regulated by Sp1/Sp3 binding elements in their 
proximal promoters, and the recruitment of the transactivator Sp1 or the transrepres-
sor Sp3 are inversely regulated by signals passing through Cx43 channels (Stains and 
Civitelli, 2005a). Cx43 must therefore be considered a genuine osteogenic marker 
gene.  
The third most highly expressed gene in the library was TGF-3 (Fig 4–7; page 
111), and this was an unexpected finding. Subsequent RT-qPCR experiments failed 
to replicate this high expression (data not shown). It therefore seems that the high 
TGF-3 expression was an exception, and given that mRNA from as many as 21 
separate cell lines were pooled and used for the cDNA library template, it is possible 
that any one of these cell lines could have overexpressed TGF-3 in response to the 
osteogenic induction medium. This medium contained 10-7 M Dex and the effect of 
Dex on osteoblasts and bone is paradoxical. Long term administration of glucocorti-
coids, such as Dex, increases bone resorption by stimulating osteoclastogenesis via 
the expression of RANK ligand, and also significantly decreases the number of os-
teoblasts and their function (Canalis and Delany, 2002). On the other hand, Dex acts 
in a fashion similar to progesterone in stimulating proliferation and differentiation of 
osteoprogenitor cells derived from rat vertebrae (Ishida et al., 1996), most likely via 
a DNA response element that is similar to that of the sex hormone (Klock et al., 
1987). Progesterone has been shown to upregulate all three TGF-beta isoforms (1, 
2, and 3) in human osteoblast like cells (Luo et al., 2002) and this may explain 
why Dex stimulation elicited an unusually high TGF-3 expression in the cDNA li-
brary.  
TGF-1 had a high relative expression in the library; however, relative to TGF-
3, its expression was three orders of magnitude less (Fig 4–8; page 112). Other os-
teogenic cytokines with high relative expression was BMP2, which has been shown 
to promote bone formation and osteogenesis in a number of animal models (Osyczka 
et al., 2004).  
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At the opposite end of the expression spectrum was osteocalcin (OCN) and os-
teopontin (OPN) (Fig 4–10; page 113). Both OCN and OPN are, as their names sug-
gest, intrinsically linked to osteogenesis.  
Osteocalcin (Bone gamma-carboxyglutamic acid protein; BGLAP; OMIM #  
112260) is a vitamin K-dependent protein that is characterized by the presence of 
gamma-carboxyglutamic acid residues, through which they bind calcium-containing 
minerals such as hydroxyapatite.  
Osteopontin (Secreted phosphoprotein 1; SPP1; OMIM # 166490), belongs to 
the small integrin-binding ligand N-linked Glycoproteins (SIBLING) family of pro-
teins, which also include bone sialoprotein (BSP), dentin matrix protein-1 (DMP1), 
and dentin sialophosphoprotein (DSPP). All are acidic proteins which are found in 
the matrices of bone and teeth (Ogbureke and Fisher, 2007). OPN expression is re-
ported to be strongly upregulated in rat osteoblasts by 10-8 M Dex stimulation (Sodek 
et al., 1995), whereas in human BMSCs, Dex at 10-8 M results in a drastic downregu-
lation of both OPN and OCN mRNA expression (Cheng et al., 1996).  
Other experiments conducted with mOBs and tOBs grown in osteogenic induc-
tion medium, show that Dex induced a significant downregulation of OCN and OPN 
mRNA expression over the course of the experiment (Fig 5–2). These results are 
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Figure 5-2: OPN and OCN mRNA expression is downregulated by 10-7 M dexamethasone in
sheep osteoblasts. Mandible and tibial osteoblasts from two sheep were treated with osteo-
genic induction medium for 7 and 14 days. The effects are seen immediately in OPN,
whereas OCN expression was significantly downregulated by day 14. (Data courtesy of Dr Jan
Gohlke) 
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consistent with those by Cheng et al (1996), who found that downregulation of BSP, 
OPN and OCN did not impede the mineralization of human BMSCs by Dex.  
The Alizarin Red staining of a subset of the cells used for the cDNA library 
showed that these cells mineralized strongly when exposed to Dex for 21 days (Fig 
4–12; page 116), which clearly demonstrated that OPN and OCN was not required 
for mineralization under these conditions with these cell lines. 
 
Library screening 
Screening a large number of clones for genes of interest (GOI) is a key step in 
many applications of recombinant DNA technology. Hybridization became the stan-
dard technique and is still widely used as the default screening method (Campbell 
and Choy, 2002). In this procedure the colonies are first lifted onto nitrocellulose fil-
ters placed on the surface of agarose plates, and a reference set of these colonies are 
made by replica plating and stored at 4ºC. The colonies are lysed and their DNA de-
natured and fixed to the filter. RNA probes, typically 32P-labelled, are then hybrid-
ized to the DNA and the fixed DNA with the GOI located by autoradiography on x-
ray film. The positive colonies are identified by aligning the x-ray film with the 
colonies on the original agarose plate (Grunstein and Hogness, 1975). Although a 
large number of colonies can thus be screened, the use of nitrocellulose filters is a 
time consuming task and tends to only work with highly expressed genes (Campbell 
and Choy, 2002).  
PCR based methods were developed in which cDNA clones were propagated 
as individual plaques on solid medium in 24 well plates and a phage suspension pre-
pared from each well and transferred to a 96 well format–so-called arrayed PCR 
screening. This was followed by repeated PCR screening of incrementally smaller 
pools from which a positive signal had been observed. Although this approach did 
away with the need for filter hybridization and, more importantly, radioisotope label-
ling, the end result is a labour intensive and relatively insensitive method of screen-
ing (Alfandari and Darribere, 1994; Bloem and Yu, 1990; Munroe et al., 1995). 
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Comparison of PCR based screening methods 
Using the MACH protocol, we were able to isolate one clone containing the 
full-length ORF of the housekeeping gene GAPDH and another clone containing a 
partial ORF of TGF-3 (JX534544), from a cDNA library from cells derived from 
sheep bones. The Self-Ligation of Inverse PCR Products (SLIP) library screening 
method (Wan et al., 2006) was used to isolate a 1905 bp full-length -actin clone 
(ACTB; HM067830). The SLIP protocol is a slightly simplified version of the 
MACH protocol and has been used for high throughput library screening of the Dro-
sophila transcriptome (Hoskins et al., 2005). Both methods rely on the use of inverse 
PCR, however, whereas two primer pairs are needed for MACH, the SLIP protocol 
only uses one pair of abutting primers. The ORF of the SLIP isolated -actin was 
identical to the existing Ovis aries ACTB mRNA (NM_001009784), whereas the 3’ 
UTRs only had limited similarities. When compared with the Bos taurus C 
mRNA (NM_173979), the SLIP ACTB mRNA sequence had 93% nucleotide identity 
of the 3’ UTR and 96% overall identity with this sequence. Interestingly, a recent 
sheep EST library study (Jager et al., 2011) identified an ACTB sequence (Q862P9) 
that was identical to NM_001009784, whereas an earlier study (Hecht et al., 2006) 
had identified an ACTB sequence (Oa5078.1) in an ovine EST library that was 97% 
identical to the 3’ UTR of the SLIP-ACTB sequence, and 94% identical with the cor-
responding Bos taurus sequence.  
We were prompted to try the MACH protocol when it was found that the SLIP 
protocol had introduced nucleotide deletions at the ligation site of the GAPDH 
mRNA. SLIP requires the phosphorylation of the 5’ end of the inverse primers to aid 
the ligation of the linearized PCR products after DpnI digestion of the un-amplified 
plasmid library DNA. Any imperfect oligonucleotides that are phosphorylated can 
result in frame shifts or loss of codons in the sequence, something that becomes ap-
parent from the sequence analysis. The MACH protocol requires more manual han-
dling since the two PCR products must be separated by gel electrophoresis and then 
purified. However, one of the chief advantages of this method is the fact that it only 
requires the use of thermostable DNA polymerases and eliminates the need for costly 
and labile enzymes such as polynucleotide kinases and T4 DNA ligases. The linear 
PCR products form circularized plasmids by the action of basepair complementarity 
of the overhangs that form when the two PCR products are combined, denatured and 
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annealed (Haerry and O'Connor, 2002). Thus, reverse strand 1 can only form a circu-
larized product with forward strand 4, and likewise, the reverse strand 3 will only 
circularize with forward strand 2 (Fig. 3–3 B; page 55). This mode of circularizing 
the plasmids is, in effect, a proofreading feature that ensures the high fidelity of the 
insert, since it is highly unlikely that two strands of unequal length or homology 
would anneal and form compatible overhangs.  
 
cDNA libraries and the discovery of novel genes 
Although many C12orf29 clones had been isolated in a number of vertebrate 
species, and indeed even in the sheep, prior to our isolation and sequencing of it from 
this cDNA library, the fact remains that novel genes in EST library and large scale 
transcriptome sequencing studies tend to be obscured by the vast amounts of infor-
mation that these studies produce. In the screening of our library, the C12orf29 clone 
clearly stood out as the only gene amongst approximately 30 whose function was 
completely unknown. To some this undoubtedly would reason not to wish to pursue 
it, whereas for other, this writer included, it was all the more reason for wanting to 
characterize it. There were a number of genes that would have been interesting re-
search targets, and that were in many ways still novel genes, being very much under-
represented in the literature. The small-scale approach taken in this project certainly 
pushed the emphasis towards curiosity and discovery rather than one of data man-
agement and bioinformatics. As such, the construction of cDNA libraries still has a 
place in today’s laboratory, simply for its potential to uncover novel discoveries 
more than a decade after the human genome and that of many other model species 
have been sequenced.  
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5.3 EXPERIMENTAL CHARACTERIZATION OF C12ORF29 – ANALYSIS AND DISCUSSION 
There was any number of technical approaches that could be applied in order to 
begin to piece together the function of C12orf29. The very first experiment was an 
RT-qPCR assay with C12orf29 specific oligonucleotides on mOBs treated with os-
teogenic induction medium for 3 and 12 days. The C12orf29 mRNA expression was 
normalised against GAPDH and showed an exponential increase over the time course 
(Fig 5–3). The linear regression (R2) value of the exponential trend line equalled 1, 
which suggested that the increase in C12orf29 expression in response to the medium 
was not a chance event.  
5.3.1 Molecular cloning experiments 
It was clear from the initial RT-qPCR results that C12orf29 was a gene that 
was active in osteoblastic cells and therefore a clear candidate gene for further char-
acterization. At the time of these experiments there were no antibodies available for 
C12orf29, so it was decided to subclone the sheep C12orf29 cDNA into a mammal-
ian expression vector with an HA tag. 
Epitope tagging is a proven method to bring immunochemical and immunocy-
tochemical methods to bear on the protein encoded by cloned gene. Most epitope 
tags have validated and commercially available antibodies specifically raised against 
these epitopes. In the case of the HA epitope, the mouse monoclonal antibody 
12CA5 is the most commonly used antibody and is produced by a number of anti-
body manufacturers. The alternative to using an epitope tag is to raise antibodies to 
Figure 5-3: An initial RT-qPCR assay indicated that C12orf29 gene expression was upregu-
lated in response to osteogenic induction medium. The exponential trend line shows a per-
fect fit with the data, with an R squared value of 1.00. These results were instrumental in the
decision to pursue the characterization of the C12orf29 gene, especially since it was a novel
gene that appeared to be active in skeletal cell types. 
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the encoded protein; this is generally a reliable approach but is also slow, costly, and 
can be unpredictable (Brizzard, 2008).  
An epitope-tagged protein is a special kind of fusion protein in which the 
added amino acids do not add new biological activity to the protein. These features 
make it likely that a protein carrying the tag will retain its normal structure and func-
tion. Other fusion systems involve large biologically active fusion partners such as -
galactosidase, alkaline phosphatase, glutathione S-transferase, Protein-A, and green 
fluorescent protein (GFP); the GFP, for example, is 238 amino acids in length (Yang 
et al., 1996). Fusion proteins made using these systems have been shown to have lo-
calization and activity patterns similar to the target proteins themselves, making 
them, like epitope-tagged proteins, very informative molecules for examining in vivo 
and in vitro protein function (Jarvik and Telmer, 1998).  
The initial cloning experiment had been designed for a pcDNA3.1 plasmid 
with an HA epitope already engineered into the 5’ end of the MCS, and the subclon-
ing of the C12orf29 cDNA was completed within a period of two weeks. The discov-
ery that the vector did not contain the HA tag was a firm lesson to always sequence a 
vector before starting a cloning experiment. Over the following 5 months, 5 to 6 at-
tempts were made to subclone C12orf29 using a 57mer forward cloning primer with 
an HA sequence motif, coming very close yet falling short of isolating a positive 
clone. The retrofitting of the initial recombinant vectors succeeded in splicing an HA 
tag onto the C12orf29 cDNA and it was now possible to transfect this plasmid into 
cells to study the cellular distribution of C12orf29 using an anti HA antibody. 
 
5.3.2 Validation of the commercial C12orf29 antibodies 
No sooner had the HA retrofitting been accomplished than it was discovered 
that three anti-C12orf29 antibodies had been released onto the market by three sepa-
rate vendors only months earlier. This presented a great opportunity to study the en-
dogenous expression of C12orf29 in cells and tissues, but also demanded that the an-
tibodies themselves be characterized to ascertain their specificity for the intended 
target protein, C12orf29. A considerable amount of time and effort went into deter-
mining their specificity and it did become apparent that, although all three antibodies 
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–and later a forth (EB49)–were created for the same target protein, not all antibodies 
are created equal.  
Verifying antibody specificities 
The HA-C12orf29 recombinant vector was used as a positive control for these 
experiments. It was reasoned that since the C12orf29 protein was very highly con-
served across mammalian species, the recombinant protein it should be detected by, 
initially, all three antibodies, and later the EB49 C12orf29 antibody.  
Interpreting the results proved not to be so straight forward. Using a double la-
belling WB system, which allowed the HA-C12orf29 protein to be labelled with both 
an anti-HA antibody and the C12orf29 specific antibodies, the Santa Cruz was the 
only one of three (Abcam, Sigma and Santa Cruz) antibodies that was able to detect 
the recombinant protein (Fig 4–14; page 119). On the other hand, the Abcam 
C12orf29 antibody was the only one that reliably detected, by IF, a highly expressed 
protein in mOB and PDL cells (Fig 4–21 and 22; pages 126–7), and a cartilage 
bound protein by IHC (Fig 4–25; page 131).  
It turned out that the Abcam antibody did not work well in the Licor buffer, 
whereas it produced very clear bands using BSA-TBST buffer and ECL detection 
reagent. Evidence produced by lining up side-by-side WBs of overexpressed HA-
C12orf29 protein, showed that the Abcam C12orf29 had a discernible, but low affin-
ity for the HA-C12orf29 protein when compared to the anti-HA antibody (Fig 4–15; 
page 120). This blot also revealed that the Abcam antibody detected a highly ex-
pressed protein at approximately 37 kDa, which was the theoretical size of the 
C12orf29 protein based on its primary structure.  
An effort was therefore made to determine whether the Abcam, Sigma and 
Santa Cruz antibodies could detect proteins of the same MWs. It was reasoned that if 
three antibodies, all raised against the same protein but to different epitopes within 
that protein, could detect bands of the same MW, then it was most likely each anti-
body were detecting the same protein, namely C12orf29. The most compelling evi-
dence for this reasoning is seen in WBs of murine 3T3-E1 pre-osteoblast cell lysates 
(Fig 4–16; page 121), which clearly demonstrates that all three C12orf29 antibodies 
detected a 37 kDa protein band, and also one at approximately 60 kDa. A further se-
ries of WBs, on the human chondrosarcoma cell line C-28/12 also demonstrated co-
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localization of bands, in this case particularly at 50 kDa, but also at 37 kDa, although 
this band was quite faint with the Sigma antibody compared to the other two antibod-
ies (Fig 4–17; page 122). It was also apparent that the Santa Cruz antibody was quite 
promiscuous in the C-28/12 samples, binding a large number of bands not seen in 
either the Sigma or Abcam lanes; but those in common with Sigma and Abcam were 
nevertheless more prominent in the Santa Cruz blot than the other bands (Fig 4–17 
C).  
Delivery was taken of the custom made EB49 C12orf29 antibody in medio 
2012 and it was subjected to tests to compare its specificity vis-à-vis the Santa Cruz 
and Abcam C12orf29 antibodies. These tests showed that the EB49 antibody could 
detect both the recombinant C12orf29 proteins, with and without the HA tag (Fig 4–
18; page 123). In these samples, which were harvested from CHO cells, EB49 also 
detected an endogenous 37 kDa protein in the non-transfected control, as well as a 
robustly expressed protein at 50 kDa in the transfected and control samples. Interest-
ingly, the HA-C12orf29 protein, which was 3 kDa heavier than the endogenous pro-
tein and therefore shifted up compared to the latter, appeared to have suppressed the 
expression of the endogenous protein at 37 kDa (Fig 4–18 A; arrowhead).  
Finally, the EB49 and Abcam C12orf29 antibodies were tested on 3T3-E1 cell 
lysates and showed that both antibodies detected a robustly expressed protein band at 
50 kDa and that EB49 had a weaker affinity for the 37 kDa band compared to the 
Abcam antibody, which consistently detected a strong band at this MW (Fig 4–19; 
page 124).  
These experiments have demonstrated that: (i) the Santa Cruz antibody could 
detect the both of the C12orf29 recombinant proteins; (ii) the Abcam antibody had a 
distinct but weak affinity for the HA-C12orf29 protein and only worked in BSA-
TBST buffers; (iii) all three antibodies (Sigma, Abcam, and Santa Cruz) were detect-
ing protein bands at the same MWs when probing the same samples; (iv) the EB49 
antibody could detect both of the C12orf29 recombinant proteins, as well as an en-
dogenous C12orf29 protein in CHO cell lysates; (v) both EB49 and Abcam C12orf29 
antibodies detected protein bands in 3T3-E1 cell lysates that completely overlapped 
each other when the two images were superimposed. 
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C12orf29 antibody specificity and characterization – concluding remarks 
All four C12orf29 antibodies detected a 37 kDa band, the predicted MW of the 
primary C12orf29 protein, albeit with varying affinities. Only the Abcam antibody 
consistently detected this band with strong affinity, which is particularly evident in 
figure 4–16 (page 121). Ideally, the best evidence for the Abcam C12orf29 anti-
body’s specificity would have been that it co-localize with the anti-HA antibody in a 
double labelling system using HA-C12orf29 recombinant protein; however in the 
absence of such data, the facts remains that all four antibodies produced bands that 
could be superimposed on each other when comparing blots from the same samples. 
It would be highly improbable that four antibodies, all designed to recognised differ-
ent parts of the same protein, could detect non-specific proteins at the same MWs of 
each other. The most parsimonious explanation is therefore that all four antibodies 
are detecting C12orf29, but have varying affinities for what appears to be a range of 
MW bands. Of the four, the Abcam C12orf29 antibody produces the most consistent 
results, and the specificity of this antibody, in particular, was important to resolve 
since it has produced compelling data in both IF and IHC experiments.  
At the time of writing, a delivery is still pending of a C12orf29 blocking pep-
tide for the Abcam antibody. Once this is reagent has been received a series of ex-
periments will be conducted to further characterize the Abcam C12orf29 antibody.  
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5.3.3 Immunofluorescent microscopy – Discussion 
The IF microscopy analysis showed there was strong C12orf29 protein expres-
sion in both periodontal ligament and mandible osteoblast cells. In some of these 
cells the protein can be seen aggregating at high density along what appears to be the 
outer edge of the cell surface (Fig 5–4; arrows); an expression pattern that suggests 
that the protein is being secreted to the extracellular space via cells’ Golgi apparatus 
(Glick, 2000).  
 
Figure 5-4: Periodontal ligament cell stained with the Abcam C12orf29 antibody. The protein 
can be seen here as a dense aggregation along the outer edge of the cell surface (arrows). 
This pattern of expression suggests the protein is being secreted into the extracellular space 
via the Golgi apparatus. Bar = 20 m. 
There is no data to suggest that C12orf29 has a nuclear function; confocal Z 
stack microscope analysis did not resolve any nuclear localization of the protein 
(data not shown). The PC3 prostate cancer cell lines showed that these cells had a 
low intracellular C12orf29 protein expression (Fig 4–24; page 129), which suggests a 
constitutive background expression in PC3s and possibly other cell types. 
   
 212  Chapter 5: Analysis and Discussion 
5.3.4 Immunohistochemistry – Discussion 
The IHC analysis showed clear evidence of high extracellular expression levels 
of C12orf29, in both cartilage and growth plate and suggested that C12orf29 was a 
structural protein. It also showed that C12orf29 had a cartilage specific expression 
pattern and only had limited expression in bone.  
Only the EB49 and Abcam C12orf29 antibodies produced reliable results in a 
variety of different samples. Both antibodies produced robust signals in the growth 
plates and articular cartilage in the rat (Fig 5–5). The pattern of expression detected 
by both antibodies showed distinct differences between the two. In the growth plate, 
the EB49 antibody signal was most intense in the proliferation zone (arrowheads), 
whereas the Abcam antibody signal was strongest in the hypertrophic or mineralizing 
zone of the growth plate (arrowhead). In these samples, the EB49 antibody stained 
strongly throughout the articular cartilage (arrows), whereas the Abcam C12orf29 
antibody stain was restricted to the chondrocytes themselves (arrows).  
Figure 5-5: C12orf29 expression in tibial head in the rat. The EB49 and Abcam C12orf29
antibodies both detected robust protein expression in the growth plate (GP) and articular
cartilage (AC) but the pattern of expression was distinct for each antibody. Bar = 500 m. 
Abcam C12orf29EB49 C12orf29 
GP
AC
SCB
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The most likely explanation for what is a similar yet distinctly different pattern 
of expression is the varying affinities for different MW sizes of the same protein. The 
antibody specificity data suggests that there are more than one isoform of the 
C12orf29 gene product. In murine 3T3-E1 cell lysates, the Abcam C12orf29 anti-
body preferentially detected a 37 kDa form of the protein (Fig 4–16; page 121), 
whereas the EB49 antibody has relatively weak affinity for this particular sized pro-
tein; both antibodies detected a 50 kDa band of equal intensity (Fig 4–19; page 124). 
It therefore seems feasible that this preferential affinity for different isoforms of the 
same protein is reflected in the tissue sections as well.  
C12orf29 expression in early mouse embryos 
In the 13.5 dpc mouse embryo the expression of C12orf29 is very similar with 
both antibodies, although the signal intensity is more intense with the Abcam anti-
body compared to the EB49 antibody (Fig 5–6 A and B).  
 
Figure 5‐6: Comparison of C12orf29 signal  in the cranial vault of the forebrain  in 13.5 dpc 
mouse embryos. (A) EB49 C12orf29 antibody shows C12orf29 expression most intensely at 
the outer edge of the cranial vault (arrows). (B) The Abcam C12orf29 antibody shows the 
expression of C12orf29 more strongly throughout the chondrocranial parietal lobe (arrows). 
(C) COL2 expression is seen in the parietal cartilage anlagen (arrows). Bar = 500 m 
It is a commonly held view that the calvarial bones of the skull, which develop 
via the process of membranous ossification, are absent of cartilaginous tissues 
(Holmbeck et al., 1999). However, contrary to the long bones, in which the cartilage 
in the growth plate undergo hypertrophy and subsequent mineralization (Karsenty 
and Wagner, 2002), the bones of the skull form on top of a cartilaginous anlagen but 
in a process that does not involve the chondrocyte hypertrophy, mineralization and 
osteoclastic resorption that characterizes endochondral bone formation. In the cranial 
bones, the parietal cartilage remains completely unmineralized, and is separated from 
A B C
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the de novo bone by a cell-rich layer, before it is removed by membrane type 1 ma-
trix metalloproteinase (MT1-MMP) (Holmbeck et al., 2003).  
The expression of C12orf29 does appear to be restricted to cartilaginous tis-
sues; it is therefore likely that the C12orf29 expression seen in the 13.5 dpc mouse 
embryos is in the calvarial cartilage anlagen, preceding the osteoblast differentiation, 
which agrees with a study that could not find any evidence of expression of the os-
teogenic marker genes Runx2 and osterix in the calvarium of 13.5 dpc mice (Day et 
al., 2005). There is a clear overlap of expression pattern between C12orf29 and 
COL2 seen particularly in the chondrocranium at 13.5 dpc (Fig 5–6 C) and this pat-
tern of expression is found in the other tissues that have been tested. 
 
C12orf29 expression in human cartilage 
Normal and osteoarthritic human cartilage samples were probed with EB49 and 
Abcam C12orf29 antibodies and both antibodies detected the expression of C12orf29 
in these samples. In the normal cartilage the Abcam antibody detected strong 
C12orf29 expression in the mid to deep layer of the cartilage. The EB49 antibody 
detected C12orf29 expression that overlapped that of the Abcam antibody, and which 
extended into the superficial layer of the cartilage. It is noteworthy that neither anti-
body detected any C12orf29 expression extending into the subchondral bone (Fig 4–
25; page 131). In the osteoarthritic cartilage the C12orf29 expression detected by the 
two antibodies was indistinguishable (Fig 4–26; page 132). C12orf29 expression in 
both the cartilage and growth plates overlaps that of COL2. Type II collagen is one 
of the major components of the extracellular matrix of cartilage and is present in a 
fibrillar form which provides tensile strength to the cartilage (Hollander et al., 1994).  
 
C12orf29 expression in early developing human axial skeleton 
The IHC results from the 7–8 week old human embryo slides provided the 
strongest data yet on which to formulate a hypothesis as the physiological role of 
C12orf29. We have established that both the Abcam and EB49 antibodies have 
strong but distinct affinities for cartilaginous tissues in both human and rat samples. 
It was therefore not entirely surprising that the staining patterns in the human embryo 
samples differed between these two antibodies. The Abcam C12orf29 antibody 
showed a C12orf29 expression that was strictly limited to the developing skeletal 
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elements and strongly resembles that of COL2 (see Figs 4–31 and 32; pages 138 and 
139). A high magnification image demonstrates that C12orf29 is expressed in the 
extracellular space between the cells (Fig 4–32 B) and, most significantly, is ex-
pressed very strongly in the sacral vertebrae, which at this particular developmental 
stage have just fused together or are about to fuse (Fig 4–32 C). This intense pattern 
of staining is not seen with COL2 (Fig 4–31).  
In human and rat cartilage, the EB49 C12orf29 antibody worked well using 
Proteinase K enzyme for antigen retrieval. In the human embryo sample it was nec-
essary to apply heat based antigen retrieval (HBAR) in order to elicit a signal with 
this antibody. This method probably produced a higher degree of non-specific back-
ground staining (Fig 4–33; page 141) with this antibody. By comparison, the COL2 
antibody produced no non-specific staining in the human embryo sample using 
HBAR (Fig 4–31; page 138). Despite the likelihood of non-specific staining with the 
EB49 antibody using HBAR, the pattern of staining, in particular, in the sacrum ap-
pears to be highly specific. In contrast to the Abcam C12orf29 image, the EB49 anti-
body detected strong protein expression in the IVDs between the sacral vertebrae 
(Fig 4–33 C); however, there was also strong expression of C12orf29 at the edges of 
the unfused vertebrae as well as in the ECM of the S1 and S2 vertebrae, which mir-
rors that seen in figure 4–32 (page 139). 
 
SOX9 and BAPX1 expression in human embryo  
The transcription factors SOX9 and BAPX1 play a vital role for the develop-
ment of the axial skeleton. They act as pro-chondrogenic factors and regulate the dif-
ferentiation of sclerotome into chondrocytes (Lengner et al., 2004; Tribioli and 
Lufkin, 1999; Yamashita et al., 2009). The bioinformatics analysis of the human 
C12orf29 promoter region indicated there were a number of SOX9 and BAPX1 TF 
binding sites, suggesting that C12orf29 was regulated by these TFs.  
Antibodies for SOX9 and BAPX1 were included in the panel of antibodies 
used for the human embryo tissue samples. The results presented here are prelimi-
nary in nature given that the antibodies are yet to be tested on other tissues, and for 
this reason the data has been difficult to interpret. At this stage it does not seem fea-
sible to draw any conclusions from the SOX9 data as the staining appears to be quite 
non-specific. Although the manufacturer recommended using HBAR, it may well be 
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that Proteinase K is the more optimal antigen retrieval method for the SOX9 anti-
body. However, this was not possible to test this since our stock of human embryo 
slides were limited and were rapidly exhausted.  
The BAPX1 antibody, on the other hand, did not have this issue. The areas of 
strong staining are located on each side of the vertebrae and which may be remnant 
sclerotome. In human embryos, BAPX1 expression is reported to be visible at day 
52, in the gut mesoderm, in the sclerotome, and in the cartilaginous templates of de-
veloping bones in the limbs (Tribioli and Lufkin, 1997).  
Because of its expression in the early stages of chondrogenesis, BAPX1 is re-
garded as one of the earliest markers for the sclerotome lineage that forms the axial 
skeleton. In mature human cells, the expression of BAPX1 is greatest in chondro-
cytes and gut (small intestine and colon), whereas moderate expression is observed in 
trachea and brain, and none in heart and liver derived cells (Hellemans et al., 2009).  
In light of this information it is unclear whether the expression pattern seen in 
figure 4–34 is a true reflection of BAPX1 expression in a human embryo at this de-
velopmental stage, further studies are therefore needed. 
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5.3.5 RT-qPCR and western blot analysis – Discussion 
RT-qPCR 
The gene and protein expression of C12orf29 in various bone derived cell types 
was assayed in response to osteogenic induction medium. The RT-qPCR data shows 
that C12orf29 gene expression does increase in response to osteogenic medium, and 
this was supported by a Wilcoxon signed rank test analysis. Over a number of RT-
qPCR experiments there was quite a high degree of what could be termed “inter pa-
tient” variability, such that one could not definitely state that one cell type had a 
greater C12orf29 increase in response to osteogenic induction medium to the other. 
In some experiments the gene expression would be far greater in tOBs than in mOBs 
and BMSCs, in other experiments the mOB gene expression might exceed that of 
tOBs and BMSCs (data not shown). These individual sample differences were large 
enough that it was unfeasible to pool data in terms of cell types; the error bars cre-
ated from such divergent data would have been so large as to have rendered it mean-
ingless. In general, the gene expression of C12orf29 in mesenchymal cell types 
tended to increase robustly over time in response to osteogenic induction medium. 
The question posed by these experiments was whether C12orf29 gene expression 
was being upregulated in the process of in vitro osteogenic differentiation and the 
answer from this point of view was a resounding yes.   
Western blot analysis 
The western blot analysis of cell lysates from sheep primary cells showed a 
species specific affinity for the C12orf29 protein between the Santa Cruz and Abcam 
C12orf29 antibodies. The Santa Cruz antibody failed to bind to the 37 kDa isoform 
of C12orf29, whereas the Abcam antibody detected robust protein expression at this 
MW (Fig 4–37; page 147). This WB experiment illustrated the challenge encoun-
tered with verifying the specificity of the various C12orf29 antibodies. In this ex-
periment, periodontal ligament cells, mandible osteoblast cells and femur osteoblast 
cells were treated with osteogenic induction medium for 3 and 12 days before har-
vesting. As was the case with the RT-qPCR data, the WB could not give an unambi-
guous answer as to whether C12orf29 protein expression would consistently increase 
in a given cell type in response to stimulation with osteogenic induction medium. In 
qualitative terms the answer is affirmative that C12orf29 protein expression is 
upregulated in response to such growth medium. However, in light of other experi-
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mental data, in particular the IHC which shows that the protein is expressed in carti-
laginous tissues, it could be argued that looking at C12orf29 expression in osteoblast 
cells is simply asking the wrong question. This was most likely a reflection of an os-
teogenic bias that prevailed for some time until it became clear that C12orf29 was 
intimately linked to chondrogenesis and cartilage and not osteogenesis and bone. The 
western blot data is therefore qualitative and becomes more data on which to charac-
terize the various C12orf29 antibodies.  
An alternative hypothesis will therefore have to be tested in future experiments, 
namely, if C12orf29 is a chondrogenic gene does its protein expression become 
upregulated in chondrogenic conditions and is there a correlation between its expres-
sion and that of chondrogenic markers such as type II collagen and aggrecan? On the 
strength of the IHC data, which show a clear co-localization between C12orf29 and 
COL2, this seems a question that could be resolved in the affirmative. 
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5.4 DISCUSSION – C12ORF29 PHYLOGENETIC ANALYSES   
Introduction 
The origin of eukaryotic cells–characterized by a nuclear envelope containing 
the genetic material and distinct organelles–is one of the most fundamental and hotly 
debated areas in evolutionary biology (Archibald, 2008). The evolutionary history of 
life is inscribed in the sequence information of DNA and proteins of living organ-
isms, and the molecular mechanism of evolution cannot be understood without 
knowing the phylogenetic relationships among extant organisms (Hashimoto and 
Hasegawa, 1996). Based on phylogenetic and molecular characterization of the small 
subunit of ribosomal RNA, it was established in the 1980s that eukaryotic cells were 
more closely related to archae–which comprise extreme halophiles, thermophiles and 
methanogens–than to eubacteria, commonly known as bacteria (Woese et al., 1990). 
It was therefore proposed that early eukaryotes could have arisen from an archae-like 
ancestor, having evolved a nucleus, endomembrane, and cytoskeleton but with an 
inefficient prokaryote-like metabolism. It was assumed that the earliest eukaryotes 
acquired organelles, such as mitochondria and chloroplasts, by a process of phagocy-
tosis (Vellai and Vida, 1999). More recent molecular evidence seems to support the 
notion that the eukaryotic genome derived from a fusion between archaeal prokaryo-
tes and proteobacteria (Rivera and Lake, 2004). Support for a fusion event, thought 
to have taken place more than 2.2 billion years ago (Feng et al., 1997), comes from 
the fact that extant eukaryotic nuclear genomes contain genes that manifest sister-
group phylogenetic relationships with both eubacterial and archaebacterial genes 
(Alvarez-Ponce and McInerney, 2011). There seems to be a clear pattern of inheri-
tance whereby eukaryotic informational genes (genes involved in transcription, trans-
lation and other related processes) are most closely related to archaeal genes, 
whereas operational genes (genes involved in cellular metabolic processes such as 
amino acid biosynthesis, cell envelope, lipid synthesis, and so on) are most closely 
related to eubacterial genes. Whether operational nuclear genes were obtained from 
chloroplast and mitochondrial endosymbionts or elsewhere is still not clear. Opera-
tional genes appear to be easily transferred horizontally, whereas informational genes 
do not. The coherence of the informational lineage might reflect demanding func-
tional constraints imposed on a tightly integrated set of genes (Rivera et al., 1998; 
Rivera and Lake, 2004). 
 220  Chapter 5: Analysis and Discussion 
Phylogenetic analysis of C12orf29 suggests a gene of prokaryote origins  
The phylogenetic analysis of C12orf29-like sequences from non-vertebrate 
species revealed the ancient pedigree of C12orf29, and also suggests that its original 
template is still found in extant bacteria. This analysis infers that the prototype of this 
gene has been under selective pressure for at least 2.2 billion years, and yet it is clear 
that the eukaryote version is no longer the same gene as that of the prokaryote, and 
therefore could not have the same role that it once had in its bacterial ancestor. The 
eukaryote C12orf29-like proteins have grown over 50% in size compared to the bac-
terial prototype. The expansion of the eukaryote gene size must have happened early 
during the eukaryote diversification given the uniform protein length across these 
species, ranging from 337 residues in the single celled Naegleria to 325 residues in 
humans.  
 
 
The expansion of the C12orf29 sequence can be thought of as a eukaryotic innova-
tion. The Hahella HCH_06039 protein contains a weak similarity to a conserved 
domain which is related to an information-processing gene family (Fig 5–7). This 
domain spans 64 amino acids from residue 113 to 177, but it does not appear to have 
been retained in the eukaryotic protein and it therefore cannot be inferred that 
C12orf29 has an information processing role in eukaryotes.  
The most striking feature of the prokaryote and eukaryote alignment is the fact 
that the greatest level of similarity between the eukaryotic proteins corresponds with 
those areas defined by the Hahella sequence (Fig 4–38; page 151). It appears that, 
although the gene has most likely evolved to have a completely different function in 
the eukaryotes than what is its role is in the Hahella, the ancestral domains within the 
gene has been under greater selective pressure than the domains that are eukaryote 
specific. This is particularly evident in the C terminal end of the eukaryote proteins, 
which has the least degree of sequence homology even in the higher metazoan spe-
cies.  
Figure 5-7: The H.chejuensis HCH_06039 protein contains a conserved domain with 
similarity to the adenylation DNA ligase superfamily. This suggests the prokaryotic gene 
ancestor could have belonged to an information-processing gene family.  
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5.4.1 Distribution of C12orf29-like proteins in eukaryata  
The distribution of C12orf29-like proteins in eukaryote species suggests that 
the gene could once have been ubiquitous throughout the early eukaryote domain, 
only, over time, to be lost to the majority of species within it. When the eukaryotes 
emerged more than two billion years ago, their metabolic, cytoskeletal and compart-
mental complexity allowed them to occupy new niches. Descendants of these early 
eukaryotes are distributed among only 5 to 6 major divisions, referred to as the 
plants, excavates, chromalveolates, rhizaria, which belong to the assemblage of bik-
onts (meaning "two flagella”), and the unikonts (meaning "one flagellum"), which 
comprise the Opisthokonts and Amoebozoa (Burki and Pawlowski, 2006). We find a 
C12orf29-like gene in the Naegleria, which is a critical taxon for comparative studies 
of eukaryotic diversification. The Naegleria belongs to excavates, which are a di-
verse group of unicellular bikonts. The Naegleria lineage is distantly related to the 
Euglenazoa and Jakobid flagellates, which together form an ancient and ecologically 
diverse clade. The Nagleria gruberi is a free-living protist found around the world in 
freshwater and moist soils. It grows as an amoeba that completely lacks a cytoplas-
mic microtubule cytoskeleton. However, when exposed to stressors such as tempera-
ture, osmotic, or pH changes, Naegleria rapidly differentiate into a flagellate, form-
10 m
Figure 5-8: The free-living protist Nagleria predominant form is as an amoeba. However,
when stressed, it can rapidly differentiate into a streamlined flagellate form with two anterior
9+2 flagella. Inset shows a cross section of a 9+2 flagellum. (Wikimedia com-
mons/Naegleria/Flagellum) 
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ing a complete de novo cytoplasmic cytoskeleton, including two anterior 9+2 flagella 
(Fig 5–8) (Fritz-Laylin et al., 2010a; Fritz-Laylin et al., 2010b).  
The Naegleria genus is on the heterolobosean sub-branch of bikonts on the eu-
karyotic tree of life. The other major eukaryotic branch, the unikonts, comprises the 
Amoebozoa and Opisthokonts, of which the metazoan, or animal kingdom, is the 
most diverse phylum. Within the metazoan branch of the eukaryota, C12orf29-like 
genes have been identified in the cnidarian species Hydra magnipapillata (freshwater 
Hydra), in the chordate superphylum, most recently in the protostome species 
Crassostrea gigas (Pacific oyster).  
 
The Cnidaria – The diploblastic body plan 
Metazoans are divided into two major taxonomic units, namely, animals with 
two embryonic layers and radial symmetry (diploblasts) and those with three embry-
onic layers and bilateral symmetry (triploblasts). The diploblast unit consists of three 
major phyla, the Porifera (sponges), Cnidaria, and Ctenophora, in addition to two 
phyla of uncertain affinity, the Placozoa and Mesozoa (Kobayashi et al., 1996). The 
phylum Cnidaria contains approximately 9,000 species ranging from the freshwater 
Hydra  (Fig 5–9) to marine jellyfish and coral reefs (Steele et al., 2011). There are 
five different classes of Cnidaria, of which the genomes of two Anthozoa, the sea 
anemones Nematostella vectensis (Putnam et al., 2007) and the coral Acropora 
digitifera (Shinzato et al., 2011), and one Medusazoa, the freshwater Hydra Hydra 
Figure 5-9: The freshwater Hydra is a member of the Cnidaria superphylum, class meduso-
zoa. It is the only diploblastic animal to carry a copy of C12orf29.  Bar = 5 mm (NewScientist,
2006) 
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magnipapillata (Chapman et al., 2010) have been fully sequenced.  Cnidarians are 
widely regarded as possessing only two germ layers (endoderm and ectoderm). The 
mesoglea, an extracellular matrix containing a few scattered cells, separates the en-
doderm and ectoderm, but there is no well-organized intermediate tissue layer such 
as a mesoderm (Martindale et al., 2004). In Bilateria, genes associated with meso-
derm specification are predominantly expressed in the mesoderm or presumptive 
mesoderm. In a study using the sea anemone (Nematostella vectensis) as a model, a 
number of developmental genes associated with mesodermal formation and differen-
tiation in bilaterian animals exhibited endodermal expression during early Nematos-
tella larvae development. This restricted expression suggests that these genes are im-
portant for germ-layer specification, and the predominance of endodermal expression 
supports the hypothesis that both endo and mesoderm in triploblasts evolved from 
the endoderm of a diploblastic ancestor (Martindale et al., 2004). Although the N. 
vectensis does not appear to have a C12orf29 homologous gene, the data from this 
study offers a plausible mechanism as to how C12orf29 made its way from a dip-
loblastic body plan, such as that of the Hydra magnipapillata, into the bilaterate 
branch of the eukaryote tree of life.  
 
Protostomes – The Pacific oyster 
The draft genome of the Pacific oyster Crassostrea gigas was announced in 
October 2012. The Pacific oyster (Fig 5–10) is a marine bivalve belonging to the 
phylum Mollusca, which is the most specious member of the Lophotrochozoa sub-
phylum of the superphylum Protostoma (Zhang et al., 2012).  
 
The other major protostome branch is the Ecdysozoa, which encompasses ani-
mals such as insects, crustaceans, Myriapoda, and Nematode worms (Dunn et al., 
2008). The protostomes, together with deuterostomes, have a bilateral body plan 
placing them both in the same monophylum, bilaterians (Fig 5–14; page 227).  
Figure 5-10: The Pacific oyster Crassostera gigas. 
(http://www.dpi.nsw.gov.au/fisheries/pests-diseases/marine-
pests/nsw/pacific-oyster)  
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Other key protostome species with fully sequenced genomes, include the fruit 
fly Drosophila melanogaster (Adams et al., 2000), honey bee Apis mellifera 
(Weinstock et al., 2006) and Nematode worm Caenorhabditis elegans (CESC, 1998). 
The C. gigas is the only sequenced protostome species to date that has a C12orf29-
like gene (GenBank: EKC30616). The amino acid sequence similarity with human 
C12orf29 is 63% overall, with 41% identities, but the effective range of similarity is 
limited to less than half of the amino acid residues (Fig 5–11). However, an E value 
of 3e-36 for this sequence similarity all but rules out the possibility that this similarity 
arose by chance; an E-value of e-5 and lower is accepted as a measure of a unique 
alignment and not due to error or chance (Metzler, 2006; Mitrophanov and 
Borodovsky, 2006). The C. gigas C12orf29-like protein, at 317 amino acids, is simi-
lar in length to the human C12orf29 protein (325 aa). The two proteins overlap such 
that the N-terminal half of the human protein matches the C-terminal half of the C. 
gigas protein.  
The C. gigas C12orf29-like sequence was aligned by ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) with C12orf29 sequences from 12 other 
species and the evolutionary relationship of the proteins inferred by the Maximum 
Likelihood (ML) method based on the JTT matrix-based mode (Jones et al., 1992) 
using the MEGA5 phylogenetic analysis program (Tamura et al., 2011). The reliabil-
ity of the inferred tree was tested by 10,000 bootstrap resamplings (Felsenstein, 
1985). The tree has been drawn to scale, with branch lengths measured in the number 
Figure 5-11: Amino acid alignment of human C12orf29 against Pacific oyster C12orf29-like
protein. The sequence similarity is limited to the opposite halves of the respective proteins,
such that the N-terminal half of the human protein has a higher degree of similarity with the
C-terminal half of the oyster protein, highlighted in yellow. 
 
Homo sapiens C12orf29 (Query)  vs  C. gigas  C12orf29-like protein (Sbjct) 
Score Expect Method Identities Positives Gaps 
122 bits(305) 3e-36 Compositional matrix adjust. 61/147(41%) 93/147(63%) 14/147(9%) 
 
Query  32   FKVLATETVSHKALDADIYSAIPTEKVDGTCCYVTTYKDQPYLWARLDRKPNKQAEKRFK  91 
            +KV+A++ + + AL +D+  +I TEK+DGTC ++  +K +P+LWARLDRKPNK  +KRFK 
Sbjct  173  YKVVASDVLKNTALLSDVTRSIATEKLDGTCVFIAEFKGRPWLWARLDRKPNKAGDKRFK  232 
 
Query  92   NFL--------HSKENPK-EFFWNVEEDFKPAPECWIPAKETEQINGNPVPDENGHIPGW  142 
             +          S++ PK    W++E+DFK  PE WIPA +   +NG+P PD+NGH PG  
Sbjct  233  QYRSSLQKWEQSSQDLPKPSLEWDIEKDFKQVPEHWIPASDVPIVNGHPQPDQNGHTPGM  292 
 
Query  143  VPVEKNNKQYCWHSSVVNYEFEIALVL  169 
            +  E +      HS    +E E +L++ 
Sbjct  293  LGGEGS-----MHSCKEKFEVEKSLIV  314 
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of substitutions per site (Fig 5–12). In this tree the C. gigas forms a branch with the 
freshwater Hydra and its branch length is indicative of how far its C12orf29 protein 
has evolved from that of the other taxa. The C. gigas sequence was not included in 
the final MrBayes analysis because it failed to resolve its phylogenetic relationship in 
repeated analyses.  
The presence of a C12orf29 gene in the cnidarian freshwater Hydra and a ves-
tigial C12orf29-like gene in the protostome Pacific oyster is evidence that C12orf29 
was likely to have had a widespread distribution in the early metazoan fauna. The 
common metazoan ancestor of must have carried a C12orf29-like gene, a proposition 
that is all the more likely given the presence of a C12orf29-like gene in the Naegleria 
genome. Over time, the C12orf29 has been lost to the vast majority of non-chordate 
taxa, whereas in chordates its function has been retained and conserved from its 
emergence from the earliest deuterostome ancestor. 
 
Figure 5-12: Molecular phylogenetic analysis by ML method using MEGA5. The evolutionary 
history of Pacific oyster C12orf29-like protein sequence was inferred by using the ML 
method based on the JTT matrix-based model. The tree with the highest log likelihood is 
shown. The percentage of trees in which the associated taxa clustered together is shown 
next to the branches. The tree is drawn to scale, with branch lengths measured in the num-
ber of substitutions per site. The analysis involved amino acid sequences from 13 taxa.  
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5.4.2 C12orf29 and the chordate superphylum 
Acorn worm, Branchiostoma and Ciona – The ABC of chordate development  
The chordates are a group of animals that include the familiar vertebrates: fish, 
amphibians, reptiles, birds and mammals; but these animals represent only one of a 
larger, more inclusive group. Less familiar are the non-vertebrate chordates, which 
include the urochordates, or tunicates; the cephalochordates, or lancelets; and the 
more controversial inclusion, the hemichordates, or acorn worms. 
 All chordates share some or all of a number of characters at some point of their 
development: (i) a stiffening rod of mesodermally derived tissue that runs along the 
body axis, known as the notochord; (ii) mesoderm that forms segmented muscles 
known as somites; (iii) a hollow nerve trunk that runs along the dorsal side of the 
body; (iv) a post anal tail that is connected with movement, but has no viscera; (v) 
paired gill slits that are lined with epithelial cells with hair-like cilia; and (vi) an en-
dostyle that is an iodine-binding organ and considered a homologous organ to the 
vertebrate thyroid (Fig 5–13). The lancelets and vertebrates bear all of these features 
as adults (Gee, 1996). 
 
Figure 5-13: Schematic showing the principal common features of the Chordate superphy-
lum. At some stage of their lifecycle, display the developmental characteristics typical of 
chordates: post anal tail, dorsal nerve cord, notochord, endostyle, and pharyngeal gill slits. 
From Campbell Biology (9th Edition)   
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Saccoglossus kowalevskii – The acorn worm 
 The class Hemichordata is a sister group of the Echinodermata, and together 
these two classes form a monophyletic outgroup with the rest of the chordates (Fig 
5–14). All of the chordate characteristics (post anal tail, dorsal nerve cord, noto-
chord, endostyle, and pharyngeal gill slits) have at one time or another been sug-
gested to have homologous structures present in hemichordates; none of these fea-
tures are found in echinoderms, the closest relative to hemichordates, suggesting that 
they were lost during echinoderm evolution (Rychel et al., 2006).  
 
Figure 5-14: A simplified phylogenetic tree showing the relationship between bilateria and 
cnidaria. Chordates, together with echinoderms and hemichordates, are deuterostomes, a 
division of animals that are distinguished from other bilaterian animals in that the anus de-
velops from the blastopore and the mouth forms a perforation elsewhere in the gastrula. The 
protostomes are represented by the invertebrate phyla ecdysozoa (e.g. the nematode 
Caenorhabditis elegans, the insect Drosophila melanogaster, and the crustacea) and the 
lophotrochozoa (e.g. rotifera, annelida, and mollusca). Molecular phylogenetic evidence 
suggests the diploblastic cnidaria is the sister clade of the bilaterians. (Gerhart et al., 2005; 
Martindale et al., 2004) 
 The Hemichordata is represented by the acorn worm Saccoglossus kowalevskii (Fig 
5–15), a species that has been studied extensively as a model system of basal chor-
date development since the late nineteenth century (Lowe et al., 2003).  
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Chordate 
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Protostomes
Deuterostom
es
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(Adapted from Martindale et al, 2004 and Gerhart et a l, 2005)
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Figure 5-15: A juvenile acorn worm at day 13 of development. The three major body regions  
are well developed and several gill slits are perforated in the anterior metasome. The juve-
nile post-anal tail is still present, which is eventually lost in adult animals (Lowe, 2008). 
The S. kowalevskii is unique in that it carries not one, but two copies of a C12orf29-
like gene. One copy translates into a 398 amino acid protein (XP_002736673) and 
the other into a 337 amino acid protein (XP_002740769). The shorter protein has the 
greatest sequence homology with human C12orf29 (Fig 5–16), and aligns against the 
C terminal end of the longer protein. The C terminal end of the long protein 
(XP_002736673) is incomplete since its mRNA does not have the complete 3’ se-
quence information. The presence of two of C12orf29-like genes could be the result 
of a gene duplication event in the Saccoglossus genome, resulting in two fully func-
tional versions (Johnson and Moore, 2012). The inferred protein of the long version 
appear to be a full open reading frame and the gene is unlikely to be a pseudogene 
since there are no missense mutations present within its mRNA. The Saccoglossus is 
the only species surveyed thus far that carries two C12orf29-like homologs. The rate 
of change of the of the Saccoglossus C12orf29-like homolog relative to human 
C12orf29 is–at 50% amino acid identity and 67% sequence similarity–equal to that 
of human BMP2 (NP_001191) and Saccoglossus BMP2/4 (NP_001158387) at 53% 
amino acid identity and 67% sequence similarity; the amino acid identity and se-
quence similarity between human (NP_003229) and Saccoglossus (NP_001171727) 
TGF-2 is 42% and 59%, respectively. C12orf29 has a similar rate of amino acid 
change, which suggests it has been under the same selective pressure in Saccoglossus 
as both BMP and TGF-genes, both of which are important developmental genes 
and highly conserved throughout the metazoans (Galat, 2011). 
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> ref|XP_002740769.1|     PREDICTED: hypothetical protein [Saccoglossus kowalevskii] 
Length=337 
 
 GENE ID: 100370438 LOC100370438 | uncharacterized LOC100370438 
[Saccoglossus kowalevskii] 
 
 Score =  337 bits (863),  Expect = 7e-118, Method: Compositional matrix adjust. 
 Identities = 165/332 (50%), Positives = 223/332 (67%), Gaps = 12/332 (4%) 
 
Query  5    GSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDGTCCY  64 
            GSVQ K+PCVF T V EE S+KR++Q + V+A+  +   A++  I  A PTEK+DGTC Y 
Sbjct  3    GSVQCKVPCVFKTRVIEEKSNKRQYQQYNVVASNELQDSAIEDSIEEATPTEKLDGTCVY  62 
 
Query  65   VTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSK----------ENPKEFFWNVEEDFKPA  114 
            V  YK +P+LWARLDRKP KQA+K FK +  +K          E P  + WN ++DF+ A 
Sbjct  63   VHEYKGRPWLWARLDRKPTKQADKHFKRYQAAKRAWMLNGMSGEEPM-WNWNADKDFRTA  121 
 
Query  115  PECWIPAKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPD  174 
             + WIPAK    ING   PD  GHIPGW+PVE  ++QYCWHSS  +  + IA+VLK   D 
Sbjct  122  RDSWIPAKGVPIINGTAQPDLYGHIPGWLPVESKDRQYCWHSSTFDVNYGIAVVLKSSND  181 
 
Query  175  DSGL-LEISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLK  233 
             +   +E++ V LS+LLEQTLELIGTNINGNPYGLG K++P+H+L+PHG  Q  +   +  
Sbjct  182  GNQYSMEVTIVELSELLEQTLELIGTNINGNPYGLGCKRNPIHVLVPHGVIQFPSSIPIS  241 
 
Query  234  HNDLVSWFEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNK  293 
            +++L  WFE   EGK+EGIVWHC +  L K+HRHH GL WPI D Y  SRPV INM+L++ 
Sbjct  242  YDELKLWFESSDEGKVEGIVWHCKNQQLYKLHRHHFGLPWPIEDVYFTSRPVAINMDLSR  301 
 
Query  294  CDSAFDIKCLFNHFLKIDNQKFVRLKDIIFDV  325 
             +  FD   +F+   + + Q+F +L+++  D  
Sbjct  302  YECDFDSTSMFSVLSQFNGQRFEQLRNVPQDT  333 
 
 
> ref|XP_002736673.1|    PREDICTED: hypothetical protein, partial [Saccoglossus kowalevskii]
Length=398 
 
 GENE ID: 100372883 LOC100372883 | uncharacterized LOC100372883 
[Saccoglossus kowalevskii] 
 
 Score =  214 bits (545),  Expect = 4e-69, Method: Compositional matrix adjust. 
 Identities = 124/266 (47%), Positives = 158/266 (59%), Gaps = 34/266 (13%) 
 
Query  7    VQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDGTCCYVT  66 
            V R++   F +E  + PSS     P+ V+A   +   ALD +I  AIPTEK DGTC YV  
Sbjct  161  VNRRLMRKFTSEYYD-PSS----DPYSVVALNDIRRSALDDNIEKAIPTEKFDGTCVYVH  215 
 
Query  67   TYKDQPYLWARLDRKP-NKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIPAKETE  125 
             Y  +P+LWAR +R+P  K A K++                   D KP P+ WIPAK  + 
Sbjct  216  EYNGRPWLWARFERRPRTKCAAKKY-------------------DLKPVPDNWIPAKGVQ  256 
 
Query  126  QINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLEISAVP  185 
             I+G P P   GHI GWVPVEK N+QYCWHSS V+    IA+VLK  P D G  +++ V  
Sbjct  257  IIDGKPQPGRFGHILGWVPVEKENRQYCWHSSTVDMARGIAMVLK--PTDQG-NQVTIVE  313 
 
Query  186  LSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGA-----FQIRNLPSLKHNDLVSW  240 
            LS+LLEQ LELIGT INGNPYGLG K  P+H L+PH        +   LP L +  L  W 
Sbjct  314  LSELLEQPLELIGTKINGNPYGLGCKTTPVHFLVPHAGNSSIVKRSFRLP-LSYPLLKLW  372 
 
Query  241  FEDCKEGKIEGIVWHCSDGCLIKVHR  266 
            FED  EG++EGIVW+C +  L K++R 
Sbjct  373  FEDFHEGRVEGIVWYCENQQLYKLNR  398 
Figure 5-16: The acorn worm has two putative C12orf29 orthologs, a 337 amino acid pro-
tein (XP_002740769) and a longer 398 amino acid protein (XP_002736673). The acorn 
worm sequences are highlighted in yellow and have been BLAST aligned against human 
C12orf29. The longer protein is a partial sequence; the mRNA (XM_002736627) is in-
complete at the 3’ end.  
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Ciona intestinalis – The sea squirt 
Ascidians and their two sister classes, the Larvaceans and Thaliaceans, define 
the subphylum Urochordata and represent the most basal branch of known chordates. 
This clade is thought to have arisen 543 million years ago in the “Cambrian explo-
sion” (Chen et al., 2003). This divergence creates over 500 million years of inde-
pendent evolution between extant ascidians and modern vertebrates, and despite this 
evolutionary distance, the basic features of the chordate body plan remain recogniz-
able in ascidian larvae (Fig 5–17). The similarities between ascidian larvae and ver-
tebrate embryos were first pointed out by the Russian embryologist Alexander 
Kowalevsky in the mid nineteenth century, who observed that the notochord and a 
dorsal neural tube in the ascidian larva was clear evidence that ascidians were mem-
bers of the phylum Chordata (Passamaneck and Di Gregorio, 2005). At 159 
megabases (Mb), the size of the Ciona intestinalis genome is in the same range as 
genomes of protostomes; it is around 50 Mb larger than that of the nematode worm 
C. elegans and 30 to 80 Mb smaller than most insects (Adams et al., 2000; 
Weinstock et al., 2006). The Ciona genome is approximately 5% the size of the hu-
man genome, and less than half the size of the of the compact pufferfish Takifugu 
rubripes genome (Canestro et al., 2003; Taylor and Semple, 2002). More than half 
(62%) of Ciona genes have a detectable protostome homolog, which constitute an 
ancient core of genes common to bilaterian animals. Approximately 15% of Ciona 
genes lack a clear protostome homolog, yet have a vertebrate counterpart. These 
could have arisen in the deuterostome lineage after the split from protostomes, or al-
Figure 5-17: Ciona intestinalis larva. The notochord and muscle cells are clearly visible. The
nerve cord and sensory organs are indicated. Bar = 100 m. (Canestro et al., 2003) 
Notochord
Muscle 
cells
Nerve cord
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ternatively, they could be homologs of ancient bilaterian genes that have diverged 
beyond detection or been lost from modern protostomes (Dehal et al., 2002). A 
C12orf29-like gene has been found in each of two ascidian species C. intestinalis and 
C. savignyi. The inferred proteins from both species have 43% and 44% amino acid 
identity and 59% and 61% sequence similarity, respectively, compared to human 
C12orf29. The comparable figures between S. kowalevskii and C. intestinalis 
C12orf29-like proteins is 44% amino acid identity and 59% sequence similarity, 
which would suggest there is equal evolutionary distance between humans and Ciona 
as there is between acorn worm and Ciona (Rosenberg, 2005). Surprisingly, the simi-
larity between C. intestinalis and C. savignyi C12orf29-like proteins is only 60% 
identity and 75% similarity, a measure of how much these two closely related species 
must have diverged during their evolutionary histories (Fig 5–18).  
 
Figure 5-18: The ascidian species C. intestinalis and C. savignyi each carry a copy of the 
C12orf29 gene. The inferred proteins of both species vis-à-vis the human and Saccoglossus 
C12orf20 orthologs are 44% identical and 60% similar, suggesting equal evolutionary dis-
tance between Ciona and humans as between Ciona and Saccoglossus. Surprisingly, the 
identity between the respective C12orf29-like proteins in C. intestinalis and C. savignyi is 
only 60%, indicating that these morphologically related species diverged early during their 
evolutionary histories. 
There are several online resources available which allows access to research 
data on ascidian organisms. The most comprehensive site is ANISEED (Ascidian 
 
C12orf29    C.intestinalis (Query) vs C.savignyi (Sbjct) 
Length=327 
 
 Score =  415 bits (1067),  Expect = 3e-149, Method: Compositional matrix adjust.
 Identities = 194/324 (60%), Positives = 243/324 (75%), Gaps = 8/324 (2%) 
 
Query  9    VQSKIDCLFETEVQQLPSNKRLGQNYRVVATKVVAQSAIESGIEHSVATEKLDGTCCYID  68 
            VQSKI C+F T+V ++PS KR GQNY++VATK +++ A+ S ++ +  TEK+DGTCC +  
Sbjct  9    VQSKISCIFGTQVIEIPSKKRFGQNYKIVATKQISKQALASDVKFATVTEKIDGTCCCVK  68 
 
Query  69   AYQGKLVLCARLDRKPNKSTEKKFKKFQNEKREWMINGGQGKEPKYEWKYPDDMKVVPPC  128 
             YQG++ L AR DRKP+KS EK+FKKFQN+ REW+ NG QG+EP+++W YPDDMKVVP   
Sbjct  69   KYQGQICLWARFDRKPSKSAEKRFKKFQNQHREWINNGKQGEEPRFKWNYPDDMKVVPQN  128 
 
Query  129  WYPAHGVRREGGMVQPDGNGHVPGWVPISSDARQYCWHQNAII-DDRALVLLRNTDGLVV  187 
            W PA GV R G  + PD NGH+PGWVPISSD RQYCWH   ++  D  LVLLRN  GL + 
Sbjct  129  WVPADGVERTGVGLVPDANGHIPGWVPISSDPRQYCWHHCVVVAGDSILVLLRNNGGLKI  188 
 
Query  188  TTLPLSKLAGKTFELIGTNINGNPYGLGSKASPFHILVEHGSFQITNPPRLDYDVIKDWL  247 
            TT+ +S+L GKT ELIGT++NGNPYGLGSK SPFHILVEHG   + NPP +DYD IKDWL 
Sbjct  189  TTVHMSELEGKTLELIGTHVNGNPYGLGSKQSPFHILVEHGQILVNNPPVIDYDDIKDWL  248 
 
Query  248  SASGTIEGIVWHCDDGQMFKVHRHHLNLSWPIKKQEDCDVIMPLLCQIPVTIDIEQSIVT  307 
            +    IEGIVWHC+DG MFK+HRHHL L WP      CDV  PLLCQ+PVTI+IE S++  
Sbjct  249  NDKAPIEGIVWHCEDGNMFKIHRHHLGLEWP------CDVTTPLLCQMPVTIEIEDSVMI  302 
 
Query  308  KQTQ-ISKLMKLNRKMFSSLVDIL  330 
            +Q+  I+KL +     F SL D+L 
Sbjct  303  QQSPLINKLFESETVFFKSLKDVL  326 
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Figure 5-19: The amphioxus is a fish-like filter feeding animal that spends its adult life 
burrowed, tail first, in sand near shore. The amphioxus has been studied as a model of 
chordate development since the 19th century. Bar = 1 cm. (Schubert, Trends in Ecol Evol, 2005) 
Network for InSitu Expression and Embryological Data), which is hosted by 
France’s National Centre for Scientific Research (CNRS). ANISEED hosts a vast 
combination of anatomical and molecular data on ascidian development (Tassy et al., 
2010). This database was mined for information relevant to Ciona C12orf29, but the 
information it holds was found to be of limited value and did not add any more bio-
logically relevant data than what was already available from traditional sources such 
as Genbank. This is proof that C12orf29 has yet to catch the attention of the evolu-
tionary and developmental research communities.  
 
Branchiostoma floridae – The Florida lancelet  
The most familiar member of the cephalochordate sub-phylum is the Branchio-
stoma, or amphioxus, commonly known as lancelets. These are animals that are a 
few centimetres long, leaf-shaped, laterally compressed, and translucent, and al-
though superficially fish-like, have no scales, eyes, jaws, or paired fins (Fig 5–19). 
The features that marks them as true chordates is the presence of a notochord, a dor-
sal nerve chord, segmented muscles, pharyngeal gill slits, and a secretory endostyle. 
The amphioxus shares a filter feeding habit with the tunicates, or sea squirts, and al-
though free-living, the adults tend to spend their lives buried in sand near shore (Gee, 
1996). The sequencing of the 520 megabase genome of the Branchiostoma floridae 
provides crucial insights into the basal chordate condition. The amphioxus genome 
exhibits considerable synteny with the human genome, but lacks the whole-genome 
duplications characteristic of vertebrates. Moreover, amphioxus, although very ver-
tebrate-like, lacks several key vertebrate innovations such as neural crest, bone, and 
an endoskeleton (Holland et al., 2008).  
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The traditional textbook view considers cephalochordates as the closest living 
relatives of vertebrates, to the exclusion of the morphologically more distinct tuni-
cates. This picture, however, is supported by only a few morphological features: for 
example, the presence of muscle segmentation–used to link cephalochordates and 
vertebrates–might instead be considered an ancestral feature of deuterostomes. Tuni-
cates are possibly more closely related to vertebrates, but have developed morpho-
logically and molecularly towards genomic simplification; the more distantly related 
cephalochordates might therefore have retained more ancestral characters (Delsuc et 
al., 2006).  
A clear example of genomic simplification can be seen in the larvacean 
Oikopleura dioica, a tunicate species with a 73 Mb genome, the most compact of all 
bilaterian taxa. Developmental signaling by retinoic acid (RA) is thought to be an 
innovation essential for the origin of the chordate body plan (Schubert et al., 2006), 
and yet the Oikopleura, which maintains a chordate body plan throughout life, ap-
pears to lack genes for RA synthesis, degradation, and reception. This suggests that 
the RA-machinery was lost during larvacean evolution, and that Oikopleura devel-
opment has become independent of RA-signaling (Canestro and Postlethwait, 2007). 
In the phylogenetic analysis of C12orf29, the Oikopleura stands out as being the only 
chordate species without a version of this gene, which it would seem was lost to-
gether with a host of other genes during the evolution of the compact larvacean ge-
nome (Kugler et al., 2011).  
If the urochordates were the invertebrate group most closely related to verte-
brates, this would have profound implications for our understanding of early deu-
terostome evolution and the origins of the chordate body plan, because it suggests 
that a number of conserved chordate features were present in the common ancestor of 
all deuterostomes and were secondarily lost in echinoderms and hemichordates 
(Bourlat et al., 2006). However, if C12orf29 alone was used as a measure of phy-
logenetic relationships, the acorn worm, representing hemichordates, would rank as 
the closest subphylum to the vertebrates, followed by the Amphioxus, whereas the 
Urochordata would rank as a sister subphylum.  
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Figure 5-20: Phylogenetic relationships of extant chordates. Molecular analyses support 
the view that the hagfish and lamprey genera are monophyletic, which makes the Crani-
ata/Vertebrata clade paraphyletic. The Craniata differ from the other chordate lineages by: 
(i) neural crest cells and their derivatives; (ii) elaboration of the brain, including rhom-
bomeric segmentation; (iii) cartilage (and possibly mineralization); (iv) an axial skeleton 
and the head skeleton; and (v) a large increase in total number of genes in the genome.  
Adapted from (Shimeld and Holland, 2000) 
5.4.3 Vertebrates – The Craniata 
The superphylum Craniata is divided into two classes of animals: jawless ver-
tebrates, the agnathans and jawed vertebrates, the gnathostomes (Fig 5–20). The ag-
nathans comprise two extant fish groups, the hagfish and the lampreys. Both are eel-
shaped, cartilaginous, and scale-less, and their overall anatomy is roughly similar to 
that of other fish, with a brain, spinal cord, and sensory capsule. The interrelationship 
between the jawed and jawless vertebrates has been established through analysis of 
their microRNA (miRNA) repertoire; miRNAs are small, noncoding regulatory 
genes that exceed ribosomal DNA in sequence conservation. Ancient miRNAs have 
rarely been lost, and have steadily been accumulated in all metazoan lineages 
(Heimberg et al., 2010). The lamprey (Petromyzon marinus) genome has been se-
quenced and preliminary data has revealed a genome that is very A/T rich and highly 
repetitive. The repetitive nature of the genome has severely complicated the assem-
bly process, causing stacking of repetitive elements into a few blocks of contigs with 
very deep coverage per contig. In addition, the heterozygosity rate for a single animal 
is very high, which again is impeding an effective assembly (Bronner-Fraser et al., 
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2012). This is certainly the case for the lamprey C12orf29 gene. A request was made 
to the Genome Institute at Washington University–the lead institution of the Lam-
prey Genome Sequencing Consortium–to perform a BLASTN search of the human 
C12orf29 mRNA sequence (NM_001009894) against the existing lamprey sequence 
database. This request returned 138 matching sequence contigs and the analysis of 
this material confirmed that the lamprey genome was indeed highly fragmented and 
repetitive. The data is estimated to be six-fold redundant, which is sufficient to make 
judgements of the presence of absence of a gene (Doolittle et al., 2008). It was possi-
ble to identify several contigs that contained a high degree of sequence similarity 
with the human C12orf29 mRNA sequence (Fig 5–21). All of the lamprey contigs 
were matched to the 3’ end of the human sequence; this is, however, not proof of an 
absence of sequence similarity with the rest of the human C12orf29 gene, but simply 
reflects the fact that the 3’ most exon is the longest exon at 1927 bases and is statisti-
cally more likely to return a matching sequence; the other six exons are between 100 
and 200 bases long and are therefore not sufficiently long to return a positive match 
given the repetitive nature of the lamprey genome.  
  
 
C12orf29: Human (Query) vs Lamprey Contig5759 (Sbjct) 
Curated sequence  
 
Query:  1035 AAATGTGACTCTGCCTTTGATATTAAGTGT-TTG-T-TTAATCATTT---T-TTAAAAAT 1087 
             |||| | |  | | |||  |||||||  || ||  | |||| ||| |   | |||||  | 
Sbjct: 28826 AAATATTAcACtGTCTTAgATATTAAACGT TTA T TTAAACATCT   T TTAAACGT 28883
 
Query:  1088 AGATAATCAGAAATTTGTTAGACTCAAAGATAT-AATATTTGATGTATAAAATGCAAA-- 1144 
                |||||  |||  | |||  || |||  | | ||| ||  | || ||||    |||   
Sbjct: 28884 CTaTAATCTTAAACGTCTTAATCTTAAACGTCT AATCTTAAACGTCTAAATCTTAAACG 28942
 
              
 
C12orf29 protein: Human (Query) vs Lamprey (Sbjct) 
 
 Score = 28.5 bits (62),  Expect = 3e-06, Method: Composition-based stats. 
 Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 0/30 (0%) 
 
Query  296  SAFDIKCLFNHFLKIDNQKFVRLKDIIFDV  325 
            +  DIK LF H L + N K + LK +I +V 
Sbjct  1    TVLDIKRLFKHLLNVYNLKRLNLKRLILNV  30 
Figure 5-21: A BLASTN search returned 138 lamprey contigs with sequence similarity to
human C12orf29. The best fitting lamprey sequence was curated against the human CDS;
by replacing gaps in the lamprey sequence with the corresponding base in the human se-
quence and removing bases in the lamprey sequence that produced gaps in the human se-
quence. This resulted in a 30 residue C terminal peptide that closely matched the human
sequence. The positive identification of C12orf29 in P. marinus is further proof of the gene’s
ubiquitous presence in all animals in the chordate/vertebrate superphylum. 
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5.4.4 Conclusions – Tracing C12orf29 through biological time and space 
The phylogenetic history of C12orf29 potentially dates back several billion 
years, on a geological time scale that has been referred to as “Deep Time”(Gee, 
1999). The distribution of C12orf29-like proteins in the two main branches of the 
eukaryotes, the unikonts (Metazoa) and a bikont (Naegleria), together with the find-
ing of a bacterial C12orf29 template in the -proteobacteria Hahella chejuensis, is 
strong evidence that C12orf29 was present in the earliest eukaryotes.  
Eukaryotes are thought to have emerged sometime during the early Paleopro-
terozoic period of Earth’s geological history. During this period, approximately 2.4 
billion years ago (Ga), the Great Oxygenation Event (GOE) took place when atmos-
pheric oxygen concentrations rose from less than 10-5 of the present atmospheric 
level (PAL), to more than 0.01 PAL, and possibly to as high as 0.1 PAL (Shields-
Zhou and Och, 2011). The transition from an anoxic to an oxic world was the most 
radical transformation of Earth’s bio-geochemical state and a direct consequence of 
life itself. An oxidizing atmosphere would most easily be understood as the immedi-
ate consequence of the emergence of photosynthesising organisms, but evidence 
suggests this innovation had occurred at least 300 Myr earlier, by 2.7 Ga. It is most 
likely that the Earth’s crust underwent progressive oxidation, which would have ab-
sorbed much of the earliest free oxygen, leading to a slowly decreasing flux of 
metamorphic reductants. In the Archean and Paleoproterozoic oceans, biological 
processes would have been fuelled predominantly by Fe, with Fe(II) used as the elec-
tron donor for photosynthesis and Fe(III) as the main electron acceptor for respira-
tion (Holland, 2006). Oxidation of Fe(II) would have taken place by photoautotro-
phic Fe(II)-oxidizing bacteria, transforming the dissolved iron into what is known as 
green rust (Kappler and Newman, 2004). Green rust has a strong adsorptive capacity 
for anions and trace metals and would have exerted a major control on macro- and 
micronutrient cycling under ferruginous conditions. Nickel (Ni), in particular, is a 
key metal cofactor in hydrogenases and methyl-coenzyme M reductase, which is 
used by methanogens to generate methane. Ni uptake by green rust decreased oce-
anic Ni concentrations over time, limiting the rate of methanogenesis, thus depleting 
a major O2 sink and accelerated the oxygenation of Earth’s atmosphere (Zegeye et 
al., 2012). Biologically complex life forms could not develop until oxygen levels had 
accumulated to a certain level and an ozone layer had formed, capable of shielding 
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the troposphere from ultraviolet radiation; this level is thought to have been 10-5 PAL 
(Goldblatt et al., 2006). There is evidence that GOE was followed by a planetary-
scale glaciation event between 2.3 to 2.2 Ga, known as the Makganeyene Snowball 
Earth Event, right at the time of the emergence of the first eukaryotes. The earliest 
living organisms would have evolved under reducing conditions, and a rise of atmos-
pheric oxygen beyond 0.01 PAL would have triggered catastrophic global species 
extinction due to the toxic effects of oxygen, which would have favoured an oxygen-
consuming symbiont to support an essentially anaerobic host. In modern organisms 
activities such as peroxidases, catalases, and superoxide dismutases protect cells 
against the toxic effects of oxygen respiration. The sudden release of oxygen from 
the evolution and radiation of oxygenic phototrophs destroyed greenhouse gases such 
as methane and initiated snowball conditions (Kopp et al., 2005; Kurland and 
Andersson, 2000). The early Earth’s biosphere promoted an atmosphere in strong 
thermodynamic disequilibrium. The dominant process in restoring equilibrium is at-
mospheric methane oxidation, which produces another greenhouse gas, CO2. Carbon 
was then actively removed from the atmosphere by the carbon cycle, a task per-
formed predominantly by marine plankton (Goldblatt et al., 2006).  
The timescale needed to reach a partial pressure of atmospheric O2 that could 
support complex multicellular life forms on Earth–The Oxygenation Time–was 3.9 
billion years. It would take almost 2 billion years after GOE before the emergence of 
metazoan organisms (animals), during the Neoproterozoic Oxygenation Event 
(NOE), when oxygen levels rose above 0.1 PAL. This event unleashed major bio-
logical innovations and with it the appearance of first large and architecturally com-
plex organisms during the Ediacaran and the Cambrian Explosion–between 600 and 
450 Ma. One of the contributing factors was a dramatic reduction of the atmospheric 
carbon during this period due to organic burial on the subsiding margins of rupturing 
supercontinents, carried down with marine carbonate snow (Shields-Zhou and Och, 
2011).  Extant marine species such as Oikopleura dioica have and still do play a ma-
jor role in the Earth’s carbon flux; it does this by living inside a complex gelatinous 
house, used to sieve food particles down to 200 m in size. This house is repetitively 
synthesized and discarded throughout the short 7 day lifecycle of the animal and 
make up a substantial fraction of marine snow carrying organic carbon from the at-
mosphere to the bottom of the ocean (Bouquet et al., 2009).  
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Respiration provides approximately one order of magnitude more energy than 
anaerobic metabolisms for a given intake of food, and in all cells energy is converted 
to ATP. The significantly less energy produced by anaerobic metabolism imposes an 
absolute limit to the size of an organism. Aerobic respiration, on the other hand, is 
efficient enough to allow aerobic eukaryotes to eat other organisms and grow large 
and multicellular in a food chain, and the metabolic difference in growth efficiency 
offers the most likely explanation for why eukaryotes, both plants and animals, were 
able to grow large, such as the 2x105 kg blue whale or the giant redwood; whereas 
anaerobe organisms were doomed to a unicellular lifestyle, relying mostly on simple 
diffusion through their cell membranes for nutrients (Catling et al., 2005).  
The history of C12orf29 is intrinsically linked to the bio-geological history of 
Earth itself, as it is defined by the major branch points on the tree of life. The root of 
the eukaryotic tree is thought to lie between the animals, fungi and amoebozoa (the 
unikonts) on the one side, and plants, algae and most protozoa (bikonts) on the other. 
This root scheme has been based on the genes for dihydrofolate reductase (DHFR) 
and thymidylate synthase (TS), which in fungi and animals are separate, as they are 
in prokaryote outgroups; in the bikonts sampled so far, DHFR and TS are fused 
(Roger and Simpson, 2009). Assuming that the DHFR–TS fusion is a derived feature 
uniting bikonts, this suggests that the eukaryote root lies outside this group. Animals, 
fungi and various unicellular eukaryotes, together called opisthokonts, are united 
with the amoebozoa by the presence of a type II myosin to form the unikonts. If both 
unikonts and bikonts are monophyletic groups–and together they encompass extant 
eukaryotic diversity–then the root of eukaryotes should lie between them. From the 
phylogenetic analysis we have been able to place the original C12orf29 template to a 
prokaryote and, therefore, to a time point that precedes the acquisition of mitochon-
dria by anaerobe archeabacteria in response to oxidative stress–the result of the slow 
but steady oxygenation of the planet.  
The mitochondrial endosymbionts is thought to have belonged to -
proteobacteria, because some genes and proteins still encoded by the mitochondrial 
genome have homologs to this group (Embley and Martin, 2006). The last common 
ancestor of the eukaryotes must have carried the C12orf29 gene template; whether it 
was carried in the host genome or the endosymbiont/mitochondrial genome is not 
known, although it is most likely to have been in an endosymbiont since no gene re-
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motely similar to C12orf29 have been found in any of the sequenced archaebacterial 
genomes. The first symbiotic acquisition produced cells with the typical eukaryotic 
carbohydrate oxidative pathways. Anaerobic breakdown of glucose by glycolysis 
would have occurred in the soluble cytoplasm under the direction of the host ge-
nome; further oxidation of glucose would have occurred via the Krebs cycle in the 
symbiotic protomitochondrion under the direction of its own genes (Margulis, 1967). 
In the ensuing aeons since the mitochondrial acquisition event, the mammalian mito-
chondrion has been reduced in size to a circular 16.6 kb genome encoding 70-odd 
genes: there are 37 canonical mitochondrial genes encoding for two ribosomal 
RNAs, 22 for tRNAs, and 13 for the RC subunits, the multienzymatic system which 
creates the proton gradient necessary for ATP synthesis (Castellana et al., 2011). The 
mammalian mitochondrion cannot generally be classified as either prokaryote-like or 
eukaryote-like, and are very different to that of other eukaryotes. Yeast mitochon-
dria, for example, have widely spaced genes and in a different order, and also have a 
different genetic code, whereas the genes in mammalian mitochondria are separated 
by only a handful of nucleotides (Anderson et al., 1981).  
The smallest genome of a free-living -proteobacterium is that of Bartonella 
henselae, with less than 2x106 base pairs, which encodes 1,600 or more proteins. A 
free-living bacterium that initiates a symbiotic relationship with another cell will be 
bathed in the metabolic intermediates of its host, making some of the symbiont’s 
own genes redundant. Redundant genes are subject to mutational degradation, par-
ticularly when the genes for the free-living mode are forfeited and the facultative 
symbiont evolves into an obligate symbiont. The mitochondrial genome of the exca-
vate protist Reclinomonas americana contains a total of 67 protein coding sequences, 
18 of which are not found in any other mitochondrial genomes. However, the strong-
est evidence for the monophyletic character of the mitochondrial lineages is the fact 
that all of the proteins found in all other mitochondrial genomes are among the re-
maining 49 protein-coding genes of the R. americana mitochondrion. There are hun-
dreds of mitochondrial proteins coded by genes in the nuclei of eukaryotes and the 
asexual character of mitochondrial lineages suggests that genes in the mitochondrion 
have much higher mutation rates than similar genes in the nucleus. A transfer 
mechanism, moving genes from the organelle to the nucleus, has therefore clearly 
existed and been selectively advantageous for the cells. Data for metazoan mito-
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chondria support this notion, because in these organisms, the mutation rates are sig-
nificantly higher in their mitochondria than in their nuclei. The genomes of plant mi-
tochondria tend to be less mutation prone than plant nuclear genomes, and in fungi 
the mutation frequencies of the two genomes is more or less equivalent (Kurland and 
Andersson, 2000). If C12orf29 made its way into eukaryotic cells via an early endo-
symbiont proteobacteria, this hypothesis could therefore account for the fact that the 
gene is found in metazoan genomes but not in plant or fungi. In such a scenario the 
vast majority of the genes from the endosymbiont would either be transferred to the 
host’s genome or lost by degradation and subsequent deletions from the endosymbi-
ont’s genome.  
The major clades of extant eukaryotes are thought to have diverged before 1.2 
Ga, with Stramenopiles, Alveolates, and Rhizaria (SAR), and Excavata, and Amoe-
bozoa arising within a similar time frame. At this period of the Earth’s history the 
level of atmospheric oxygen is estimated to have been approximately 0.1 PAL 
(Parfrey et al., 2011) and most of the surface oceans were mildly oxygenated, as 
were the deep oceans. This period, lasting from approximately 1.85 Ga to 0.85 Ga, 
was characterised by environmental stability and has been called the “boring billion” 
(Holland, 2006). This was followed by a period of great instability when Earth was 
visited by perhaps three of its largest ice ages and which may all have been followed 
by unusually hot climates. Biologically, this time in the Earth’s history was its most 
burgeoning and dynamic. Evolution proceeded apace and culminated in the appear-
ance of animals and the biological explosion near the Cambrian–Precambrian bound-
ary (Holland, 2006). The atmospheric oxygen was now starting to reach a level that 
could support multicellular organisms and with it the emergence of the metazoan 
animals. Extant species such as Cnidaria have their origins in this period and brought 
with them the innovation of diploblastic. An ortholog of C12orf29 has been found in 
the diploblast animal freshwater Hydra, which indicates the gene was carried by a 
primitive metazoan ancestor into the eumetazoan lineages. In the eumetazoan linage, 
C12orf29 was carried by a bilaterarian ancestor and was passed on to the deu-
terostome lineages. There is only one example of a C12orf29-like gene in the pro-
tostome superphylum, in the mollusc C. gigas, which has only limited similarity to 
vertebrate C12orf29, but which nevertheless is similar enough to be recognised in 
BLAST searches.  
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Figure 5-22: Tracing C12orf29 through biological time and space. The gene may have been 
carried by a prokaryotic endosymbiont and became integrated into the eukaryotic genome 
following the symbiotic acquisition event. The gene has been found in the excavate genus 
Naegleria, the cnidarian freshwater Hydra, the protostome Pacific oyster, the hemichordate 
Saccoglossus (acorn worm), the Amphioxus (Florida lancelet), the tunicate C. intestinalis 
(sea squirt) and is ubiquitous in all vertebrate species, which suggests it plays a role in the 
chordate and vertebrate body plan. The red ticks represent the key species in which 
C12orf29-like genes have been identified [Adapted from (Shinzato et al., 2011)]. 
Other key protostome taxa, such as Drosophila and C .elegans, do not carry a 
C12orf29-like gene. This suggests the gene is likely to have been carried by the last 
common ancestor of Cnidaria and Bilaterata but was lost, or mutated to such an ex-
tent in the majority of Cnidaria and protostomes taxa to no longer be recognisable. 
However, within the deuterostome phylum, C12orf29 became an integral part of the 
genome of chordate organisms. From the gentle filter feeding sea squirt, at the most 
basal end of the chordate body plan, it spread to every class and order of the verte-
brate lineage to become a gene ubiquitous in some of the largest animals to have in-
habited the Earth. Figure 5–22 traces C12orf29 place in biological time and space, 
from its prokaryotic origins through to higher vertebrate species such as humans, an 
evolutionary distance spanning of more than 2 billion years (Feng et al., 1997).  
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5.5 DISCUSSION – PROMOTER ANALYSIS 
The analysis of the promoter region of C12orf29 yielded a rich vein of biologi-
cal information as to the possible function of this gene. This preliminary analysis has 
focussed on a limited number of regulatory pathways that could potentially control 
the expression of C12orf29 in humans. Although this analysis is conceptual in na-
ture, the overall impression is that of a gene that is likely to be activated during early 
development, as well as having a function in the adult organism. The phylogenetic 
analysis had already revealed that C12orf29 is a universal gene in all chordates, but 
is not found in any non-chordate invertebrates, with the exception of the Saccoglos-
sus, which is a member of the hemichordate sub-phylum. The phylogenetic distribu-
tion of C12orf29 indicates that it has a specific role in the chordate body plan, possi-
bly, but not exclusively, related to the notochord, a hypothesis borne out of the fact 
that this organ is one of the defining features of the chordate super-phylum. 
Early development makes use of a surprisingly small toolkit; five pathways are 
predominant: the Wnt, TGF-, Hedgehog, Receptor tyrosine kinase (RTK), and 
Notch signalling pathways (Gerhart, 1999). The pattern of transcription factor bind-
ing sites suggests that at least three of these pathways converge on the C12orf29 
promoter region: Wnt, TGF- and Notch-1. In the earliest stages of embryonic de-
velopment these pathways are active before organogenesis begins and suggests 
C12orf29 may be expressed already at this early stage.  
There is compelling evidence to suggest that C12orf29 has an expression pat-
tern that mirrors that of type II collagen, a cartilage matrix protein, and that it there-
fore may have a structural role in vertebrate skeletogenesis. The strongest evidence 
for this hypothesis is the presence of two SOX9 consensus binding sites and a num-
ber of other SOX binding sites nearby. The SOX9 binding site has been shortlisted as 
one of the most highly conserved transcription sites in mammals (Xie et al., 2005), 
and this is therefore a strong indication that C12orf29 is a target gene for SOX9 regu-
lation. The other pathway that supports a COL2-like expression pattern is the pres-
ence of a number of NKX3.2/BAPX1 consensus sites. NKX3.2 is a homeobox tran-
scription factor that controls the differentiation of the sclerotome cells, which are 
precursors for the axial skeleton that gives rise to the cartilage template of the verte-
brae and ribs (Akazawa et al., 2000; Kim et al., 2003). Interestingly, NKX3.2 ap-
pears to be a gene that was acquired and adapted specifically by vertebrates follow-
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ing a gene duplication event after the agnathan and gnathostome divergence (Lettice 
et al., 2001). It also has a key role in supporting chondrocyte viability during endo-
chondral ossification by activating the NF-kappa pathway (Park et al., 2007).  
The presence of as many as eleven TCF/LEF binding sites in the promoter re-
gion suggests a strong link with Wnt/-catenin pathway. During skeletal develop-
ment, Wnt/-catenin signaling controls the fate of mesenchymal progenitor cells as 
to whether they differentiate into chondrocytes or osteoblasts. In the absence of -
catenin, the progenitor cells differentiate into chondrocytes instead of osteoblasts, 
indicating that -catenin is required to suppress early mesenchymal cell differentia-
tion into chondrocytes (Day et al., 2005).  
TGF- signaling in skeletogenesis is many and varied and it could potentially 
interact directly with both SOX9 and Wnt/-catenin on the C12orf29 promoter. 
TGF- ligand transduces its signal through binding with type I and type II receptors 
leading to Smad2/3 phosphorylation, which interact with Smad4 and translocates into 
the nucleus. SMAD3 and SMAD4 have been shown to interact with -catenin and 
form a protein complex. This complex not only stabilizes -catenin to prevent it from 
proteasome degradation, but also assists -catenin in nuclear translocation and even-
tually facilitates -catenin transcription of target genes. SMAD3 associates with 
SOX9 in a TGF--dependent manner and forms transcriptional complexes with 
SOX9 on the enhancer region of COL21. SMAD3, rather than SMAD2, has a 
strong potential to stimulate the SOX9-dependent transcriptional activity by modulat-
ing the interaction between SOX9 and the co-activator CBP/p300, and suggests that 
the TGF-/SMAD3 pathway is key player in the SOX9-dependent transcriptional 
activation in primary chondrogenesis (Furumatsu et al., 2005; Zhang et al., 2010b).  
The transcription factor AP-2which is heavily represented in the core pro-
moter region, is reported to inhibit chondrocyte differentiation by suppressing the 
expression of the SOX5 and SOX6, both of which are needed for the proper func-
tioning of SOX9 in chondrogenesis (Huang et al., 2004).  
The Notch-1 signaling pathway is represented by several HES-1 binding sites. 
Some of the most well-defined canonical, or RBP-Jk-dependent, Notch target genes 
include specific members of the Hes/Hey family of basic helix-loop-helix transcrip-
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tion factors. In vivo and in vitro data suggests that Notch regulation of mesodermal 
progenitor cell differentiation acts upstream of both SOX9 and RUNX2 during skele-
togenic differentiation, and is potentially mediated by the RBP-Jk-dependent Notch 
target gene, HES-1. The presence of a consensus RBP-Jk binding site in the core 
promoter is strong evidence that C12orf29 may be a direct target of canonical Notch-
1 signaling, which would make it one of only a limited number of such genes (Kopan 
and Ilagan, 2009). The Notch pathway appears to play a critical role at both the pre- 
and post-gastrulation stages of development. There is evidence to suggest that Notch 
regulates proliferation of floor plate cells. Later, Jagged and other Notch ligands are 
expressed in the notochord. Activation of Notch signaling through Jagged, results in 
preferential development of non-vacuolated notochordal cells that are responsible for 
the formation of the peri-notochordal sheath. It is also noteworthy that notochord de-
velopment is dependent on NKX3.2 as well as L-SOX5 and SOX6, all of which are 
expressed in sclerotome-derived cells and in the notochord (Risbud and Shapiro, 
2011).  
The Specificity Protein-1 (Sp1) was the first mammalian transcription factor to 
be isolated and cloned. These TFs bind to GC-rich sequences, including GC and 
CACCC and GT boxes, and are basic transcription elements. Sp1 sites are found in 
the promoters of many housekeeping genes and this led to the widely held notion that 
Sp1 acts as a basal transcription factor and that Sp1 sites represent constitutive pro-
moter elements that support basal transcription at these promoters (Dynan and Tjian, 
1983; Imataka et al., 1992; Yu et al., 1991). Immediately downstream from the 
TATA box in the core promoter of C12orf29 is an Sp1 site and a conserved E box 
(CACGTG), the preferred binding motif for c-MYC (see Fig 4–44, page 166). Co-
localization of c-MYC and Sp1 sites is overrepresented at evolutionarily conserved 
promoters, and these binding sites also tend to be enriched near active promoters. 
Chromatin immunoprecipitation (ChIP) analysis has shown that for genes with dual 
sites, c-MYC susceptibility generally increases with the strength of Sp1 binding 
(Parisi et al., 2007). Sp1 is a member of the SP/KLF (Krüppel-like factor) family of 
transcription factors. Two KLF binding sites were identified in the C12orf29 pro-
moter and KLFs are of interest since C12orf29 mRNA levels have been reported to 
increase in endometrial carcinoma cells when KLF9 is suppressed (Simmen et al., 
2008).  
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6.1 CONCLUSIONS AND FUTURE WORK – INTRODUCTION 
This project began with the purpose of exploring the expression of genes in the 
fracture callus in sheep. To this end a cDNA library was constructed using cells de-
rived from sheep bones cells were grown in monocultures and stimulated with osteo-
genic induction medium. Characterization of the library showed that it contained a 
number of cDNAs with full-length open reading frames and mRNA sequences that 
were not present in Genbank. All of the isolated clones were fully sequenced and an-
notated and have been submitted to and accepted by Genbank; the sequence tran-
scripts are found in Appendix C. These submissions will play a part in the Sheep Ge-
nome Annotation Project underway by the International Sheep Genome Consortium 
and are therefore a small contribution to the effort to decipher the sheep genome 
(Personal communication, Dr Brian Dalrymple, CSIRO).  
A surprising aspect of the analysis of what was only a limited of clones was the 
amounts of work required to sequence and assemble, then analyse and annotate the 
sequences to a standard that was acceptable for Genbank submissions. This gave a 
keen appreciation of the resources required to assemble a whole genome containing 
mega to giga bases of sequence information. The approach taken with our cDNA li-
brary was definitely a low tech and hands-on effort compared to that of a well re-
sourced genomics lab; however, this approach also made it easier to identify a truly 
novel gene from what was only a limited pool of candidates.  
The cDNA library construction and associated work was therefore the pream-
ble that led to the discovery that the uncharacterized gene C12orf29 plays an unam-
biguous role in skeletal biology, and has most likely been part of the metazoan gene 
repertoire for literally billions of years. For a writer with a keen interest in natural 
history, unravelling the ancient pedigree of this gene has been one of the most fasci-
nating aspects of the entire project. Needless to say, we did not intentionally set out 
to investigate the phylogenetic relationships of the metazoan kingdom, but in an ef-
fort to better understand the potential role of C12orf29 this was a prudent and re-
warding route to take and underpinned the early hypothesis that C12orf29 had an im-
portant and highly conserved role in the chordate body plan. 
One of the other lines of investigation taken was to analyse the promoter region 
of the human C12orf29 gene in an effort to understand what signalling pathways 
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might regulate its expression in human physiology. This work led to the prediction 
that C12orf29 would have an expression pattern similar to type II collagen and po-
tentially be expressed at a very early stage during axial development. It was therefore 
particularly satisfying when these predictions were made true by immunohistochem-
istry in human embryo samples; the data presented here strongly supports this notion. 
The project was technically challenging, not least the molecular biology as-
pects, such as the cDNA library construction, the trials and tribulations of molecular 
cloning, characterization of the various C12orf29 antibodies, mastering the art of 
immunofluoresence and immunohistochemistry and so forth.  
The convergence of the phylogenetic and bioinformatics analyses, experimen-
tal data and an in-depth search of the scientific literature has laid a firm foundation 
for a strong working hypothesis of the role of C12orf29 and also points towards fol-
low-up studies to further explore this ancient gene. 
 
6.1.1 The ancient gene C12orf29 – Putting together the pieces of the puzzle 
We still do not have the definitive answer to the above question; however, out 
of the data has emerged a clear working hypothesis.   
The earliest experimental data indicated that C12orf29 was active in mesen-
chymal cell types such as osteoblasts, BMSCs, and periodontal ligament cells, its 
mRNA being robustly upregulated by stimulation of osteogenic induction medium. 
At first it was assumed that its highest expression would be in bone, however, none 
of the IHC data bore this out. Instead, the IHC data unambiguously showed the pro-
tein to be abundantly expressed in human articular cartilage, as well as in the growth 
plates of 2 month old rats. The pattern of expression strongly suggested that it plays a 
role in: (i) cartilage homeostasis and maintenance, (ii) is potentially an important 
component of the dynamic environment of the growth plate, and (iii) comes in dif-
ferent isoforms that are expressed in very distinct zones, particularly in the growth 
plate. The fact that the expression of C12orf29 overlaps that of type II collagen, one 
of the classical markers of chondrogenesis and cartilage formation, strongly suggests 
that C12orf29 is a structural protein that is indispensible for the structural integrity of 
cartilage and therefore, by extension, the vertebrate body plan.  
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The strength of this hypothesis was further supported by the immunohisto-
chemistry data in mouse and human embryos. In the 13.5 dpc mouse embryo there 
was very strong C12orf29 expression in the parietal cartilage anlagen of the cranial 
vault, and in the human embryo the expression was found to be highly specific to the 
axial skeleton. The latter finding was particularly exciting, not least because a predic-
tion had been made that this was a likely site of C12orf29 expression, and was based 
entirely on the in silico analysis of the promoter region.  
 
What the in silico promoter analysis revealed 
The in silico promoter analysis indicated that C12orf29 is potentially regulated 
by SOX9 and BAPX1. Both transcription factors are pivotal in activating chondro-
genesis in the developing sclerotome, which go on to form the axial skeleton 
(Kawato et al., 2012; Tribioli and Lufkin, 1999; Yamashita et al., 2009). SOX9 is 
itself regulated by parathyroid hormone-related peptide (PTHrP) and BMP2 (Huang 
et al., 2001; Pan et al., 2008), whereas BAPX1 is regulated by SHH by means of the 
PAX1/9 transcriptional regulators (Cairns et al., 2008; Murtaugh et al., 2001; 
Rodrigo et al., 2003).  
Another major pathway that may regulate C12orf29 expression is the Notch 
signalling pathway. Notch signalling is conveyed via NICD which, when binding to 
the transcription repressor CSL/RBP-Jk, becomes an activator of known Notch effec-
tor genes (Iso et al., 2003; Mumm and Kopan, 2000; Schroeter et al., 1998). The 
identification of a consensus CSL/RBP-Jk binding motif in the core promoter region 
of C12orf29 strongly suggests that it may be a target of canonical Notch signalling, 
one of limited number that are direct effector genes of Notch (Wang et al., 2010). 
This hypothesis is all the more compelling given the fact that Notch plays a pivotal 
role at the earliest stages of somite segmentation by a process known as the segmen-
tation clock (Conlon et al., 1995; Goldbeter and Pourquie, 2008; Mead and Yutzey, 
2012; Wright et al., 2011) and that  IHC data show that C12orf29 is expressed early 
in the developing human axial skeleton.  
The WNT/-catenin and TGF-/SMAD3 are the other two major pathways that 
may affect C12orf29 expression and which suggestive of its early and important role 
in embryonic development. The C12orf29 promoter region contains a number of 
  251 
Chapter 6: Conclusions and future work  251 
TCF/LEF binding sites, through which -catenin signalling is conveyed (Kitagaki et 
al., 2003; Novak and Dedhar, 1999), whereas SMAD3 could potentially bind to the 
many CAGA motifs within the promoter region (Dennler et al., 1998). SMAD3 and 
-catenin interact closely in chondrogenesis (Zhang et al., 2010b) and the close prox-
imity if their respective DNA target binding sites within the C12orf29 promoter sug-
gest they may interact in its regulation as well (Jian et al., 2006; Labbe et al., 2000).  
 
Methods for determining promoter response elements 
The in silico analysis of the 5’ flanking region of a gene of interest can identify 
conserved response elements within a promoter region and therefore the signalling 
pathways most likely to control the expression of the gene. Identification of the cis-
acting DNA sequences required for accurate and efficient initiation of transcription 
can only be determined by in vitro and in vivo experiments. Promoter dissection, or 
deletion mutagenesis, has been used since the 1980s and is still used to determine the 
actual cis-acting element in a promoter (Charnay et al., 1985; Li and Shapiro, 1993). 
The promoter region is amplified using flanking oligonucleotides and the cloned into 
a luciferase reporter vector. Different portion of the promoter region can be amplified 
to isolate the region of greatest activity. The vector constructs are transfected into 
suitable cell lines and the relative luciferase activity can be measured in basal and 
treatment conditions. By applying a systematic series of deletions it is possible to 
narrow down the minimum promoter area to activate the reporter gene and then in-
troduce point mutations into specific binding motifs to determine what transcription 
factor is responsible for the activity in a particular section of a promoter (Ganster et 
al., 2005). Other methods used for in vitro promoter analysis are electrophoretic mo-
bility shift assay (EMSA) which is used to detect protein–nucleic acid interactions 
(Hellman and Fried, 2007), typically in conjunction with DNase footprinting 
(Hampshire et al., 2007). 
The in silico analysis has revealed that the promoter region of C12orf29 may 
be a veritable junction point in which a number of major signalling pathways inter-
act. This is a hypothesis that should be tested and which will lead to novel and im-
portant knowledge. In vitro promoter analysis is therefore high on the list of future 
work required to better understand the function of C12orf29.  
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What the phylogenetic analyses revealed 
The phylogenetic analysis became an exercise of applied comparative genom-
ics. It was possible to trace the presence of a potential ur-C12orf29 template to sev-
eral bacterial species, of which the best match was found in the marine -
proteobacteria Hahella chejuensis. From the prokaryote kingdom the gene made its 
way into both of the two major branches of eukaryotes: is has been identified in the 
bikont amoeboflagellate Naegleria gruberi, a single celled protist; and the unikont 
metazoan superphylum.  
In metazoan species, the C12orf29 gene is found in the diploblastic freshwater 
Hydra, a species related to the cnidaria. In protostomes the only sequenced taxon 
with a C12orf29-like gene is the Pacific oyster, a lophotrochozoan organism. This 
suggests that C12orf29 must have been present in the last common ancestor of both 
the Cnidaria and Bilaterata, for only to have been lost to the vast majority of animals 
within both phyla. However, within the Deuterostoma, the sister phylum of the Pro-
tostoma, the distribution of C12orf29 is near universal, with the exception of the 
Echinodermata. Within the chordate superphylum, which encompasses the verte-
brates, C12orf29 is near universal in all species, suggesting a role specific to chor-
dates and vertebrates.  
There is evidence to suggest that there may have been more than one C12orf29 
gene loci in vertebrates but, over time, only one functional copy has survived. For 
example, the hemichordate acorn worm Saccoglossus kowalevskii has two different 
copies of a C12orf29-like gene. This is unique to this particular genus; whereas all 
the true chordates and the vertebrates posses only one C12orf29 gene locus. There is, 
however, evidence of several C12orf29 pseudogenes in the primate genomes (data 
not shown). There is one processed pseudogene on chromosome 3 and another on 
chromosome 5. These are pseudogenes that appear to have arisen by retrotransposi-
tion events, the strongest clue for this is an absence of intron sequences (Mighell et 
al., 2000). A third C12orf29 pseudogene is found on chromosome 8, and this loci has 
the hallmarks of being a remnant of a gene duplication event, having a clearly dis-
cernible intron (Harrison and Gerstein, 2002).  
What role does C12orf29 play in invertebrate species such as the Saccoglossus¸ 
the Ciona and the Amphioxus? The one defining feature that unites these animals 
with the higher vertebrate species, is the presence of gill slits and pharangeal arches 
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at some stage during their development (Ruppert, 2005; Rychel et al., 2006). En-
teropneust hemichordates have cartilage-like skeletal tissue supporting the gills and 
proboscis and histological analysis of the skeletal tissues in S. kowalevskii reveals 
them to be acellular and potentially high in collagen but not in acidic mucopolysac-
charides (Cole and Hall, 2004). Geneticially, expression of orthologs of the verte-
brate Pax1/9 genes have been found in the pharynx of hemichordates, cephalochor-
dates and chordates, and is further support for homology of their gill slits (Holland 
and Holland, 1996; Ruppert, 2005). The phylogenetic analysis therefore points to gill 
slits as a common factor linking hemichordates and chordates, but there may also be 
a possible link between C12orf29 and the notochord in the most basal chordate spe-
cies. The sea squirt Ciona intestinalis would be a suitable model in which to explore 
the role of C12orf29 in basal chordates and would include in situ hybridization and 
morpholino knockout studies.   
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6.2 C12ORF29: THE WORKING HYPOTHESIS – WHAT DOES IT DO?  
The phylogenetic analysis has revealed C12orf29 to be a truly ancient gene that 
is conserved in all vertebrate species, whereas the molecular genetics analysis sug-
gests it is regulated by signalling pathways that control the bauplan of vertebrates, in 
particular pathways that are heavily involved in the axial skeleton.  
The most compelling experimental data deriving from the experimental work is 
the IHC data which showed that C12orf29 is expressed in cartilaginous tissues in the 
skull of early mouse embryos, in the cartilaginous growth plates of young rats, and 
the articular cartilage of humans. In the human embryo sample the expression pattern 
of C12orf29 (Fig 4–32; page 139), as it was detected with the Abcam C12orf29 anti-
body, was near identical to that of type II collagen but with one significant different. 
In the sacral vertebrae of the embryo there was a particularly high expression of 
C12orf29 in the areas of the S1 and S2 vertebrae that had just fused and also at the 
ends of the still unfused sacral vertebrae.  
Based on all the data thus assembled, we have arrived at the following working 
hypotheses as to the nature and role of C12orf29:  
1. C12orf29 is a structural protein that is required for the structural integ-
rity of skeletal cartilage. 
2. C12orf29 acts akin to the mortar in a brick wall. The bricks in a 
physiological sense are the other ECM proteins, in particular type II 
collagen. Without the mortar the wall collapses. 
3. In the vertebrate spine C12orf29 is required to secure the vertebrae as 
they fuse together and then stays in situ in the cartilaginous skeleton 
until osteogenesis has been completed and the cartilage has disap-
peared. 
4. The role of C12orf29 is therefore crucial for skeletal development and 
we therefore predict that a homozygous knockout will be lethal in 
utero.  
5. We predict that C12orf29 could potentially play a role in the skeletal 
phenotypes of spina bifida and KFS, skeletal abnormalities that have 
been linked to the Pax1 transcription factor. 
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6. The Pax1 transcription factor acts in conjunction with Pax9 in the ax-
ial skeleton, as intermediaries of Sonic hedgehog to activate BAPX1. 
7. We predict that during axial development C12orf29 is controlled by 
BAPX1, which establishes a causal link between C12orf29 and spina 
bifida/KFS.  
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6.3 FUTURE WORK 
Zebrafish knockout model 
In the immediate future, experiments are planned using zebrafish Danio rerio 
as an in vivo model. The zebrafish is a frequently used model system for a wide 
range of human medical conditions, such as congenital heart disease, vascular dis-
eases, kidney disease, osteoporosis and osteogenesis imperfect, haematology, neu-
rology, Alzheimer’s disease (Shin and Fishman, 2002) and cancer (Zhang et al., 
2010a). 
 Preliminary analysis of the D. rerio C12orf29 gene has revealed a number of 
features which suggests the zebrafish will be a very useful model for exploring its 
function. The Danio C12orf29 protein has the same length (325 aa) and its sequence 
is 60% identical and 79% similar amino acids to the human protein (Fig 6–1). An-
other feature is a conserved gene order, also known as microsynteny (Engstrom et 
al., 2007). The C12orf29 gene resides within a block of four genes (C12orf29, 
CEP290, TMTC3, and KITLG) that has been conserved in both fish and human and 
most likely in all other vertebrate species (Fig 6–2). We have also shown that the 
exon sizes have been conserved across vertebrates, which suggests the gene has been 
under selective pressure throughout vertebrate evolution (Table 4–6; page 158). Mi-
Human C12orf29 (Query) vs D. rerio C12orf29 (Sbjct)
Score  Expect Method  Identities Positives Gaps
436 bits (1122) 1e‐157 Compositional matrix adjust. 196/324(60%) 256/324(79%) 0/324(0%)
Query  1    MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG  60 
            M+RLGSVQ+K+PCVF+TEV++EPS KR+ Q F+V+ATE VS  AL +D++ A  TEKVDG 
Sbjct  1    MRRLGSVQQKIPCVFLTEVRDEPSRKRDCQQFQVVATENVSPAALASDVHCAAATEKVDG  60 
 
Query  61   TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP  120 
            TCCYVTT+  +PYLWARLDRKP KQA+KRFK + +S++  K F WNV EDF+  PE W+  
Sbjct  61   TCCYVTTFNGEPYLWARLDRKPTKQADKRFKKYQYSQKTCKGFVWNVNEDFREVPEFWMA  120 
 
Query  121  AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE  180 
            A   +  NG+PVPDE+GHIPGWVPV+  NKQYCWHSSVVNY   +ALVLK H +D G LE 
Sbjct  121  AHRVQHENGHPVPDEHGHIPGWVPVDHTNKQYCWHSSVVNYGTGVALVLKTHGEDEGQLE  180 
 
Query  181  ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW  240 
            I +VPL+DL+EQTLELIGTN+NGNPYGLGSKKHP+H+L+PHG  +IRN P+++   + SW 
Sbjct  181  IVSVPLADLMEQTLELIGTNVNGNPYGLGSKKHPVHVLVPHGVLRIRNPPAVEFQQICSW  240 
 
Query  241  FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI  300 
            F++C+EG++EGIVWHC DG LIK+HRHHLGL WP+ DT++N+RPV+++++ +  D      
Sbjct  241  FQECQEGRVEGIVWHCDDGMLIKIHRHHLGLKWPVADTFLNTRPVVVHVDESDADPCASE  300 
 
Query  301  KCLFNHFLKIDNQKFVRLKDIIFD  324 
            K LF  F  ++ Q F  ++DI F+ 
Sbjct  301  KDLFKSFSSVNRQTFSSVRDIQFE  324 
Figure 6-1: Protein alignment comparing human C12orf29 protein with the zebrafish
C12orf29 homolog. The two proteins have equal length with 60% identical and 79% similar
sequences of amino acids. The zebrafish sequence is highlighted in yellow. 
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crosynteny is thought to have been retained to keep intact arrays of highly conserved 
noncoding elements (HCNEs). Often the HCNEs contain developmental regulatory 
genes as well as genes whose function is unrelated to the target gene, termed by-
stander genes (Engstrom et al., 2007). After whole genome duplication in teleosts 
these genome regulatory blocks (GRBs), including HCNEs and target genes, were 
often maintained in both copies, whereas bystander genes were typically lost from 
one GRB. The target genes within these GRBs are likely to be fundamental to gen-
eral vertebrate development (Kikuta et al., 2007).  
The promoter region of the zebrafish C12orf29 gene contains a 180 bp CpG is-
land, as well as a number of conserved TF binding sites, including Sry, Sox9, and 
Bapx1 (Fig 6–3). These are binding sites that have been identified in the promoter 
region of the human C12orf29 gene and suggests that the gene is regulated by the 
same pathways in both species. 
 
   
C12orf29
D. rerio
Chr 25
H. sapiens
Chr 12
C12orf29
Figure 6-2: Conserved gene order between zebrafish and humans. C12orf29 has been 
conserved in a block with three other genes (CEP290, TMTC3, and KITLG) throughout ver-
tebrate evolution. Arrows show the relative positions of these genes in D. rerio chromosome 
25 and H. sapiens chromosome 12.  
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Figure 6-3: The promoter region of D. rerio C12orf29 gene. Analysis of this region identified 
a 180 bp CpG island and a number of putative Sox, Sox9 and Bapx1 TF binding sites, fea-
tures also found in the promoter region of human C12orf29. This suggests that the gene in 
both species is regulated by the same signalling pathways. 
A cDNA clone containing the zebrafish C12orf29 mRNA has been purchased 
from Source Bioscience in the UK and will be used as a template to produce in situ 
hybridization riboprobes. These will be used to identify C12orf29 gene expression at 
various stages of zebrafish development. Once the specificity of C12orf29 expression 
 
>25 dna:chromosome chromosome:Zv9:25:18409714:18421965:1 
TTATATATCAGGGAGAGAGTAGGATAATTGCATTTTAATCACTTGAAATATAAGGGAAAA 
AACACTTTAAAAATATTATTATATATATTTTTGTATTTTATATATAATATGAAATTGAAC 
AGCCTTTTAGTTCAGTAAGCCACTGTTCTGCCAGTTTTCTTCTGTTGTATTATAACAGCG 
AAAAGAATGAAACGTGTCTTGTATGTCGCTGTCTTGGTGAATTATCATATTGGAGCTCTT 
GAGGACTTGTTGTTGTGGTGTATTTTCAAGTTTACTTTGCATTCAGCACTGTTTGATAAA 
AAGTTGCAAAATATATATATATATTTTTTACATTTTTTCATGTGCAATTGACATATCTGT 
CTTCAAAGTGTTTATCCGAGTATTGATTCAAATGCCTACAAACAAATAAGAGCTAAACTT 
AGACATGTTTTTTATGTTTATTTTAAACTTCAATATAATAAATGTACTAACTGACTAGAT 
TCTGTTTGCATTTAGTTACAGTGTCCTGCTTTAACATAAGAATCCCGTTTTCAGTAAAAC 
AATCAAATCAACCCAAAGCAAAAGGCTTTTATTTAATATAGAGATTAATGTGGTTTATGT 
GGTGCTATTGTGGTTTCTTCACCATTTGGGCTGATCACCCCCCTAAACAAATGGTAATTA 
GCTGTAGAATGGTAAACATTATACTCAAAGGGTGTCTGAAATTAATTAGGAGAGCACACT 
GCTGTAACAGCAGGCACAACTACATTTACATTAGGGGAGTAAATTATAATGGTAATGTAA 
ATGTAAAGGTTTTTAGTTTAAGATGCTTTGGGGTTTATTTCAACTCTGCTGAACCCAAGT 
TACTTCCACTTTGTGTACATTGTGACTGCTGTGCTGCATTAATTTTTTCATCAAAATCAT 
GTGCTGACTTTTTCTTACAACCGTATACTTTACAGAATCAGCTGAGAGGTTGCTGCCCTC 
AGGAAAAAATAATAATTTCATTACTTTGTGAAAACATTTAGTCAATAAGAGCAGCATTTT 
GTACTATATACACTCTCTGGCCACTTTATTAGGTTAATTAGGTGCTTTATCTGGTGATGT 
CAGAGGAGAATGGCCAGACTGGTTCAAGCTGATAGAAAGGCAACAGTAACTAAGGGCGTA 
CTCACACTGTGTACAGTTGCCTTGAACCATGCCGAAGCACACATGTCCCGTCTCCCCTCT 
GCTCCGACGGCCTGCAGTGCATGCATCCGGTCTTAGGCAGTGCATGCTGGTTAGAAATTT 
TGTCCTTATTGATGCTGTGCGGATCCCACATGACTGTCACATGGAATGGCAAATGTTTGA 
ATTATCAGTCAGTAAAAAAAAACAAAATCATTTGGGATGATGCACTACACAGTTTATTGA 
ATAGTGTGTCATTTGGGAAGTAACTAATATATGAATCCTAAATTGATCCTAATATTGTTG 
TGATCCTCTCAGGTGTTCTCAGTGGACAAACCTCCCCCAGCACTGTGTGTTTAGAAAAGC 
TGGATTCAGCACAGGTCCTGCAACTGTGTGTAAGATATCAGGATCATCTGCACCAGTGTG 
CGGAGGCTGTTGCATTTGACCAGAATGCTTTGGTCAAGAGGATCAAAGAGGTATTCACCA 
TCATTTCTAATCAGCAAAACAATTTCAGAAAGCACATCCAAAATACTAAATAGTGTGTGT 
GTTTTTGTCAGATGGACCTGTCAGTCGAGGCGCTGTTCAGCATCATGCAGGAAAGGCAAA 
AGCGGTACGCCAAATACGCCGAGCAGATCCAAAAGGTCAATGAGATGTCGATGATTCTGA 
GACGTATTCAGATGGGGATCGACCAGACTGTACCACTCATGGAGCGCCTCAACAACATGC 
TGCCCGAGAGTGAGCGGCTGGAGCCTTTCAGCATGAAACCTGATGGAGATAGCAAATAAA 
AGTCTTAGTGTGTTGATACTGATTGACTTTGATACTGATTGACCTACCTCAGGTCTCTTC 
TGGATGTTACCAATGGAGCACATCACTTTTGCACTGGATTGCTTATCGTATGCCTGGATC 
AGGTGTTTCCTGGCGTAAATGAAGTTACATGGTACAAAAGATGAAATTATATTACTGAAA 
ATGACAATTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG 
TGTGTGTGTGTGTGCGTGTGCGCGCTCTGGTACATATTTACTCAATAGGCTTAATGGAGT 
GCTCTTGAAGGGCATGACAACATTCAGAATGCTATTCAATGAGAAGTCATTAATGCATAT 
GATGCTCTTGCACTTAAGGTTGTCTGCAGACTCTCTGTAATTAAAGTTGTTGGCATTACA 
GTTTCTGTTTTCATGAGAGATTTATTAAACACAATACTTTTTTGGCATGGGATTTGAAAA 
AAAATATATTGATGAATTTGGGGGTTGCACAATATATAGTGTATATGTAGTGTATCTTGT 
GTATAGGTATAGTATGCAGTGTATCATGTCTGTATATGTATGGAGTATGGAGTGTATCAT 
GTATATGTATAGAGTGTGCATATGTGGAAAAAGTGAAGCGCTATGAATACTTTCCGGATG 
CACTTTAGTTTTTTTTTTTTTTTCAATGATGCAGTTAATCATCCACAACCTTGACAAACC 
AAGCGAGCAGCATTTTAAATTTCAACAAAGACCACAGTTTCAGCTAAAAATAAATAAATA 
AGCATTTGCTGGGGCAGATTTAAGTTTGTGTGTAAACTATCTCTTTAACTGAACTGGACA 
TATTTACTTTCCATTCAAAACTTACAAAAATAAGCAAAAGTCGAGAGTCAACATGGCGCT 
CCCCTTAGACGACACGCTCCATGTAGAATAGAGCTTGTTATTTTAAAGCAGCATTCGTTT 
ATTTCTCAGTTCAACTATTTGAAAGTACAATTTAAAACAGATGTAGTTTTAAACAAGTCA 
CATTGCGCCATTATGAAAAGTCTCCGTTCCAATAGATGGCGACAAAGATCAGAACATGAC 
ACACTAAGGAACGAGAGGAAATCTGAACAAAATAGCACTGGGCGCATGGCTGATCTGATA 
ATGTGTTGATGTCATCAGTCCATAGTAATTCTGCAAAGCAACTTGACAATCGAGCTGATC 
AACAGCGGTAATAATGCGGCGTCTGGGTTCAGTGCAGCAGAAGATTCCATGCGTTTTCCT 
GACGGAAGTGAGAGACGAACCATCCAGAAAACGCGACTGTCAGGTGGGTAAAAAAATCGG
NKX3.2/Bapx1 
HRAGTG 
H=ACT  
R=AG
SOX
(A/T)(A/T)CAAAG 
 
SOX9 
CATTGT(C/T)(C/T) 
Exon 1 
Imperfect CSL 
(RBPj)  
(C/T)GTGGGAA 
(C/T)GTGTGAA 
CpG island 
E‐box 
 
N‐box 
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has been established, experiments will be conducted in which the phenotypic effects 
of C12orf29 knockdown will be investigated using morpholinos. This work will be 
conducted in the lab of Dr Ben Hogan in the Institute of Molecular Bioscience, at the 
University of Queensland, St Lucia.    
 
Chick embryo study 
Chick embryos have been used extensively for developmental biology studies 
and will be a good model to study the expression of C12orf29 using either whole 
mount in situ hybridization (WMISH) or whole mount immunohistochemistry 
(WMIHC). Fertilized chick eggs are inexpensive and can be purchased from local 
suppliers. The time points of greatest interest range from 1 to 7 days and at these 
early stages of development an animal ethics proposal is not required, which means 
this work can commence immediately. We will also look at the expression of Sox9, 
Bapx1 and the Notch signalling pathway to determine co-expression and localization 
of these transcription regulators in the axial skeleton in the chick embryo.  
 
In vitro promoter analysis 
An in vitro promoter analysis is high priority on the list of future experiments 
to conduct. These experiments will help determine which signalling pathways are 
involved in the regulation of C12orf29. Standard promoter analysis protocols will be 
used such as EMSA, chromatin immunoprecipitation assays, and luciferase assays.    
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Appendix A – Microbiology materials 
   
Microbiology	
materials	
NZY+ broth (per l iter) 
10 g  NZ  amine (casein hydrosylate) 
5 g yeast extract 
5 g NaCl 
Add ddH2O to a final volume of 1 l iter 
Adjust  to pH 7.5 with NaOH 
Autoclave 
Add the following filter sterilized  
supplements prior to use: 
12.5 mL of 1 M MgCl2  
12.5 mL of 1 M MgSO4 
20 mL of 20% (w/v) glucose 
 
LB broth (per l iter) 
10 g  NaCl 
10 g  tryptone 
5 g yeast extract 
Add ddH2O to a final volume of 1 l iter 
Adjust  to pH 7 with NaOH 
Autoclave 
 
2x LB broth  (per liter) 
20 g  NaCl 
20 g  tryptone 
10 g  yeast extract 
Add ddH2O to a final volume of 1 l iter 
Adjust  to pH 7 with NaOH 
Autoclave 
  
LB agar  
10 g  NaCl 
10 g  tryptone 
5 g yeast extract 
20 g  bact agar 
Add ddH2O to a final volume of 1 l iter 
 
2x LB agar 
450 mL of 2x LB 
1.35 g SeaPrep agarose 
Mix with magnetic st ir bar 
Autoclave  for 30 min 
Adjust  to pH 7 with NaOH 
Autoclave 
Pour into petri  dishes (~25 mL/dish) 
 
 
 
 
 
 
 
LB‐Ampicillin agar (per li ter) 
1 liter of LB agar, autoclaved 
Cool to 55ºC 
Add 2 mL of 50 mg/ml filter steril ized ampicillin 
Pour into petri dishes (~25 mL/dish) 
 
LB‐Kanamycin agar  (per liter) 
1 liter of LB agar, autoclaved 
Cool to 55ºC 
Add 5 mL of 10 mg/ml filter steril ized kanamycin 
Pour into petri dishes (~25 mL/dish) 
 
2x LB‐Glycerol [12 % (v/v)] 
175 ml  2x LB broth 
25 mL 100% glycerol   
Fi lter sterilize 
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Appendix B – Methods   
1. Library Screening Method: Self ligation of inverse PCR products 
(SLIP)  
SLIP screening is a rapid PCR based method for screening cDNA libraries 
consisting of five stages: PCR amplification, ligation, digestion, transformation, and 
DNA sequence verification (Fig 1). The method is described in detail below. 
Primer design 
Primers were designed by first aligning the relevant human mRNA sequence 
with the virtual sheep genome on the International Sheep Genome Consortium data-
base (https://isgcdata.agresearch.co.nz/). For example, the human housekeeping gene 
Figure 1: Overview of the cDNA screening process by self‐ligation of PCR products (SLIP). 
The  target cDNA  is amplified by PCR, using phosphorylated gene specific primers. This 
creates linearized PCR products which are self‐ligated. The resulting circular PCR product 
differs  from  the non‐amplified plasmids by an absence of methylation. The  restriction 
enzyme DpnI only cuts methylated DNA thereby eliminating the parental cDNA  library. 
After transformation  into competent cells the plasmid DNA  is extracted and verified by 
sequencing. (Adapted from Hoskins et al., NAR, 2005) 
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glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was first nucleotide BLAST 
searched and revealed that no complete ovine transcript existed for this gene. There 
was, however, sufficient sequence information in the sheep database to design spe-
cific SLIP primers for this gene (Fig 2). This gene was chosen to test the viability of 
the protocol since it would be one of the most highly expressed genes in the library. 
A suitable stretch of the ovine sequence was chosen as the template for two abutting 
primers using the following parameters: (i) primer length: 23 nt ± 2; (ii) Tm: 65ºC ± 
5; (iii) GC clamp: most 3’ bases G or C; and (iv) no hairpin formation or self anneal-
ing. The ACTB specific primers are shown in table 1. 
 
Table 1: ACTB specific SLIP primers 
 
PRIMER SEQUENCE LENGTH
GC 
CONTENT T m
ACTB FWD SLIP 5'- GAG CAA GAG AGG CAT CCT GAC 21 57.1% 57.6ºC  
ACTB REV SLIP 5'- TGA GCC TCA TCC CCC ACG TAG 21 61.9% 60.9ºC  
Figure 2: (A) The human GAPDH housekeeping gene was compared against the sheep 
genome  database.  The  figure  shows  the  amount  of  sequence  information  currently 
available  for  this gene, and  is  typical of  the many gaps  in  the annotated sheep  tran‐
scriptome. The sequence indicated by yellow arrow was chosen as candidates for spe‐
cific primers.  (B) Primers specific  to  the GAPDH gene abut at  their 5’ ends with zero 
overlap. The primers are phosphorylated and in opposite direction. 
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Kinase oligonucleotide pairs 
The primers were first diluted to a working concentration of 20 µM and 6 µL 
each of forward and reverse from each specific primer were pooled in 200 µL tubes. 
The primers were 5’ phosphorylated by the addition of 3 µL of a master mix contain-
ing 1.5 µL of 10X PNK buffer, 0.15 µL of 100X BSA, 0.2 µL 100 mM ATP 
(Sigma), 1 µL of T4 polynucleotide kinase (Genesearch, Arundel, QLD, Australia) 
and 0.15 µL of water for total reaction volume of 15 µL. The reaction was incubated 
at 37ºC for 1 h then inactivated at 65ºC for 20 min. 
SLIP PCR setup 
A master mix containing 2.5 µL of plasmid cDNA (40 ng/µL), 3 µL 5X HF 
buffer, 0.3 µL of 10 mM dNTPs, 0.15 µL Phusion Hot Start DNA polymerase 
(Genesearch), and 7.2 µL of ddH2O was aliquoted into a 200 µL PCR tube to which 
1.85 µL of PNK treated specific primer pairs was added. The PCR cycles were the 
following: 
Step down PCR protocol
Phase 1 Step Temp Time
1 Denature 98oC 40 sec
2 Anneal 70oC 30 sec
3 Elongate 72oC 3 min
4 Denature 98oC 10 sec
5 Anneal 70oC 30 sec
6 Elongate 72oC 3 min
Phase 2 Step Temp Time
7 Denature 98oC 10 sec
8 Anneal 52oC 30 sec
9 Elongate 72oC 3 min
Steps 7-9 repeated 34 times
Termination Step Temp Time
10 Elongate 72oC 7 min
11 Halt reaction 4oC 15 min
12 Hold RT  
 
Buffer exchange 
The PCR buffer used in the PCR step is incompatible with the T4 DNA ligase 
and DpnI restriction enzyme, so the PCR products were purified using a MN Nu-
cleoSpin Extract II kit following the manufacturer’s instructions. The PCR products 
were eluted in a 20 µL final volume. 
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Ligation 
A master mix, prepared on ice, containing 10 µL of 10x ligase buffer, 1 µL of 
T4 DNA ligase, and 74 µL of ddH2O was added to 15 µL of purified PCR product. 
The reaction were incubated at 16ºC for 18 h, and inactivated at 65ºC for 10 min.  
 
DpnI digestion 
The DpnI digestion enzyme only cleaves methylated recognition sites (GATC). 
The PCR amplified plasmids are not methylated and therefore not cut by DpnI. One 
microliter of DpnI (NEB, Genesearch) was added to each reaction sample and incu-
bated at 37ºC for 2 h before the enzyme was inactivated at 80ºC for 20 min. 
Transformations and plasmid extractions 
Forty five microliters of-select Chemically Competent Cells into (Bioline Pty 
Ltd, Alexandria, NSW, Australia) were transformed with 2 µL of the DpnI digested 
PCR product was transformed as described above. The cell were plated out on selec-
tive agarose plates and incubated at 37ºC overnight. One clone per plate was selected 
and grown overnight in 2 mL of 2x LB broth containing 12.5% glycerol and 100 
µg/mL ampicillin. A 200 µL aliquot from each sample was frozen, as previously de-
scribed, as archival stocks and the rest was used for plasmid extraction with a MN 
NucleoSpin Plasmid Miniprep kit.  
Sequencing and analysis 
In the cases where the miniprep plasmid DNA yield was limited, only outside 
universal primers were used for sequencing reactions; else both gene specific primers 
and universal primers were used. The samples were prepared with 400 ng of plasmid 
DNA to a final volume of 12 µL and 1 µL of 10 µM sequencing primer, and submit-
ted to AGRF for sequencing.  
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Results 
Beta-actin (ACTB) SLIP screen 
The house keeping gene beta actin was sequenced with four oligonucleotides: 
the outside M13 forward and reverse oligos and the inside gene specific oligos. 
Three of the sequences (M13 Rev, ACTB SLIP Fwd and Rev) partially overlapped 
and were joined into one contiguous transcript which had perfect sequence homology 
across the 5’ UTR and CDS of the Genbank Ovis aries ACTB transcript 
(NM_001009784).  The underlined sequence highlighted in blue show the position of 
the reverse SLIP oligo; the forward SLIP oligo is highlighted in yellow. 
 
>TEF128 and TEF75 and TEF76 joined 
CCAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGTGGCGG 
CCGCTCTAGAACTAGTGGATCCCCCGGGCTGCAGGAATTCGGCACGAGGCCCCGCCAGCA 
CAGGCCTCTCGCCTTCGCCGCTCCGCCTTCGCCGCCGGTCGACACCGCAACCAGTTCGCC 
ATGGATGATGATATTGCTGCGCTCGTGGTTGACAACGGCTCCGGCATGTGCAAGGCCGGC 
TTCGCGGGCGACGATGCTCCCCGGGCCGTCTTCCCTTCCATCGTGGGGCGCCCCCGGCAC 
CAGGGCGTGATGGTGGGCATGGGCCAGAAGGACTCCTACGTGGGGGATGAGGCTCAGAGC 
AAGAGAGGCATCCTGACCCTCAAGTACCCCATTGAGCACGGCATTGTCACCAACTGGGAC 
GACATGGAGAAGATCTGGCACCACACCTTCTACAACGAGCTGCGTGTGGCCCCCGAGGAG 
CACCCCGTGCTGCTGACCGAGGCCCCCTTGAACCCCAAGGCCAACCGTGAGAAGATGACC 
CAGATCATGTTTGAGACCTTCAACACCCCTGCCATGTACGTGGCCATCCAGGCTGTGCTG 
TCCCTGTACGCCTCTGGCCGCACCACTGGCATCGTGATGGACTCCGGTGACGGGGTCACC 
CACACGGTGCCCATCTACGAGGGGTACGCCCTCCCCCACGCCATCCTGCGTCTGGACCTG 
GCTGGCCGGGACCTGACGGACTACCTCATGAAGATCCTCACGGAGCGTGGCTACAGCTTC 
ACCACCACGGCCGAGCGGGAAATCGTCCGTGACATCAAGGAGAAGCTCTGCTACGTGGCC 
CTGGACTTCGAGCAGGAGATGGCCACCGCGGCCTCCAGCTCCTCCCTGGAGAAGAGCTAC 
GAGCTGCCGGACGGGCAGGTCATCACCATCGGCAATGAGCGGTTCCGCTGCCCTGAGGCT 
CTCTTCCAGCCTTCCTTCCTGGGCATGGAATCCTGCGGCATTCACGAAACTACCTTCAAT 
TCCATCATGAAGTGTGACGTCGACATCCGCAAGGACCTCTACGCCAACACGGTGCTGTCC 
GGCGGGACCACCATGTACCCTGGCATCGCAGACAGGATGCAGAAAGAGATCACTGCCCTG 
GCACCCAGCACGATGAAGATCAAGATCATCGCGCCCCCTGAGCGCAAGTACTCCGTGTGG 
ATTGGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCAGCAAGCAG 
GAGTACGACGAGTCCGGCCCCTCCATCGTCCACCGCAAATGCTTCTAGGCGGACTGTTAG 
CTGCGTTACACCCTTTTTCTTGACAAACCTAACTTGCGCAGAAACGAGATGAGATTGGCA 
TGGCTTTATTTGTTTTTTTTTTTTTTGTATTTT   
 
 
 
BLASTn  
>ref|NM_001009784.1|  Ovis aries actin, beta (ACTB), mRNA 
 gb|U39357.1|OAU39357  Ovis aries beta actin mRNA, complete cds 
Length=2191 
 
 
 Score = 2359 bits (1277),  Expect = 0.0 
 Identities = 1284/1287 (99%), Gaps = 2/1287 (0%) 
 Strand=Plus/Plus 
 
Query  95    GAATTCGGCACGAGGCCCCGCCAGCACAGGCCTCTCGCCTTCGCCGCTCCGCCTTCGCCG  154 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1     GAATTCGGCACGAGGCCCCGCCAGCACAGGCCTCTCGCCTTCGCCGCTCCGCCTTCGCCG  60 
 
Query  155   CCGGTCGACACCGCAACCAGTTCGCCATGGATGATGATATTGCTGCGCTCGTGGTTGACA  214 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61    CCGGTCGACACCGCAACCAGTTCGCCATGGATGATGATATTGCTGCGCTCGTGGTTGACA  120 
 
Query  215   ACGGCTCCGGCATGTGCAAGGCCGGCTTCGCGGGCGACGATGCTCCCCGGGCCGTCTTCC  274 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121   ACGGCTCCGGCATGTGCAAGGCCGGCTTCGCGGGCGACGATGCTCCCCGGGCCGTCTTCC  180 
 
Query  275   CTTCCATCGTGGGGCGCCCCCGGCACCAGGGCGTGATGGTGGGCATGGGCCAGAAGGACT  334 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181   CTTCCATCGTGGGGCGCCCCCGGCACCAGGGCGTGATGGTGGGCATGGGCCAGAAGGACT  240 
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Query  335   CCTACGTGGGGGATGAGGCTCAGAGCAAGAGAGGCATCCTGACCCTCAAGTACCCCATTG  394 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241   CCTACGTGGGGGATGAGGCTCAGAGCAAGAGAGGCATCCTGACCCTCAAGTACCCCATTG  300 
 
Query  395   AGCACGGCATTGTCACCAACTGGGACGACATGGAGAAGATCTGGCACCACACCTTCTACA  454 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301   AGCACGGCATTGTCACCAACTGGGACGACATGGAGAAGATCTGGCACCACACCTTCTACA  360 
 
Query  455   ACGAGCTGCGTGTGGCCCCCGAGGAGCACCCCGTGCTGCTGACCGAGGCCCCCTTGAACC  514 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361   ACGAGCTGCGTGTGGCCCCCGAGGAGCACCCCGTGCTGCTGACCGAGGCCCCCTTGAACC  420 
 
Query  515   CCAAGGCCAACCGTGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCTGCCA  574 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421   CCAAGGCCAACCGTGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCTGCCA  480 
 
Query  575   TGTACGTGGCCATCCAGGCTGTGCTGTCCCTGTACGCCTCTGGCCGCACCACTGGCATCG  634 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481   TGTACGTGGCCATCCAGGCTGTGCTGTCCCTGTACGCCTCTGGCCGCACCACTGGCATCG  540 
 
Query  635   TGATGGACTCCGGTGACGGGGTCACCCACACGGTGCCCATCTACGAGGGGTACGCCCTCC  694 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541   TGATGGACTCCGGTGACGGGGTCACCCACACGGTGCCCATCTACGAGGGGTACGCCCTCC  600 
 
Query  695   CCCACGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACGGACTACCTCATGAAGA  754 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601   CCCACGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACGGACTACCTCATGAAGA  660 
 
Query  755   TCCTCACGGAGCGTGGCTACAGCTTCACCACCACGGCCGAGCGGGAAATCGTCCGTGACA  814 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  661   TCCTCACGGAGCGTGGCTACAGCTTCACCACCACGGCCGAGCGGGAAATCGTCCGTGACA  720 
 
Query  815   TCAAGGAGAAGCTCTGCTACGTGGCCCTGGACTTCGAGCAGGAGATGGCCACCGCGGCCT  874 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  721   TCAAGGAGAAGCTCTGCTACGTGGCCCTGGACTTCGAGCAGGAGATGGCCACCGCGGCCT  780 
 
Query  875   CCAGCTCCTCCCTGGAGAAGAGCTACGAGCTGCCGGACGGGCAGGTCATCACCATCGGCA  934 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  781   CCAGCTCCTCCCTGGAGAAGAGCTACGAGCTGCCGGACGGGCAGGTCATCACCATCGGCA  840 
 
Query  935   ATGAGCGGTTCCGCTGCCCTGAGGCTCTCTTCCAGCCTTCCTTCCTGGGCATGGAATCCT  994 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  841   ATGAGCGGTTCCGCTGCCCTGAGGCTCTCTTCCAGCCTTCCTTCCTGGGCATGGAATCCT  900 
 
Query  995   GCGGCATTCACGAAACTACCTTCAATTCCATCATGAAGTGTGACGTCGACATCCGCAAGG  1054 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sbjct  901   GCGGCATTCACGAAACTACCTTCAATTCCATCATGAAGTGTGACGTCGACATCCGCAAAG  960 
 
Query  1055  ACCTCTACGCCAACACGGTGCTGTCCGGCGGGACCACCATGTACCCTGGCATCGCAGACA  1114 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  961   ACCTCTACGCCAACACGGTGCTGTCCGGCGGGACCACCATGTACCCTGGCATCGCAGACA  1020 
 
Query  1115  GGATGCAGAAAGAGATCACTGCCCTGGCACCCAGCACGATGAAGATCAAGATCATCGCGC  1174 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1021  GGATGCAGAAAGAGATCACTGCCCTGGCACCCAGCACGATGAAGATCAAGATCATCGCGC  1080 
 
Query  1175  CCCCTGAGCGCAAGTACTCCGTGTGGATTGGCGGCTCCATCCTGGCCTCGCTGTCCACCT  1234 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1081  CCCCTGAGCGCAAGTACTCCGTGTGGATTGGCGGCTCCATCCTGGCCTCGCTGTCCACCT  1140 
 
Query  1235  TCCAGCAGATGTGGATCAGCAAGCAGGAGTACGACGAGTCCGGCCCCTCCATCGTCCACC  1294 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1141  TCCAGCAGATGTGGATCAGCAAGCAGGAGTACGACGAGTCCGGCCCCTCCATCGTCCACC  1200 
 
Query  1295  GCAAATGCTTCTAGGCGGACTGTTAGCTGCGTTACACCCTTTTTCTTGACAAA-CCTAAC  1353 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||| 
Sbjct  1201  GCAAATGCTTCTAGGCGGACTGTTAGCTGCGTTACACCCTTTTTCTTGACAAAACCTAAC  1260 
 
Query  1354  TTGCGCAGAAA-CGAGATGAGATTGGC  1379 
             ||||||||||| ||||||||||||||| 
Sbjct  1261  TTGCGCAGAAAACGAGATGAGATTGGC  1287 
 
 
The M13 forward sequence, had no homology with sheep ACTB, and at first 
glance did not appear to contain any meaningful information. It did, however, re-
turned a match with high homology (80%) with the 3’ UTR of the Canis familiaris 
(domestic dog) ATCB transcript and a similarly high homology (76%) with human 
ACTB. A putative poly adenylation site is highlighted in yellow.  
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>ACTC SLIP M13 Fwd reverse complement 
TTTTTTTTTTAAAATAGTCATTCCAAATATTGTGAGATGCATTGTTACAGGAAGTCCTTT 
GCCTTCCCAAAAGCCCCCCTCCTTTTTTTTAAGGGGAAGGGGCCCGTCCTCGCCCGGGTC 
CCCCCAGGGGGGGGGATTGGTTTTGTGTAAATTATGTACTCCAAAAAAAGTTTTGTTTTT 
AATTTTTGCCTTAATACTTGTTTTTTTTTTGTTTGTTTTTATTTTGAATGGTCAGCCATC 
CCGGCCCCCTTTTTTTGTCCCCCAACTTGATGTATGAAGGCTTTTGGTCCCCTTGGGAGG 
GGGTTGGGGGGGGGGGGCAGTCAGGGGTTTCCTGCACACTGACTTGAGACCAGTTAAATA 
AAGTGCCCAATTAAACCCGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
 
 
>ref|XM_845524.1|  PREDICTED: Canis familiaris actin, transcript variant 2  
(ACTB), mRNA 
Length=2173 
 
 GENE ID: 403580 ACTA1 | actin, alpha 1, skeletal muscle 
[Canis lupus familiaris] (10 or fewer PubMed links) 
 
 Score =  338 bits (374),  Expect = 1e-96 
 Identities = 303/378 (80%), Gaps = 24/378 (6%) 
 Strand=Plus/Plus 
 
Query  1     ttttttttttAAAATAGTCATTCCAAATATTGTGAGATGCATTGTTACAGGAAGTCCTTT  60 
             ||||||||||  |||||||||||||||||| ||||||||||||||||||||||||||||| 
Sbjct  1569  TTTTTTTTTTTTAATAGTCATTCCAAATATCGTGAGATGCATTGTTACAGGAAGTCCTTT  1628 
 
Query  61    GCCTTCCCAAAAGCCCCCCTCCttttttttAAGGGGAAGGGGCCCGTCCTCGCCCGGGTC  120 
             ||||||||||||||| |||   || |   |   | ||| ||||| ||||||||||| ||| 
Sbjct  1629  GCCTTCCCAAAAGCCACCCCGTTTCTCCCTGCAGAGAA-GGGCCTGTCCTCGCCCGAGTC  1687 
 
Query  121   CCCCCAggggggg------ggATTGGTTTTGTGTAAATTATGTACTCCaaaaaaaGtttt  174 
             | | |||||| ||      | |||| |||||||||||||||||| ||||||       || 
Sbjct  1688  CACACAGGGGAGGGAAAGAGAATTGCTTTTGTGTAAATTATGTAGTCCAAA-------TT  1740 
 
Query  175   gtttttaatttttgccttaatacttgttttttttttgtttgtttttattttgAATGGTCA  234 
              |||||||| || ||||||||||||||| |||||        |||||||||||||||||  
Sbjct  1741  TTTTTTAATCTTCGCCTTAATACTTGTTCTTTTT-------GTTTTATTTTGAATGGTCT  1793 
 
Query  235   GCCATCCCGGCCCCCtttttttGTCCCCCAACT--TGATGTATGAAGGCTTTTGGTCCCC  292 
             |||||| ||||||   ||||||||||||||| |   ||| ||||||||||||||||| || 
Sbjct  1794  GCCATCACGGCCCTTGTTTTTTGTCCCCCAATTGAAGATTTATGAAGGCTTTTGGTCTCC  1853 
 
Query  293   TTGGGAg-ggggttggggggggggggCAGTCAGGGGTTTCCTGCACACTGACTTGAGACC  351 
              |||||| |||| || ||   || ||||  ||||| || |||| |||||||||||||||| 
Sbjct  1854  CTGGGAGTGGGGCTGAGGCATGGAGGCATCCAGGGCTTACCTGTACACTGACTTGAGACC  1913 
 
Query  352   AGTTAAATAAAGTGCCCA  369 
             |||| |||||||||| || 
Sbjct  1914  AGTTCAATAAAGTGCACA  1931 
 
 
The translated ORF of the joined SLIP screened ACTB returned a perfect 
match (375 out of 375 residues) against both the sheep and human ACTB, and a near 
perfect match (374 out of 375 residues) against dog ACTB.  
 
>Translation of ORF TEF128+TEF75+TEF76 joined 375 aa 
MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS 
KRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT 
QIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDL 
AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSY 
ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLS 
GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQ 
EYDESGPSIVHRKCF 
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       1 cgcgtccgcc ccgcgagcac agagcctcgc ctttgccgat ccgccgcccg tccacacccg  
      61 ccgccagctc accatggatg atgatatcgc cgcgctcgtc gtcgacaacg gctccggcat  
     121 gtgcaaggcc ggcttcgcgg gcgacgatgc cccccgggcc gtcttcccct ccatcgtggg  
     181 gcgccccagg caccagggcg tgatggtggg catgggtcag aaggattcct atgtgggcga  
     241 cgaggcccag agcaagagag gcatcctcac cctgaagtac cccatcgagc acggcatcgt  
     301 caccaactgg gacgacatgg agaaaatctg gcaccacacc ttctacaatg agctgcgtgt  
     361 ggctcccgag gagcaccccg tgctgctgac cgaggccccc ctgaacccca aggccaaccg  
     421 cgagaagatg acccagatca tgtttgagac cttcaacacc ccagccatgt acgttgctat  
     481 ccaggctgtg ctatccctgt acgcctctgg ccgtaccact ggcatcgtga tggactccgg  
     541 tgacggggtc acccacactg tgcccatcta cgaggggtat gccctccccc atgccatcct  
     601 gcgtctggac ctggctggcc gggacctgac tgactacctc atgaagatcc tcaccgagcg  
     661 cggctacagc ttcaccacca cggccgagcg ggaaatcgtg cgtgacatta aggagaagct  
     721 gtgctacgtc gccctggact tcgagcaaga gatggccacg gctgcttcca gctcctccct  
     781 ggagaagagc tacgagctgc ctgacggcca ggtcatcacc attggcaatg agcggttccg  
     841 ctgccctgag gcactcttcc agccttcctt cctgggcatg gagtcctgtg gcatccacga  
     901 aactaccttc aactccatca tgaagtgtga cgtggacatc cgcaaagacc tgtacgccaa  
     961 cacagtgctg tctggcggca ccaccatgta ccctggcatt gccgacagga tgcagaagga  
    1021 gatcactgcc ctggcaccca gcacaatgaa gatcaagatc attgctcctc ctgagcgcaa  
    1081 gtactccgtg tggatcggcg gctccatcct ggcctcgctg tccaccttcc agcagatgtg  
    1141 gatcagcaag caggagtatg acgagtccgg cccctccatc gtccaccgca aatgcttcta  
    1201 ggcggactat gacttagttg cgttacaccc tttcttgaca aaacctaact tgcgcagaaa  
    1261 acaagatgag attggcatgg ctttatttgt tttttttgtt ttgttttggt tttttttttt  
    1321 tttttggctt gactcaggat ttaaaaactg gaacggtgaa ggtgacagca gtcggttgga  
    1381 gcgagcatcc cccaaagttc acaatgtggc cgaggacttt gattgcacat tgttgttttt  
    1441 ttaatagtca ttccaaatat gagatgcgtt gttacaggaa gtcccttgcc atcctaaaag  
    1501 ccaccccact tctctctaag gagaatggcc cagtcctctc ccaagtccac acaggggagg  
    1561 tgatagcatt gctttcgtgt aaattatgta atgcaaaatt tttttaatct tcgccttaat  
    1621 acttttttat tttgttttat tttgaatgat gagccttcgt gccccccctt cccccttttt  
    1681 tgtcccccaa cttgagatgt atgaaggctt ttggtctccc tgggagtggg tggaggcagc  
   1741 cagggcttac ctgtacactg acttgagacc agttgaataa aagtgcacac ctta 
   1 gaattcggca cgaggccccg ccagcacagg cctctcgcct tcgccgctcc gccttcgccg
  61 ccggtcgaca ccgcaaccag ttcgccatgg atgatgatat tgctgcgctc gtggttgaca
 121 acggctccgg catgtgcaag gccggcttcg cgggcgacga tgctccccgg gccgtcttcc
 181 cttccatcgt ggggcgcccc cggcaccagg gcgtgatggt gggcatgggc cagaaggact
 241 cctacgtggg ggatgaggct cagagcaaga gaggcatcct gaccctcaag taccccattg
 301 agcacggcat tgtcaccaac tgggacgaca tggagaagat ctggcaccac accttctaca
 361 acgagctgcg tgtggccccc gaggagcacc ccgtgctgct gaccgaggcc cccttgaacc
 421 ccaaggccaa ccgtgagaag atgacccaga tcatgtttga gaccttcaac acccctgcca
 481 tgtacgtggc catccaggct gtgctgtccc tgtacgcctc tggccgcacc actggcatcg
 541 tgatggactc cggtgacggg gtcacccaca cggtgcccat ctacgagggg tacgccctcc
 601 cccacgccat cctgcgtctg gacctggctg gccgggacct gacggactac ctcatgaaga
 661 tcctcacgga gcgtggctac agcttcacca ccacggccga gcgggaaatc gtccgtgaca
 721 tcaaggagaa gctctgctac gtggccctgg acttcgagca ggagatggcc accgcggcct
 781 ccagctcctc cctggagaag agctacgagc tgccggacgg gcaggtcatc accatcggca
 841 atgagcggtt ccgctgccct gaggctctct tccagccttc cttcctgggc atggaatcct
 901 gcggcattca cgaaactacc ttcaattcca tcatgaagtg tgacgtcgac atccgcaaag
 961 acctctacgc caacacggtg ctgtccggcg ggaccaccat gtaccctggc atcgcagaca
1021 ggatgcagaa agagatcact gccctggcac ccagcacgat gaagatcaag atcatcgcgc
1081 cccctgagcg caagtactcc gtgtggattg gcggctccat cctggcctcg ctgtccacct
1141 tccagcagat gtggatcagc aagcaggagt acgacgagtc cggcccctcc atcgtccacc
1201 gcaaatgctt ctaggcggac tgttagctgc gttacaccct ttttcttgac aaaacctaac
1261 ttgcgcagaa aacgagatga gattggcctc gtgcgattcg gcacgagttt tttttttttt
1321 ttttttccca ctgtgtacaa aaggtttaat tttgataaag ggttatgagg ctgggatggc
1381 ccttccacag ccaccagtgg ctgggaagag ggctctgggg gcactgcccc ctctccactg
1441 ctcctgtctt cgaactccac tctatgatgg ggcccaatcc tgcccttagc aaccatgctg
1501 tgaccttcag taagacccag tcactgtccc cataaaaggg ctcaggaatc catcttcaca
1561 aagactttgg gacgggaaaa gatcttgatg gcctcctcta cctgcaccag cttccggtcc
1621 agctcagcac ggtggctctg ggccctcagt gaatccgccc cccgcaggca gcagcaccag
1681 ctcgcgcagc agctggctct ggctctggag cagactgctc agtgtctcca gccgctggtt
1741 ctcaggcatg cgagtgtggc cagggggcac ggccgggtct ggttggctgt gctgacgggc
1801 ctcagcctcc cgccgccaca ggtccctgcg ctccaacaag tcttgggaga gcccctgggc
1861 ctagggagat acccccgagc tgcagcagca caccacccac gccgcgacgg ccacgctcca
1921 ggatttctag gcctcccgga cggatgcgag gggcgcgggg aggggtggcg tctaggtccg
1981 ggtccgtatc tgtcgtcagc aggtccaact tcggcgcgtt tccctcaagg cgcccttggc
2041 cgaagacggc ctccggtagt agtccggaca gagcgtaggg tctgggggga tgggccccga
2101 gatgcgggac ggaccctcac acataccgcc gccgccgtcc tctcagtacc gttggcaggc
2161 ttctcactcg ggcaaggctc gtgccgaatt c A B
 
 
 
BLASTp 
>lcl|31691 ACTB SLIP Screen vs Ovis aries actin, beta (ACTB) 375aa 
Length=375 
 
 Score =  785 bits (2028),  Expect = 0.0, Method: Compositional matrix adjust. 
 Identities = 375/375 (100%), Positives = 375/375 (100%), Gaps = 0/375 (0%) 
 
Query  1    MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS  60 
            MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS 
Sbjct  1    MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQS  60 
 
Query  61   KRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT  120 
            KRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT 
Sbjct  61   KRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMT  120 
 
Query  121  QIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDL  180 
            QIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDL 
Sbjct  121  QIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDL  180 
 
Query  181  AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSY  240 
            AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSY 
Sbjct  181  AGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSY  240 
 
Query  241  ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLS  300 
            ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLS 
Sbjct  241  ELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLS  300 
 
Query  301  GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQ  360 
            GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQ 
Sbjct  301  GGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQ  360 
 
Query  361  EYDESGPSIVHRKCF  375 
            EYDESGPSIVHRKCF 
Sbjct  361  EYDESGPSIVHRKCF  375. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 3: ACTB  SLIP  screen. The  joined  transcript  from  the M13 Rev, ACTB  SLIP 
Fwd and Rev oligos matched the 5’ UTR, CDS and part of the 3’UTR in both sheep 
ACTB (A) and human ACTB (B), highlighted in green. The start and stop codons are 
highlighted  in yellow. The sequence from the M13 Fwd oligo had 76% homology 
with human ACTB  in the area highlighted  in blue, but has no homology with the 
sheep  transcript.  This  sequence  has  been  submitted  to  Genbank  as  beta  actin 
variant 2 (Accession number HM067830). 
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ACTB & TGF‐3
Figure  4:  RT‐qPCR  showed  that  TGF‐3  ex‐
pression  was  as  high  as  the  housekeeping 
gene ‐actin. 
2. Isolation of TGF-beta 3 by MACH isolation method 
 
One of the most surprising dis-
coveries in the cDNA library was the 
high expression of transforming 
growth factor-beta 3 (TGF-3). The 
expression was comparable with that 
of type I collagen, and the house keep-
ing genes GAPDH and -actin (Fig 4). 
With such high TGF-3 levels it was 
decided to isolate the clone using the 
MACH isolation method that had 
been used to isolate GAPDH. A TGF-
3 clone could later be used to produce a recombinant TGF-3 protein using a 
method described by Zhu, et al. (Zhu et al., 2006). 
Methods 
The MACH clonal isolation method was used for this experiment. This method 
has been adapted from a paper by Haerry and O’Connor (Haerry and O'Connor, 
2002) and is described above (page 51–54).  
Primer design 
The MACH primers used to isolate sheep TGF-3 were placed within a stretch 
of the sheep TGF-3 sequence between previously designed RT-qPCR primers (Fig 
5 A). The primers were designed specifically for sheep by BLASTing the human 
TGF-3 sequence (NM_003239) against the ISGC sheep genomic database, which is 
hosted by AgResearch.co.nz. The primer sequences are listed in the table 2 below.  
Table 2: TGF‐b3 specific primers for MACH isolation 
 
PRIMER SEQUENCE LENGTH
GC 
CONTENT Tm
TGF-b3 Fwd 5'-ACC GGC TAG ACA GCC CAG 18 66.70% 59.7 ºC  
TGF-b3 Rev 5'-TGT CTG AGC TGC GGA GGT ATG 21 57.10% 58.9 ºC  
MACH R1 5'-ATC CTG TCG GAA GTC AAT GTA GAG 24 45.80% 56.0 ºC  
MACH F2 5'-CTG GGC TGG AAG TGG GTC 18 66.70% 58.3 ºC  
MACH R3 5'-TTG GCA TAG TAG CCC TTA GGT TC 23 47.80% 56.4 ºC  
MACH F4 5'-CTT CTG CTC AGG CCC CTG 18 66.70% 58.3 ºC  
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         >>>>>TGF-b3 Fwd>>> 
  1 cccaaaccggctagacagcccaggccagggcagtcagaggaagaagcgggccctggacaccaattactgcttccg 
    ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
  1 gggtttggccgatctgtcgggtccggtcccgtcagtctccttcttcgcccgggacctgtggttaatgacgaaggc 
 
                                                           >>>>>>>>MACH F2>>> 
 76 caacttggaggagaactgctgtgtgcgccctctctacattgacttccgacaggatctgggctggaagtgggtcca 
    ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
 76 gttgaacctcctcttgacgacacacgcgggagagatgtaactgaaggctgtcctagacccgaccttcacccaggt 
                                   <<<MACH R1<<<<<<<<<<<<<< 
 
                            >>>>>>>>MACH F4>>> 
151 cgaacctaagggctactatgccaacttctgctcaggcccctgcccatacctccgcagctcagacacaacccacag 
    ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
151 gcttggattcccgatgatacggttgaagacgagtccggggacgggtatggaggcgtcgagtctgtgttgggtgtc 
     <<<MACH R3<<<<<<<<<<<<<                    <<<TGFb3 Rev<<<<<<<<< 
 
Primer 
regionHuman TGF-b3
A
B
C
Figure 5: (A) The coding sequence of human TGF‐3 was BLAST searched against the 
sheep genomic database to find an appropriate region in which to place the MACH 
primers. (B) This shows the arrangement of the forward and reverse MACH primers. 
Separate  reverse PCR  reactions are  set up with primer pairs R1/F2 and R3/F4.  (C) 
The PCR products were separated on an agarose gel and bands of  the anticipated 
sizes were cut out and column purified. The use of two different primer pairs greatly 
improves the chance that PCR products of equal size both represent the gene of in‐
terest.  
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PCR setup  
The TGF-3 MACH primers (Geneworks) were diluted to a working concen-
tration of 10 M. A total of 320 ng of cDNA library template was used in two sepa-
rate reactions.  
1x
5x HF buffer 10
dNTP (10 mM) 4
cDNA (80 ng/uL) 4
Fwd primer 5
Rev primer 5
Phusion DNA pol 2.5
Water to 50 uL 19.5
Volume 50 uL  
One reaction was set up with primers R1 and F2 (tube 1/2) and another with primers 
R3 and F4 (tube 3/4). The DNA polymerase used was Finnzyme Phusion Hot Start II 
High-Fidelity DNA Polymerase (Genesearch, Arundel, QLD, Australia).  
Cycling parameters 
Phase 1 Step Temp Time
1 Initial denature 98oC 3 min
Stop and add 2.5 uL Phusion polymerase per tube
Phase 2 Step Temp Time
2 Intitial denature 98oC 20 s
3 Denature 98oC 10 s
4 TD anneal 70-55oC 30 s
5 Elongation 72oC 3'45"
Steps 3-5 repeated 15 times, temp decreasing 1oC/cycle
Phase 3 Step Temp Time
6 Denature 98oC 10 s
7 Anneal 58oC 30 s
8 Elongation 72oC 3'45"
Steps 6-8 repeated 33 times
Termination Step Temp Time
9 Elongation 72oC 7 min
10 Halt reaction 11oC 10 min  
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DpnI digest 
The PCR products were cleaned up using a NucleoSpin Extract II kit following 
the manufacturer’s instructions, and eluted in 25 µL final volumes. The template 
cDNA was digested with DpnI restriction enzyme, which does not digest the un-
methylated PCR product. The following reagents were added to each of the PCR 
products: 
Dpn I digest 1x
10x NEB 4 3
10x BSA 3
Dpn  I 1
Total vol 7 uL  
The samples were incubated at 37oC for 3 h and denatured at 70oC for 20 min. 
Gel separation and purification 
The digested samples were separated on a 0.7% agarose gel. There were 
prominent bands at 6 kbp in both the 1/2 and 3/4 samples. These bands were cut out 
and purified using NucleoSpin Extract II columns and eluted in 21 L of buffer; 1 
L aliquots were run out on a 1% agarose gel and showed very distinct bands of 
equal sizes (Fig 5 C).   
Annealing of DNA  
 Equal volume (6 L) of 1/2 and 3/4 sample were mixed with 1.5 L of 10x 
NEB 2 buffer and 1.5 L of water. The annealing was performed in a PCR machine 
using the following temperature parameters: 
Step Temp Time
1 Denature 95oC 5 min
2 Annealing 65oC 2 min
3 Annealing 25oC 15 min
x4
 
Transformation into competent cells 
Eighty microliters of -Select Competent cells were transformed with 10 L of 
annealed DNA following standard procedure. The transformed cells were plated out 
on bacteriological agarose plates containing 100 g/mL ampicillin. There were no 
colonies visible after an overnight incubation, but after 2 days incubation there were 
approximately 30 colonies on the plate. Ten colonies were picked and grown over-
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night in 5 mL of LB broth with 100 g/mL ampicillin. Only one of the colonies 
managed to grow in the LB broth. The plasmid DNA was extracted and revealed 
relatively low plasmid yield at approximately 26 ng/uL. This could be interpreted as 
the cells struggling to survive in the selective medium.  
Analytical digest 
 The DNA plasmid was subjected to an analytical digest to determine if there 
was any inserts in the multiple cloning site. The enzymes used were EcoRI, EcoRV, 
and XhoI. Five separate digests were set up: (1) EcoRI + EcoRV; (2) EcoRI +  XhoI; 
(3) EcoRI; (4) EcoRV; and (5) XhoI.  The digests were run out on a 1% agarose gel 
and the results were negative; there appeared to be a complete absence of any DNA, 
which would suggest the colonies picked from the plate were false negatives.  
Isolating viable colonies 
The original agar plate had been kept in cold storage. The remaining colonies 
were first streaked out on this plate and incubated overnight. The following day the 
surface of the agar was covered with a lawn of colonies. Colonies were transferred to 
a lawn on a fresh LB-amp agar plate and streaked out in a 16 line pattern to isolate 
individual colonies. This plate was grown overnight at 37oC and resulted in a number 
of robust and distinct colonies. Five colonies were picked and grown overnight in 5 
mL of LB-amp broth and the plasmid DNA extracted. These minipreps yielded high 
DNA concentrations with optimal A260/A280 and A260/A230 ratios (table 3).   
 
Sample ID ng/ul A260 A280 260/280 260/230 
TGFb3-i 587.3 11.75 6.33 1.85 2.43
TGFb3-ii 520.9 10.42 5.58 1.87 2.47
TGFb3-iii 504.5 10.09 5.40 1.87 2.47
TGFb3-iv 516.3 10.33 5.54 1.86 2.48
TGFb3-v 486.3 9.73 5.21 1.87 2.49  
 
 
 
   
Table 3: When colonies from the first plate out failed to produced any plasmid DNA, 
the  colonies were  re‐streaked out on  fresh ampicillin plates. This  second  round of 
ampicillin selection yielded highly concentrated plasmid DNA.  
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Analytical digest 
The plasmids were digested with EcoRI to determine the apparent size of the 
linearised plasmids. Three microliter of plasmid prep (~ 1.5 g) was used in the di-
gest reaction. 
1x 5x
EcoRI buffer 1.5 7.5
10x BSA 1.5 7.5
EcoRI 1 5
Water 11 55
Volume (L) 15 75  
The samples were incubated for 2 h at 37oC and the reaction inactivated at 80oC for 
20 min. The digests and uncut plasmid were run out on a 1% agarose gel for visuali-
zation (Fig 6). 
 
 
PCR analysis 
Before the plasmids were submitted for sequencing they were subjected to 
PCR analysis to ascertain whether they did contain a TGF-3 insert. This was done 
by performing PCR reactions with four primer pairings: (1) inside TGF-3 Fwd and 
Rev; (2) outside M13 Fwd and inside TGF-3 Fwd; (3) outside M13 Rev and inside 
TGF-3 Rev; and (4) outside M13 Fwd and Rev (Fig 7 B). The M13 oligonucleo-
tides are specific to the pBluescript vector backbone and flank each side of the mul-
tiple cloning site. Note the direction of the M13 oligos, the cDNAs are inserted in an 
antisense direction in the pBluescript (SK+) vector, such that the M13 Fwd has the 
opposite orientation to the TGF-3 Fwd, and similar for the reverse oligonucleotides. 
The following master mix was made for the PCR reactions: 
EcoRI
I        II   III   IV      V 
Uncut
6 Kb ‐>
I        II   III   IV      V 
Figure 6: The original plate out of the cells transformed with the annealed DNA failed at first 
to produce viable colonies. The remaining colonies were re‐streaked and this resulted in ro‐
bust  colonies  that  produced  a  high  yield  of  plasmid DNA. An  analytical  digest with  EcoRI 
showed that the plasmid DNA was of the right size to carry the TGF‐3 cDNA. 
  315 
Appendices  315 
1x 21x
HF buffer 5x 4 84
dNTP (10 M) 0.3 6.3
Fwd primer 1 /
Rev primer 1 /
Template 3 /
Phusion DNA pol 0.1 2.1
Water to 20 L 10.6 222.6
Total vol 20 L 315L  
 
The temperature cycling parameters were the following: 
Step Temp Time
1 Intitial denature 98oC 30 s
2 Denature 98oC 10 s
3 Annealing 60oC 30 s
4 Elongation 72oC 45 s
Steps 2-4 repeated 35 times
Termination Temp Time
5 Elongation 72oC 5 min
6 Halt reaction 11oC 5 min  
The PCR products were separated by electrophoresis on a 1% agarose gel (Fig 7 A). 
The gel analysis showed bands at the anticipated sizes for the primer combinations 
used for all five plasmid preps. 
Sequencing 
Samples from all five plasmid preps were sent to the Australian Genome Re-
search Facility for sequencing. Each plasmid was sequenced with both M13 Fwd and 
Rev primers. 
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3. Results MACH isolation protocol 
PCR results 
The PCR reaction products, using the sheep specific MACH primers, were 
run out on an agarose gel and excised and the DNA extracted by column purification. 
The two products were of equal size and roughly equal concentration, and this was 
an early indication that the primers had worked as anticipated (Fig 5 C). A touch-
down PCR protocol was used for this experiment to assure maximal specificity of the 
reaction (Korbie and Mattick, 2008).  
  
Annealing and phenol-chloroform extraction 
The original MACH methodology paper by Haerry and O’Conner (Haerry and 
O'Connor, 2002) describes the use of phenol-chloroform extraction followed by 
<‐ 210 bp
1550 bp ‐> <‐1600 bp
<‐ 3 Kbp
M13 Fwd TGFb3 Rev
TGFb3 Fwd M13 Rev
(1)
(2)
(3)
(4)
(1) (2) (3) (4)
I     II    III    IV   V    I     II    III    IV   V    I     II    III    IV   V    I     II    III    IV   V   
A
B
Figure 7:  (A) The colonies  isolated  from a  subsequent amp‐agar plate  streakout were 
tested  for  the  presence  of  a  TGF‐3  insert  by  PCR  analysis.  The  PCR  reactions were 
separated by gel electrophoresis and this revealed the presence of bands of the antici‐
pated sizes.  
(B) Schematic showing the combination of oligonucleotides used to analyse the plasmid 
DNA.   
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Figure 8: There are only two possible annealing combinations that will allow the PCR prod‐
ucts to form circular plasmids: F4 with R1, creating a long overhang; and F2 with R3, creat‐
ing a short overhang. These overlapping sequences are strong enough for the plasmids to 
be  transformed  into  competent  cell. DNA  repair  enzymes,  typically DNA  ligases,  catalyse 
phosphodiester  bonds  between  adjacent  5'‐phosphoryl  and  3'‐hydroxyl  groups  in  nicked 
duplex DNA, stabilising the plasmids. 
ethanol precipitation to isolate the plasmids. This method was applied here but re-
sulted in the loss of the DNA, as was evident by the failure of any colonies to grow 
from the transformed cells. The phenol-chloroform extraction and ethanol precipita-
tion steps were omitted in the second annealing step. This resulted in transformed 
cells forming colonies which contained the annealed plasmids. It is doubtful whether 
the extraction and precipitation steps are at all necessary, particularly in light of the 
danger of losing what is extremely low DNA concentration. This step is therefore 
better left out.  
Isolating positive clones 
The MACH method relies on the annealing of complementary overhangs for 
the circularization of the DNA strands. Because there are no kinases and ligases in-
volved in this method, which could otherwise bind the two ends together. There are 
only two possible configurations that will generate overhangs that allow the circu-
larization of the PCR products: (i) an F4 strand with an R1 strand, which creates a 
long overhang; and an F2 strand with an R3 strand, which creates a short overhang 
(Fig 8). These overhangs will anneal to each other by their base complementarity, 
forming circles that are stable enough to be transformed into competent cells. Once 
inside the cells, any nicks are repaired by the cells’ own DNA repair enzymes 
(Lehman, 1974).  
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It is likely that the nick repair may have impeded the antibiotic resistance of the cells, 
which is why the first streak out appeared not to produce any plasmid-containing 
colonies. An additional round of ampicillin selective pressure produced cells that had 
repaired the plasmids and which gave these colonies a robust resistance to the am-
picillin.  
The analytical digest and PCR showed that the plasmids had inserts that corre-
sponded to the anticipated size of the TGF-3 mRNA (Fig 6 and 7 A). Five colonies 
were PCR analysed and were sent to AGRF for sequence analysis.  
Sequence analysis 
The sequence analysis returned positive results. All five clones contained TGF-
3. However, the clone also contained a large fragment of the ferritin heavy chain 
(FTH1) mRNA. This is what is what is referred to as a chimeric clone in which the 
full-length FTH1 mRNA had ligated with the fragment of TGF-3. This would have 
occurred as the result of the XhoI sticky end on the FTH1 cDNA ligating to the 5’ 
end of the TGF-3 cDNA and was an artefact of the library construction (Bonaldo et 
al., 1996). An FTH1 clone (p7.46) had earlier been isolated from the library from the 
randomly selected colonies. That particular clone did not produce a full-length 
mRNA, but the sequence contained within the TFG-3 clone resulted in a complete 
mRNA sequence when the two sequences were conceptually spliced (Fig 9 A). Sur-
prisingly, the translated protein sequence from the ORF produced a perfect match to 
Capra hircus (goat) ferritin heavy chain protein (ABL07498) (Fig 9 B), but not the 
official Ovis aries FTH1 GenBank entry (NM_001009786), the inferred protein of 
which, is 16 amino acids shorter than both the Capra hircus and Bos taurus proteins. 
This suggested that the current GenBank entry for Ovis aries FTH1 is incorrect and 
needs to be updated.  
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TGF-3 sequence analysis 
The MACH clonal isolation protocol was capable of isolating a TGF-3 con-
taining clone. The clone was 1,863 base pairs in length, including the poly A tail. 
The coding sequence was 760 bases long and the 3’ UTR was 1,087 bases. The cod-
ing sequence translated to a 253 amino acid which was 100% identical across the C 
>Ovis aries FTH1 mRNA 
GGCACGAGGGTTTCCTGCTTCAACAGTGCTTGAACGGAACCCGGCTGCTCGTCCCCCCCT 
CACCCCGGCCGGCCACTCAGAGCCAGCCTTCGTCACCACTTGACAGCGCCCTCCGACCGG 
CCCAAGGTCCCCGCCGCCACTCCAGCGCCGCTCAGCCGTCGCCGCCGCCACCACCACCAC 
CGCCCCTTTTCAGCCGCCCACCATGACGACCGCATCCCCCTCGCAGGTGCGCCAGAACTA 
CCACCAGGACTCGGAGGCCGCCATCAACCGCCAGATCAACCTGGAGCTCTACGCCTCCTA 
TGTCTACCTGTCCATGTCGTACTATTTTGACCGTGATGATGTGGCTTTGAAGAACTTTGC 
CAAATACTTTCTTCACCAATCTCATGAGGAGAGGGAACATGCTGAGAGACTGATGAAGCT 
GCAGAACCAGCGAGGCGGCCGAATCTTCCTTCAGGATATCAAGAAACCAGACCGTGATGA 
CTGGGAGAATGGGCTGAATGCAATGGAATGTGCGCTGTGCTTGGAAAGAAGTGTGAATCA 
GTCGCTACTGGAACTGCACAAACTGGCCACTGAAAAAAATGATCCCCATCTGTGTGATTT 
CATTGAGACTCATTACCTGAATGAGCAGGTGGAAGCCATCAAAGAATTGGGTGACCACAT 
AACCAACCTGCGCAAGATGGGGGCCCCTGGATCGGGCATGGCAGAGTACCTCTTTGACAA 
GCACACCCTGGGACACAGTGACAGCTAAGCCTCAGGCTGGCTCCCCACAGCCACACGGGT 
GACTTCCCTGGTCACCAAGGCAGTGCATGCATATTTGGGTTACCTTCATCTTTTCTATAA 
GTTGTAACAAAACATCTACTTAAGTTCTTTCTTTAGTACCATTCCTTCAAATAAAGTAAT 
TTGGTACCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Goat FTH1 (Query) vs Sheep FTH1 (Sbjct) 
Length=181 
 
 Score =  380 bits (977),  Expect = 1e-140, Method: Compositional matrix adjust.
 Identities = 181/181 (100%), Positives = 181/181 (100%), Gaps = 0/181 (0%) 
 
Query  1    MTTASPSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQS  60 
            MTTASPSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQS 
Sbjct  1    MTTASPSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQS  60 
 
Query  61   HEEREHAERLMKLQNQRGGRIFLQDIKKPDRDDWENGLNAMECALCLERSVNQSLLELHK  120 
            HEEREHAERLMKLQNQRGGRIFLQDIKKPDRDDWENGLNAMECALCLERSVNQSLLELHK 
Sbjct  61   HEEREHAERLMKLQNQRGGRIFLQDIKKPDRDDWENGLNAMECALCLERSVNQSLLELHK  120 
 
Query  121  LATEKNDPHLCDFIETHYLNEQVEAIKELGDHITNLRKMGAPGSGMAEYLFDKHTLGHSD  180 
            LATEKNDPHLCDFIETHYLNEQVEAIKELGDHITNLRKMGAPGSGMAEYLFDKHTLGHSD 
Sbjct  121  LATEKNDPHLCDFIETHYLNEQVEAIKELGDHITNLRKMGAPGSGMAEYLFDKHTLGHSD  180 
 
Query  181  S  181 
            S 
Sbjct  181  S  181 
A
B
Figure 9: The TGF‐3 clone surprisingly  included a nearly  full‐length mRNA of  ferritin 
heavy chain (FTH1) sequence, which had somehow ligated to the 5’ end of the TGF‐3 
mRNA.  (A) When  this  sequence was conceptually  spliced  to another FTH1 clone  that 
had been isolated from the randomly selected clones, it resulted in an mRNA that was 
similar  in  length  to  the  Bos  taurus  FTH1 mRNA  (NM_174062.3).  The  start  and  stop 
codons are coloured in purple and the coding sequence in yellow. The poly‐adenylation 
signal is highlighted in blue. 
 (B) The  inferred protein from the mRNA sequence perfectly matched the goat (Capra 
hircus) FTH1 protein sequence. 
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terminal half of the Bos taurus (cow) TGF-3 protein (Fig 10 A). Most members of 
the TGF-beta family of cytokines, which includes TGF-1–3, activins and BMPs, are 
secreted as precursor proteins that are approximately four times longer than the ma-
ture protein. The precursor region shares little conservation between the various 
members of this protein family, whereas the mature protein shares a high degree of 
similarity between members and is typically 95 to 115 residues in length. In all 
members of the TGF- family, this region is characterised by a conserved pattern of 
cysteine residues, C...CXGXC...CC...CXCX; TGF-1, 2, and 3 have a further two 
cycteine residues, C...CC...CXGXC...CC...CKCS. The mature protein is cleaved at a 
dibasic arginine motif (RXXR) immediately preceding an alanine residue (Fig 10 B) 
(Derynck et al., 1988; Gentry et al., 1988; Ozkaynak et al., 1990). There is a partial 
Ovis aries TGF-3 sequence in the Genbank (AY656798), which is missing 105 
residues at the C terminal end and anywhere from 11 to 58 residues at the N terminal 
end, depending on which species it is compared with. The Canis lupus familiaris 
(dog) and B. taurus TGF-3 have the longest precursor proteins at 457 and 452 resi-
dues respectively, whereas those of H. sapiens and Mus musculus are 412 residues 
and that of Sus scrofa (pig) is the shortest at 409 residues. These varying protein pre-
cursor lengths, even within the same protein, illustrate the fact that the precursor re-
gion is under less conservation than the mature protein that forms the active homo-
dimer. Until the entire sheep TGF-3 mRNA has been isolated and sequenced it is 
impossible to say what the actual length of the protein is. 
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A Bos taurus TGF-3 (Query) vs MACH isolated TGF-3 (Sbjct) Length=253  
Score =  533 bits (1374),  Expect = 0.0, Method: Compositional matrix adjust. 
 Identities = 252/252 (100%), Positives = 252/252 (100%), Gaps = 0/252 (0%) 
 
Query  201  PASKRSEQRIELFQILQPGEHIAKQRYIDGKNLPTRGTGEWLSFDVTDTVREWLLRRESN  260 
            PASKRSEQRIELFQILQPGEHIAKQRYIDGKNLPTRGTGEWLSFDVTDTVREWLLRRESN 
Sbjct  1    PASKRSEQRIELFQILQPGEHIAKQRYIDGKNLPTRGTGEWLSFDVTDTVREWLLRRESN  60 
 
Query  261  LGLEISIHCPCHTFQPNGDILENIQELMEIKFKGVDSDDDPGRGDLGRLKKKKEHIPHLI  320 
            LGLEISIHCPCHTFQPNGDILENIQELMEIKFKGVDSDDDPGRGDLGRLKKKKEHIPHLI 
Sbjct  61   LGLEISIHCPCHTFQPNGDILENIQELMEIKFKGVDSDDDPGRGDLGRLKKKKEHIPHLI  120 
 
Query  321  LMMIPPNRLDSPGHSQRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYY  380 
            LMMIPPNRLDSPGHSQRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYY 
Sbjct  121  LMMIPPNRLDSPGHSQRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYY  180 
 
Query  381  ANFCSGPCPYLRSSDTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQ  440 
            ANFCSGPCPYLRSSDTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQ 
Sbjct  181  ANFCSGPCPYLRSSDTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQ  240 
 
Query  441  LSNMVVKSCKCS  452 
            LSNMVVKSCKCS 
Sbjct  241  LSNMVVKSCKCS  252 
 
BMP2_hs  MVAGTRCLLALLLPQVLLGGAAGLVPELGRRKFAAASSGRPSSQPSDEVLSEFELRLLSMFGLKQRPTPSRDA---VVPP  77 
BMP7_hs  --------------------DFSLDNEV--------HSSFIHRRLRSQERREMQREILSILGLPHRPRPHLQGKHNSAPM  52 
TFGb3_oa --------------------------------------------------------------------------------   
 
BMP2_hs  YMLDLYRRHSGQP--------------------GSPAPDHRLERAASRANTVRSFHHEESLEELPETSGKTTRRFFFNLS  137
BMP7_hs  FMLDLYNAMAVEEGGGPGGQGFSYPYKAVFSTQGPPLASLQDSHFLTDADMVMSFVNLVEHDKEFFHPRYHHREFRFDLS  132
TFGb3_oa --------------------------------------------------------------------------------   
 
BMP2_hs  SIPTEEFITSAELQVFREQMQDALGNNSSFHHRINIYEIIKPATANSKFPVTRLLDTRLVNQNASR-WESFDVTPAVMRW  216
BMP7_hs  KIPEGEAVTAAEFRIYKDYIRERF---DNETFRISVYQVLQEHLGRESD--LFLLDSRTLWASEEG-WLVFDITATSNHW  206
TFGb3_oa ------------------------PASKRSEQRIELFQILQPGEHIAKQRY---IDGKNLPTRGTGEWLSFDVTDTVREW  56 
 
BMP2_hs  TAQGHANHGFVVEVA----HLEEKQGVSKRHVRISRSLHQDEHSWSQIRPLLVTFGHDGKGHPLHK-------REKRQAK  285
BMP7_hs  VVNPRHNLGLQLSVE----TLDGQ------SINPKLAGLIGRHGPQNKQPFMVAFF---KATEVHF-------RSIRSTG  266
TFGb3_oa LLRRESNLGLEISIHCPCHTFQPNGDILENIQELMEIKFKGVDSDDDPGRGDLGRLKKKKEHIPHLILMMIPPNRLDSPG  136
 
BMP2_hs  HKQRKRLKS------------------------SCKRHPLYVDFS-DVGWNDWIVAPPGYHAFYCHGECPFPLADHLNST  340
BMP7_hs  SKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFR-DLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNAT  345
TFGb3_oa HSQRKKRALDT-------------NYCFRNLEENCCVRPLYIDFRQDLGWK-WVHEPKGYYANFCSGPCPYLRSSD---T  199
 
BMP2_hs  NHAIVQTLVNSVN-SKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR  396 
BMP7_hs  NHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH  402 
TFGb3_oa THSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRTP-KVEQLSNMVVKSCKCS  255 
 
Figure 10: (A) The MACH protocol was used to  isolate TGF‐3 from the cDNA  library. 
This protocol captured more than half of the protein coding region of the mRNA. The 
protein  sequence was compared with  the Bos  taurus TFG‐3  sequence and  the  two 
sequences were found to be identical.  
(B) All members  of  the  TGF‐  superfamily  share  a  distinctive  pattern  of  seven  cys‐
teines: C...CXGXC...CC...CXCX, whereas TGF‐1–3contains an additional  two cysteine 
residues: C...CC...CXGXC...CC...CKCS, all highlighted in purple. The mature TGF‐3 pro‐
tein starts at  the alanine  residue  immediately  following  the proteolytic cleavage site 
RKKR, highlighted in yellow. Here, human BMP2 and BMP7 are aligned with the trans‐
lated sheep TGF‐3 protein using COBALT (www.ncbi.nlm.nih.gov) and shows the con‐
served pattern of the cysteine residues in the C‐terminal end of the proteins.   
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Appendix C – Transcripts of cDNA library se‐
quences submitted to Genbank 
LOCUS       JX889613                1402 bp    mRNA    linear   MAM 22-DEC-2012 
DEFINITION  Ovis aries stearoyl-CoA desaturase (SCD1) mRNA, 3' UTR. 
ACCESSION   JX889613 
VERSION     JX889613.1  GI:429999291 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1402) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1402) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (02-OCT-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
COMMENT     ##Assembly-Data-START## 
            Assembly Method       :: MS Word v. 2007 
            Sequencing Technology :: Sanger dideoxy sequencing 
            ##Assembly-Data-END## 
FEATURES             Location/Qualifiers 
     source          1..1402 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="p3.1" 
     gene            <1..1402 
                     /gene="SCD1" 
                     /note="stearoyl-CoA desaturase" 
     3'UTR           <1..1402 
                     /gene="SCD1" 
     polyA_signal    1357..1362 
                     /gene="SCD1" 
ORIGIN       
        1 ttgtcttttg agctgttcct ctcagtaggg gaaaaaaaaa aaatctaatg gaagatcact 
       61 gtagattaga tcctctgact gaagcaccta ccccttggaa atgcctgtgg ggtagtttta 
      121 attccacagg tcatcagatg catgctttac aactgatgat cagaaacaac ttatctttct 
      181 attctaattg tattccatgg atctgatcta taccatgacc ctacacaagg ctggatggtg 
      241 tccttgggcc cagggtactt gtacttgtgt aggtgggggt tgtctactga gtaaggaata 
      301 ctgtttttaa ggttctaaag ctaaattcaa atgatgcgtt aatgacccag aaactcagat 
      361 ctgatggtgt ctgaatttct aacagtcctt gctttgtggg tatgctgaca acttatctgg 
      421 atgccttaca tcttttctaa acagtgttgc ctctgagcct gttctgctcc ctccctgctc 
      481 cctctgtgga gtccctttgc accccagagc ctgcagaagt ggctggtata aaagggggcc 
      541 tggctagaga atgagcagta tagctgtttg caggattcct ttctgggctt cattttggaa 
      601 actttgctta gggctgtttt tcttaattgc ccgcatttga tggagggtag aaggaatttt 
      661 gaatgtattt gatttattat tattattatt attttagatt aaaagatggt tgtagcattt 
      721 aaaatggaaa attttcctcc tggttagcta gtatcctgag tgtattctct ataaatgtag 
      781 ctcaaatggg tcatcatgaa aagttcaaga aagcttgatg tcaaagttat atgggtggtt 
      841 aaggccaggg cctgtcctac cactgtgcca ctgacttgct gtgtgaccct gggcaagtca 
      901 tttaactata atgtgcctca gttttccttc tgttaaaatg ggataataat actgacctac 
      961 ctcaaagggc agttttgagg cgtgactaat gctttttata aagcatcttg gaattttttt 
     1021 aagtcctgag tatttttata gtagcagtat ccactgtaaa gtgtgtccac catgaaccac 
     1081 gtgtcctgga tgcaatcagg aatctatatg gttctttttg agagactgaa taaatgcatc 
     1141 agctaagggg tggataacta gccagacaaa atttgagaat gcataaactc attgccatgg 
     1201 aaacatacac aggatacctt ttccttgatt gggtgggatt tttccctttt ttatgtggga 
     1261 tagtagttat ttgtgaccta agaataattt tggaataatt tctattaata tcaactctga 
     1321 agctagttgt actgatttga gattgtgttt gttcataata aaagtgaatt tgattgccct 
     1381 gtgaaaaaaa aaaaaaaaaa aa 
// 
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LOCUS       JX889615                3607 bp    mRNA    linear   MAM 22-DEC-2012 
DEFINITION  Ovis aries NIPA-like domain containing protein 3 (NIPAL3) mRNA, 3' 
            UTR. 
ACCESSION   JX889615 
VERSION     JX889615.1  GI:429999294 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 3607) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 3607) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (02-OCT-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
COMMENT     ##Assembly-Data-START## 
            Assembly Method       :: MS Word v. 2007 
            Sequencing Technology :: Sanger dideoxy sequencing 
            ##Assembly-Data-END## 
FEATURES             Location/Qualifiers 
     source          1..3607 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="p3.2" 
     gene            <1..3607 
                     /gene="NIPAL3" 
                     /note="NIPA-like domain containing protein 3" 
     3'UTR           <1..3607 
                     /gene="NIPAL3" 
     gap             853..2733 
                     /estimated_length=1881 
     polyA_signal    3567..3573 
                     /gene="NIPAL3" 
                     /note="atypical polyA_signal" 
ORIGIN       
        1 gtgcctctcc agggaagacg tgcttgatgt gtttgtactg ggtccaccct ggaaactaat 
       61 ttgattctgg ttctgctgct tttttttttt ttcccctcaa aggaactgag aaattaagag 
      121 aaggggaaaa ataaaaaaga gtaggagtga tgagccctta aaggaaaaaa aatccctttt 
      181 catttgacaa gaggtgactg catcacttat caaaggacag acagacaatc tggtgttttg 
      241 tgttgtattt tcctgtaccc cagtgccctc tgggaaaact agcggggtgg aggggggagg 
      301 tgcttatttc aaagacagcc ttgctcacct ctcctccatc ctctcctgtg ctgatcgact 
      361 aaccaagctt gagtcattgg ctaacttcct tggggtcaat agactctttg ggtccccata 
      421 tacatacatc ttcgggaagc aggaattctc agaaatgggg ctgctgccgg ctggctgcat 
      481 acacagctgt cttcccttag gctgactgta tacttctgag aatagcaggt tctataaagt 
      541 tctgtaaact ttaatgagag taaggatccc ttagggaatt tatttaaaat gcagattccc 
      601 acaccccaac ctcagattaa gtgggactgg gaccaggccc aagcatctgc atccttgggg 
      661 cttccctggt ggtccagggg tgaagactcc acactttcag tatagggggc acaggttgga 
      721 tccctggtcc aggaactaag atctcacaag ccgagtggtg cagcaccccc ccaaaaaaga 
      781 gtctgcgttc ttaactggca gcacaggtga ttttgagact ggtaactcaa gtatcacata 
      841 ccttgaaagt ct                                                    
          [gap 1881 bp]    Expand Ns 
     2734                                     gtcttgg gctggcatct cccagtctat 
     2761 gtgcccaagt gtaaaaggac tgtttgccgg tgaccaataa gcagcacttg ctgttaggat 
     2821 gggggacaag gacatccatt ttccattcgc agccctgatt ctttatttct ctcacggtcc 
     2881 tcacatcccc aaaccctctc aaaggctcca agcaacgtga catgtcccgc cagaatcccg 
     2941 ttccctgcca ccagcacgta aggcaaggtc accaaacttg ggtttcaact ttccagttgt 
     3001 tctccagctt tctctgcccg ccccactcca tccccctctc ctaaagactg ggattttgga 
     3061 gtccctactc agacattaat atcggttcac agatgggcac ctgcagcttt tagagagctt 
     3121 agccccactc cactggcccc cacccctccc atggagctgc aggtttgaag atgccatccc 
     3181 atgaagcctc aggtggtggg agggttttgc aggatggaac tagatactgg gaaggcaagg 
     3241 gtgaatcgac ctctttccat cgctttcctg gtggaaacca agcaacggga tggcacagcg 
     3301 tggagacaag atgcccagca gggtagtgtt ggggaacctc caacctgcag ccttgtgaat 
     3361 cccaaatccg gtcccacgct ggctggtagg caaaaccatt ttactgattt tactgtgtgt 
     3421 ttttttgaga agctgtgtaa gtgaagtcac cttagaatat attttatgag gatgctcaca 
     3481 ttttgttaat ttaatgacta atgtatggca tgttattttt caaaaaggtg tgtgctaggt 
     3541 acaaataaca ttatgaagtg gtatttaatt aaaaacaaaa tccacatgaa aaaaaaaaaa 
     3601 aaaaaaa 
// 
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LOCUS       JX534540                1518 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries Cbp/p300-interacting transactivator 2 (CITED2) mRNA, 
            complete cds. 
ACCESSION   JX534540 
VERSION     JX534540.1  GI:410066855 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1518) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1518) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1518 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..1518 
                     /gene="CITED2" 
     CDS             233..1054 
                     /gene="CITED2" 
                     /note="contains Glu/Asp-rich carboxy-terminal domain" 
                     /codon_start=1 
                     /product="Cbp/p300-interacting transactivator 2" 
                     /protein_id="AFV58069.1" 
                     /db_xref="GI:410066856" 
                     /translation="MAHHMLAMNHGRFPDGTNGLHHHPAHRMGMGQFPSPHHHQQQQP 
                     QHAFNALMGEHIHYGASNMNASSGIRHAMGPGTVNGGHPPSALAPAARFNNSQFMGPP 
                     VASQGGSLPASMQLQKLNNQYFNHHPYPHNHYMPDLHPAAGHQMNGTNQHFRDCNPKH 
                     SGGSSTPGGSGGSSTPGGSAGTSGGGAGSSNSGGGSGGGSSSNMPASVAHVPAAVLPP 
                     NVIDTDFIDEEVLMSLVIEMGLDRIKELPELWLGQNEFDFMTDFVCKQQPSRVSC" 
ORIGIN       
        1 gttggcagct gccgggcggt ctcgccgatc tgtgagtgca gcagagggga aattaaaggg 
       61 aacggctccg atcctgcccc atcggctgct gtatgacttc ggcgcagact tcgccactgt 
      121 gaccgccttg cacgccaaga aggccccctc tatgtgctgc tgaaccggtc tggaccttac 
      181 gatcccgccc tcggtcttcg gagcacaaat tgccaggact gaaggactgg aaatggcaca 
      241 ccatatgttg gccatgaacc atgggcgctt ccccgacggc accaatgggc tgcaccacca 
      301 ccctgcccac cgcatgggta tggggcaatt tcctagcccc catcatcacc agcagcagca 
      361 gccgcaacac gccttcaacg ccctgatggg cgagcacata cactacggcg cgagcaacat 
      421 gaatgcctcg agcggcatca ggcacgcgat ggggccgggg actgtaaacg gagggcaccc 
      481 cccgagcgct ctggcccccg cggccaggtt taacaactcc cagtttatgg gccccccggt 
      541 ggccagccag ggaggctccc tgccagccag catgcagctg cagaagctca acaaccagta 
      601 tttcaaccat cacccctacc cccacaacca ctacatgccg gatttgcacc ctgctgcggg 
      661 ccaccagatg aacgggacaa accagcactt ccgagattgc aaccccaagc acagcggcgg 
      721 cagcagcacc cccggcggct cgggcggcag cagcaccccc ggcggctccg cgggcacttc 
      781 gggcggcggc gcgggcagca gcaatagcgg cggcggcagc ggcggcggca gcagcagcaa 
      841 catgcccgcc tccgtggccc acgtccctgc tgcagtgctg ccgcccaatg tcatagacac 
      901 tgatttcatc gacgaggaag tgctcatgtc cttagtgata gaaatgggtt tggaccgcat 
      961 caaggagctg cccgaactct ggctggggca aaacgagttt gattttatga cggacttcgt 
     1021 gtgcaaacaa cagcccagca gagtaagctg ttgactcgat cgaaaccccg gcgaaaaaaa 
     1081 aaatcaaatc ccccaacttc ttcggtgtga attaaaaaaa acattccctt tagacacagt 
     1141 atctcacttt tcagagcgtg aaaggtttga gaacttggaa acaaagtaaa ctataaactt 
     1201 gtacaaattg gtttaaaaaa ttgctgccac tttttttttt tttttcctgt ttttgtttcg 
     1261 tttttgtagc ctggacattc cccctcccct tatgtagttg aaatacctag ctaacttggt 
     1321 cttttttgtt gtttgttttt actccttatt tcctcacttt ctccagtgct caactgtgta 
     1381 gatattaatc ttggcaaact gcttaatctt gtggattttg tagatggttt cacatgactg 
     1441 aactgcattc agatttatga ggaaaaggaa aaattgcatt agttggttgc atgaactttg 
     1501 aagggcagat attactgc 
// 
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LOCUS       JX534537                1813 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries serpin peptidase inhibitor clade H member 1 (SERPINH1) 
            mRNA, complete cds. 
ACCESSION   JX534537 
VERSION     JX534537.1  GI:410066851 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1813) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1813) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1813 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..1813 
                     /gene="SERPINH1" 
     CDS             101..1357 
                     /gene="SERPINH1" 
                     /note="collagen binding protein 1" 
                     /codon_start=1 
                     /product="serpin peptidase inhibitor clade H member 1" 
                     /protein_id="AFV58067.1" 
                     /db_xref="GI:410066852" 
                     /translation="MRALLLISTICLLARALAAEVKKPAAAAAPGTAEKLSPKAATLA 
                     ERSAGLAFSLYQAMWHIWAVENILLSPVVVASSLGLVSLGGKAATASQAKAVLSAEQL 
                     RDDEVHAGLGELLRSHESATARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSK 
                     INFRDKRSALQSINEWIAANTDGKLPEVTKDVERTDGALLVNAMFFKPHWDERFHHKM 
                     VDNRGFMVTRSYTVGVTTDHKTGLYNYYDDEKEKLQMVEMPLAHKLSSLIIIMPHHVE 
                     PLERLEKLLTKEQLKVWMEKMEKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNK 
                     ADLSRMSGKKDLYLASVFHATAREWDTDGNPFDQDIYGREELRSPKLFYADHPFIFLV 
                     RDTQSGSLLFIGRLVRPKGDKMRDEL" 
ORIGIN       
        1 aggcacgagg cgcggctcca gtgtggcact gtgactgcgg tcccggcgcc agcccagccc 
       61 ggccaggtcc tcctcggtgc tcacaaccca cctcccagcc atgcgtgccc tcttgctcat 
      121 cagcaccatc tgcctcctgg ccagggccct ggccgctgag gtgaagaaac ccgccgctgc 
      181 agcagctccg ggcaccgcgg agaagctgag ccccaaggcg gccacactgg ctgagcgcag 
      241 cgctggcctg gccttcagcc tataccaggc catggccaag gaccaggcgg tggagaacat 
      301 cctgttgtca cccgtggtgg tggcctcgtc cctggggcta gtgtcgctgg gcggcaaggc 
      361 ggccacggcg tcgcaggcca aggcggtgct gagcgccgag cagctgcgcg acgatgaggt 
      421 gcacgcgggc ctgggcgagc tgctgcgctc gctcagcaac agcacggcgc gcaacgtcac 
      481 ctggaagctg ggcagccgcc tgtatgggcc cagctctgtg agcttcgcag aggacttcgt 
      541 gcgtagcagc aaacagcact acaattgtga gcactccaag atcaacttcc gcgacaagcg 
      601 gagcgccctg cagtccatca acgagtgggc ggcgcagacc accgacggca agctgcccga 
      661 ggtcaccaag gacgtggagc gcaccgatgg cgcgctgcta gtcaatgcca tgttcttcaa 
      721 gccgcactgg gacgagagat tccaccacaa gatggtggac aaccgaggct tcatggtgac 
      781 ccgttcctat accgtgggtg tcaccatgat gcaccggaca ggtctctaca actactatga 
      841 cgacgagaaa gagaagctgc agatggtgga gatgccgctg gcgcacaagc tgtccagcct 
      901 catcatcatc atgccccacc acgtggagcc ccttgagcgc ctggaaaagc tgctgaccaa 
      961 agagcagctg aaggtctgga tgggcaagat gcagaagaag gctgtggcca tctccctgcc 
     1021 caagggagtc gtggaggtga cccacgacct gcagaaacac ttggctgggc tgggtctgac 
     1081 cgaggccatc gacaagaaca aggcagacct gtctcgcatg tcgggcaaga aggacctgta 
     1141 cctggccagc gtgttccacg ccactgcctt cgagtgggac acggacggca accccttcga 
     1201 ccaggatatc tacgggcgtg aggagctgcg cagccccaag ctcttctacg cggaccaccc 
     1261 cttcatcttc ctggttcgag acacccagag cggctctctg ctgttcatcg ggcgcctagt 
     1321 ccggcccaag ggcgacaaga tgcgagacga gttgtagggc cccagggtgg gtgtgggatg 
     1381 gcagggggca gtgggaggct cctgagacac atgggtgcta caggggtggg ggagctgagg 
     1441 taccgacctt ggatagtctg gggtgggggt gggaaaacag ggggcttcct gtgtgtctga 
     1501 gcagcccttc cctgcctgga ttcactctgc ttggacacgg tcccccaggt gtcatgatgc 
     1561 tgagcccgga gaccccgtgt cccatgggag ctggacggca gtcgtcgagc cccgctctca 
     1621 gtcctgggat ccagcctgcc tcaatcagtg ttcatattta tagcccagtg ctttctcatc 
     1681 tgtgagatgg aatcgagctg ggggttcagc caagccctca tggaatgggg gccctcttcc 
     1741 tgacacgacc accacctcag ccccctccca atcttctccc acttccctca tttataaact 
     1801 agtgctgcag tcc 
// 
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LOCUS       JX534539                 888 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries proteasome subunit alpha type, 2 (PSMA2) mRNA, partial 
            cds. 
ACCESSION   JX534539 
VERSION     JX534539.1  GI:410066853 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 888) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 888) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..888 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..888 
                     /gene="PSMA2" 
     CDS             <1..696 
                     /gene="PSMA2" 
                     /note="prosome; macropain" 
                     /codon_start=1 
                     /product="proteasome subunit alpha type, 2" 
                     /protein_id="AFV58068.1" 
                     /db_xref="GI:410066854" 
                     /translation="RGYSFSLTTFSPSGKLVQIEYALAAVAGGAPSVGIKAANGVVLA 
                     TEKKQKSILYDERSVHKVEPITKHIGLVYSGMGPDYRVLVHRARKLAQQYYLVYQEPI 
                     PTAQLVQRVASVMQEYTQSGGVRPFGVSLLICGWNEGRPYLFQSDPSGAYFAWKATAM 
                     GKNYVNGKTFLEKRYNEDLELEDAIHTAILTLKESFEGQMTEDNIEVGICNEAGFRRL 
                     TPTEVKDYLAAIA" 
     polyA_signal    851..856 
                     /gene="PSMA2" 
ORIGIN       
        1 cgaggttaca gcttttcgct gactacattc agcccgtctg gtaagcttgt ccagatagaa 
       61 tatgctttgg ctgctgtagc tggaggagct ccttcagtgg gaattaaagc tgcaaatggc 
      121 gtggtcttgg caactgagaa gaaacagaag tccattctgt atgatgagcg aagtgtccac 
      181 aaagtggaac caatcaccaa gcatataggt ttggtgtata gtggcatggg cccagattac 
      241 agggtacttg tgcacagagc tcgaaaacta gctcaacagt actatcttgt ttaccaagaa 
      301 cccattccca cagctcagct ggtccagaga gtagcttctg tgatgcagga atacacccag 
      361 tcaggtggtg ttcgcccatt tggagtttct ttacttatct gtggttggaa tgagggacgg 
      421 ccatatttat ttcagtcaga tccatctgga gcttactttg cctggaaagc cacagcaatg 
      481 ggaaagaact atgtgaatgg gaagactttc cttgagaaaa gatataatga agatctggaa 
      541 cttgaagatg ccattcatac agccatatta accctaaagg aaagctttga agggcagatg 
      601 acagaagata atattgaagt tggaatctgc aacgaagccg gatttaggag gcttacccca 
      661 actgaagtta aggattattt ggctgccatt gcataataat gcaaatgatg aagtgactga 
      721 aaatccagaa tttcagataa cttctctact taaacatgtt taaagtatgt tttgttttgc 
      781 agactttttg catacttatt tttacatggt ttgatggact gatgttttta aaatgagact 
      841 tataaatcat aataaactct taaattaaaa aaaaaaaaaa aaaaaaaa 
// 
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LOCUS       JX534527                1729 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries annexin A5 (ANXA5) mRNA, partial cds. 
ACCESSION   JX534527 
VERSION     JX534527.1  GI:410066832 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1729) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1729) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1729 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..1729 
                     /gene="ANXA5" 
     CDS             <1..603 
                     /gene="ANXA5" 
                     /codon_start=1 
                     /product="annexin A5" 
                     /protein_id="AFV58058.1" 
                     /db_xref="GI:410066833" 
                     /translation="LRAIKQVYEEEYGSSLEDDVVGDTSGYYQRMLVVLLQANRDPDA 
                     RIDEAQVEQDAQALFQAGELKWGTDEEKFITIFGTRSVSHLRRVFDKYMTISGFQIEE 
                     TIDRETSGNLEQLLLAVVKSIRSIPAYLAETLYYAMKGAGTDDHTLIRVVVSRSEIDL 
                     YNIRKEFRKNFGTSLYSMIKGDTSGDYKKTLLLLCGGEDD" 
     polyA_signal    1694..1699 
                     /gene="ANXA5" 
ORIGIN       
        1 ctgagagcca taaaacaagt ttatgaagaa gagtatggct cgagcctgga agatgatgtg 
       61 gtgggggata cttcagggta ctaccagagg atgttggtgg tcctccttca ggctaataga 
      121 gaccctgacg ctagaattga tgaagcacag gttgaacaag atgctcaggc tttgtttcag 
      181 gctggagaac ttaaatgggg aacggatgaa gaaaagttta tcaccatctt tggaacacga 
      241 agtgtatctc acttgagaag agtgtttgac aaatacatga ctatatctgg gtttcaaata 
      301 gaagaaacca ttgaccggga gacttctggc aatttggaac agcttctcct tgctgttgtg 
      361 aaatccattc gcagtatacc tgcctacctt gcagaaaccc tctactatgc tatgaaggga 
      421 gctggaacag atgatcatac cctcatcaga gttgtggttt ccagaagtga gattgatctg 
      481 tataacatta ggaaggagtt taggaagaat tttggcacct ctctttattc catgattaag 
      541 ggggacacgt ctggggacta caagaaaacc ctcctgctgc tctgtggagg cgaagatgac 
      601 tgacgggagc ctggggagct gccccacgcc gtgtccgccc ggcaccactg ccttcctgca 
      661 gcgcagctca ccacactcta cacgccagtg ctgagcacac tgccttactc acgctagcat 
      721 gctgtggcca aaacataaat gtaaaagaat gtagcggtgc tcctttctga tctttagtta 
      781 agatctttct ctttaactgt tgtagcacta aagtgtactt atgttactag gactaaagtc 
      841 tggatcattt atattttcct gtaagaggca gactgctttc accctttttt aaaagcttca 
      901 tttatattaa attgataacc atattacctt agtcagagcc ttagccttga aattgtgaac 
      961 tcctggaagt gttattaatc aagtttgcta ccaagttaaa ccaaaaaaat tgtagtggtt 
     1021 gcaatcaaaa gattagtgaa taataaacat ttccaaaaaa aaataataat aataataaac 
     1081 atttccatct tcctgaattt ctcgtgggtg tatgtctaga aaacttattt gatttacgta 
     1141 ttgaacaagg atgtatttgt ttcaggctaa tcagttgaca gtgttatcag ttgaccactg 
     1201 aattgtcgaa agttattaaa agttgacttt tggttgaaaa gcatgaaata caacactgca 
     1261 gaaagaattt cctgggcagt aggggatgag ggaggagtta aagtggggga cttccctggt 
     1321 aactcagatg gtaaagcacc cgcctgctaa tttgggagat gtaagagatg ctggagtggg 
     1381 gaagatcccc tgggaaatgc agtggctacc cactccagta ttcttgcctg gagaatcccc 
     1441 tggactttca gaggagcctg gtgggctaca gtccatgggg ttgcagagtc agacacaagt 
     1501 tacccactaa gcacatacat agcatttaat aagccggtaa gcattttcat ttattggtag 
     1561 cacgtttatg tgggcatcag ttaaagcagt gctaacacta gttgcttatt ggaaaagttg 
     1621 atttaaaaac ttaaactaaa aaacaaaacc caaacattcc tgatgtgaaa gtcacttgga 
     1681 gaaaagtcat atgaataaaa catgttacca gaaaaaaaaa aaaaaaaaa 
// 
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LOCUS       JX534542                1021 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries MAX dimerization protein 4 (MDX4) mRNA, complete cds. 
ACCESSION   JX534542 
VERSION     JX534542.1  GI:410066859 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1021) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1021) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1021 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..1021 
                     /gene="MDX4" 
     CDS             143..772 
                     /gene="MDX4" 
                     /codon_start=1 
                     /product="MAX dimerization protein 4" 
                     /protein_id="AFV58071.1" 
                     /db_xref="GI:410066860" 
                     /translation="MELNSLLILLEAAEYSCARDREAEHGYASVLPFDGDFARKKTKA 
                     AGLVRKAPNNRSSHNELEKHRRAKLRLYIAKDKQLVPLGPDSTRHTTLSLLKRAKMHI 
                     KKLEEQDRRALSIKEQLQREHRFLKRRLNDHSAQSLERVRTDSTGSAVSTDDSEQEVD 
                     VEGMEFGPGELDSVGSSSDVDDHYSLRGIIESHGSFGPPCKRPGRPGLS" 
ORIGIN       
        1 gcacgaggga gcgctcgggg agtccgcggg cgtctgggga agtggggccg ccgggcgcgc 
       61 ggggcgggcg gcgagcggag ccggccgggc agcggccgcc gccgtcccga agcgcgcacg 
      121 cggggggcgg gcaggcggga ggatggagct gaactccctg ctgatcctgc tggaggcggc 
      181 cgagtacctg gagcgcaggg accgagaggc cgagcacggc tacgcgtcgg tgctgccctt 
      241 cgacggcgac ttcgccagga agaaaacaaa ggcggccggc ctggtgcgaa aggccccgaa 
      301 caacaggtcc tcgcacaacg agctcgagaa gcacagacga gccaaacttc ggctctacct 
      361 ggagcagctc aagcagctgg tgcccctggg cccggacagc acccgccaca ccacgctgag 
      421 cctcctgaag cgcgccaaga tgcacatcaa gaaactggag gagcaggacc ggcgggcgct 
      481 gagcatcaag gagcagctgc agcgggagca ccgcttcctg aagcggcgct tggagcagtt 
      541 gtcggcgcag agcctggagc gcgtgcgcac cgacagcacg ggctccgccg tctccactga 
      601 cgactcggag caagaagtgg acgtcgaggg catggagttt ggccccggcg agctggacag 
      661 tgtgggcagc agcagtgatg tggacgacca ctacagcctg cggggcggcg gctgcagcca 
      721 cggcagcttt gggcccccct gcaagcggcc cggccgccct ggcctctcgt aagcgctgcc 
      781 ctccccgctc ctcggcccgc ccgcccgccc ggccgacgca tcgaccctct ggtccttgaa 
      841 gcctctccac gggcccactg ctgtgccatt ctggaagctc cgccgccgcc cgggctgccc 
      901 gcttgccggt caggcccgcc gtgccgcccg ctcctccacc cgggcaggta cccttcggag 
      961 ccggccagct cccacaatcc ggtagtccag tatagccgcc ccaccgcctg ttctcaaaat 
     1021 a 
// 
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LOCUS       JX534530                 717 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries peptidylprolyl isomerase A (PPIA) mRNA, complete cds. 
ACCESSION   JX534530 
VERSION     JX534530.1  GI:410066838 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 717) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 717) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..717 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..717 
                     /gene="PPIA" 
     CDS             2..496 
                     /gene="PPIA" 
                     /note="cyclophilin A" 
                     /codon_start=1 
                     /product="peptidylprolyl isomerase A" 
                     /protein_id="AFV58061.1" 
                     /db_xref="GI:410066839" 
                     /translation="MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEK 
                     GFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFDDENFILKHTGPGILSMAN 
                     AGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD 
                     CGQI" 
     polyA_signal    684..689 
                     /gene="PPIA" 
ORIGIN       
        1 catggtcaac cccaccgtgt tcttcgacat cgctgtcgac ggcgagccct tgggccgcgt 
       61 ctcttttgag ctgtttgcag acaaagtccc gaagacagca gaaaactttc gtgctctgag 
      121 cactggagag aaaggatttg gttataaagg ttcctgcttt cacagaataa ttccgggatt 
      181 tatgtgccag ggtggtgact tcacacgcca taatggtact ggtggcaagt ccatctatgg 
      241 cgagaaattt gatgatgaga atttcattct gaagcataca ggtcctggca tcttgtccat 
      301 ggcaaatgct ggccccaaca caaacggttc ccagtttttc atttgcactg ccaagactga 
      361 gtggttggat ggcaagcatg tggtctttgg caaagtgaaa gagggcatga atattgtgga 
      421 agccatggag cgctttgggt ccagaaatgg caagaccagc aagaagatca ccattgctga 
      481 ctgtggacaa atctaataaa tttgacttac gttttactta accaccagac cattccttct 
      541 gtagcccagg agagcacccc ttcaccccat ctgctcgaaa tatcctataa tctttgtgct 
      601 ctcgctacag ttctttggat tccatatttt ccttatcccc ctccaagttt agctggattg 
      661 caaagttaaa tttatgatta tgaaataaaa actaaacaac taaaaaaaat aaaaaaa 
// 
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LOCUS       JX889612                 524 bp    mRNA    linear   MAM 22-DEC-2012 
DEFINITION  Ovis aries syntaxin 12 (STX12) mRNA, 3' UTR. 
ACCESSION   JX889612 
VERSION     JX889612.1  GI:429999290 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 524) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 524) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (02-OCT-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
COMMENT     ##Assembly-Data-START## 
            Assembly Method       :: MS Word v. 2007 
            Sequencing Technology :: Sanger dideoxy sequencing 
            ##Assembly-Data-END## 
FEATURES             Location/Qualifiers 
     source          1..524 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="p4.2" 
     gene            <1..524 
                     /gene="STX12" 
                     /note="syntaxin 12" 
     3'UTR           <1..524 
                     /gene="STX12" 
     polyA_signal    480..485 
                     /gene="STX12" 
ORIGIN       
        1 attgactgca gttcatccat atatatgcta aaccatcttg tccacttttt gaagaggtta 
       61 attgaatcaa cattacgatg ctctgtggcg ttcctctccc acctgtctgt atagaatggg 
      121 agaattagac aaagcatgct tttggaaagc aaacaggaat tgtttggaat gatttaatct 
      181 tctgttgttg ttgctcagtt gtggttctac attcctggta aatgatgact gttgccgtca 
      241 aaaggctgcc ccctacccta ataaggtttg ctgggcattt ggtggcaggg aaattttaaa 
      301 agctagactg aagttggttt aaaatttaga atttagtcct gtgaactggc aagaaaacaa 
      361 agaaaaggta ctttttttgt aaataatatt ggtttggaat agtgatgtta gaattatcct 
      421 aatttatgaa caagaggtta atctctccat gcataatttt agaccaaaaa aaatgtttca 
      481 ataaaagatt gctgtcttgt aatataaaaa aaaaaaaaaa aaaa 
// 
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LOCUS       JX889614                 791 bp    mRNA    linear   MAM 22-DEC-2012 
DEFINITION  Ovis aries peroxiredoxin-5 (PRDX5) mRNA, complete cds. 
ACCESSION   JX889614 
VERSION     JX889614.1  GI:429999292 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 791) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 791) 
  AUTHORS   Friis,T.E., Stepenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (02-OCT-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
COMMENT     ##Assembly-Data-START## 
            Assembly Method       :: MS Word v. 2007 
            Sequencing Technology :: Sanger dideoxy sequencing 
            ##Assembly-Data-END## 
FEATURES             Location/Qualifiers 
     source          1..791 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="p4.3" 
     gene            1..791 
                     /gene="PRDX5" 
     5'UTR           1..162 
                     /gene="PRDX5" 
     CDS             163..651 
                     /gene="PRDX5" 
                     /codon_start=1 
                     /product="peroxiredoxin-5" 
                     /protein_id="AGA19346.1" 
                     /db_xref="GI:429999293" 
                     /translation="MAPIKVGDAIPSVEVFEKEPGNKVNLAELFKGKKGVLFGLPGAF 
                     TPGCSKTHLPGFVEQAGALKAKGIQVVACLTVNDVFVTEEWGRAHKAEGKVRLLADPN 
                     GTFGKETDLLLDDSLVFLFGNHRLKRFSMVIEDGIVKSLNVEPDGTGLTCTLAPNILS 
                     QL" 
     3'UTR           652..791 
                     /gene="PRDX5" 
     polyA_signal    768..773 
                     /gene="PRDX5" 
ORIGIN       
        1 cggtggttac gagtcctggg ctgcagaccg ggctcggtgg tgtcccgggc gaccatcgtt 
       61 gagggtgcgt cagcgacagc ggcgggagcc cgagggtgcc tggaaggaat cctcgactgg 
      121 acttttggcg gggtccgagg tttcagaagc gctgctgtag ccatggcccc tatcaaggtg 
      181 ggagatgcca ttccgtcggt ggaggtattt gaaaaggagc ccgggaacaa ggtgaacctg 
      241 gcggagctgt tcaaaggcaa gaagggagtg ctgtttgggc tccctggtgc ctttacccct 
      301 ggctgttcca agacccacct gccagggttt gtggagcagg ctggcgctct gaaggccaag 
      361 gggatccagg tggtggcatg tctgaccgtt aatgatgtct ttgtgactga agagtgggga 
      421 cgtgcccaca aggcagaggg caaggttcgg ctcctggcag accccaatgg gacctttggg 
      481 aaggagacag atttgttact tgatgattca ctggtgtttc tctttgggaa tcaccgactg 
      541 aagaggttct ccatggtgat agaggatggc atcgtcaaat ccctgaatgt ggagccagat 
      601 ggcacaggcc tcacctgcac cctggctccc aacatcctct cacagctctg aggcttggag 
      661 cccagatatc ctcctccggc actttcctgt ttcacctgcc cagtcctggg cagagggccc 
      721 caccctagcc tgtgatcact cagctgaaat cttcgccaaa tttctgcaat aaacacttct 
      781 ggtttaaaaa a 
// 
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LOCUS       JX534543                 724 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries cystatin C (CST3) mRNA, complete cds. 
ACCESSION   JX534543 
VERSION     JX534543.1  GI:410066861 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 724) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 724) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..724 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..724 
                     /gene="CST3" 
     misc_feature    53..59 
                     /gene="CST3" 
                     /note="Kozak initiation site" 
     CDS             56..496 
                     /gene="CST3" 
                     /codon_start=1 
                     /product="cystatin C" 
                     /protein_id="AFV58072.1" 
                     /db_xref="GI:410066862" 
                     /translation="MVGSPRAPLLLLAALIVSLALALSPVAAQGPRKGRLLGGLMEAD 
                     VNEEGVQEALSFAVSEFNKRSNDAYQSRAMRVVRARKQVVSGMNYFLDVKLGRTTCTK 
                     SQTNLDSCPFHDQPHLKREKLCSFQVYVVPWMNTINLVKFSCQD" 
     polyA_signal    714..719 
                     /gene="CST3" 
ORIGIN       
        1 atgctagcat ccacggatcg cccctcgact gcagtctgtt tgcatctgag agaccatggt 
       61 gggctccccg cgcgccccgc tgctcctgct ggccgccctg atcgtctccc tggccctggc 
      121 cttgagccct gtggccgcgc agggccctag aaagggtcgc ctgctgggcg gcctgatgga 
      181 ggcggacgtc aacgaggagg gcgtgcagga ggcgctgtcc tttgcggtca gcgagttcaa 
      241 caagcgaagc aacgacgctt accagagccg cgcgatgcgc gtggtgcgcg cccgcaagca 
      301 ggttgtgtcg gggatgaact acttcttgga cgtgaagctt ggccggacta catgtaccaa 
      361 gtcccagacc aacttagaca gctgtccctt ccatgaccag ccgcacctga agagggaaaa 
      421 gctgtgctcc ttccaggttt acgtcgtccc gtggatgaac accatcaacc tggtgaagtt 
      481 tagctgccag gattaatagg ggactgggtg tcaggcaggc cactgaccgc ctctcactca 
      541 cgcccctgca gagcgcccac acctgcggtg ggtgactgcc tactggtcgt gccctcccca 
      601 tgctgccccc gcagacacag gctccttggg cattttctga tctgccaggg gtctctaact 
      661 tgtgtctttc ttctaattgc tttccaagtg cacggtgctc tgctatttta ctcaataaaa 
      721 aagt 
// 
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LOCUS       JX534534                1434 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries coiled-coil domain containing 80 (CCDC80) mRNA, partial 
            cds. 
ACCESSION   JX534534 
VERSION     JX534534.1  GI:410066845 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1434) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1434) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1434 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..1434 
                     /gene="CCDC80" 
     CDS             <1..1234 
                     /gene="CCDC80" 
                     /codon_start=2 
                     /product="coiled-coil domain containing 80" 
                     /protein_id="AFV58064.1" 
                     /db_xref="GI:410066846" 
                     /translation="ARGKPEKEKKKKVKSEKADKLLKSEKQVKKDKAEKKSRQEKEKN 
                     KKKKVGRTEQDAHLKPAKPFTQNPRKSVTDLLGPFEGKRRLLLITAPKAENSMYVQQR 
                     DEYLESFCKMATRKVSVITIFGPVSNSTMKIDHFQLDNEKPMRVVDDEDLVDQHLISE 
                     LRKEYGMTYNDFFMVLTDVDLRVKQYYEVPIAMKYINISANDTFQSRIKDMEKQKKDGI 
                     ICKEDKKQSLENFLSRFRWRRRLLVISAPNDEDWASSHQLEALSGQACNFGLRHITVL 
                     KLLGVGEEVGGVLELFPINGSSVVEREDVPAHLVKDIRNYFQVSPEYFSMLLVGKDGN 
                     VKSWYPSPMGSMGIVYDLIDWMQLRRQEMAIQQSLGMRCPEDEYAGYGYHSYHQGYQE 
                     GYQEDSRHHGSYPHGYPY" 
     polyA_signal    1371..1376 
                     /gene="CCDC80" 
ORIGIN       
        1 ggcacgaggg aaacccgaga aagagaagaa aaaaaaggtg aagagtgaga aagcagacaa 
       61 gttactcaag agtgaaaagc aagtgaagaa ggacaaggct gagaaaaaga gcaggcagga 
      121 gaaagagaag aacaagaaga aaaaggtggg gaggacagag caggatgccc acctgaaacc 
      181 cgcaaaaccc ttcactcaga atcccaggaa gtcggtgacc gacctactgg ggccctttga 
      241 aggcaaacga aggctgcttc tgatcactgc tcccaaggct gaaaacagca tgtatgtgca 
      301 gcagcgagat gagtatctgg aaagtttctg caagatggcc accaggaaag tctccgtgat 
      361 caccatcttc ggtcctgtca gcaacagcac catgaaaatt gaccacttcc agctagacaa 
      421 tgagaaacct atgcgagtcg tggatgatga ggacttggta gaccagcatc tcatcagcga 
      481 gctgaggaag gagtatggaa tgacctacaa tgatttcttt atggtgctca cggacgtgga 
      541 cctcagagtc aagcaatatt atgaggtgcc tatagcaatg aagtccgtgt ttgatttgat 
      601 cgatactttc cagtcccgaa tcaaagacat ggaaaagcag aagaaggacg gcatcatttg 
      661 caaggaagac aagaagcagt cactggaaaa cttcctatcc aggttccgtt ggaggaggcg 
      721 gttgctggtg atctcggccc ctaatgatga agactgggcc tattcacagc agctctctgc 
      781 cctcagtggt caggcatgca attttggtct gcgccacata acggttctga agcttttagg 
      841 tgttggagag gaagtagggg gcgttttaga actgttccca attaatggga gctctgttgt 
      901 ggagcgagaa gacgtaccag ctcatttggt gaaagacata cgcaactatt tccaagtgag 
      961 cccagagtac ttctccatgc ttctagttgg gaaagatgga aatgtgaaat cctggtatcc 
     1021 ttccccaatg gggtccatgg ggattgtgta tgatttaatt gattggatgc aactccggag 
     1081 acaggaaatg gccattcagc agtcactggg gatgcgctgt ccagaagatg agtatgcagg 
     1141 ctatggttac catagttacc atcaaggata ccaggagggt taccaggagg actcccgtca 
     1201 tcatgggagt tacccccatg gatatcctta ctgaacagaa aaatgtaacc ttagcctcag 
     1261 ccagtttccc ctgcaactgt taaagtcaca tggggccagc tacataaagg agagtttttc 
     1321 ccccctgcct gcactccctg cctttttttt tcagtgtttt tccaagatta aataaatagc 
     1381 aacattttgc ctaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaa 
// 
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LOCUS       HQ438587                1176 bp    mRNA    linear   MAM 04-DEC-2010 
DEFINITION  Ovis aries hypothetical protein mRNA, complete cds. 
ACCESSION   HQ438587 
VERSION     HQ438587.1  GI:312861572 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1176) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Xiao,Y., Crawford,R.W. and 
            Hutmacher,D.W. 
  TITLE     Complete coding sequence for Ovis aries ortholog of C12ORF29, 
            coding a protein of unknown function, 37 KDa (PUF37K) 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1176) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Xiao,Y., Crawford,R.W. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (26-OCT-2010) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, Queensland 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1176 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     5'UTR           1..146 
     misc_feature    141..146 
                     /note="Kozak initiation signal" 
     CDS             147..1124 
                     /note="protein of unknown function, 37KDa (PUF37K); 
                     similar to human C12ORF29" 
                     /codon_start=1 
                     /product="hypothetical protein" 
                     /protein_id="ADR10276.1" 
                     /db_xref="GI:312861573" 
                     /translation="MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETVSHKA 
                     LDADIYNAIPTEKVDGTCCYVTNYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKE 
                     FFWNVEEDFKPVPECWIPAKDIEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVN 
                     YEFEIALVLRHHPDDPGLLEISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLL 
                     IPHGAFQIRNLPTLKHSDLLSWFDGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIP 
                     DTYMNSKPVIINMNLNKYEYAFDAKCLFNHFSKIDNQKFGRLKDIILNV" 
     polyA_signal    1136..1142 
                     /note="atypical polyadenylation signal" 
     polyA_site      1159 
ORIGIN       
        1 ggcacgaggg gggagcgagg ctacctggcc agctcgcggc gtgttggcga cttgagtaca 
       61 cggctgaccc ctctgaacgc tctcctggtc aggacccggc gctgctctga agggccttct 
      121 ctactagcac cgcttgagga cccaccatga ggcgcttggg gtcggtgcag cggaaaatgc 
      181 cgtgtgtgtt tgtgacggag gtgaaagagg agccttccac caaaagggag catcagccat 
      241 ttaaagtttt ggcaactgaa actgtaagtc acaaggcatt agatgcagat atatacaatg 
      301 caattccaac agaaaaagtg gatggaacat gttgttatgt tactaactac aaaggtcagc 
      361 catacctctg ggctcggcta gataggaaac ctaacaaatt agctgagaaa agatttaaaa 
      421 attttctaca ttcaaaacaa aactcgaaag aatttttttg gaatgttgag gaggacttca 
      481 aacctgttcc agagtgctgg ataccagcga aggatataga acagttaaat gggaatccga 
      541 tgcctgatga aaatggacac attcctggtt gggtaccagt ggagaaaaac aacaaacagt 
      601 actgctggca ttcgtctgta gtcaattacg agtttgagat cgccctggtc ctgaggcatc 
      661 atcctgatga tcctggcctt ttggaaatta gtgcagtgcc gctctcagat cttctagaac 
      721 aaacactgga gctcatagga accaatatta atggaaatcc ttatgggtta ggaagcaaaa 
      781 agcatccatt acatcttctt ataccacatg gagcatttca aataagaaat ctacctacct 
      841 tgaagcacag tgatctgttg tcctggtttg atggttgcag agagggtaaa attgaaggaa 
      901 tagtatggca ttgtaatgat ggttgtttaa tcaaggtcca tcgccaccat cttggtttat 
      961 gttggccgat cccagatact tatatgaatt caaaaccagt tattatcaac atgaatctga 
     1021 acaaatatga gtatgccttt gatgctaagt gtttgtttaa tcatttttca aaaatagaca 
     1081 atcagaaatt tggtaggctc aaagatataa tacttaatgt ataaactgga agtgcaatta 
     1141 aaaaccagct tcattgttaa aaaaaaaaaa aaaaaa 
// 
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LOCUS       JX534526                 754 bp    DNA     linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries cytochrome c oxidase subunit 3 (CO3) gene, partial cds; 
            mitochondrial. 
ACCESSION   JX534526 
VERSION     JX534526.1  GI:410066830 
KEYWORDS    . 
SOURCE      mitochondrion Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 754) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 754) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..754 
                     /organism="Ovis aries" 
                     /organelle="mitochondrion" 
                     /mol_type="genomic DNA" 
                     /db_xref="taxon:9940" 
     gene            <1..>754 
                     /gene="CO3" 
     CDS             <1..>754 
                     /gene="CO3" 
                     /codon_start=1 
                     /transl_table=2 
                     /product="cytochrome c oxidase subunit 3" 
                     /protein_id="AFV58057.1" 
                     /db_xref="GI:410066831" 
                     /translation="VNPSPWPLTGALSALLMTSGLIMWFHFNSTALLTLGLTTNMLTM 
                     YQWWRDVIRESTFQGHHTPAVQKGLRYGMILFIISEVLFFTGFFWAFYHSSLAPTPEL 
                     GGCWPPTGIHPLNPLEVPLLNTSVLLASGVSITWAHHSLMEGNRYHMLQALFITIALG 
                     VYFTLLQASEYYEAPFTISDGVYGSTFFVATGFHGLHVIIGSTFLIVCFFRQLKFHFT 
                     SSHHFGFEAAAWYWHFVDVVWLFLYVSIYWWGS" 
ORIGIN       
        1 gtaaatccaa gcccctgacc tctcacagga gcactatctg ccctcctaat aacatctggt 
       61 ctcatcatat gatttcactt caactcaaca gctctactaa ctctgggcct aacaacaaat 
      121 atacttacaa tatatcagtg atgacgagat gtgattcgag aaagcacctt ccaaggccac 
      181 catactccgg ctgtccaaaa gggccttcgt tacggaatga ttcttttcat tatctccgaa 
      241 gttctattct ttactggatt tttctgagcc ttctaccact caagccttgc ccccacaccc 
      301 gaactaggcg gctgctgacc tccaacaggc attcacccac ttaatccctt agaagtccca 
      361 ctactcaaca cctctgtcct tctagcctca ggagtatcca ttacttgagc tcaccatagc 
      421 ctcatagaag ggaaccgtta ccacatgtta caagccctat tcattaccat cgcactaggc 
      481 gtatacttta cactgttaca ggcatcagag tattatgaag caccctttac aatctcagac 
      541 ggggtttacg gttcaacttt cttcgtagct acaggatttc acggcctcca tgtcatcatc 
      601 ggatccacct tcctaattgt ctgcttcttc cgccaattga aatttcattt cacctctagt 
      661 caccatttcg gtttcgaagc cgctgcctga tactgacact tcgtagatgt agtatgactt 
      721 ttcctctatg tatccatcta ctgatgaggc tcat 
// 
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LOCUS       JX534521                 632 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries ribosomal protein L17 (RPL17) mRNA, complete cds. 
ACCESSION   JX534521 
VERSION     JX534521.1  GI:410066821 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 632) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 632) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..632 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..632 
                     /gene="RPL17" 
     CDS             28..582 
                     /gene="RPL17" 
                     /codon_start=1 
                     /product="ribosomal protein L17" 
                     /protein_id="AFV58053.1" 
                     /db_xref="GI:410066822" 
                     /translation="MVRYSLDPENPTKSCKSRGSNLRVHFKNTRETAQAIKGMHIRKA 
                     TKYLKDVTLKKQCVPFRRYNGGVGRCAQAKQWGWTQGRWPKKSAEFLLHMLKNAESNA 
                     ELKGLDVDSLVIEHIQVNKAPKMRRRTYRAHGRINPYMSSPCHIEMILTEKEQIVPKP 
                     EEEVAQKKKISQKKLKKQKLMARE" 
     polyA_signal    593..598 
                     /gene="RPL17" 
ORIGIN       
        1 ggcacgaggc tgaggtgact cctaaaaatg gtgcgctatt cacttgaccc agaaaacccc 
       61 acaaaatcat gcaaatcaag aggttcaaat cttcgtgtac actttaagaa cactcgtgaa 
      121 actgcccagg ccataaaggg tatgcatatc cgaaaagcca ccaagtatct gaaggacgtc 
      181 acgttaaaga agcagtgtgt gccgttccgc cgctacaacg gtggagttgg caggtgtgca 
      241 caggccaaac agtggggctg gactcagggt cgatggccca aaaagagtgc tgaattttta 
      301 ctacacatgc tcaaaaatgc agagagtaat gctgaactta agggcttaga tgtagattct 
      361 ctggtcattg agcacatcca agtgaacaaa gcccccaaga tgcgacgcag gacttacaga 
      421 gctcacggtc ggatcaaccc ctacatgagc tctccctgcc acattgagat gatccttact 
      481 gaaaaagaac agattgttcc taaaccagaa gaggaggttg cacagaagaa aaagatatcc 
      541 cagaagaaac tgaagaaaca aaaacttatg gcccgggaat aaatgccgca aaaaataaat 
      601 gcaaataaaa gtaaaaaaaa aaaaaaaaaa aa 
// 
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LOCUS       JX534532                 817 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries catenin beta-1 (CTNNB1) mRNA, partial cds. 
ACCESSION   JX534532 
VERSION     JX534532.1  GI:410066842 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 817) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 817) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..817 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..817 
                     /gene="CTNNB1" 
     CDS             <1..228 
                     /gene="CTNNB1" 
                     /codon_start=1 
                     /product="catenin beta-1" 
                     /protein_id="AFV58063.1" 
                     /db_xref="GI:410066843" 
                     /translation="LGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPV 
                     DGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL" 
ORIGIN       
        1 cttggatatc gccaggatga tcccagctat cgttcttttc actccggtgg gtacggccag 
       61 gacgccttgg ggatggaccc catgatggag catgagatgg gcggccacca ccccggtgct 
      121 gactatccag ttgacgggct gccagatctg gggcatgccc aggacctcat ggatgggctg 
      181 cccccgggcg acagcaatca gctggcctgg tttgatactg acctgtaaat catcctttag 
      241 gagttacaat acaaatggat tttgggagtg actcaagaag tgaagaatgc acaagaatgg 
      301 atcacaagat ggaatttatc aaactctagc cttgcttgtt aaattttttt tttttttaat 
      361 atctgtaatg gtactgactt tgcttgcttt gaagtagctt tttttttttt tttttttttg 
      421 ccataactgt tagttttttt aatcccccgt agtggtaagt tatagtgaaa aaccgctacc 
      481 gcaatttctg aatttttaga atccagtaat ggggtaaaaa ccctaattcc taatcacccc 
      541 taattgtaat ccgaaaaagg gtaacttgtg taaccttttt tgtataaata aacaaataga 
      601 aaggtcccat tagtttcctt tttaatatgc gctaaaaaaa ccgggggatc tattttcccg 
      661 tttttgaatc aaactttttt tggatatgta tgggtaggta aatcgtaaaa ggggtattgg 
      721 aacctgtttg agacgttaca cgttgccttt atcccaagtg ttgtgacccc gcgggaacag 
      781 gcctcagaga aatgcggtta aaaaatggtc aaaatta 
// 
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LOCUS       JX534523                 933 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries maspardin isoform b (SPG21) mRNA, partial cds. 
ACCESSION   JX534523 
VERSION     JX534523.1  GI:410066825 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 933) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 933) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..933 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..933 
                     /gene="SPG21" 
     CDS             <1..364 
                     /gene="SPG21" 
                     /note="spastic paraplegia 21" 
                     /codon_start=2 
                     /product="maspardin isoform b" 
                     /protein_id="AFV58055.1" 
                     /db_xref="GI:410066826" 
                     /translation="ESLGQSELASRLTLNCQNSYVEPHKIRDIPVTIMDVFDQSALST 
                     EAKEEMYKLYPNARRAHLKTGGNFPYLCRSAEVNLYVQIHLLQFHGTKYAAIDPSMVS 
                     AEELEVQKGSLGVSQEEQ" 
     polyA_signal    901..906 
                     /gene="SPG21" 
ORIGIN       
        1 ggaaagtttg ggtcagagtg aactggcttc aagacttacc ctgaattgtc aaaattctta 
       61 tgtggaacct cataaaattc gggacatccc tgtaaccatt atggatgtgt ttgaccagag 
      121 tgcactttca actgaagcta aagaagaaat gtacaaactg tatcctaatg cccggagggc 
      181 tcaccttaaa acaggaggca atttcccata cctgtgcaga agtgcagagg tgaatctcta 
      241 tgtacagata catttgcttc aattccatgg aaccaaatac gcagctattg acccatcaat 
      301 ggtcagtgcc gaggaacttg aggtgcagaa aggcagcctt ggcgtcagtc aggaggagca 
      361 gtagctgtta gtgacgaatg gtccagcgtg tttgtacaat cagtgacgtc agtgcccgcc 
      421 agtcggcctc tcttcggttg gtcaggttca ccggttatca ctgtgtttgg aactaggact 
      481 gatggtcatc tttgtgacag gcggcggctc ttttaagcca gtgtaactat ttcctcttcc 
      541 gttttttagc ttttgaactt aagtactttt ggagactccc attttaagaa ctgaaaattt 
      601 tgctaccaaa agtatttacc cactgtgttt ttaattgtta atttcttagt ttgggggttt 
      661 tgcagatttt ttttcctttt ctttctgtct tcctttcttc ctgttatttg ctgtaaatgc 
      721 tgcatagcca tgttatatat cagcacattt ttttttatgc tttcttggtt ataacagtta 
      781 ttagagtgcc aaggccgtca cccactgttt gctctcctgc aaatcaacta cttttaattt 
      841 ccagttaagc cagttgtttt taattttggc tgttgtcttt ctacccatta cagtctttgg 
      901 aataaaaatt caatttcaaa aaaaaaaaaa aaa 
// 
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LOCUS       JX534545                1855 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries RNA binding protein S1 (RNPS1) mRNA, complete cds. 
ACCESSION   JX534545 
VERSION     JX534545.1  GI:410066865 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1855) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1855) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1855 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..1855 
                     /gene="RNPS1" 
     CDS             153..1070 
                     /gene="RNPS1" 
                     /note="contains serine-rich domain" 
                     /codon_start=1 
                     /product="RNA binding protein S1" 
                     /protein_id="AFV58074.1" 
                     /db_xref="GI:410066866" 
                     /translation="MDLSGVKKKSLLGVKENNKKSSTRAPSPTKRKDRSDEKSKDRSK 
                     DKGATKESSEKDRGRDKTRKRRSASSGSSSTRSRSSSTSSSGSSTSTGSSSGSSSSSA 
                     SSRSGSSSTSRSSSSSSSSGSPSPSRRRHDNRRRSRSKSKPPKRDEKERKRRSPSPKP 
                     TKVHIGRLTRNVTKDHIMEIFSTYGKIKMIDMPVERMHPHLSKGYAYVEFENPDEAEK 
                     ALKHMDGGQIDGQEITATAVLAPWPRPPPRRFSPPRRMLPPLPMWRRSPPRMRRRSRS 
                     PRRRSPARRRSRSPGRRRHRSRSSSNSSR" 
ORIGIN       
        1 acgagggcgg gaggaggtag cggcggcggg aagatgctgc actttggcgt aaattgcaat 
       61 cgattaggga tcgtttctca gactcaagtt agacgtgaga gttcagataa gtgaggccgc 
      121 cattgctgct ttgaacacct cagaagggga gaatggattt atcaggagtg aaaaagaaga 
      181 gcttgctagg agtcaaagaa aataataaaa agtccagcac tagggcgcct tctcccacca 
      241 aacgcaaaga ccgctctgat gagaagtcca aggaccgctc taaagataaa ggggccacca 
      301 aggagtcgag cgagaaggat cgtggcaggg ataagactcg gaagaggcgc agtgcttcca 
      361 gcgggagcag cagcaccagg tcccggtcca gctctacctc cagctcaggc tccagcacca 
      421 gcacgggctc cagcagcggc tccagctcgt cttcggcttc gagccgctcg ggaagttcca 
      481 gcacgtcgcg cagctccagc tccagcagct cctccggctc cccgagccct tctcggcgca 
      541 gacacgacaa caggcggcgt tcccgctcca agtccaaacc acccaaaaga gatgaaaagg 
      601 aaaggaaaag gcggagccct tcccctaaac ccaccaaagt acacattggg cggctcacca 
      661 ggaatgtgac caaggatcac atcatggaga tattctctac ctatgggaaa attaaaatga 
      721 ttgacatgcc tgtagaaagg atgcaccccc atttgtctaa aggctacgcc tatgtggagt 
      781 ttgagaatcc agacgaggct gagaaggcgc tgaagcacat ggacggagga caaatcgatg 
      841 gccaggagat cactgccacc gctgtgctag ctccctggcc ccggccaccg ccccggagat 
      901 tcagtccccc caggaggatg ctgccgccgc ttcctatgtg gcgcaggtca cccccgcgga 
      961 tgagaagaag gtcacgctct ccacgccgtc gttcgcccgc gcgccgtcgc tcccgctcgc 
     1021 ctggccgccg ccgccaccgc agccgctcca gctccaactc ctcccgatag gcggggcccg 
     1081 gagctccgcc cctgcgactc cctcccactg ctcttgttgg tttccagagg ggtcacaggg 
     1141 aagaaatccc tccctcgggg caggcttcaa ggtggaggca gcgatcagac gtctccccag 
     1201 cggcagggtt ctagcggcag gagtgttgtg ggtctggggt cgtgcttgta aagatgctct 
     1261 ccagttttct agctagagca attccacgtt tttagttcct gagagtcagt ttagtggcag 
     1321 agccagcagg ggtgagcagg ggactccagg tggggggata gccccagcct gggagcccat 
     1381 tttcccattc cacagatgac ctggggccag tttcagggcc ccacaggaaa cgcatgcttt 
     1441 taggcaactg ctattcctgt tagcctggcc cagcctgagt ccttttttaa cctttagggt 
     1501 caaataccac ccccaccccc atcatttgcc cagaacggtt ctttacacac gtagccgtgt 
     1561 gcagggacac acacagagac cccctctttt tgaaattgtt gagagccagc tttgccaggt 
     1621 catcacagaa ccccaccctc accccaactc cactgtgttg gtattcttgg tggtcttgct 
     1681 ggttaccttg gcaacgtgta cattgctttt tcagctttta ttgtacagtc agtactataa 
     1741 attttgtttt gagttttgta actttgtagc attttagatg atgttgtgtt tgtacttcgt 
     1801 tgtgtagatt aaaagaactg tgttgaataa aaaaaaaaaa aaaaaaaaaa aaaaa 
// 
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LOCUS       JX534524                1509 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries vimentin (VIM) mRNA, partial cds. 
ACCESSION   JX534524 
VERSION     JX534524.1  GI:410066827 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1509) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1509) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1509 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..1509 
                     /gene="VIM" 
     CDS             <1..1169 
                     /gene="VIM" 
                     /codon_start=3 
                     /product="vimentin" 
                     /protein_id="AFV58056.1" 
                     /db_xref="GI:410066828" 
                     /translation="LLQDSVDFSLADAINTEFKNTRTNEKVELQELNDRFANYIDKVR 
                     FLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAE 
                     DIMRLREKLQEEMLQREEAESTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLH 
                     DEEIQELQAQIQEQHVQIDMDVSKPDLTAALRDVRQQYESVAAKNLQEAEEWYKSKFA 
                     DLSEAANRNNDALRQAKQESNEYRRQVQSLTCEVDALKGTNESLERQMREMEENFSVE 
                     AANYQDTIGRLQDEIQNMKEEMARHLREYQDLLNVKMALDIEIATYRKLLEGEESRIS 
                     LPLPNFSSLNLRETNLDSLPLVDTHSKRTLLIKTVETRDGQVINETSQHHDDLE" 
     polyA_signal    1468..1473 
                     /gene="VIM" 
ORIGIN       
        1 ggctgctgca ggactcggtg gacttctcgt tggccgacgc catcaacacc gagttcaaga 
       61 acacccgcac caacgagaag gtggagctgc aggagctcaa tgaccgcttc gccaactaca 
      121 tcgacaaggt gcgcttcctg gagcagcaga acaagatcct gctggctgag ctcgagcagc 
      181 tcaagggaca gggcaagtcg cgcctggggg acctctacga ggaggagatg cgagagctgc 
      241 gccggcaggt ggaccagctc accaacgaca aggcccgcgt cgaggtggag cgcgacaacc 
      301 tggccgaaga catcatgagg ctccgggaga agttgcagga ggagatgctt cagagagagg 
      361 aagccgagag cactctgcag tctttcagac aggatgttga caatgcctct ttggcacgtc 
      421 ttgacctgga gcgtaaagtg gaatccctgc aagaagagat tgcctttttg aagaaactgc 
      481 acgatgagga aatccaggag cttcaggccc agattcaaga gcagcacgtc caaatcgata 
      541 tggatgtttc caagcctgac ctcacggctg ccctgcgtga tgtccgtcag cagtatgaga 
      601 gcgtggccgc caagaacctt caggaggctg aggaatggta caagtccaag tttgctgacc 
      661 tctctgaagc tgctaaccgc aacaacgacg ccctgcgcca ggccaagcag gagtcgaacg 
      721 agtaccgccg gcaggtgcag tctctcacct gcgaggtgga tgcgctcaaa gggactaacg 
      781 agtctctgga acgccagatg cgtgaaatgg aagagaactt ctctgtggaa gctgctaact 
      841 accaagacac tattggccgc ctgcaggatg agattcagaa catgaaggaa gagatggctc 
      901 gtcacctgcg cgaataccaa gacctgctga atgtcaagat ggcgctcgac atcgagatcg 
      961 ccacctacag gaagctgctg gaaggagagg agagcaggat ttctctgcct cttccaaact 
     1021 tttcttccct gaacctgagg gaaaccaatt tggattcact ccctttggtt gacacccact 
     1081 caaaaaggac acttttgatt aagacggtgg aaaccagaga tggacaggtt atcaacgaaa 
     1141 cttcccagca tcacgatgat ttggaataaa aactgcacat acttcgtgca gcaaaatact 
     1201 accagcaaga aggaaaaaaa aatccatttt ttaaagaaac agctttcaag tgcctttttg 
     1261 cagttttttc aggagcgcaa gatagatttg gaataggaat aagccctagt tcttgaacca 
     1321 acacccataa aagatttaga aaaaagttta caacataatt tagtttactg aagacccctt 
     1381 gtgctagaat actttttaaa aagtattttt gaataccatt aaaactgctt ttttccatca 
     1441 agtatttgac caacttgttt ttgcttcaat aaatctttgg aaaattcaaa aaaaaaaaaa 
     1501 aaaaaaaaa 
// 
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LOCUS       JX534520                 626 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries CD9 protein (CD9) mRNA, partial cds. 
ACCESSION   JX534520 
VERSION     JX534520.1  GI:410066819 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 626) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 626) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..626 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..626 
                     /gene="CD9" 
     CDS             <1..152 
                     /gene="CD9" 
                     /codon_start=3 
                     /product="CD9 protein" 
                     /protein_id="AFV58052.1" 
                     /db_xref="GI:410066820" 
                     /translation="ACPEAIDEIFRSKFHIIGAVGIGIAVVMIFGMVFSMILCCAIRR 
                     NRDMV" 
     polyA_signal    581..586 
                     /gene="CD9" 
ORIGIN       
        1 aggcctgccc tgaagccatc gacgagatct tccgaagcaa attccacatc atcggcgctg 
       61 tgggtattgg gattgccgtg gtgatgatat tcggcatggt tttcagcatg atcctgtgtt 
      121 gtgccatccg cagaaaccga gacatggtct agagtcgagc tttgtgccct gagcaggaac 
      181 gttcacccat gaagaccgct ggttattttc gcggggttct gtttttatgg gttttttttt 
      241 tcctttgcca ctaactctag tattcattct gcatttctaa acaaagaaag ttattctatg 
      301 tttgtgtttt taatgctttc ttcaacattg atgtttgtag ttaagggact tggggatttg 
      361 ggtttgcttt ggttttatat aaatatatat attttttggt catttgtttt tgcttattat 
      421 attaagcaaa aatcctgcaa tgaaaggtac tatgtttgct agactctaga caaaagatat 
      481 tgtacatagc gagatttgtg tgtgtgtgtc tttaaataga taaaaatgtc tatcaagttt 
      541 aatcaggttg taacttaatg ttaaagacaa tttgatacat aataaaagat gatgacaaca 
      601 ttccaaaaaa aaaaaaaaaa aaaaaa 
// 
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LOCUS       JX534541                1700 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries aminolevulinate synthase 1 (ALAS1) mRNA, partial cds. 
ACCESSION   JX534541 
VERSION     JX534541.1  GI:410066857 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1700) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1700) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1700 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..1700 
                     /gene="ALAS1" 
     CDS             <1..1531 
                     /gene="ALAS1" 
                     /codon_start=2 
                     /product="aminolevulinate synthase 1" 
                     /protein_id="AFV58070.1" 
                     /db_xref="GI:410066858" 
                     /translation="EDVQEMHAVREEVVQTSVNPSVINVKTEGGELNGLLKNFQDIMR 
                     KQRPEGVSHLLQDNLPKSVCTFQYDHFFEKKIDEKKNDHSYRVFKTVNRKAQSFPMAD 
                     DYSDSLISKKQVSVWCSNDYLGMSRHPRVCGAVIDTLKQHGTGAGGTRNISGTSKFHV 
                     DLERELADLHGKDAALLFSSCFVANDSTLFTLAKMMPGCEIYSDAGNHASMIQGIRNS 
                     GVPKYIFRHNDVSHLRELLQRSDPAVPKIVAFETVHSMDGAVCPLEELCDVAHEFGAI 
                     TFVDEVHAVGLYGLQAGGIGDRDGVMPKMDIISGTLGKAIGCVGGYIASTSSLIDTVR 
                     SYAAGFIFTTSLPPMLLAGALESVRILRSTEGQTLRRQHQRNVKLMRQMLMDAGLPVV 
                     HCPSHIIPVRVADAAKNTEVCDELMTRHNIYVQAINYPTVPRGEELLRIAPTPHHTPQ 
                     MMSYFVDHLLATWKRVGLELKPHSSAECNFCRRPLHFEMMSEREKSYFSGMSKLVSAQ 
                     A" 
     polyA_signal    1660..1665 
                     /gene="ALAS1" 
ORIGIN       
        1 ggaagatgta caggagatgc atgccgtgag ggaagaggtt gtccaaacct cagtgaatcc 
       61 cagtgtgatt aacgtgaaga ccgaaggagg ggagctgaat ggactgttga agaactttca 
      121 ggatatcatg cgaaagcaac gaccagaagg agtgtcccac cttcttcaag ataacttgcc 
      181 aaaatccgtt tgcacttttc agtatgatca cttctttgag aagaaaattg atgagaaaaa 
      241 aaatgaccat agctatcgag ttttcaaaac tgtgaaccgg aaggcgcagt ccttccccat 
      301 ggcagatgac tattcggact ctctcatcag caaaaagcaa gtgtctgtct ggtgtagcaa 
      361 tgactaccta ggaatgagtc gccacccacg ggtgtgtgga gccgtcatag acactttgaa 
      421 acagcatggt actggagcag ggggtactag aaatatttct ggaactagta aattccacgt 
      481 ggacctggag cgggagctgg ctgacctcca tgggaaagat gccgcactct tgttctcctc 
      541 gtgttttgtg gccaatgact cgaccctctt cactctggct aagatgatgc caggctgtga 
      601 gatttactct gacgctggga accatgcttc catgatccaa gggattcgga acagcggagt 
      661 gccaaagtac atcttccgcc acaacgatgt cagccacctc cgagaactgc tgcaaaggtc 
      721 cgaccctgcc gtgcccaaga tcgtcgcctt tgaaactgtc cactcaatgg acggggcagt 
      781 gtgcccgctg gaagagctct gtgatgtggc ccacgagttt ggagcaatca ccttcgtgga 
      841 tgaggtccac gcagtggggc tctacgggct gcaagcggga gggattggcg atcgggatgg 
      901 agttatgcca aaaatggaca tcatttctgg aacacttggc aaagccattg gctgcgttgg 
      961 agggtacatc gccagcacga gttccctgat cgacaccgtc cggtcctatg cagcgggctt 
     1021 catcttcacc acctccctgc cgcccatgct gctggctgga gcactggagt ctgtgcggat 
     1081 cctgaggagt actgagggcc agacacttcg ccgccaacac cagcgcaacg tgaagctcat 
     1141 gaggcagatg ctgatggatg ccggcctgcc agtggtccac tgccccagtc acatcatccc 
     1201 tgtccgggtg gcagatgctg ctaaaaacac ggaggtctgt gatgaactaa tgactagaca 
     1261 taatatctat gtccaagcga tcaattaccc cacagtgccc cggggcgagg agctgctgcg 
     1321 catcgccccc acgccgcacc acacgccgca gatgatgagc tacttcgtgg atcatttgct 
     1381 ggccacatgg aagcgagttg ggctggaact caagccacat tcctcagccg agtgcaactt 
     1441 ttgcaggagg ccactgcatt ttgaaatgat gagcgaaaga gagaaatcct acttttccgg 
     1501 tatgagcaag ctggtatctg ctcaggcctg aatgtgctgt gccctaagtt actccaccta 
     1561 ccccaagtca cactgtatcc aggtagtccc tccacagttg tctttgtatg tgaattaaat 
     1621 tatattaatt ttaatctatg gtaaacatgt agtccagaaa ataaattctt gtctaaatta 
     1681 aaaaaaaaaa aaaaaaaaaa 
// 
   
 344  Appendices 
LOCUS       JX534538                 670 bp    RNA     linear   MAM 03-NOV-2012 
DEFINITION  Ovis aries kallikrein-related peptidase 7 (KLK7) pseudogene RNA, 
            complete sequence. 
ACCESSION   JX534538 
VERSION     JX534538.1  GI:410111024 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 670) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 670) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..670 
                     /organism="Ovis aries" 
                     /mol_type="transcribed RNA" 
                     /db_xref="taxon:9940" 
     gene            complement(1..670) 
                     /gene="KLK7" 
                     /note="kallikrein-related peptidase 7" 
                     /pseudogene="processed" 
ORIGIN       
        1 cgatgatttg tcatggtgtc atttatccac ttggtgcact tgcacacttg agtgtagact 
       61 catgggtcat taggttggcc gcaagggaca gttccacagg acaccagacc ttgcagggta 
      121 cctatgcaca ccaacggtca ccttgagtca ccattgcagg cgtttttctt ggattcgggg 
      181 atgccagcgc acagcatgga attttccagt aagtcctcgt aaacatttgt gcagtcctgg 
      241 ggggagatga gcttgacatc cacgcacatg aggtcagagg ggaaggtcac atctgggctc 
      301 gtggtagtgc cccagccgga gacagcacag gtggttccag gggcccgcag cgggagggca 
      361 gcctgacttt gttcgccatg gatgacagcc tggcctggat attgagcttc acgagcatgg 
      421 ggtcattaac atgggtctgt gtggagtagc cggggtggcg gaaagacttc gaggccttga 
      481 tcctctgagc tctcctgtcg cccagcgtat caccgcccag gtccacggtg taatcattca 
      541 tcttgcagtg cgcgacagtg aacaccaagg aatcaaaccc ccggtcgcct ctgcaatgca 
      601 accgccatag ccgagcaggc tttctcaata accaaaaaaa aaaaaaaaaa aaaaaaaaaa 
      661 aaaaaaaaaa 
// 
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LOCUS       JX534535                 944 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries phosphatidylinositol glycan anchor biosynthesis class F 
            (PIGF) mRNA, complete cds. 
ACCESSION   JX534535 
VERSION     JX534535.1  GI:410066847 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 944) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 944) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..944 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..944 
                     /gene="PIGF" 
     CDS             72..731 
                     /gene="PIGF" 
                     /codon_start=1 
                     /product="phosphatidylinositol glycan anchor biosynthesis 
                     class F" 
                     /protein_id="AFV58065.1" 
                     /db_xref="GI:410066848" 
                     /translation="MKDTDIKKLLYTHLLCIFSIILSVFIPSFFLENFSILETHLTWL 
                     YICSVSATAVNLVLYLVVKPNVSSKRSSLSYKVTRFLKCCLYFLTSCFFFHVIFVLYG 
                     APLIELVLETFSLAVILSTFTTVPCLCLLGPNFKAWLRIFSRNGVTSVWENSLQITTI 
                     SSFVGIWLGAFPIPLDWGRPWQEWPISCTLGATFGYVAGLVISPLWIYWNRKKLTYKN 
                     N" 
     polyA_signal    906..911 
                     /gene="PIGF" 
ORIGIN       
        1 agggtgggag gtagtagtcc tcgcttccgt ttggcgggcg ggagagatag atagccactc 
       61 aagaaaacac catgaaagat actgacatca agaaactact gtatacccat cttttatgca 
      121 tattttcaat tatcctaagc gtcttcattc catcattctt cttggagaac ttctcaatat 
      181 tggagacaca cttgacatgg ttatacatct gttctgtttc tgcaactgcc gtcaatttag 
      241 tattgtattt agtagtgaaa ccaaatgtgt cttctaaaag aagttcatta tcatacaagg 
      301 taaccagatt tttgaaatgc tgtctctact ttcttacatc ttgtttcttc tttcacgtaa 
      361 tttttgttct gtatggagca ccgctaatag agttggtatt ggagacattt tcacttgcgg 
      421 ttattttgtc cactttcact accgtgcctt gtttatgttt gttaggacca aacttcaaag 
      481 cctggctaag aattttcagt aggaatggag ttacgtccgt ttgggagaat agtcttcaga 
      541 tcactacaat ttctagtttt gtaggaatat ggcttggagc ctttcctatt ccactggatt 
      601 ggggaagacc atggcaggaa tggcccatct cctgcacgct tggagcaacc tttggctacg 
      661 tggctggcct tgttatttca ccactctgga tatactggaa tagaaagaaa ctcacataca 
      721 agaacaatta atcggagcaa agggagaaga gatttctttg tgcagattcc ataaagactg 
      781 tgcagaaatg tatatggttt aggccaggca gtcccactta acagcactgt tttttatgta 
      841 gttacatgat gtgattgtag ctttttaaac tatgaaaccc ctgagagatt gtaccttcta 
      901 gttgaaataa agtatttata atagaaaaaa aaaaaaaaaa aaaa 
// 
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LOCUS       JX534531                 484 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries ribosomal protein S17 (RPS17) mRNA, complete cds. 
ACCESSION   JX534531 
VERSION     JX534531.1  GI:410066840 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 484) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 484) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..484 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..484 
                     /gene="RPS17" 
     CDS             15..422 
                     /gene="RPS17" 
                     /codon_start=1 
                     /product="ribosomal protein S17" 
                     /protein_id="AFV58062.1" 
                     /db_xref="GI:410066841" 
                     /translation="MGRVRTKTVKKAARVIIEKYYTRLGNDFHTNKRVCEEIAIIPSK 
                     KLRNKIAGYVTHLMKRIQRGPVRGISIKLQEEERERRDNYVPEVSALDQEIIEVDPDT 
                     KEMLKLLDFGSLSNLQVTQPTVGMNFKTPRGAV" 
     polyA_signal    450..455 
                     /gene="RPS17" 
ORIGIN       
        1 ggcacgaggc caacatgggc cgcgttcgca ccaaaaccgt aaagaaagcg gcccgggtca 
       61 tcattgagaa gtactacacg cgcctgggca atgacttcca caccaacaag cgggtgtgcg 
      121 aggaaatcgc cattattccc agcaagaagc ttcgcaataa gatcgcaggc tacgtcacac 
      181 atctgatgaa gcggattcaa agaggccctg tgagaggtat ctccatcaag ctgcaggagg 
      241 aggagagaga gaggagagac aattacgtgc ctgaggtctc agccctggat caggaaatca 
      301 ttgaagtaga tcctgacact aaggaaatgc tgaagctatt ggactttggc agtctgtcca 
      361 acttgcaggt cactcagcct acagttggga tgaacttcaa aacaccgcgt ggagccgttt 
      421 gagtctttct gctgtgctgt aatattttca ataaacctcg gacaacaaaa aaaaaaaaaa 
      481 aaaa 
// 
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LOCUS       JX534522                 762 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries homocysteine-inducible endoplasmic reticulum 
            stress-inducible ubiquitin-like domain member 1 (HERPUD1) mRNA, 
            partial cds. 
ACCESSION   JX534522 
VERSION     JX534522.1  GI:410066823 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 762) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 762) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..762 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..762 
                     /gene="HERPUD1" 
     CDS             <1..173 
                     /gene="HERPUD1" 
                     /codon_start=3 
                     /product="homocysteine-inducible endoplasmic reticulum 
                     stress-inducible ubiquitin-like domain member 1" 
                     /protein_id="AFV58054.1" 
                     /db_xref="GI:410066824" 
                     /translation="FQGGPDPESEDPSHLPPDRDVRGDEQTSPSFMSTAWLVFKTFFA 
                     SLLPEGPPAIAN" 
ORIGIN       
        1 acttccaggg gggccctgat cctgaaagtg aagatcccag ccacctccct ccagacagag 
       61 atgtacgagg tgacgagcag accagccctt catttatgag cacagcctgg cttgtcttca 
      121 agacgttctt tgcctctctc cttccagaag gccctccagc catagcaaac tgacagtgtt 
      181 tcctctctgg ctgctggaag ctttgacagg cgtgggctgg atcatctgat gctggctcga 
      241 tttccttacc tggatgtggc ggtggcacag aaatagtata agaatctaca aagaggatga 
      301 tatgcttttg tgattaagca aaagcagtaa gtaagacatg aagccatgat acaattgatg 
      361 aacaaaaaat gcctacaggc ttctcatgtc tttgttctga agagctttaa tatatactgt 
      421 tgtagtttaa taggcattgt aagtagaagg cattagtttc gcatgtttat gcctgaggaa 
      481 cttttccaga tgtgtgtgtc tgcatgagtg tttgtacata gatgtcatag acgcagaaat 
      541 ggttctgctg gtacgatttg attcctgttg gaatgtttaa attacactaa gtgtactact 
      601 ttatataatc aatgaaattg ctagacatgt tttagcagga cttttctagg aaagacttat 
      661 gtataattgc tttttaaaat gcagtgcttt actttaaacc aagaggagct gtgcagaggt 
      721 gaaaaccttt gctgggtttt ctgttcataa gttttactat ga 
// 
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LOCUS       JX534525                 268 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries HSP70 mRNA, 3' UTR. 
ACCESSION   JX534525 
VERSION     JX534525.1  GI:410066829 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 268) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 268) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..268 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..268 
                     /gene="HSP70" 
     3'UTR           <1..268 
                     /gene="HSP70" 
ORIGIN       
        1 ggcacgaggg ccagcctagc atagatttag cattgttcca cacaaaacat ggaaggaccc 
       61 aaattgtagc aaatcccatg gcagttacaa agttgagctg ctatagtaaa taaactgggc 
      121 attcttgata cttgaacatg gaatgtgtgt gcacatggaa aagcattgca ctttacaagc 
      181 actgtattgt aagtggaaaa atgcaatgtc ttaaataaaa ctgtatttaa aattggcaaa 
      241 aaaaaaaaaa aaaaaaaaaa aaaaaaaa 
// 
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LOCUS       JX534533                 764 bp    DNA     linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries D-loop, partial sequence; mitochondrial. 
ACCESSION   JX534533 
VERSION     JX534533.1  GI:410066844 
KEYWORDS    . 
SOURCE      mitochondrion Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 764) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 764) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..764 
                     /organism="Ovis aries" 
                     /organelle="mitochondrion" 
                     /mol_type="genomic DNA" 
                     /db_xref="taxon:9940" 
     D-loop          <1..>764 
ORIGIN       
        1 tcagctgcat ctccctagcc atctctcacc cactaggata ccaacaaacc tacccaccct 
       61 ccacagtaca tagtacataa agccatttac cgtacatacc acatttcact caaatccctt 
      121 ctcgtcccca tggatgaccc ccctcagata ggggtccctt gaccaccatc ctccgtgaaa 
      181 tcaatatccc gctctggatt gctactctcc tcgctccggg cccttaacac ttgggggtag 
      241 ctaaagtgaa ctgtatccga cttctggttc ctacttcagg gccataaagc ctaaatagcc 
      301 cacacgttcc ccttaaataa gacatcccga tggatcacag gtctatcacc ctattaacca 
      361 ctcacgggag ctctccatgc atttggtatt ttcgtctggg gggcatgcac gcgatagcat 
      421 tgcgagacgc tggagccgga gcaccctatg tcgcattatc tgtctttgat tcctgcctca 
      481 tcctattatt tatcgcacct acgttcaata ttacaggcga acatacttac taaagtgtgt 
      541 taattaatta atgcttgtag gacataataa taacaattga atgtctgcac agccgctttt 
      601 ctacacatac atcataacaa aaaatttcca ccaaaccccc ccccctcccc ccgcttctgt 
      661 gcccagcact tatacacatc tctgccagac cccaaaagca aagatgccta acaccggcga 
      721 accagatttc aattttatct tttgggagga tccttttttt acag 
// 
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LOCUS       JX534536                 761 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries ribosomal protein S8 (RPS8) mRNA, complete cds. 
ACCESSION   JX534536 
VERSION     JX534536.1  GI:410066849 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 761) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 761) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..761 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..761 
                     /gene="RPS8" 
     CDS             6..632 
                     /gene="RPS8" 
                     /codon_start=1 
                     /product="ribosomal protein S8" 
                     /protein_id="AFV58066.1" 
                     /db_xref="GI:410066850" 
                     /translation="MGISRDNWHKRRKTGGKRKPYHKKRKYELGRPAANTKIGPRRIH 
                     TVRVRGGNKKYRALRLDVGNFSWGSECCTRKTRIIDVVYNASNNELVRTKTLVKNCIV 
                     LIDSTPYRQWYESHYALPLGRKKGAKLTPEEEEILNKKRSKKIQKKYDERKKNAKISS 
                     LLEEQFQQGKLLACIASRPGQCGRADGYVLEGKELEFYLRKIKARKGK" 
     polyA_signal    662..667 
                     /gene="RPS8" 
ORIGIN       
        1 cgaggatggg catctctcgg gacaactggc acaagcgccg taagaccggg ggcaagagaa 
       61 agccctacca caagaagcgg aagtatgagc tgggacgccc cgctgccaac acaaagattg 
      121 gcccccgccg catacacaca gtccgtgtgc ggggaggcaa caagaagtac cgggccttga 
      181 ggctggacgt ggggaacttc tcctggggct cggagtgttg tacacgcaag acaagaataa 
      241 tcgatgttgt ctataatgca tccaacaacg aactggtccg taccaagacc ctggtgaaga 
      301 actgtattgt gcttatcgac agcacaccgt accgacagtg gtacgagtcc cactatgcac 
      361 tgcccctggg ccgcaagaag ggggctaagc tgactcctga ggaggaagag attttaaaca 
      421 agaaacgatc aaagaaaatt cagaagaaat acgatgagag gaaaaagaac gcaaaaatca 
      481 gcagtcttct agaggagcag ttccagcagg gcaagcttct tgcatgcatc gcttcaagac 
      541 caggccagtg tggccgagca gacggctatg tgctagaggg aaaagagctt gagttctatc 
      601 tgaggaagat caaggcccgg aaaggcaaat aaaccctctt ccctcctgtc ttagctcatc 
      661 taataaaggc gtttactgtt ctatgccccc caagaaaaga acaaaaaaaa aaaaaaacac 
      721 caaaaaaaaa gaaacaaaaa aaaaaaaaaa aaaaaaaaaa a 
// 
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LOCUS       JX534529                 834 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries tumor protein translationally-controlled 1 (TCTP) mRNA, 
            complete cds. 
ACCESSION   JX534529 
VERSION     JX534529.1  GI:410066836 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 834) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 834) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..834 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..834 
                     /gene="TCTP" 
     CDS             100..618 
                     /gene="TCTP" 
                     /codon_start=1 
                     /product="tumor protein translationally-controlled 1" 
                     /protein_id="AFV58060.1" 
                     /db_xref="GI:410066837" 
                     /translation="MIIYRDLISHDEMFSDIYKIREVADGLCLEVEGKMVSRTEGNID 
                     DSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTKEAYKKYIKDYMKSIKGK 
                     LEEQRPERVKPFMTGAAEQIKHILANFKNYQFFIGENMNPDGMVALLDYREDGVTPYM 
                     IFFKDGLEMEKC" 
     polyA_signal    808..813 
                     /gene="TCTP" 
ORIGIN       
        1 ccccctcccc ccgagcgccg ctctggccgc actgcgctcg ctctgagctc cgggctcctg 
       61 ctaagccagc gccgctgtcg cctccctcca gtcgccatca tgatcatcta ccgggacctc 
      121 atcagccatg acgagatgtt ctccgacatc tacaagatcc gggaggtcgc ggacgggctg 
      181 tgtctggagg tggaggggaa gatggtcagt aggacagagg gtaacatcga tgactcgctc 
      241 attggtggaa atgcctccgc tgaaggcccc gagggcgaag gtaccgaaag cacagtaatc 
      301 actggtgtcg atattgtcat gaaccatcac ttgcaggaaa ccagcttcac aaaagaagcc 
      361 tacaagaagt acatcaaaga ttacatgaag tcaatcaaag ggaaacttga agaacagaga 
      421 ccagaaagag taaaaccttt tatgacaggg gctgcagaac aaatcaagca catccttgct 
      481 aatttcaaaa actatcagtt ctttattggt gaaaacatga atccagatgg catggttgct 
      541 ctgctggact accgtgagga tggtgtaacc ccatatatga ttttctttaa ggatggttta 
      601 gagatggaaa aatgttaaca aagttggcag ttactttgga tcaatcacct gtcgtcaaaa 
      661 ctggctggcc actgcttttc atccacacaa caccaggact tagacagatg ggactgatgt 
      721 catctcgagc tcttcatttg ttttgaacgt tgatttattt ggagcggagg cattgttttt 
      781 gagaaaacgt gtcatgtagt tgtctaaaat aaacacattt aaactcattg gaaa 
// 
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LOCUS       JX534528                 929 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries ferritin heavy polypeptide 1 (FTH1) mRNA, complete cds. 
ACCESSION   JX534528 
VERSION     JX534528.1  GI:410066834 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 929) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 929) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..929 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            1..929 
                     /gene="FTH1" 
     CDS             194..739 
                     /gene="FTH1" 
                     /codon_start=1 
                     /product="ferritin heavy polypeptide 1" 
                     /protein_id="AFV58059.1" 
                     /db_xref="GI:410066835" 
                     /translation="MTTASPSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDR 
                     DDVALKNFAKYFLHQSHEEREHAERLMKLQNQRGGRIFLQDIKKPDRDDWENGLNAME 
                     CALCLERSVNQSLLELHKLATEKNDPHLCDFIETHYLNEQVEAIKELGDHITNLRKMG 
                     APGSGMAEYLFDKHTLGHSDS" 
     polyA_signal    881..886 
                     /gene="FTH1" 
ORIGIN       
        1 gtttcctgct tcaacagtgc ttgaacggaa cccggctgct cgtccccccc tcaccccggc 
       61 cggccactca gagccagcct tcgtcaccac ttgacagcgc cctccgaccg gcccaaggtc 
      121 cccgccgcca ctccagcgcc gctcagccgt cgccgccgcc accaccacca ccgccccttt 
      181 tcagccgccc accatgacga ccgcatcccc ctcgcaggtg cgccagaact accaccagga 
      241 ctcggaggcc gccatcaacc gccagatcaa cctggagctc tacgcctcct atgtctacct 
      301 gtccatgtcg tactattttg accgtgatga tgtggctttg aagaactttg ccaaatactt 
      361 tcttcaccaa tctcatgagg agagggaaca tgctgagaga ctgatgaagc tgcagaacca 
      421 gcgaggcggc cgaatcttcc ttcaggatat caagaaacca gaccgtgatg actgggagaa 
      481 tgggctgaat gcaatggaat gtgcgctgtg cttggaaaga agtgtgaatc agtcgctact 
      541 ggaactgcac aaactggcca ctgaaaaaaa tgatccccat ctgtgtgatt tcattgagac 
      601 tcattacctg aatgagcagg tggaagccat caaagaattg ggtgaccaca taaccaacct 
      661 gcgcaagatg ggggcccctg gatcgggcat ggcagagtac ctctttgaca agcacaccct 
      721 gggacacagt gacagctaag cctcaggctg gctccccaca gccacacggg tgacttccct 
      781 ggtcaccaag gcagtgcatg catatttggg ttaccttcat cttttctata agttgtaaca 
      841 aaacatctac ttaagttctt tctttagtac cattccttca aataaagtaa tttggtaccc 
      901 aaaaaaaaaa aaaaaaaaaa aaaaaaaaa 
// 
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LOCUS       HM067830                1905 bp    mRNA    linear   MAM 30-MAY-2010 
DEFINITION  Ovis aries clone ACTB_SLIP_1 beta-actin variant 2 (ACTB) mRNA, 
            complete cds. 
ACCESSION   HM067830 
VERSION     HM067830.1  GI:296803210 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1905) 
  AUTHORS   Friis,T.E., Xiao,Y., Crawford,R.W. and Hutmacher,D.W. 
  TITLE     Complete coding sequence for Ovis aires actin, beta (ACTB) variant 
            2 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1905) 
  AUTHORS   Friis,T.E., Xiao,Y., Crawford,R.W. and Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (07-APR-2010) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Queensland 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1905 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="ACTB_SLIP_1" 
     gene            1..1905 
                     /gene="ACTB" 
     CDS             73..1200 
                     /gene="ACTB" 
                     /codon_start=1 
                     /product="beta-actin variant 2" 
                     /protein_id="ADH51685.1" 
                     /db_xref="GI:296803211" 
                     /translation="MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVM 
                     VGMGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHP 
                     VLLTEAYINPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVT 
                     HTVPIYISYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCY 
                     VALDFAEMATAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHE 
                     TTFNSWANCDVDIRKDLYANTVLSGGTTMYPGIADRMQKEITALAPSTMKIKIIAPPE 
                     RKYSVKERGSILASLSTFQQMWISKQEYDESGPSIVHRKCF" 
     polyA_signal    1798..1803 
                     /gene="ACTB" 
ORIGIN       
        1 gccccgccag cacaggcctc tcgccttcgc cgctccgcct tcgccgccgg tcgacaccgc 
       61 aaccagttcg ccatggatga tgatattgct gcgctcgtgg ttgacaacgg ctccggcatg 
      121 tgcaaggccg gcttcgcggg cgacgatgct ccccgggccg tcttcccttc catcgtgggg 
      181 cgcccccggc accagggcgt gatggtgggc atgggccaga aggactccta cgtgggggat 
      241 gaggctcaga gcaagagagg catcctgacc ctcaagtacc ccattgagca cggcattgtc 
      301 accaactggg acgacatgga gaagatctgg caccacacct tctacaacga gctgcgtgtg 
      361 gcccccgagg agcaccccgt gctgctgacc gaggccccct tgaaccccaa ggccaaccgt 
      421 gagaagatga cccagatcat gtttgagacc ttcaacaccc ctgccatgta cgtggccatc 
      481 caggctgtgc tgtccctgta cgcctctggc cgcaccactg gcatcgtgat ggactccggt 
      541 gacggggtca cccacacggt gcccatctac gaggggtacg ccctccccca cgccatcctg 
      601 cgtctggacc tggctggccg ggacctgacg gactacctca tgaagatcct cacggagcgt 
      661 ggctacagct tcaccaccac ggccgagcgg gaaatcgtcc gtgacatcaa ggagaagctc 
      721 tgctacgtgg ccctggactt cgagcaggag atggccaccg cggcctccag ctcctccctg 
      781 gagaagagct acgagctgcc ggacgggcag gtcatcacca tcggcaatga gcggttccgc 
      841 tgccctgagg ctctcttcca gccttccttc ctgggcatgg aatcctgcgg cattcacgaa 
      901 actaccttca attccatcat gaagtgtgac gtcgacatcc gcaaggacct ctacgccaac 
      961 acggtgctgt ccggcgggac caccatgtac cctggcatcg cagacaggat gcagaaagag 
     1021 atcactgccc tggcacccag cacgatgaag atcaagatca tcgcgccccc tgagcgcaag 
     1081 tactccgtgt ggattggcgg ctccatcctg gcctcgctgt ccaccttcca gcagatgtgg 
     1141 atcagcaagc aggagtacga cgagtccggc ccctccatcg tccaccgcaa atgcttctag 
     1201 gcggactgtt agctgcgtta cacccttttt cttgacaaac ctaacttgcg cagaaacgag 
     1261 atgagattgg catggcttta tttgtttttt tttttttttg tattttttga tttttttttt 
     1321 tttttttttt tggcgcttga ctcaggattt aaaaactgga acggtgaagg cgacagcagt 
     1381 cggttggatc cagcatcccc caagttctac catggggccg aagactttga ctgtacatgg 
     1441 tttttttttt taaaatagtc attccaaata ttgggaaatg cattgttaca ggaagtcctt 
     1501 tgccttccca aaagcccccc tccttctctc taaggagaag gggccagtcc tcgcccgagt 
     1561 ccacacaggg gaggggattg cttttgtgta aattatgtac tccaaaaaaa gttttgtttt 
     1621 taatcttccc cttaatactt gttttttttt tgtttgtttt tattttgaat gggcagccat 
     1681 cacggccccc tttttttgtc ccccaacttg atgtatgaag gcttttggtc cccttgggag 
     1741 cgggttgagg tgcggaggca gtcagggctt tcctgcacac tgacttgaga ccagttaaat 
     1801 aaagtgcaca atttaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 
     1861 aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaa 
// 
   
 354  Appendices 
LOCUS       HM043737                1285 bp    mRNA    linear   MAM 30-MAY-2010 
DEFINITION  Ovis aries clone GAPDH_MACH_9 glyceraldehyde-3-phosphate 
            dehydrogenase (GAPDH) mRNA, complete cds. 
ACCESSION   HM043737 
VERSION     HM043737.1  GI:296785214 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1285) 
  AUTHORS   Friis,T.E., Xiao,Y., Crawford,R.W. and Hutmacher,D.W. 
  TITLE     Complete coding sequence for Ovis aries glyceraldehyde-3-phosphate 
            dehydrogenase (GAPDH) 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1285) 
  AUTHORS   Friis,T.E., Xiao,Y., Crawford,R.W. and Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (29-MAR-2010) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Queensland 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1285 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
                     /clone="GAPDH_MACH_9" 
     gene            1..1285 
                     /gene="GAPDH" 
     misc_feature    37..41 
                     /gene="GAPDH" 
                     /note="Kozak initiation site" 
     CDS             40..1041 
                     /gene="GAPDH" 
                     /codon_start=1 
                     /product="glyceraldehyde-3-phosphate dehydrogenase" 
                     /protein_id="ADH43296.1" 
                     /db_xref="GI:296785215" 
                     /translation="MVKVGVNGFGRIGRLVTRAAFNTGKVDIVAINDPFIDLHYMVYM 
                     FQYDSTHGKFHGTVKAENGKLVINGKAITIFQERDPANIKWGDAGAEYVVESTGVFTT 
                     MEKAGAHLKGGAKRVIISAPSADAPMFVMGVNHEKYNNTLKIVSNASCTTNCLAPLAK 
                     VIHDHFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGAAQNIIPASTGAAKAVGKV 
                     IPELNGKLTGMAFRVPTPNVSVVDLTCRLEKPAKYDEIKKVVHQASEGPLKGILGYTE 
                     DQVVSCDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMVHMASKE" 
     polyA_signal    1219..1224 
                     /gene="GAPDH" 
ORIGIN       
        1 gtaacttctg tgctgtgcca gccgcatccc tgagacaaga tggtgaaggt cggagtgaac 
       61 ggatttggcc gcatcgggcg cctggtcacc agggctgctt ttaatactgg caaagtggac 
      121 atcgttgcca tcaatgaccc cttcattgac cttcactaca tggtctacat gttccagtat 
      181 gattccaccc atggcaagtt ccacggcaca gtcaaggcag agaacgggaa gctcgtcatc 
      241 aatggaaagg ccatcaccat cttccaggag cgagatcctg ccaacatcaa gtggggtgat 
      301 gctggtgctg agtacgtggt ggagtccact ggggtcttca ctaccatgga gaaggctggg 
      361 gctcacctga agggtggcgc caagagggtc atcatctctg caccttctgc tgacgctccc 
      421 atgtttgtga tgggcgtgaa ccacgagaag tataacaata ccctcaagat tgtcagcaat 
      481 gcctcctgca ccaccaactg cttggccccc ctggccaagg tcatccatga ccactttggc 
      541 atcgtggagg gacttatgac cactgtccac gccatcactg ccacccagaa gactgtggat 
      601 ggcccttccg ggaagctgtg gcgtgatggc cgaggggctg cccagaacat catccctgct 
      661 tctactggcg ctgccaaggc cgtgggcaag gtcatccctg agctcaacgg gaagctcact 
      721 ggcatggcct tccgcgtccc cacccccaac gtgtccgttg tggatctgac ctgccgcctg 
      781 gagaaacctg ccaagtatga tgagatcaag aaggtggtga agcaggcctc agagggccct 
      841 ctcaagggca ttctaggcta cactgaggac caggttgtct cctgcgactt caacagcgac 
      901 actcactctt ctaccttcga tgctggggct ggcattgccc tcaacgacca ctttgtcaag 
      961 ctcatttcct ggtacgacaa tgaattcggc tacagcaaca gggtggtgga cctcatggtc 
     1021 cacatggcct ccaaggagta aggtccttgg acccccagcc ccagcaggag cacgagagga 
     1081 agagagagtt cctcagctgc tggggagtcc tgccccacct ccaccacact gagaatctcc 
     1141 cgacctccat acatttccat cctcaaggcc ctgaggaaag ggaggggctt agggagccct 
     1201 gccttgtcac gtaccatcaa taaaagtacc ctatacccag aaaaaaaaaa aaaaaaaaaa 
     1261 aaaaaaaaaa aaaaaaaaaa aaaaa 
// 
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LOCUS       JX534544                1862 bp    mRNA    linear   MAM 31-OCT-2012 
DEFINITION  Ovis aries transforming growth factor-beta 3 (TGF-beta 3) mRNA, 
            partial cds. 
ACCESSION   JX534544 
VERSION     JX534544.1  GI:410066863 
KEYWORDS    . 
SOURCE      Ovis aries (sheep) 
  ORGANISM  Ovis aries 
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; 
            Pecora; Bovidae; Caprinae; Ovis. 
REFERENCE   1  (bases 1 to 1862) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     PCR based method for isolating clones from a cDNA library in sheep 
  JOURNAL   Unpublished 
REFERENCE   2  (bases 1 to 1862) 
  AUTHORS   Friis,T.E., Stephenson,S.A., Whitehead,J.P., Xiao,Y. and 
            Hutmacher,D.W. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (25-AUG-2012) Institute of Health and Biomedical 
            Innovation, Queensland University of Technology, 60 Musk Ave, 
            Kelvin Grove, Brisbane, QLD 4059, Australia 
FEATURES             Location/Qualifiers 
     source          1..1862 
                     /organism="Ovis aries" 
                     /mol_type="mRNA" 
                     /db_xref="taxon:9940" 
     gene            <1..1862 
                     /gene="TGF-beta 3" 
     CDS             <1..759 
                     /gene="TGF-beta 3" 
                     /codon_start=1 
                     /product="transforming growth factor-beta 3" 
                     /protein_id="AFV58073.1" 
                     /db_xref="GI:410066864" 
                     /translation="PASKRSEQRIELFQILQPGEHIAKQRYIDGKNLPTRGTGEWLSF 
                     DVTDTVREWLLRRESNLGLEISIHCPCHTFQPNGDILENIQELMEIKFKGVDSDDDPG 
                     RGDLGRLKKKKEHIPHLILMMIPPNRLDSPGHSQRKKRALDTNYCFRNLEENCCVRPL 
                     YIDFRQDLGWKWVHEPKGYYANFCSGPCPYLRSSDTTHSTVLGLYNTLNPEASASPCC 
                     VPQDLEPLTILYYVGRTPKVEQLSNMVVKSCKCS" 
     polyA_signal    1823..1828 
                     /gene="TGF-beta 3" 
ORIGIN       
        1 cccgcctcca agcgcagcga gcagaggatt gagctcttcc agatcctcca gccgggtgag 
       61 cacatagcca agcagcggta tatcgatggc aagaacctgc ccacgcgggg cactggcgag 
      121 tggctgtctt tcgacgtcac agacactgtg cgtgaatggc tcttgcggag agaatccaac 
      181 ttaggtctgg aaatcagcat ccactgtccc tgtcacacct ttcagcccaa tggggatatc 
      241 ctggaaaaca ttcaagagct gatggaaatc aaattcaaag gtgtggacag tgatgatgat 
      301 ccgggccgtg gagacctggg gcgactgaag aagaagaagg aacacatccc tcatctaatt 
      361 ctcatgatga ttcccccaaa ccggctagac agcccaggcc acagtcagag gaagaagcgg 
      421 gccctggaca ccaattactg cttccgcaat ctggaggaga actgctgtgt gcgccctctc 
      481 tacattgact tccgacagga tctgggctgg aagtgggtcc acgaacctaa gggctactat 
      541 gccaacttct gctcaggccc ctgcccatac ctccgcagct cagacacaac ccacagcacg 
      601 gtgctgggcc tgtacaacac cctgaaccct gaagcctcgg cctccccttg ctgcgtaccc 
      661 caggacttgg agcccctgac catcctgtac tatgtcggga ggacccccaa agtggagcag 
      721 ctgtctaaca tggtggtgaa gtcctgcaag tgcagctgag gcccgactgc cacaggagag 
      781 aggagggatc accactgcct gcccgcctgc ccctcgggaa acacagcagc gacggacctc 
      841 gccgcgaggc ctggggcccg cgacctccgg ctccaggcag atgatggccg agacgggggt 
      901 tccccttctg gaacatttct ttttcttgct gggtctgaga atcactgtag taaagcaagt 
      961 gtgggtttgg ttaggggaag gtcgatttct tcaggagaca tggattttcc atgtcagagg 
     1021 tggtggggac agaggaagag gggtggttga gttgacgcat tgcagggttc acgggattcg 
     1081 ggacacccta cggggggaag gtggggcaga gaatggcctg gacagggcca gactggaaga 
     1141 cccctggtgc tgaggtcaga ttgctcatcc atcgctgccc cacgtctgct cgaggggcat 
     1201 ccggatcacg tcataccagg caagcatctt tctttaggca ggttcctcaa gacaaaagtc 
     1261 ccagaattgt atctcgtact tacctgggat taaagacaag tctgttagtt ttgcaaattg 
     1321 tcccctggac gtcagtcggc attgagggtt gttctgggag aagatccagg taacgcagtc 
     1381 ccaggggcca tcaactatac tgggcccaat ggatatgcag aactctgagg tagagggtgg 
     1441 gaactgaccc tttctggtct gctccttggg ttcttcctct tgccctcttc cttgattgtt 
     1501 ttccttggac atttggctag aacccttcca ggtcagggcg cacatgactg gagtttgggt 
     1561 ctttgcagcc ttggggcatc atggatttcc cctcctgacc cccaccccct caccccgaga 
     1621 ccctgtgttc atttggtgtt cctggaagca ggtgctgcga cgtgagaggc atgcaggaag 
     1681 gtgcacgcgt gccacgcaat gacttggccc cagacgcata gactgaggta taaagacaaa 
     1741 tacagatatt actctcaaaa tctttgtata aatttttggg gaatcttgga tcgtttcatc 
     1801 ttctggaaga ttgtttctaa acaataaaag ccttatttta aggtgtaaaa aaaaaaaaaa 
     1861 aa 
// 
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Appendix D – All known C12orf29 protein se‐
quences (Dec 2012)  
>Homo sapiens (Human) 
MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFLKIDNQKFVRLKDIIFDV 
 
>Homo sapiens (Human) v2 
GGRSRGGWARSVRGLSRAGDCFRASPRLDRAPLESTPSIRTACWAHHEALGLRAAENAVC 
VCDGGERGAFLQKGASDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKP 
APECWIPAKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHP 
DDSGLLEISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLK 
HNDLLSWFEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNK 
CDSAFDIKCLFNHFLKIDNQKFVRLKDIIFDV 
 
>Pan troglodytes (Chimpanzee) 
MKRLGSVQRKIPCVFVTEVKEEPSSKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFLKIDNQKFVRLKDIIFDV 
 
>Gorilla gorilla (Gorilla) 
MKRLGSVQRKIPCVFVTEVKEEPSSKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
AKETEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLVSW 
FEDCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFLKIDNQKFVRLKDIIFDV 
 
>Pongo abelii (Orangutan) 
MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENAKEFFWNVEEDFKPAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELVGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLLSW 
FEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFLKIDNQKFARLKDIIFDV 
 
>Nomascus leucogenys (Northern white-cheeked gibbon) 
MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKLAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLLSW 
FEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFLKIDNQKFARLKDIIFDV 
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>Macaca mulatta (Rhesus macaque) 
MKRLGSVQRKMPCVFVTEVKEEPSAKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQVRNLPSLKHNDLLSW 
FEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKCDSAFDI 
RCLFNHFSKIDNQKFARLKDIIFDV 
 
>Macaca mulatta (Rhesus macaque) v2 
GRSRGGWARSASGVDAAGDCCRASPQLDWALLESALSTRTACWAHHEALGLRAAENAVCV 
CDGGERGAFRQKGASDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPA 
PECWIPAKEIEQINGNPVPDENGHIPDWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPD 
DSGLLEISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQVRNLPSLKH 
NDLLSWFEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKC 
DSAFDIRCLFNHFSKIDNQKFARLKDIIFDV 
 
> Macaca fascicularis (Crab-eating macaque) v2 
GRSRGGWARSASGLDPAGDCCRASPQLDWALLESALSTRTACWAHHEALGLRAAENAVCV 
CDGGERGAFRQKGASDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPA 
PECWIPAKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHAD 
DSGLLEITAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQVRNLPSLKH 
NDLLSWFEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKC 
DSAFDIRCLFNHFSKIDNQKFARLKDIIFDV 
 
>Callithrix jacchus (Common marmoset) 
MKRLGSVQRKMPCVFVTEVKQEPSAKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKGNPKEFFWNVEEDFKPAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFGIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGNKKHPLHLLIPHGAFQIRNRPSLKHNHLLSW 
FEGCKEGKIEGIVWHCGDGCLIKVHRHHLGLCWPIPDTYMSSRPVIINMNLNKCHSAFDI 
KCLFNHFSKIDNQKFARLKDIIFDV 
 
>Papio anubis (Olive baboon) 
MKRLGSVQRKMPCVFVTEVKEEPSAKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKENPKEFFWNVEEDFKPAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQVRNLPSLKHNDLLSW 
FEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKCDSTFDI 
RCLFNHFSKIDNQKFARLKDIIFDV 
 
>Saimiri boliviensis (Squirrel monkey) 
MKRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQAEKRFKNFLHSKGNPKEFFWNVEEDFKPAPECWIP 
AKEIEQINGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGNKKHPLHLLIPHGAFQIRNLPSLKHNHLLSW 
FEGCKEGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSRPVIINMNLNKCDSAFDI 
KCLFNHFSKIDNQKFARLKDIIFEV 
 
>Otolemur garnettii (Small-eared Galago) 
MRRLGSVQRKVPCVFVTEVKEEPSAKREHQPFKVLATEAVSHKALDADIYSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQADKRFKNFLHSKDNSKEFFWNVEEDFKPAPECWIP 
AKEIEQLDGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLRHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQITNLPTLKHNDLLSW 
FEGCREGQIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIVNMNLNKYDYAFDN 
KCLFHHFLKLDNQKFSKLKDIIFDT 
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>Ovis aries (Sheep) 
MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETVSHKALDADIYNAIPTEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKDIEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLRHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHSDLLSW 
FDGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKYEYAFDA 
KCLFNHFSKIDNQKFGRLKDIILNV 
 
>Bos taurus (Cow) 
MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETLSHKALDADIHNAIPTEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKLAEKRFKNFLHLKQNSKEFFWNVEEDFKPVPECWIP 
AKEIEQINGNPIPDENGHIPGWVPVEKNSKQHCWHSSVVDYESEIALVLRHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHSDLLSW 
FDGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKYEYAFDA 
KCLFNHFSKIDNQKFGRLKDIILTV 
 
>Sus scrofa (Pig) 
MRRLGSVQRKMPCVFVTEVKEEPSAKREHQPFKVLATETISHKALEADIYSAIPTEKVDG 
TCCYVTTYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKDTEQLNGSPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHSDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHNDLLSW 
FEGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYLNSKPVTINMNLNKYEYAFDA 
KCLFNYFSKIDNQKFSRLKDIVFSV 
 
>Tursiops truncatus (Bottlenose dolphin) 
MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETISHKALDADIHSAIPTEKVDG 
TCCYVTTYKGQPYLWALLDRKHNKQAEKRFKIFLYLKENSKEFFWNVEEDFKPVPECWIP 
AKEIEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLRHHSDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHNDLLSW 
FEGCREGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNNYVYAFDA 
KCLFNHFSKIDNQKFGRLKDIILNV 
 
>Canis lupus familiaris (Dog)  
MRRLGSVQRKMPCVFVTEVKEEPSGKREQQPFKVLATETLSHKALDADIYSAIPTEKVDG 
TCCYITTYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKEIEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHNDLLSW 
FEGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVVINMNLNKYDHAFDT 
KCLFNLFSKIDNQKFGRLKDIILDV 
 
>Felis catus (Cat) 
MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCYITNYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKEIEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEVALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHNDLLSW 
FEGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKYDHAFDT 
KSLFNLLSKIDNQKFGRLRDIILDV 
 
>Ailuropod melanoleuca (Panda) 
MRRLGSVQRKMPCVFVTEVKEEPSSKREHQPFKVLATETLSHQALDADIYSAIPTEKVDG 
TCCYITTYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKETEQLNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEVALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHHDLLSW 
FEGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKYDHAFDT 
KCLFSRLSKIDNQKFGRLKDIILDV 
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>Equus caballus (Horse) 
MKRLGSMQRKMPCLSVTEGKEEPSSKREQQPFKVLATETVNHKALDADIYSAIPTEKVDG 
TCCYITTYKGQPYLWARLDRKPNKLAEKRFKNFLHSKQNSKEFFWNVEEDFKPVPECWIP 
AKEIEQFNGNPMPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDPGLLE 
VSAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPSLKHNDLLSW 
FEGCREGKIEGIVWHCNDGCLIKVHRHHLGLCWPIPDTYMNSKPVIINMNLNKYDYAFDT 
KCLFNHFSKLDNQKFGRLKDIILDV 
 
>Desmodus rotundus (Vampire bat) 
MKRLGSVQRKIPCVFVTEVKEELSTKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
TCCYVTTYKGQPYLWARLDRKPNKLAEKRFKNFRHSKQNSKEFVWNVEEDFKPVAECWVP 
AKEIEQLNGNPVPDENGHIPGWVPVEKSNKQHCWHSSVVDYELGTALVLKQHPDDPGLLE 
VSAVPLSGLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIHNLPTLKYKDLLSW 
FEGCREGKIEGVVWHCNDGCLIKVHRHHLGLCWPIPDTYLNSKPVIVNMNLNKHDYAFDT 
KCLFHHFLKIDNQKFSRLKDIILDV 
 
>Oryctolagus cuniculus (European rabbit) 
MRRLGSVQRKMPCVFVTEVKEEPSTKREHQPFKVLATETVSHKALDADIYSAIPTEKVDG 
TCCYVTTYKGQPYLWARLDRKPNKQADKRFKNFLHSKDNSKEFFWNIEEDFKPVPECWIP 
AKEIEQLNGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFEIALVLKHHPDDPGLLE 
ISAVPLADLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFQIRNLPTLKHNDLLSW 
FEGCREGKIEGIVWHCSDGCLIKVHRHHLGLCWPIPDPYMNSKPVVINMNLNKYDCAFDA 
KCLFNHFSKIDNQKFGRLKDIILDV 
 
>Loxodonta africana (African elephant) 
MRRLGSVQRKMPCVFVTEVKEEPSAKREHQPFKVLATETINHKALDADIYSAVPTEKVDG 
TCCYVTTYKGQPYLWARLDRKPNKQAEKRFKKFLYSKENSKEFFWNVEEDFKPVPECWIP 
AKEIEQLDGKPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFDIALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPLHLLIPHGAFHIRNLPTLKHNDLLSW 
FESCREGKIEGIVWHCNDGCLIKVHRHHLGLHWPIPDTFMNSKPVIINMDLNKYDYAFDS 
KCLFSYFSKIDNQKFSRLKDIMFDV 
 
>Rattus norvegicus (Rat) 
MNRLGSVQRKMPCVFVTEVKAEPSAKREHQPFKVLATETLSEKALDADVYNAVATEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKQADKRFKKFLHSKENAKEFHWNTEEDFKPVPECWIP 
AKEIEKQNGKPVPDENGHIPGWVPVEKNSKQYCWHSSVVSYEFGIALVLRHHPDDPGVLE 
ISAVPLSELLEQTLELIGTNINGNPYGLGSKKYPLHFLTPHGAFQVRNLPTLKHNDLLSW 
FEGCREGQIEGIVWHCGDGCLIKVHRHHLGLCWPLPDTYMNSKPVIINMNLDKYDCAFDH 
QSLFNKFSKIDKQKFDRLKDITLDI 
 
>Mus musculus (Mouse) 
MKRLGSVQRKMPCVFVTEVKAEPSAKREHQPFKVLATETLSEKALDADVYNAVATEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKQADKRFKKFLHSKESAKEFHWNTEEDFKPVPECWIP 
AKEIEKQNGKPVPDENGHIPGWVPVEKGSKQYCWHSSVVNYEFGIALVLRHHPDDPGVLE 
ISAVPLSELLEQTLELIGTSINGNPYGLGSKKSPLHFLTPHGAFQVRNLPTLKHNDLLSW 
FEDCREGQIEGIVWHCGDGCLIKVHRHHLGLCWPLPDTYMNSKPVIINMNLNLNNYDCAF 
DNQSLFNQFSKIDKQKFERLKDIILDV 
 
>Peromyscus maniculatus bairdii (Prairie deer mouse) 
MRRLGSVQRKMPCVFVTEVKAEPSAKREHQPFKVLATETLSEKALDADVYSAIATEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKQADKRFKKFLHSKESSKEFLWNTEEDFKPVPECWIP 
AKEIEQQNGKPVPDENGHIPGWVPVEKNSKQYCWHSSVVNYESGIALVLRHDPDKPGLLE 
ISAVPLSELLEQTLELIGTNINGNPYGLGSKKYPLHFLIPHGAFQVRNVPALKHNDLLSW 
FEDCREGKVEGIVWHCGDGCLLKVHRHHLGLCWPLPDTYMNSKPVIINMNLNKYDCAF 
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>Cricetulus griseus (Chinese hamster) 
MSRLGSVQRKMPCVFVTEVKAEPSAKREHQPFKVLATETLSEKALDADVYNAIATEKVDG 
TCCYVTNYKGQPYLWARLDRKPNKQADKRFKKFLHSKDNSKAFLWNMEEDFKPVPECWIP 
AKEIEQQNGKPVPDENGHIPGWVPVEKNSKQYCWHSSVVNYEFGIALVLRHDPDEPGLLE 
ICAVPLSELLEQTLELIGTNINGNPYGLGSKKSPLHFLIPHGAFPVRNLPTLKHNDLLSW 
FEDCREGKIEGIVWHCGDGCLIKVHRHHLGLCWPLPDTYMNSKPVIVNMNLNKYDCAFDN 
ECLFNQFLKKDKQKFDRLKDIMLDV 
 
>Cavia porcellus (Domestic guinea pig) 
MRRLGSVQRKMPCVFVTEVKDEPSAKREHQPFTVLATETISHKALDADIHSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQADKRFKNFLRSQENSKEFLWNVEEDFKPVPECWIP 
AKEIEHLKGNPVPDENGHIPGWVPVEKSNKQYCWHSSVVNYEFEIALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGNKKHPIHLLIPHGAFQIRNLPKLKHNDLLSW 
FEGCREGKIEGIVWHCSDGCLIKVTTKVLVLSWHYYVPTAYNSPKNLSCIINMNLNKYGY 
AFDTKCLFNHFSKIDNQKFGRLKDIILDV 
 
>Nannospalax galili (Blind mole rat) 
CYVTTYKGQPYLWARLDRKPNKQADKRFKKFLHSKENSKEFLWNIEEDFKPIPECWIAAK 
EAEQHNGHPVPDENGHIPGWVPVERTSKQYCWHSSVVNYELGIALVLRHHPDDPGLLEIS 
SVPLSELLEQTLELIGTNINGNPYGLGSKKYPLHFLIPHGAFQVRNLPALKHNDLLSWFE 
GCREGKIEGIVWHCGDGCLIKVHRHHLGLCWPLPDTYMNSKPVIINMNLNKYDYTFDNKC 
LFNQFFKIDKQKFGRLKDIIFDV 
 
>Heterocephalus glaber (Naked mole rat) 
MRRLGSVQRKMPCVFVTEVKDEASAKREHQPFKVLATETISHKALDADIHSAIPTEKVDG 
TCCYVTTYKDQPYLWARLDRKPNKQADKRFKNFLCSKENSKEFLWNIEEDFKPVPECWIP 
AKEIKHLKGNPVPDENGHIPGWVPVEKSNKQYCWHSSVVNYEFEIALVLMHHPDDPGLLQ 
ISPVPLTDLLEQTLELIGTNINGNPYGLGNKKHPIHLLIPHGAFQIRNLPRLKHNDLLSW 
FEGCREGKIEGIVWHCSDGCLIKVHRHHLGLSWPIPDTYMNSKPVIINMNLNKYDYTFDT 
KCLFNYFSKIDNQKFGRLKDITLDV 
 
>Spermophilus lateralis (Ground squirrel) 
MRRLGSVQRKMPCVFVTEVKDEPSAKREHQPFKVLATETISHKALDADIYSAIPTEKVDG 
TCCFVTTYKDQPYLWARLDRKPNKKADKRFKNFLHSKENSKEFLWNVEEDFKPVPECWIP 
AKEIEQLNGNPVPDENGHIPGWVPVDKNNKQYCWHSSVVNYEFEIALVLKHHPDDPGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGNKKHPLHLLVPHGAFQISNLPTLKHSDLLSW 
 
>Monodelphis domestica (Brazilian opossum) 
MRRLGSVQRKVPCVFVTEVKDEPSVKREHQPFKVLATETINHKALDADIYNAIPTEKVDG 
TCCYVTTYKGQPYLWARLDRKPNKQAEKRFKRFLYSKENSKEFIWNVEEDFKSVPECWIP 
AKEIEQLNGNPVPDENGHIPGWVPVEKNNKQYCWHSSVVNYEFELALVLNHHADDSGLLE 
ISAVPLSDLLEQTLELIGTNINGNPYGLGSKKHPVHLLVPHGAFQIKNQPALKHHDLLSW 
FEGCREGRIEGIVWHCNDGCLIKVHRHHLGLRWPIPDTYMNSQPVIINMNRTRYDCAFDS 
KCLFNHFSKLDNQKFGRLKDIKLDV 
 
>Ornithorhynchus anatinus (Platypus) 
MNEGEFLVQLQEERVTRRQEPFKVLATETINHKALDADIYNAIPTEKVDGTCCYVTTYKG 
RPYLWARLDRKPNKQAEKRFKRFLYSKENTKEFVWNVEEDFKPVPERWIPAKEIEYLNGN 
PVPDENGHIPGWLPVEKNNKQYCWHSSVVNYEFETALVLNCHAGDPGLLEISAVPLSDLL 
EQTLELIGTNINANPYGLGSKKHPVHLLVPHGAFKIKSQPSLKHSDLLTWFESCREGKIE 
GIVWHCSDGCLIKVHRHHLGLRWPIPDTHMNSQPVVVNISSSKYGCDLDSKCLFSHFSKL 
DSQKFGSLRDIKLDG 
 
>Trichosurus vulpecular (Brushtail possum) 
GSRAHGLEAALEPSVKREHQPFKVLATETINYKALDADIYNAIPTEKVDGTCCYVTTYKG 
QPYLWARLDRKPNKQAEKRFKRFLYSKENSKEFIWNVEEDFKSVPESWIPAKDIEQLNGN 
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PVPDENGHIPGWVPVEKNNKQYCWHSSVVSYEFELALVLNHHADDPGLLEISAVPLSDLL 
EQTLELIGTNINGNPYGLGSKKHPIHLLVPHGAFQIKNQPTLKHNDLLSWFXGCREEKLK 
A 
 
>Gallus gallus (Chicken) 
MSRRGAVQRKVPCLFVTEVKEEPSVKRERQPFKVLATETLSEKALEADIYNAVPTEKVDG 
TCCYVTTYKGQPYLWARLDRRPNKQAEKRFKRFLYSVEDCKEFIWNVEEDFKPVPDTWIP 
AKEIEFSNGNPLPDENGHMPGWVPVEKNSKQYCWHSSVVSYETEMALVLKHHADPGLLEI 
RPVSLSELLEQTLELIGTNINANPYGLGSKKQPIHLLVPHGAFEIKNPPTLKQSDIVSWF 
EGCSEGKVEGIVWHCRDGCLIKLHRHHLGLCWPLAETYLNSQPVVISFNRNDYDCDFGPK 
SLFHQFSKLDGQRFDRLKDIKFDD 
 
>Taeniopygia guttata (Zebra finch) 
MSRRGAVQRKVPCLFVTEVKDEPSAKRERQPFKVLATDTITGKALEADVHNAVPTEKVDG 
TCCYVTTYKGLPYLWARLDRKPTKQGEKRFKQFLYSLEDCKEFVWNVEEDFKPVPDTWIP 
AKDIEFSNGNPLPDENGHMPGWVPVEKNSKQYCWHSSVVNYEAGVALVLKHHADPGVLEI 
SPVPLSEILEQTLELIGTNINANPYGLGNKKHPVHLLVPHGAFEIKNPPALKQNDILSWF 
ETCMEGKVEGIVWHCADGCLIKIHRHHLGLPWPLAETYLNSQPVVISFNRTKCDYDFEPK 
SLFHHFSMLDGQRFDRLKDIKFDA 
 
>Meleagris gallopavo (Wild turkey) 
MPARRRSEGRRARSAAEVTANGFRLRPSPFKVLATETLNEKALEADIYNAIPTEKVDGTC 
CYITTYKGQPYLWARLDRRPNKQAEKRFKRFLYSVEDCKEFIWNVEEDFKPVPDTWIPAK 
EIEFSNGNPLPDENGHMPGWVPVEKNSKQYCWHTSVVNYEAEVALVLKHHADPGLLEIRP 
VSLSELLEQTLELIGTNINANPYGLGSKKQPIHLLVPHGAFEIKNPPTLKQSDILSWFEG 
CCEGKVEGIVWHCRDGCLIKLHRHHLGLCWPLAETYLNSQPVVISFNRNDYDCDFGPKSL 
FHQFSKLDGQRFDRLKDIKFDD 
 
>Lonchura striata (White-rumped munia) 
MSRRGAVQRKVPCLFVTEVKDEPSAKRERQPFKVLATDTITGKALEADVHNAVPTEKVDG 
TCCYVTTYKGLPYLWARLDRKPTKQGEKRFKQFLYSLEDCKEFVWNIEEDFKPVPDTWIP 
AKDIEFSNGNPLPDENGHMPGWVPVEKNSKQYCWHSSVVNYEAGVALVLKHHADPGLLEI 
SPVPLSEILEQTLELIGTNINANPYGLGNKKHPVHLLVPHGAFEIKNPPALKQNDILSWF 
ESCMEGKVEGIVWHCHDGCFNQAPSPSSWFTXGXLQKHT 
 
>Anolis carolinensis (Green anole lizard) 
MSLPLGSVQQKMPCLFVTEVREEPSAKREHQPFKVLATETINQKALDADIYNAVPTEKVD 
GTCCYITTYKGQPYLWARMDRKPNKQTEKRFKRFLYSADNSRGFTWNVEEDFRTVPESWI 
PAKEIERCNGKPLPDENGHIPGWVPVEKNSRQYCWHASVVDYEFELALILKHHTEEPGFL 
EICPVPLSTFSEHTLELIGTNINANPYGLGSKKHPVHLLVPHGIFQIKNAPALNHNDILT 
WLDGCKEGKIEGIVWHCADGNLIKLHRHHLGLSWPIADPHLISQPVVVNFSGIKYDYNFE 
PNTLFDYFSKLDGQRFNSLRNIASDL 
 
>Echis carinatus sochureki (Eastern saw-scaled viper) 
SAIPTEKVDGTCCYITTYKGHPYLWARLDRKPNKQAEKKFKQFMYSAEYSKGFTWNIEED 
FRSVPECWIPAKNIEYYNGKPFPDENGHIPGWVPVEKNSKLYCWHSSAVDYEYELALILK 
HHAEEPDLLEICPVPLIEIIEQTLELIGTNINANPYGLGNKKHPVHLLVLHGTFKIKNAP 
SINRNDILTWLDGCKEGKIEGIVWHCRGGNLIKLHRHHLGLSWPIADPSLTSKPVTVTFC 
RAKYEYNFEPKTLFHYFSNLDGHRFNSLRDIISDL 
 
>Ambystoma tigrinum (Tiger salamander) 
VFAQERESGQPYLWARLDRKPNKQAEKRFKKCVHSKQEKDFVWNVEDDFKPVPDNWIPAK 
EIHQCNGSPLPDEAGHIPGWVPVEKGNKQYCWHSSVINYEAGVALVLRPQAEDTDISEVS 
LVQLCDLLEQTLELIGTNINSNPYGLGSKK 
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>Rana catesbeiana (American bullfrog) 
GGLEDPESLEICLVHLTELLEQTLELVGTNINGNPYGIGNKKNPIHFLVPHGTFLIKNLP 
ALNHNSLISWFNHCQEGKVEGIVWHCKDGSLIKLHRHHLGLSWPLKDTYLNSKPVFIRMN 
LCKYEEASLCLAQFAKIDALRYDSLKDVLLD 
 
>Danio rerio (Zebra fish) 
MRRLGSVQQKIPCVFLTEVRDEPSRKRDCQQFQVVATENVSPAALASDVHCAAATEKVDG 
TCCYVTTFNGEPYLWARLDRKPTKQADKRFKKYQYSQKTCKGFVWNVNEDFREVPEFWMA 
AHRVQHENGHPVPDEHGHIPGWVPVDHTNKQYCWHSSVVNYGTGVALVLKTHGEDEGQLE 
IVSVPLADLMEQTLELIGTNVNGNPYGLGSKKHPVHVLVPHGVLRIRNPPAVEFQQICSW 
FQECQEGRVEGIVWHCDDGMLIKIHRHHLGLKWPVADTFLNTRPVVVHVDESDADPCASE 
KDLFKSFSSVNRQTFSSVRDIQFEP 
 
>Tetraodon nigroviridis (Puffer fish) 
MRRLGSVQQKMQCVFMIEVKEETSRKRDGQQYQVVATETVNPVALEANVDCAIATEKLDG 
TCCYVTTFEGRPHLWARLDRKPNKQAEKRFKKYQHSHRSCKGFTWNMEDDFKTVPEVWIP 
AHGVKQDNGHPLPDEHGHIPGWVPVEKNNKQYCWHSSVVDHNTGKALVLRPSADDADSLE 
IAAVPLGDLLEQTLELIGTNVNGNPYELGCKKQPVHCLVSHGSVGVRNPPPVDFQQLRLW 
FQDSPEGRVEGIVWHCIDGTLVKVHRHHLGLSWPDGHTRLGDRPLLVHVDTALDELSSSE 
DSFARFSKLNGHRFGRLRDVRFDSS 
 
>Ictalurus punctatus (Channel catfish) 
MRRLGSVQQKIPCVFLTEVKEEASRKRDGQNFQVVATDTVNPLAVESDIHRALATEKLDG 
TCCYVTLYRGEPYLWARLDRKPTKQANKKFKKYQYFQKTCIGFTWNVEEDFRTVPESWIP 
ARRVQYESGHPVPDVHGHIPGWVPVDSCNQQYCWHASVVDYDARAALVLRPNGEDEALLE 
IASVPLTELMEQALELIGTNVNGNPYGLGSKKNPLHVLVPHGILRIRNAPAVEYHQLRSW 
FQENDEGRVEGIVWHCNDGVLVKIHRHHLGLKWPDGDAFLNSRPVVVHVDQFPSDPDASA 
DSWKNLFAALAGLTGCRFSSIRDVQLEA 
 
>Esox lucius (Nothern pike) 
MRRLGSVQQKIPCVFLTEVKEEQSRKRESQQFQVVATENVNPIVLESNINSALATEKLDG 
TCCYVSMYKEQPYLWARLDRKPTKQARKRFKRHQCSYRSGKGFAWDVEEDFKTVPETWVP 
ALRVEHQNGQPVPDEHGHIPGFKVYLSNAPNNPAPSCTTKFL 
 
>Oncorhynchus mykiss (Rainbow trout) 
RKSAIMRRFGSVQQKISCVFLTEVKEEQSRKRECQQFQVVATENVNPIALESNIDCALAT 
EKLDGTCCYVSIYKGQSYLWARLDRKPTKQADKRFKKHQYSHKSYKGFTWNVKEDFKTVP 
ESWVPAHRVQHHNGQTCTR 
 
>Gadus morhua (Atlantic cod) 
RLSSVQQKVPCLFLTEVKQEQSRKRLGQPFQVIATEHLNPLALESNVESALATEKLDGTC 
CYVTYYEGQPYLWARLDRKPTKLADKSFKKYQHSHKSSKGFTWKVEEDFRTVPEAWIPAH 
GVQHHEGTPIPDDHGHIPGWVPVQTDNKQYCWHSSTVDYDAGVALVLRPGDQSPDLLELA 
LVPLVDLMEQTLELIGTNVNGNPYGMGAKKQPLHALVSHGSVGVGGPSPPPLDLQGLTSW 
FQESREGLEGIVWHCDDGTLVKVHRHHLGLGWPAGDCSFSSRPVEVRVDWTADHDYRLPT 
KDLFASLSRLDGQRFSRLQDV 
 
>Hippoglossus hippoglossus (Atlantic halibut) 
MGRLGSVQQKIPCVFVTEVKEEQSRKRESQQFQVVATEHMNPVALEADINCALATEKLDG 
TCCYVTLYKGQPYLWARLDRKPNKQAEKQFKKYQHSHRSSKGFTWNVEDDFKMVPETWIP 
AHRVKHHNGYPVPDDLGHIPGWVPVEKDNKQYCWHSSVLDYEVGVALVLRPKADDEDMLE 
IVAVPLADLMEQTLELIGTNVNGNPYGLGSKKQPVHFLVSHG 
 
>Perca flavescens (Yellow perch) 
MRRLGSVQQKIPCVFLTEVKEEQSRKRDCQQFQVVATENVNPVALEANIDCAFATEKLDG 
TCCYVTVYKGQPHLWARLDRKPNKQAEKRFKKYQHSHRSCKGFTWNVECDFKTVPEAWIP 
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AHGVKHHSGRPVPDEHGHIPGWVPVEKDNKQYCWHSSVVDEGVGAVLVLRPSSDDEDLLE 
IAAVPLADLLEQTLELIGTNVNGNPYGLGNKKQPVHCLVSHGSVGIRNPPPVDFQQLCSW 
FQESPEGRVEGIVWHCNDGTLVKVHRH 
 
>Cynoglossus semilaevis (Tongue sole) 
MRRLGSVQHKVPCVFVTEVKEEQSRKRECQQFQVLASDRVNPVALEADVHNAVATEKLDG 
TCCYVTLYKGRPHLWARLDRKPNKQAEKRFKKYQHVHRSCKGFSWNLEEDFKSVPEQWIP 
AHRVKHDNGRPIPDQLGHIPGWVPVDKDNKQYCWHSSVVD 
 
>Dicentrarchus labrax (European seabass) 
MRRLGSVQQKIVCVFVTEVKEEQSRKRDCQVFQVAATENVNPIALEANVDCALATEKLDG 
TCCYVAVYKGQPYLWARLDRKPNKQAEKRFKKYQHSHRTCKGFTWNVEEDFKTVPETWIP 
AHRVKHHNGHPVPDEHGHIPGWVPVEKDNKQYCWHSSVVDYEVRATLVLRPSADNEDGLE 
IAAVPLADLLEQTLELIGTNVNGNPYGLGSKKQPVHCLVSHGSIQISNPPPVDFQRLCSW 
FQESPEGRVEGIV 
 
>Leucoraja erinacea (Little skate) 
MQRLGTVQQKIPCAFATELRDEPSTKRPGQSYRVLATGELSVKALAADIHRAIATEKVDG 
TCCYVAKYKDSPYLWARLDRKPTKQAEKRFRKFQSSKSGSEFTWNFGEDFRKVPEAWIPA 
HGVAQSEGCPAAR 
 
>Squalus acanthias (Spiny dogfish) 
MQRLGSVQQKIPCAFSTQVRDEPASKRANQSFRVLAIGELSPKALEADIHHAVATEKVDG 
TCCYVAMCKDLPYLWARLDRKLTKQAEKRFRKFQSSKTSTEFTWNLDDDFRTVADAWIPA 
HGVVQLKGRLQPDENGHIPGWVPVEKGSKPYCWHASTVNYETGSALVFEPCSEKIF 
 
>Oreochromis niloticus (Nile tilapia) 
MRRLGSVQQKIPCVFLTDVKEEQSRKRDCQQFQVVATENVNPVALEANVHSALATEKLDG 
TCCYVTVHKGQHYLWARLDRRPNKQTEKRFKKYQHSHKSCKGFTWNIEEDFKPVPETWIP 
AHGVKHHNGRPVPDEHGHIPGWVPVERDNKQYCWHSSVVDYNVGLALVLRPRRDNEDMLE 
ITSVPLAELQEQTLELIGTNVNGNPYGLGSKKQPVHCLVTHGSVPIRNPPPVDFQQLCSW 
FHENPDGRVEGIVWHCSDGTLIKVHRHHLGLKWPEVNTCLGNKPAAIRVDAYGSTDLFTS 
FVALNGHCFSRLQDIHFEL 
 
>Saccoglossus kowalevskii (Acorn worm) 
MPGSVQCKVPCVFKTRVIEEKSNKRQYQQYNVVASNELQDSAIEDSIEEATPTEKLDGTC 
VYVHEYKGRPWLWARLDRKPTKQADKHFKRYQAAKRAWMLNGMSGEEPMWNWNADKDFRT 
ARDSWIPAKGVPIINGTAQPDLYGHIPGWLPVESKDRQYCWHSSTFDVNYGIAVVLKSSN 
DGNQYSMEVTIVELSELLEQTLELIGTNINGNPYGLGCKRNPIHVLVPHGVIQFPSSIPI 
SYDELKLWFESSDEGKVEGIVWHCKNQQLYKLHRHHFGLPWPIEDVYFTSRPVAINMDLS 
RYECDFDSTSMFSVLSQFNGQRFEQLRNVPQDTQTGS 
 
>Saccoglossus kowalevskii (Acorn worm) v2 
MFCDETRPSVLYGRQCSARKYTEDFKGLMGRSSPPVVFAVENPAANWDIALTMKWSVDSR 
ILYERYDTRMSFAEAAKKYDALVRPVGGNRVVWRIFNEKLIGKIEFVSHAHLISDSVKWV 
PVDPPPTLDPEYMSWEVGGGGVRTNHILDRMTIDNKFTIQVNRRLMRKFTSEYYDPSSDP 
YSVVALNDIRRSALDDNIEKAIPTEKFDGTCVYVHEYNGRPWLWARFERRPRTKCAAKKY 
DLKPVPDNWIPAKGVQIIDGKPQPGRFGHILGWVPVEKENRQYCWHSSTVDMARGIAMVL 
KPTDQGNQVTIVELSELLEQPLELIGTKINGNPYGLGCKTTPVHFLVPHAGNSSIVKRSF 
RLPLSYPLLKLWFEDFHEGRVEGIVWYCENQQLYKLNR 
 
>Branchiostoma floridae (Florida lancelet) 
MTDRVSVQEKIPCVFRTAVLQRQSSKRHDQSYHVGALNEVTTKALEANVRKAVASEKVDG 
TCVYIQEFRGKPWLWARHDVKPNKQAERRFKKFQSAHQAWEVGDKEGPEPTFTWNVGKDL 
KKPPEHWEPARGVRRIDGQLQPSSSGHVPGWVPVLKDSRSHCWHLASTDLDKGVALLLQR 
RKDDCNKTLEVLTVRLEELLGQTLELVGTNVNANPYGLGSKKRPVHLLVPHGALKFDTPP 
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PFDHEELADWFATPAGQVEGVVWYCDDGQLFKLHRHHLGLTWPVEEPSLTTLPVLITVDI 
GQYEWDFPESSQFYLFGRLKGQQFDSIRVVQWLDDN 
 
>Ciona intestinalis (Sea quirt) 
MAAHNKHCVQSKIDCLFETEVQQLPSNKRLGQNYRVVATKVVAQSAIESGIEHSVATEKL 
DGTCCYIDAYQGKLVLCARLDRKPNKSTEKKFKKFQNEKREWMINGGQGKEPKYEWKYPD 
DMKVVPPCWYPAHGVRREGGMVQPDGNGHVPGWVPISSDARQYCWHQNAIIDDRALVLLR 
NTDGLVVTTLPLSKLAGKTFELIGTNINGNPYGLGSKASPFHILVEHGSFQITNPPRLDY 
DVIKDWLSASGTIEGIVWHCDDGQMFKVHRHHLNLSWPIKKQEDCDVIMPLLCQIPVTID 
IEQSIVTKQTQISKLMKLNRKMFSSLVDILV 
 
>Ciona savignyi (Sea quirt) 
MQKSVTCSVQSKISCIFGTQVIEIPSKKRFGQNYKIVATKQISKQALASDVKFATVTEKI 
DGTCCCVKKYQGQICLWARFDRKPSKSAEKRFKKFQNQHREWINNGKQGEEPRFKWNYPD 
DMKVVPQNWVPADGVERTGVGLVPDANGHIPGWVPISSDPRQYCWHHCVVVAGDSILVLL 
RNNGGLKITTVHMSELEGKTLELIGTHVNGNPYGLGSKQSPFHILVEHGQILVNNPPVID 
YDDIKDWLNDKAPIEGIVWHCEDGNMFKIHRHHLGLEWPCDVTTPLLCQMPVTIEIEDSV 
MIQQSPLINKLFESETVFFKSLKDVLS 
 
>Hydra magnipapillata (Freshwater hydra) 
MYKNHVNGKIKCIFEIDIVQNGKDRQTVVAGEHLTESFSKCLKNHVLRPTIKLDGTSCYV 
AKFNGKSWLYARHDVKPNKMVSRKYKQYQKNYGLKKEGFVWNLETDYNFPKNWIAAHNNP 
FDGSMCSKPIPAENGHLVGWVPVDPSVRTHLWHLSAVDLIGGFFLCLNENAEDESLIAQI 
ALLDDYLGATFELIGTKVNGNPYDIGTSNFPVHFYVQHGELSLKNPPEISKKELSNWFVQ 
QKDGLVEGIVWHGPDGNMFKIHRHHLGLPWPVKNLPFSNRTVYIDCNGYACAENVLLNKI 
VIYSGKTFDKIKNLFNDEPYNFS 
 
>Naegleria gruberi (Amoeboflaggelate) 
MSQQATIDSSSSPANMYFPVQTKISCLFEIEFLEKEKKVLAVNRLYKKVVNLPTNSDDIR 
VNPTIKIDGTCCLVRQEKLFKRYDRKLNASGSKKNKQFQKEISQGTADTNILQFDISKDF 
KEGPKGWIPCDSIAHLFTEENNSNVVSSQHLVGWIPVDSNDAADKWHSSAIVSINNEPHA 
IMLIPYFDQNDEQAKFSVEFRKLSSLENQTLELIGSKINGNVYNFPANEKQHFLVPHGWA 
SYSWKASNAFLENVKELTVEKLKSWFEDESNIMSKSEGIVFHIMYKTEEGKDKEMLIKIH 
RHHLNLDWPLKGSAIPQFQYQLQWIEEVLRLKSENKL 
 
>Crassostrea gigas (Pacific oyster) 
MPLLTSRWKVAMFTIKSETFRVRFPTKWQANSIALKIMSYATLSNLCCLLVLVAILNIDR 
SEATLGGATCNIPTGSPGASTLCTSNKNGFCAVDTLDIDKKTVAGICICYPGFTGDKCQT 
ADPATAPGGTTGTTSSSKGTGNAVGALALGGLAALALSQLGGGGLGGGQFQGYKVVASDV 
LKNTALLSDVTRSIATEKLDGTCVFIAEFKGRPWLWARLDRKPNKAGDKRFKQYRSSLQK 
WEQSSQDLPKPSLEWDIEKDFKQVPEHWIPASDVPIVNGHPQPDQNGHTPGMLGGEGSMH 
SCKEKFEVEKSLIVLLM 
 
>Hahella chejuensis (-proteobacteria) 
MKKIKTLFVIDRHSHLATEQAVPESAWVLQGMGLATEKFDGSACLFRAGRLWKRYDRKLR 
KPFAAKLRAGRLATLEHAMFKSAPDGFTPCEAEPDAITGHWPGWLPVSKASPEDRWHCEA 
LEQAADTLIEGQTYELVGPKVQGNRYQLQRHALWAHGGKILTPPERLDFHSLRDWMAAQS 
MEGVVWHAPDGRMAKLRRKDFGFSW 
 
  
  365 
Appendices  365 
For n = 4, lower and upper tail at  = 0.025 is 10, 26. This supports the H1
hypothesis, that the gene expression of C12orf29 is greater in response to
theosteogenic induction medium than control medium.
Wilcoxon signed rank test of RT‐qPCR results 
 
Sample  
value Rank
Control 
rank 
score
Osteo 
rank 
score
580 MOB osteo 1 wk 95 1 1
580 MOB cont 1 wk 102 2 2
580 MOB osteo 6 hr 103 3 3
580 MOB cont 3 wk 110 4 4
580 MOB cont 72 hr 111 5 5
580 MOB cont 6 hr 127 6 6
580 MOB osteo 72 hr 226 7 7
580 MOB osteo 3 wk 250 8 8
17 19
Sample  
value Rank
Control 
rank 
score
Osteo 
rank 
score
580 TOB osteo 6 hr 75 1 1
580 TOB cont 1 wk 82 2 2
580 TOB cont 72 hr 88 3 3
580 TOB cont 6 hr 100 4 4
580 TOB osteo 72 hr 102 5 5
580 TOB cont 3 wk 106 6 6
580 TOB osteo 3 wk 120 7 7
580 TOB osteo 1 wk 155 8 8
15 21
Sample  
value Rank
Control 
rank 
score
Osteo 
rank 
score
559 MSC osteo 6 hr 104 1 1
559 MSC cont 6 hr 119 2 2
559 MSC cont 1 wk 139 3 3
559 MSC osteo 72 hr 143 4 4
559 MSC cont 72 hr 161 5 5
559 MSC cont 3 wk 171 6 6
559 MSC osteo 1 wk 207 7 7
559 MSC osteo 3 wk 329 8 8
16 20
Appendix E – Statistical analysis 
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Appendix F – Transcript from the Science 
Show on ABC Radio National 
Broadcast Saturday 02 June 2012 
Robyn Williams: Our PhD this week is another example of chasing an idea that seems to 
have no application...yet. A gene that's been around forever, but what is it for? Here's Thor 
Friis from the Queensland University of Technology. 
Thor Friis: Thank you, Robyn, for having me on the program. In the first stage of my PhD I 
constructed a cDNA library from cells derived from sheep bones. This is a bit like casting a 
net over a population of genes that are active in a particular cell or tissue type and gives us 
a snapshot of the molecular activities taking place. The library yielded a number of interest‐
ing genes. Today I'm going to talk about a particular gene that gives rise to a protein of un‐
known function with a molecular weight of 37 kDa. I shall refer to it here as PUF37. 
As a molecular biologist, exploring the role of a gene of unknown function is the equivalent 
of discovering a brand‐new species in the wild, which is very exciting indeed. Nature does‐
n't really give away her secrets, so how does one go about unravelling the role of a gene? 
The first step I performed was searching through biological databases to identify those spe‐
cies that carried the gene and those species that do not, to see what this might tell us about 
a possible biological role. This analysis revealed that my gene of interest was present in 
every species that has a notochord at some stage during their development. These included 
all the vertebrates, including humans, as well as three invertebrate species. 
A notochord is a primitive backbone‐like structure which organises the dorsal body plan of 
all species within the Chordate superphylum. The fact that all species with a notochord 
carry the PUF37 gene suggests it had a specific role in the Chordate body plan which is pos‐
sibly, but not exclusively, linked to the notochord. 
My gene of interest also turns out to have an ancient pedigree. I identified a PUF37 homo‐
logue in a single‐celled organism. This finding suggests that the gene has been around since 
the emergence of the earliest metazoan organisms more than 1 billion years ago. But its 
history goes back much further than that. It appears that the template for the metazoan 
PUF37 can be found in certain bacterial species, which means it had its origin in the Pro‐
karyote kingdom 2.2 billion years ago. Such high degree of conservation suggests a very 
important biological function. 
The next step in the investigation was to determine the cells and tissues in which the gene 
could be found. We found that it had a specific expression profile in the extracellular matrix 
of joint cartilage. Cartilage is an avascular tissue, meaning it has no blood supply, so the 
protein is therefore most likely secreted from cells embedded within the cartilage, or from 
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cells within the underlying subchondral bone. Its presence within the extracellular matrix 
suggests it has a structural role. PUF37 may therefore have an important role in cartilage as 
well as in notochord. 
Exploring the biological role of this gene will contribute to our understanding of evolution‐
ary biology, in particular the relationship between cartilage and the notochord. For exam‐
ple, is notochord a cartilaginous tissue, as some scientists would suggest? Or did cartilage in 
fact appropriate certain molecules from the notochord, an issue which underpins questions 
such as how vertebrates developed in the first place. I'm hoping to continue my post doc 
exploring these questions. 
Robyn Williams: Before you go Thor… 
Thor Friis: Yes? 
Robyn Williams: Your name is unusual for an Australian. Where does it come from? 
Thor Friis: Well, my folks are Norwegians, so I'm first‐generation, but I grew up in Norway, 
so hence the slight Norwegian accent. 
Robyn Williams: Thor Friis at Queensland University of Technology. And who knows what 
that gene may lead to. 
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